GO biological process complete,allexp_forGO.txt - REFLIST (12841),plastic_ref_forGO.txt (7679),plastic_ref_forGO.txt (expected),plastic_ref_forGO.txt (over/under),plastic_ref_forGO.txt (fold Enrichment),plastic_ref_forGO.txt (raw P-value),plastic_ref_forGO.txt (FDR),plastic8_ref_forGO.txt (4605),plastic8_ref_forGO.txt (expected),plastic8_ref_forGO.txt (over/under),plastic8_ref_forGO.txt (fold Enrichment),plastic8_ref_forGO.txt (raw P-value),plastic8_ref_forGO.txt (FDR),plastic32_ref_forGO.txt (7279),plastic32_ref_forGO.txt (expected),plastic32_ref_forGO.txt (over/under),plastic32_ref_forGO.txt (fold Enrichment),plastic32_ref_forGO.txt (raw P-value),plastic32_ref_forGO.txt (FDR),different_dir_832_genes_ref_forGO.txt (129),different_dir_832_genes_ref_forGO.txt (expected),different_dir_832_genes_ref_forGO.txt (over/under),different_dir_832_genes_ref_forGO.txt (fold Enrichment),different_dir_832_genes_ref_forGO.txt (raw P-value),different_dir_832_genes_ref_forGO.txt (FDR)
establishment of meiotic sister chromatid cohesion (GO:0034089),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of mitotic sister chromatid cohesion (GO:0034087),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of sister chromatid cohesion (GO:0034085),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
multivesicular body assembly (GO:0036258),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
multivesicular body organization (GO:0036257),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
establishment or maintenance of cytoskeleton polarity (GO:0030952),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
xenobiotic transport (GO:0042908),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
benzoate metabolic process (GO:0018874),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of plant-type hypersensitive response (GO:0034052),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
Golgi to endosome transport (GO:0006895),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-serine acetylation (GO:0030920),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
purine ribonucleoside bisphosphate metabolic process (GO:0034035),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
chloroplast mRNA modification (GO:1900871),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mitochondrial pyruvate transmembrane transport (GO:0006850),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pyruvate transport (GO:0006848),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of inflorescence meristem growth (GO:0010081),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of floral meristem growth (GO:0010080),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein binding (GO:0043393),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of DNA binding (GO:0043388),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cobalt ion transport (GO:0006824),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protoderm histogenesis (GO:0010068),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
embryonic shoot morphogenesis (GO:0010064),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of trichoblast fate specification (GO:0010063),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone glutamine methylation (GO:1990258),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
atrichoblast differentiation (GO:0010055),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nitric oxide biosynthetic process (GO:0006809),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
response to mycotoxin (GO:0010046),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
shikimate biosynthetic process (GO:0033587),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to manganese ion (GO:0010042),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein glycosylation in endoplasmic reticulum (GO:0033577),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
meiotic chromosome condensation (GO:0010032),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
xanthophyll cycle (GO:0010028),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
immune response-activating cell surface receptor signaling pathway (GO:0002429),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
phytochromobilin biosynthetic process (GO:0010024),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to dsRNA (GO:0043331),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to exogenous dsRNA (GO:0043330),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lipid droplet disassembly (GO:1905691),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
raffinose metabolic process (GO:0033530),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
UDP-N-acetylgalactosamine metabolic process (GO:0019276),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
S-methylmethionine cycle (GO:0033528),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of sulfur amino acid metabolic process (GO:0031337),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
respiratory chain complex III assembly (GO:0017062),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to pheromone (GO:0019236),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of DNA methylation (GO:1905642),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of mitochondrial mRNA catabolic process (GO:1905639),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of mitochondrial mRNA catabolic process (GO:1905637),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-arabinose transmembrane transport (GO:0042882),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyridoxal 5'-phosphate salvage (GO:0009443),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cyanate catabolic process (GO:0009440),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
Rho protein signal transduction (GO:0007266),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
Ras protein signal transduction (GO:0007265),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
germ-line stem-cell niche homeostasis (GO:0060250),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cyclic purine nucleotide metabolic process (GO:0052652),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of steroid metabolic process (GO:0019218),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cyanate metabolic process (GO:0009439),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of developmental vegetative growth (GO:1905615),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of developmental vegetative growth (GO:1905613),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
fluoride transmembrane transport (GO:1903424),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-alanine catabolic process (GO:0042853),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
L-alanine metabolic process (GO:0042851),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to flooding (GO:0009413),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
D-xylose catabolic process (GO:0042843),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein-heme linkage (GO:0017003),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pathogenesis (GO:0009405),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
defense response to protozoan (GO:0042832),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
endoplasmic reticulum tubular network organization (GO:0071786),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
pyridoxal biosynthetic process (GO:0042821),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
vitamin B6 catabolic process (GO:0042820),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
endoplasmic reticulum cisternal network assembly (GO:0071784),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
endoplasmic reticulum cisternal network organization (GO:0071783),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
activation of phospholipase C activity (GO:0007202),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cortical actin cytoskeleton organization (GO:0030866),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyridoxal metabolic process (GO:0042817),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
monopolar cell growth (GO:0042814),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein arginylation (GO:0016598),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone dephosphorylation (GO:0016576),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA strand elongation involved in mitotic DNA replication (GO:1902983),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of sulfur utilization (GO:0006792),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitotic DNA replication termination (GO:1902979),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transcriptional activation by promoter-enhancer looping (GO:0071733),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
heme oxidation (GO:0006788),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of protein localization to plasma membrane (GO:0061951),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
protoporphyrinogen IX biosynthetic process (GO:0006782),10,10,5.98,+,1.67,0.255,1,9,3.59,+,2.51,0.0631,1,9,5.67,+,1.59,0.343,1,0,0.1,-, < 0.01,1,1
uroporphyrinogen III biosynthetic process (GO:0006780),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of nucleotide biosynthetic process (GO:0030808),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
thiamine metabolic process (GO:0006772),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
membrane assembly (GO:0071709),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of alcohol biosynthetic process (GO:1902931),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
NADP catabolic process (GO:0006742),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
apocarotenoid catabolic process (GO:0043290),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
histone H2A phosphorylation (GO:1990164),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tetrahydrobiopterin biosynthetic process (GO:0006729),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,1,0.03,+,33.18,0.0392,1
inactivation of MAPK activity (GO:0000188),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
rDNA heterochromatin assembly (GO:0000183),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to alkaloid (GO:0043279),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tricarboxylic acid transmembrane transport (GO:0035674),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
MAPK cascade (GO:0000165),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
UDP-rhamnose metabolic process (GO:0033478),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
S-methylmethionine metabolic process (GO:0033477),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
indoleacetic acid conjugate metabolic process (GO:0033473),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
membrane protein intracellular domain proteolysis (GO:0031293),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of cyclase activity (GO:0031279),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
establishment of mitotic spindle orientation (GO:0000132),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to leucine (GO:0043201),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
FMN biosynthetic process (GO:0009398),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of lipase activity (GO:0060193),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of lipase activity (GO:0060191),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
receptor recycling (GO:0001881),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
UDP-D-galactose metabolic process (GO:0052573),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tRNA transcription by RNA polymerase III (GO:0042797),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chromatin-mediated maintenance of transcription (GO:0048096),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
plastid rRNA transcription (GO:0042794),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
signal complex assembly (GO:0007172),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
enzyme linked receptor protein signaling pathway (GO:0007167),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of tissue polarity (GO:0007164),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
primary amino compound metabolic process (GO:1901160),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of endopeptidase activity (GO:0052548),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of peptidase activity (GO:0052547),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
defense response by callose deposition in cell wall (GO:0052544),10,10,5.98,+,1.67,0.255,1,7,3.59,+,1.95,0.174,1,10,5.67,+,1.76,0.244,1,0,0.1,-, < 0.01,1,1
negative regulation of cell wall organization or biogenesis (GO:1903339),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein folding (GO:1903332),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein-DNA complex disassembly (GO:0032986),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization to microtubule organizing center (GO:1905508),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of circadian rhythm (GO:0042754),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of inositol trisphosphate biosynthetic process (GO:0032960),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
D-xylose metabolic process (GO:0042732),6,6,3.59,+,1.67,0.383,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
regulation of division septum assembly (GO:0032955),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cytokinetic process (GO:0032954),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
thiamine-containing compound biosynthetic process (GO:0042724),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
thiamine-containing compound metabolic process (GO:0042723),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
SREBP signaling pathway (GO:0032933),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
farnesol metabolic process (GO:0016487),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cell migration (GO:0016477),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prostaglandin metabolic process (GO:0006693),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prostanoid metabolic process (GO:0006692),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycosphingolipid biosynthetic process (GO:0006688),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glucosylceramide biosynthetic process (GO:0006679),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phytosphingosine metabolic process (GO:0006671),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
3-keto-sphinganine metabolic process (GO:0006666),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycerol ether metabolic process (GO:0006662),6,6,3.59,+,1.67,0.383,1,5,2.15,+,2.32,0.173,1,6,3.4,+,1.76,0.372,1,1,0.06,+,16.59,0.0676,1
phosphatidylserine biosynthetic process (GO:0006659),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phosphatidylserine metabolic process (GO:0006658),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phosphatidylcholine biosynthetic process (GO:0006656),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
triglyceride mobilization (GO:0006642),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
fruit replum development (GO:1990058),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitotic prophase (GO:0000088),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic M phase (GO:0000087),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic G2 phase (GO:0000085),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic S phase (GO:0000084),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ER to chloroplast lipid transport (GO:1990052),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
mitotic G1 phase (GO:0000080),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of chromatin binding (GO:0035563),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of chromatin binding (GO:0035561),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
geranylgeranyl diphosphate biosynthetic process (GO:0033386),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
geranylgeranyl diphosphate metabolic process (GO:0033385),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
geranyl diphosphate biosynthetic process (GO:0033384),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
geranyl diphosphate metabolic process (GO:0033383),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
farnesyl diphosphate biosynthetic process (GO:0045337),5,5,2.99,+,1.67,0.516,1,4,1.79,+,2.23,0.256,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of defense response to virus by host (GO:0002230),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cytoplasm protein quality control (GO:0140455),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
innate immune response activating cell surface receptor signaling pathway (GO:0002220),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
chlorophyll cycle (GO:0033354),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
S-adenosylmethionine cycle (GO:0033353),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
defense response to insect (GO:0002213),10,10,5.98,+,1.67,0.255,1,5,3.59,+,1.39,0.561,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
guanosine tetraphosphate biosynthetic process (GO:0015970),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maltose biosynthetic process (GO:0000024),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
guanosine tetraphosphate metabolic process (GO:0015969),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
diadenosine tetraphosphate biosynthetic process (GO:0015966),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
trichome papilla formation (GO:1905499),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
diadenosine polyphosphate biosynthetic process (GO:0015960),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
oxidative RNA demethylation (GO:0035513),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
PAMP-triggered immunity signalling pathway (GO:0140426),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
viral genome replication (GO:0019079),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
pyrimidine nucleobase salvage (GO:0043100),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
UDP-D-xylose biosynthetic process (GO:0033320),4,4,2.39,+,1.67,0.483,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
formate metabolic process (GO:0015942),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pantothenate biosynthetic process (GO:0015940),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
UDP-D-xylose metabolic process (GO:0033319),4,4,2.39,+,1.67,0.483,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
meiotic spindle assembly checkpoint (GO:0033316),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pantothenate metabolic process (GO:0015939),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
viral life cycle (GO:0019058),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
inductive cell-cell signaling (GO:0031129),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
developmental induction (GO:0031128),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
centriole replication (GO:0007099),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
centrosome cycle (GO:0007098),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
defense response by cell wall thickening (GO:0052482),10,10,5.98,+,1.67,0.255,1,7,3.59,+,1.95,0.174,1,10,5.67,+,1.76,0.244,1,0,0.1,-, < 0.01,1,1
membrane bending (GO:0097753),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of microtubule polymerization (GO:0031115),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
10-formyltetrahydrofolate biosynthetic process (GO:0009257),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
10-formyltetrahydrofolate metabolic process (GO:0009256),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of histone H3-K4 trimethylation (GO:1905435),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
exon-exon junction complex disassembly (GO:1903259),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glucosamine-containing compound biosynthetic process (GO:1901073),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glucosamine-containing compound catabolic process (GO:1901072),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
menaquinone biosynthetic process (GO:0009234),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
menaquinone metabolic process (GO:0009233),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of organic acid transport (GO:0032890),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
thiamine diphosphate biosynthetic process (GO:0009229),5,5,2.99,+,1.67,0.516,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
thiamine biosynthetic process (GO:0009228),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
positive regulation of cell fate specification (GO:0042660),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
root regeneration (GO:0062211),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
shoot regeneration (GO:0062210),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of mitotic cohesin loading (GO:1905406),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of mitotic cohesin loading (GO:1905405),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of endodermal cell differentiation (GO:1903224),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein catabolic process in the vacuole (GO:0007039),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
morphogenesis of a polarized epithelium (GO:0001738),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
establishment of planar polarity (GO:0001736),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
meiotic telomere tethering at nuclear periphery (GO:0044821),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cyanidin 3-O-glucoside metabolic process (GO:1901038),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of microtubule depolymerization (GO:0007026),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
microtubule depolymerization (GO:0007019),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
zinc ion import across plasma membrane (GO:0071578),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of vitamin E biosynthetic process (GO:1904966),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of vitamin E biosynthetic process (GO:1904965),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of phytol biosynthetic process (GO:1904964),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of phytol biosynthetic process (GO:1904963),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
plastid to vacuole vesicle-mediated transport (GO:1904962),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
quiescent center organization (GO:1904961),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ornithine catabolic process (GO:0006593),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of establishment of protein localization (GO:1904950),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ethanolamine metabolic process (GO:0006580),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phospholipid homeostasis (GO:0055091),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
isoprenoid biosynthetic process via mevalonate (GO:1902767),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
acylglycerol homeostasis (GO:0055090),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tyrosine biosynthetic process (GO:0006571),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
fatty acid homeostasis (GO:0055089),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of imprinting at mating-type locus (GO:0071516),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
genetic imprinting at mating-type locus (GO:0071515),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
proline catabolic process (GO:0006562),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of amino acid transport (GO:0051955),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of amine transport (GO:0051952),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to sterol depletion (GO:0071501),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
methylglyoxal catabolic process to lactate (GO:0061727),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
lysine catabolic process (GO:0006554),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cobalt ion homeostasis (GO:0055068),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glutamine biosynthetic process (GO:0006542),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of calcium ion transport (GO:0051928),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of calcium ion transport (GO:0051924),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
asparagine biosynthetic process (GO:0006529),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
asparagine metabolic process (GO:0006528),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
arginine catabolic process (GO:0006527),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
alanine catabolic process (GO:0006524),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
alanine metabolic process (GO:0006522),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
mitochondrial tRNA processing (GO:0090646),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein deglycosylation (GO:0006517),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
glycoprotein catabolic process (GO:0006516),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
tRNA wobble position uridine thiolation (GO:0002143),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
wobble position uridine ribose methylation (GO:0002132),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
wobble position cytosine ribose methylation (GO:0002131),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
wobble position ribose methylation (GO:0002130),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nickel cation transmembrane transport (GO:0035444),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tRNA nucleoside ribose methylation (GO:0002128),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pantothenate transmembrane transport (GO:0015887),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
sieve element differentiation (GO:0090603),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
L-ascorbic acid transmembrane transport (GO:0015882),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
coenzyme A transport (GO:0015880),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
plastid DNA replication (GO:0033259),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
plastid DNA metabolic process (GO:0033258),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
choline transport (GO:0015871),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyrimidine nucleoside transport (GO:0015864),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pre-miRNA processing (GO:0031054),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
Golgi to plasma membrane protein transport (GO:0043001),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cyclic nucleotide biosynthetic process (GO:0009190),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
polyamine transport (GO:0015846),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cyclic nucleotide metabolic process (GO:0009187),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
deoxyribonucleoside diphosphate metabolic process (GO:0009186),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
iron import into cell (GO:0033212),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity (GO:2001215),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
microtubule organizing center organization (GO:0031023),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
tryptophan transport (GO:0015827),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
meiotic spindle checkpoint (GO:0044779),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ketone body biosynthetic process (GO:0046951),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
cellular ketone body metabolic process (GO:0046950),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
gamma-aminobutyric acid transport (GO:0015812),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
aspartate transmembrane transport (GO:0015810),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
purine deoxyribonucleotide catabolic process (GO:0009155),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to caffeine (GO:0031000),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
S-adenosyl-L-methionine transport (GO:0015805),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
aromatic amino acid transport (GO:0015801),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
purine nucleoside triphosphate catabolic process (GO:0009146),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
phytochelatin biosynthetic process (GO:0046938),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
phytochelatin metabolic process (GO:0046937),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein folding in endoplasmic reticulum (GO:0034975),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
box H/ACA snoRNA processing (GO:0034964),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
box C/D snoRNA processing (GO:0034963),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of cohesin loading (GO:1905309),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of autophagosome assembly (GO:2000785),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
superoxide anion generation (GO:0042554),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
vitamin catabolic process (GO:0009111),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
photosystem II stabilization (GO:0042549),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
cell wall modification involved in multidimensional cell growth (GO:0042547),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
protein N-linked glycosylation via arginine (GO:0042543),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
lipoate biosynthetic process (GO:0009107),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
camalexin metabolic process (GO:0052317),6,6,3.59,+,1.67,0.383,1,6,2.15,+,2.79,0.0942,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
positive regulation of cytoplasmic translation (GO:2000767),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
hypotonic salinity response (GO:0042539),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of cytoplasmic translation (GO:2000765),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to UV-A (GO:0071492),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to high light intensity (GO:0071486),5,5,2.99,+,1.67,0.516,1,5,1.79,+,2.79,0.142,1,3,2.83,+,1.06,1,1,1,0.05,+,19.91,0.0582,1
cellular hyperosmotic salinity response (GO:0071475),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cellular hyperosmotic response (GO:0071474),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cellular response to ozone (GO:0071457),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to anoxia (GO:0071454),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of cell wall macromolecule metabolic process (GO:0010981),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
N-terminal protein myristoylation (GO:0006499),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
N-terminal protein lipidation (GO:0006498),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cell wall repair (GO:0071433),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of heterochromatin assembly by small RNA (GO:0010964),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
magnesium ion homeostasis (GO:0010960),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity (GO:1900490),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
C-terminal protein methylation (GO:0006481),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
malate transmembrane transport (GO:0071423),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
succinate transmembrane transport (GO:0071422),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of endopeptidase activity (GO:0010951),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of protein complex stability (GO:0061635),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of auxin mediated signaling pathway (GO:0010930),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of phosphatase activity (GO:0010923),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dsDNA loop formation (GO:0090579),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein depalmitoylation (GO:0002084),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of inositol phosphate biosynthetic process (GO:0010919),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of oxidative phosphorylation (GO:0002082),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
7-methylguanosine metabolic process (GO:0008618),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
apical protein localization (GO:0045176),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
ether lipid biosynthetic process (GO:0008611),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tyrosyl-tRNA aminoacylation (GO:0006437),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tryptophanyl-tRNA aminoacylation (GO:0006436),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
seryl-tRNA aminoacylation (GO:0006434),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
methionyl-tRNA aminoacylation (GO:0006431),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
lysyl-tRNA aminoacylation (GO:0006430),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
glycyl-tRNA aminoacylation (GO:0006426),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
aspartyl-tRNA aminoacylation (GO:0006422),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
acquisition of nutrients from other organism during symbiotic interaction (GO:0051816),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
arginyl-tRNA aminoacylation (GO:0006420),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
error-free translesion synthesis (GO:0070987),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-asparagine metabolic process (GO:0070982),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
L-asparagine biosynthetic process (GO:0070981),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
meiotic telomere clustering (GO:0045141),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cellular response to oxidative stress (GO:1900409),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cellular response to oxidative stress (GO:1900407),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
coenzyme A transmembrane transport (GO:0035349),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
UDP-N-acetylgalactosamine transmembrane transport (GO:0015789),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of histone H2B ubiquitination (GO:2001166),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
GDP-fucose transmembrane transport (GO:0015783),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
peptidyl-tyrosine dephosphorylation (GO:0035335),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
xylulose metabolic process (GO:0005997),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
morphogenesis of an epithelium (GO:0002009),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
trehalose catabolic process (GO:0005993),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lactose catabolic process (GO:0005990),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
N-methylnicotinate transport (GO:2001143),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nicotinate transport (GO:2001142),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lactose metabolic process (GO:0005988),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycogen catabolic process (GO:0005980),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
arabinose transmembrane transport (GO:0015751),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein dephosphorylation (GO:0035308),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pentose transmembrane transport (GO:0015750),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of dephosphorylation (GO:0035305),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
succinate transport (GO:0015744),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
alpha-ketoglutarate transport (GO:0015742),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
methionine catabolic process (GO:0009087),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyruvate family amino acid catabolic process (GO:0009080),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
quinolinate metabolic process (GO:0046874),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial tRNA modification (GO:0070900),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of sinapate ester biosynthetic process (GO:1903086),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of sinapate ester biosynthetic process (GO:1903085),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyruvate family amino acid metabolic process (GO:0009078),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
oxaloacetate transport (GO:0015729),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
allantoin transport (GO:0015720),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
photosynthetic state transition (GO:0062055),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
anaerobic respiration (GO:0009061),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",5,5,2.99,+,1.67,0.516,1,5,1.79,+,2.79,0.142,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
thiosulfate transport (GO:0015709),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-pipecolic acid biosynthetic process (GO:0062034),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to protozoan (GO:0001562),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of seed maturation (GO:2000693),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ethanolamine-containing compound metabolic process (GO:0042439),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
prostaglandin biosynthetic process (GO:0001516),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
choline biosynthetic process (GO:0042425),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
intracellular transport of virus (GO:0075733),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein myristoylation (GO:0018377),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to exogenous dsRNA (GO:0071360),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of steroid biosynthetic process (GO:0010894),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to dsRNA (GO:0071359),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-glutamine methylation (GO:0018364),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
medium-chain fatty acid biosynthetic process (GO:0051792),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
medium-chain fatty acid metabolic process (GO:0051791),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cellular response to cytokine stimulus (GO:0071345),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitochondrial transcription (GO:0006390),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein farnesylation (GO:0018343),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of phospholipase C activity (GO:0010863),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
termination of RNA polymerase III transcription (GO:0006386),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of redox state (GO:0051776),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to trehalose stimulus (GO:0071327),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to mannitol stimulus (GO:0071325),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
7-methylguanosine mRNA capping (GO:0006370),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
actin crosslink formation (GO:0051764),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
S-glycoside catabolic process (GO:0016145),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of reciprocal meiotic recombination (GO:0010845),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
S-glycoside biosynthetic process (GO:0016144),8,8,4.78,+,1.67,0.311,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
negative regulation of secondary metabolite biosynthetic process (GO:1900377),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of purine nucleotide biosynthetic process (GO:1900371),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
termination of RNA polymerase I transcription (GO:0006363),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptide cross-linking via L-cystine (GO:0018316),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycoside catabolic process (GO:0016139),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycoside metabolic process (GO:0016137),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of defense response to insect (GO:1900367),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
negative regulation of defense response to insect (GO:1900366),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of mRNA polyadenylation (GO:1900364),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
purine nucleotide-sugar transmembrane transport (GO:0090480),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
xanthophyll catabolic process (GO:0016124),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
shoot organ boundary specification (GO:0090470),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
carotenoid catabolic process (GO:0016118),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tetraterpenoid catabolic process (GO:0016110),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cyclic threonylcarbamoyladenosine biosynthetic process (GO:0061504),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nucleosome disassembly (GO:0006337),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA replication-dependent nucleosome assembly (GO:0006335),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
sesquiterpenoid catabolic process (GO:0016107),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
mitochondrial tRNA wobble uridine modification (GO:0070899),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
RNA polymerase III preinitiation complex assembly (GO:0070898),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
phloem glucosinolate loading (GO:0090449),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
miRNA mediated inhibition of translation (GO:0035278),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein import into mitochondrial intermembrane space (GO:0045041),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
multicellular organism growth (GO:0035264),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein import into chloroplast thylakoid membrane (GO:0045038),6,6,3.59,+,1.67,0.383,1,5,2.15,+,2.32,0.173,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
molybdate ion export from vacuole (GO:0090414),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
malonate catabolic process (GO:0090410),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
molybdate ion transport (GO:0015689),5,5,2.99,+,1.67,0.516,1,1,1.79,-,0.56,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
phloem nitrate loading (GO:0090408),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
stress-induced premature senescence (GO:0090400),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nickel cation transport (GO:0015675),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
oxygen transport (GO:0015671),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
gas transport (GO:0015669),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of cellular response to drug (GO:2001040),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of cellular response to drug (GO:2001038),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
positive regulation of urease activity (GO:1905182),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of urease activity (GO:1905181),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
viral replication complex formation and maintenance (GO:0046786),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of response to drug (GO:2001025),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of response to drug (GO:2001023),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
positive regulation of plant-type cell wall cellulose biosynthetic process (GO:2001011),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
endosome to plasma membrane protein transport (GO:0099638),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cytoplasmic streaming (GO:0099636),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of plant-type cell wall cellulose biosynthetic process (GO:2001009),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
positive regulation of cellulose biosynthetic process (GO:2001008),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cellulose biosynthetic process (GO:2001007),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
exit from dormancy (GO:0097438),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
negative regulation of meiotic chromosome separation (GO:1905133),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of meiotic chromosome separation (GO:1905132),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phylloquinone metabolic process (GO:0042374),8,8,4.78,+,1.67,0.311,1,7,2.87,+,2.44,0.0834,1,8,4.53,+,1.76,0.299,1,0,0.08,-, < 0.01,1,1
vitamin K metabolic process (GO:0042373),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phylloquinone biosynthetic process (GO:0042372),8,8,4.78,+,1.67,0.311,1,7,2.87,+,2.44,0.0834,1,8,4.53,+,1.76,0.299,1,0,0.08,-, < 0.01,1,1
vitamin K biosynthetic process (GO:0042371),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
water-soluble vitamin catabolic process (GO:0042365),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ion transmembrane transport (GO:0034766),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of transmembrane transport (GO:0034763),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
thiamine diphosphate metabolic process (GO:0042357),5,5,2.99,+,1.67,0.516,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)",4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
"regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)",4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
CDP biosynthetic process (GO:0046705),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
CDP metabolic process (GO:0046704),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of microtubule motor activity (GO:2000576),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of microtubule motor activity (GO:2000574),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
indole glucosinolate catabolic process (GO:0042344),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
indole glucosinolate metabolic process (GO:0042343),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cellular response to manganese ion (GO:0071287),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to magnesium ion (GO:0071286),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to lead ion (GO:0071284),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein-FAD linkage (GO:0018293),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA replication-dependent nucleosome organization (GO:0034723),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to iron ion (GO:0071281),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to copper ion (GO:0071280),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
histone H3-K4 demethylation (GO:0034720),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
plastid translation (GO:0032544),13,13,7.77,+,1.67,0.224,1,11,4.66,+,2.36,0.0375,1,13,7.37,+,1.76,0.155,1,0,0.13,-, < 0.01,1,1
positive regulation of protein geranylgeranylation (GO:2000541),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to cadmium ion (GO:0071276),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein geranylgeranylation (GO:2000539),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of protein import into nucleus (GO:0042306),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of translational initiation in response to starvation (GO:0071264),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of translational initiation in response to starvation (GO:0071262),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
polyprenol catabolic process (GO:0016095),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
polyprenol biosynthetic process (GO:0016094),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cellular response to gravity (GO:0071258),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cytokinetic process (GO:0032506),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
prenylcysteine metabolic process (GO:0030329),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prenylcysteine catabolic process (GO:0030328),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prenylated protein catabolic process (GO:0030327),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glucose transmembrane transport (GO:1904659),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,1,0.03,+,33.18,0.0392,1
"positive regulation of defense response to bacterium, incompatible interaction (GO:1902479)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to molecule of fungal origin (GO:0071226),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA replication termination (GO:0006274),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of stem cell population maintenance (GO:1902459),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of stomatal opening (GO:1902458),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
detection of temperature stimulus (GO:0016048),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein targeting to vacuole involved in autophagy (GO:0071211),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of phospholipase C activity (GO:1900274),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular senescence (GO:0090398),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"DNA replication, synthesis of RNA primer (GO:0006269)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
xylan acetylation (GO:1990937),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of mitochondrial RNA catabolic process (GO:0000962),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of mitochondrial RNA catabolic process (GO:0000960),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
spindle localization (GO:0051653),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization to mitotic spindle pole body (GO:1902440),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-glycine modification (GO:0018201),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-glutamic acid modification (GO:0018200),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of ornithine metabolic process (GO:0090368),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dTTP biosynthetic process (GO:0006235),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dTDP biosynthetic process (GO:0006233),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dTMP biosynthetic process (GO:0006231),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
(+)-abscisic acid D-glucopyranosyl ester transmembrane transport (GO:1902418),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic cytokinetic process (GO:1902410),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of abscisic acid biosynthetic process (GO:0090359),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of auxin metabolic process (GO:0090356),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dUDP biosynthetic process (GO:0006227),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
uracil salvage (GO:0006223),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
assembly of actomyosin apparatus involved in mitotic cytokinesis (GO:1902407),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
uridine catabolic process (GO:0006218),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phragmoplast assembly (GO:0000914),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
thymine catabolic process (GO:0006210),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
exocyst localization (GO:0051601),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
dGTP catabolic process (GO:0006203),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
homogentisate metabolic process (GO:1901999),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
negative regulation of meiotic cell cycle phase transition (GO:1901994),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of meiotic cell cycle phase transition (GO:1901993),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lipid droplet formation (GO:0140042),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
endoplasmic reticulum to chloroplast transport (GO:1901965),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cellular lipid biosynthetic process (GO:0097384),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
stem cell fate determination (GO:0048867),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
stem cell fate commitment (GO:0048865),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
stem cell differentiation (GO:0048863),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
formation by symbiont of syncytium involving giant cell for nutrient acquisition from host (GO:0052096),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
formation of specialized structure for nutrient acquisition from other organism involved in symbiotic interaction (GO:0052095),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
formation of specialized structure for nutrient acquisition from host (GO:0052093),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
auxin influx (GO:0060919),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
release of seed from dormancy (GO:0048838),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
specification of petal number (GO:0048834),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
folic acid biosynthetic process (GO:0046656),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of antifungal innate immune response (GO:1905036),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detection of peptidoglycan (GO:0032499),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to peptidoglycan (GO:0032494),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
sideretin biosynthesis (GO:0106146),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detection of molecule of fungal origin (GO:0032491),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
endoplasmic reticulum calcium ion homeostasis (GO:0032469),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of sterol biosynthetic process (GO:0106118),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of peroxidase activity (GO:2000469),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glutathione transport (GO:0034635),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
peptidyl-glutamine modification (GO:0018199),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
'de novo' NAD biosynthetic process from aspartate (GO:0034628),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
'de novo' NAD biosynthetic process (GO:0034627),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein urmylation (GO:0032447),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of protein import (GO:1904591),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
site-specific DNA replication termination at RTS1 barrier (GO:0071171),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"negative regulation of translation, ncRNA-mediated (GO:0040033)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
site-specific DNA replication termination (GO:0071170),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lipid glycosylation (GO:0030259),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of protein import (GO:1904589),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
establishment of protein localization to chromatin (GO:0071169),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization to chromatin (GO:0071168),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein nucleotidylation (GO:0018175),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-cysteine oxidation (GO:0018171),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of rate of cell growth (GO:0061388),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
RNA acetylation (GO:1990884),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
rRNA acetylation (GO:1990882),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of 1-deoxy-D-xylulose-5-phosphate synthase activity (GO:1902395),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-pyrromethane cofactor linkage (GO:0018160),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ion transmembrane transporter activity (GO:0032413),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of transporter activity (GO:0032410),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein oxidation (GO:0018158),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of mitotic spindle localization (GO:0040001),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptide cross-linking (GO:0018149),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cGMP biosynthetic process (GO:0006182),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-K23 acetylation (GO:0043972),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-K18 acetylation (GO:0043971),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
oxazole or thiazole biosynthetic process (GO:0018131),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein localization to nucleus (GO:1900180),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycosaminoglycan metabolic process (GO:0030203),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
adenosine salvage (GO:0006169),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
flavonol biosynthetic process (GO:0051555),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
flavonol metabolic process (GO:0051554),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
flavone biosynthetic process (GO:0051553),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
flavone metabolic process (GO:0051552),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein adenylylation (GO:0018117),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)",2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein transport by the Tat complex (GO:0043953),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of fatty acid beta-oxidation (GO:0031998),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
mRNA export from nucleus in response to heat stress (GO:0031990),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of chlorophyll biosynthetic process (GO:1902325),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nuclear DNA replication termination (GO:1902317),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycerophosphate shuttle (GO:0006127),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of arginine metabolic process (GO:0000821),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of monopolar cell growth (GO:0051513),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of unidimensional cell growth (GO:0051511),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
NADH oxidation (GO:0006116),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
glycerol biosynthetic process (GO:0006114),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
diaminopimelate biosynthetic process (GO:0019877),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
proteasome regulatory particle assembly (GO:0070682),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
fumarate metabolic process (GO:0006106),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
succinate metabolic process (GO:0006105),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
intralumenal vesicle formation (GO:0070676),5,5,2.99,+,1.67,0.516,1,4,1.79,+,2.23,0.256,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
positive regulation of red or far-red light signaling pathway (GO:0090228),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of red or far-red light signaling pathway (GO:0090227),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
thymine metabolic process (GO:0019859),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pyrimidine nucleobase biosynthetic process (GO:0019856),9,9,5.38,+,1.67,0.331,1,6,3.23,+,1.86,0.245,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
regulation of cell septum assembly (GO:1901891),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
gene looping (GO:0090202),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
leaf abscission (GO:0060866),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
negative regulation of Rho protein signal transduction (GO:0035024),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of floral organ abscission (GO:0060862),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of Rho protein signal transduction (GO:0035023),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of floral organ abscission (GO:0060860),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
vesicle-mediated transport involved in floral organ abscission (GO:0060858),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
somatic stem cell population maintenance (GO:0035019),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cuticle pattern formation (GO:0035017),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of Ras protein signal transduction (GO:0046580),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
sieve cell differentiation (GO:0048756),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
nicotinate metabolic process (GO:1901847),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitochondrial respirasome assembly (GO:0097250),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
signal transduction by protein phosphorylation (GO:0023014),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
chromosome attachment to the nuclear envelope (GO:0097240),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tissue morphogenesis (GO:0048729),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
formate catabolic process (GO:0042183),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
beta-glucoside metabolic process (GO:1901804),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
xenobiotic catabolic process (GO:0042178),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
sphingoid catabolic process (GO:0046521),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lipoprotein catabolic process (GO:0042159),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitochondrial respiratory chain complex II assembly (GO:0034553),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
respiratory chain complex II assembly (GO:0034552),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
mitochondrial respiratory chain complex III assembly (GO:0034551),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
sulfolipid biosynthetic process (GO:0046506),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of lipid transport (GO:0032370),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
sulfolipid metabolic process (GO:0046505),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
glycerol ether biosynthetic process (GO:0046504),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
uroporphyrinogen III metabolic process (GO:0046502),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protoporphyrinogen IX metabolic process (GO:0046501),10,10,5.98,+,1.67,0.255,1,9,3.59,+,2.51,0.0631,1,9,5.67,+,1.59,0.343,1,0,0.1,-, < 0.01,1,1
regulation of lipid transport (GO:0032368),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
melatonin biosynthetic process (GO:0030187),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
melatonin metabolic process (GO:0030186),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to estradiol (GO:0032355),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of hormone biosynthetic process (GO:0032353),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of hormone metabolic process (GO:0032351),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of phospholipid biosynthetic process (GO:0071072),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of phospholipid biosynthetic process (GO:0071071),4,4,2.39,+,1.67,0.483,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of cell adhesion (GO:0030155),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of Ras GTPase binding (GO:1904477),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of Ras GTPase binding (GO:1904475),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cytochrome c-heme linkage (GO:0018063),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA strand elongation involved in cell cycle DNA replication (GO:1902296),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell cycle DNA replication termination (GO:1902294),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to cyclopentenone (GO:0010583),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of defense response to oomycetes (GO:1902290),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
glyoxylate cycle (GO:0006097),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process (GO:0051484)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"terpenoid biosynthetic process, mevalonate-independent (GO:0051483)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of raffinose biosynthetic process (GO:1900091),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
acetate metabolic process (GO:0006083),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
substituted mannan metabolic process (GO:0006080),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of inositol biosynthetic process (GO:1900088),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of arginine biosynthetic process (GO:1900079),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tRNA threonylcarbamoyladenosine modification (GO:0002949),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
acropetal auxin transport (GO:0010541),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
UDP-glucuronate biosynthetic process (GO:0006065),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of GTP binding (GO:1904426),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of GTP binding (GO:1904424),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tRNA guanine ribose methylation (GO:0002938),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cellular response to alkaline pH (GO:1900067),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of meiotic cell cycle (GO:0051446),5,5,2.99,+,1.67,0.516,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
N-terminal peptidyl-glycine N-myristoylation (GO:0018008),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
N-terminal peptidyl-glutamic acid acetylation (GO:0018002),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of leaf senescence (GO:1900057),8,8,4.78,+,1.67,0.311,1,4,2.87,+,1.39,0.529,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
UDP-N-acetylglucosamine metabolic process (GO:0006047),8,8,4.78,+,1.67,0.311,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
glucosamine biosynthetic process (GO:0006042),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glucosamine metabolic process (GO:0006041),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nuclear membrane fusion (GO:0000740),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of phospholipase activity (GO:0010518),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of phospholipase activity (GO:0010517),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ketone body metabolic process (GO:1902224),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
Golgi to lysosome transport (GO:0090160),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chitin catabolic process (GO:0006032),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
chitin metabolic process (GO:0006030),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of cellular response to hypoxia (GO:1900039),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
transmitting tissue development (GO:0010500),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
endoplasmic reticulum membrane organization (GO:0090158),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
negative regulation of trichome patterning (GO:1900033),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of trichome patterning (GO:1900032),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
aminoglycan catabolic process (GO:0006026),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glycosaminoglycan biosynthetic process (GO:0006024),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
aminoglycan biosynthetic process (GO:0006023),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
aminoglycan metabolic process (GO:0006022),5,5,2.99,+,1.67,0.516,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
nucleoid organization (GO:0090143),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
D-ribose metabolic process (GO:0006014),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
UDP-glucose metabolic process (GO:0006011),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
meiotic DNA recombinase assembly (GO:0000707),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glucosinolate catabolic process (GO:0019762),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glucosinolate biosynthetic process (GO:0019761),8,8,4.78,+,1.67,0.311,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
glycosinolate catabolic process (GO:0019759),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glycosinolate biosynthetic process (GO:0019758),8,8,4.78,+,1.67,0.311,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
C-5 methylation of cytosine (GO:0090116),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
rDNA condensation (GO:0070550),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of lipid catabolic process (GO:0050996),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dimethylallyl diphosphate metabolic process (GO:0050993),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
dimethylallyl diphosphate biosynthetic process (GO:0050992),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
histone H3-K36 demethylation (GO:0070544),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of anion transmembrane transport (GO:1903960),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
dorsal/ventral pattern formation (GO:0009953),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detection of mechanical stimulus (GO:0050982),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to sorbitol (GO:0072709),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to sorbitol (GO:0072708),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of respiratory gaseous exchange (GO:1903942),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ether lipid metabolic process (GO:0046485),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
oxazole or thiazole metabolic process (GO:0046484),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
para-aminobenzoic acid metabolic process (GO:0046482),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
olefinic compound catabolic process (GO:0120256),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycosylceramide biosynthetic process (GO:0046476),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prephenate(2-) biosynthetic process (GO:1901747),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glycerophospholipid catabolic process (GO:0046475),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prephenate(2-) metabolic process (GO:1901745),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
prostanoid biosynthetic process (GO:0046457),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
icosanoid biosynthetic process (GO:0046456),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cell wall disassembly (GO:0044277),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA-templated transcriptional start site selection (GO:0001173),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
FMN metabolic process (GO:0046444),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-lysine metabolic process (GO:0046440),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
raffinose catabolic process (GO:0034484),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-cysteine metabolic process (GO:0046439),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization involved in auxin polar transport (GO:1901703),8,8,4.78,+,1.67,0.311,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
detection of calcium ion (GO:0005513),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
small-subunit processome assembly (GO:0034462),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
chorismate metabolic process (GO:0046417),10,10,5.98,+,1.67,0.255,1,2,3.59,-,0.56,0.743,1,9,5.67,+,1.59,0.343,1,0,0.1,-, < 0.01,1,1
'de novo' UMP biosynthetic process (GO:0044205),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
post-translational protein acetylation (GO:0034421),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
long-distance posttranscriptional gene silencing (GO:0010495),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of ribosomal DNA heterochromatin assembly (GO:0061187),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular detoxification of cadmium ion (GO:0098849),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cell projection assembly (GO:0030031),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cell projection organization (GO:0030030),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"regulation of translation, ncRNA-mediated (GO:0045974)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
stele development (GO:0010479),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chlororespiration (GO:0010478),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of shoot apical meristem development (GO:1902185),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of shoot apical meristem development (GO:1902184),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular manganese ion homeostasis (GO:0030026),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
negative regulation of peptidase activity (GO:0010466),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of tocopherol cyclase activity (GO:1902171),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
mRNA destabilization (GO:0061157),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein maturation by protein folding (GO:0022417),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of cell polarity (GO:0030010),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of cell fate commitment (GO:0010455),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-K36 methylation (GO:0010452),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular potassium ion homeostasis (GO:0030007),6,6,3.59,+,1.67,0.383,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
para-aminobenzoic acid biosynthetic process (GO:0008153),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
guard cell morphogenesis (GO:0010442),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
guard cell development (GO:0010441),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of steroid metabolic process (GO:0045939),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
box H/ACA snoRNA metabolic process (GO:0033979),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fatty acid omega-oxidation (GO:0010430),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA methylation on cytosine within a CHH sequence (GO:0010426),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA methylation on cytosine within a CNG sequence (GO:0010425),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
box C/D snoRNA metabolic process (GO:0033967),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of brassinosteroid biosynthetic process (GO:0010423),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of brassinosteroid biosynthetic process (GO:0010422),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
hydrogen peroxide-mediated programmed cell death (GO:0010421),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of lyase activity (GO:0051339),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of ribosome biogenesis (GO:0090070),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of carbohydrate metabolic process (GO:0045913),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitotic interphase (GO:0051329),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of translational termination (GO:0045905),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of translational elongation (GO:0045901),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of translational elongation (GO:0045900),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
S phase (GO:0051320),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
metaxylem development (GO:0090058),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
G1 phase (GO:0051318),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tubulin deacetylation (GO:0090042),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic sister chromatid separation (GO:0051306),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
NAD catabolic process (GO:0019677),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maintenance of protein location in plasma membrane (GO:0072660),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detection of hypoxia (GO:0070483),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of steroid hormone biosynthetic process (GO:0090032),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of steroid hormone biosynthetic process (GO:0090030),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
maintenance of protein location in membrane (GO:0072658),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of plant epidermal cell differentiation (GO:1903890),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"jasmonic acid and ethylene-dependent systemic resistance, ethylene mediated signaling pathway (GO:0009871)",4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
positive regulation of heme biosynthetic process (GO:0070455),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of heme biosynthetic process (GO:0070453),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nitrile metabolic process (GO:0050898),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
shikimate metabolic process (GO:0019632),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
pollen hydration (GO:0009859),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of oxidative phosphorylation (GO:1903862),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
arsenate ion transmembrane transport (GO:1901684),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of protein localization to chromatin (GO:0120187),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cytokinin dehydrogenase activity (GO:1903857),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of cytokinin dehydrogenase activity (GO:1903856),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of superoxide dismutase activity (GO:1901671),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"positive regulation of long-day photoperiodism, flowering (GO:0048578)",4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
"positive regulation of short-day photoperiodism, flowering (GO:0048576)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"short-day photoperiodism, flowering (GO:0048575)",4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
short-day photoperiodism (GO:0048572),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
UDP-glucuronate metabolic process (GO:0046398),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of superoxide dismutase activity (GO:1901668),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
fruit ripening (GO:0009835),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
plant-type cell wall modification involved in multidimensional cell growth (GO:0009831),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cell wall modification involved in abscission (GO:0009830),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dTDP-rhamnose metabolic process (GO:0046383),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of mitotic chromosome decondensation (GO:1901651),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
alkaloid metabolic process (GO:0009820),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cellular protein localization (GO:1903829),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"defense response to protozoan, incompatible interaction (GO:0009818)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
coumarin biosynthetic process (GO:0009805),5,5,2.99,+,1.67,0.516,1,5,1.79,+,2.79,0.142,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cinnamic acid metabolic process (GO:0009803),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cinnamic acid biosynthetic process (GO:0009800),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
fruit morphogenesis (GO:0048530),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
telomere tethering at nuclear periphery (GO:0034398),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
telomere localization (GO:0034397),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
amino sugar biosynthetic process (GO:0046349),8,8,4.78,+,1.67,0.311,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
amino sugar catabolic process (GO:0046348),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
abscisic acid catabolic process (GO:0046345),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of plasma membrane sterol distribution (GO:0097036),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of steroid biosynthetic process (GO:0050810),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of fatty acid oxidation (GO:0046322),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of phosphate transmembrane transport (GO:2000185),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
NAD salvage (GO:0034355),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
development of symbiont involved in interaction with host (GO:0044115),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
development involved in symbiotic interaction (GO:0044111),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
RNA folding (GO:0034337),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
"negative regulation of DNA-templated transcription, initiation (GO:2000143)",3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of ERAD pathway (GO:1904294),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ERAD pathway (GO:1904293),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
mitotic cell cycle phase (GO:0098763),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
homogalacturonan metabolic process (GO:0010394),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
galactoglucomannan metabolic process (GO:0010392),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein refolding (GO:0061083),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maintenance of seed dormancy by absisic acid (GO:0098755),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of stomatal complex development (GO:2000123),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of removal of superoxide radicals (GO:2000121),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
sequestering of zinc ion (GO:0032119),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peroxisome-chloroplast membrane tethering (GO:0010381),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
centrosome duplication (GO:0051298),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of cysteine-type endopeptidase activity (GO:2000116),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
GDP-mannose transmembrane transport (GO:1990570),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of spindle orientation (GO:0051294),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of spindle localization (GO:0051293),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein heterooligomerization (GO:0051291),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein heterotetramerization (GO:0051290),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
temperature compensation of the circadian clock (GO:0010378),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of gibberellin biosynthetic process (GO:0010373),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
UDP-N-acetylglucosamine transmembrane transport (GO:1990569),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
macromolecule depalmitoylation (GO:0098734),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein homotetramerization (GO:0051289),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
co-translational protein modification (GO:0043686),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of age-related resistance (GO:1904250),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of ethylene biosynthetic process (GO:0010365),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
immune response-regulating cell surface receptor signaling pathway (GO:0002768),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of anion channel activity by blue light (GO:0010362),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of anion channel activity by blue light (GO:0010361),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of anion channel activity (GO:0010360),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
immune response-regulating signaling pathway (GO:0002764),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
mitochondrial coenzyme A transmembrane transport (GO:1990559),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
symmetric cell division (GO:0098725),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of age-related resistance (GO:1904248),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to L-glutamate (GO:1902065),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
innate immune response-activating signal transduction (GO:0002758),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
immune response-activating signal transduction (GO:0002757),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cellular response to magnesium starvation (GO:0010350),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell surface pattern recognition receptor signaling pathway (GO:0002752),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pantothenate import across plasma membrane (GO:0098717),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of nitrogen utilization (GO:0045848),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
iron ion import across plasma membrane (GO:0098711),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
seed oilbody biogenesis (GO:0010344),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
endosperm cellularization (GO:0010342),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of meiotic nuclear division (GO:0045836),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
negative regulation of isoprenoid metabolic process (GO:0045827),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
negative regulation of cellular defense response (GO:0051245),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of protein import into chloroplast stroma (GO:1904216),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein import into chloroplast stroma (GO:1904215),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of seed dormancy process (GO:1902039),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
induction of programmed cell death (GO:0012502),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
membrane invagination (GO:0010324),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"negative regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0010323)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0010322)",3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
secondary thickening (GO:0080191),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detoxification of zinc ion (GO:0010312),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein transport (GO:0051224),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lateral root branching (GO:0080181),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
2-methylguanosine metabolic process (GO:0080180),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
PSII associated light-harvesting complex II catabolic process (GO:0010304),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
1-methylguanosine metabolic process (GO:0080179),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
5-carbamoylmethyl uridine residue modification (GO:0080178),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
homogentisate catabolic process (GO:1902000),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cellular response to boron-containing substance deprivation (GO:0080169),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of carbon utilization (GO:0043609),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
phytochromobilin metabolic process (GO:0051202),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
intracellular auxin transport (GO:0080162),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein destabilization (GO:0031648),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of reductive pentose-phosphate cycle (GO:0080153),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
arabinose biosynthetic process (GO:0019567),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of reductive pentose-phosphate cycle (GO:0080152),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of salicylic acid mediated signaling pathway (GO:0080151),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of inorganic anion transmembrane transport (GO:1903795),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of anion transport (GO:1903792),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
photosynthetic NADP+ reduction (GO:0009780),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
amino acid homeostasis (GO:0080144),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of amino acid export (GO:0080143),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of amino acid transmembrane transport (GO:1903789),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
multicellular organismal iron ion homeostasis (GO:0060586),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
priming of cellular response to stress (GO:0080136),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of lipid localization (GO:1905954),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
arginine catabolic process to glutamate (GO:0019544),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA double-strand break processing (GO:1903775),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
(-)-pinoresinol biosynthetic process (GO:1901599),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
(-)-pinoresinol metabolic process (GO:1901598),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pyridine-containing compound catabolic process (GO:0072526),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
indole glucosinolate biosynthetic process (GO:0009759),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ER body organization (GO:0080119),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of glycine hydroxymethyltransferase activity (GO:0080114),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
D-gluconate metabolic process (GO:0019521),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
aldonic acid metabolic process (GO:0019520),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
plant ovule morphogenesis (GO:0048482),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cell aging (GO:0007569),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
RNA destabilization (GO:0050779),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
triglyceride homeostasis (GO:0070328),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cyanide catabolic process (GO:0019500),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
carpel formation (GO:0048462),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of ethylene stimulus (GO:0009727),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of phosphatidate phosphatase activity (GO:1903730),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of cytokinin stimulus (GO:0009722),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of phospholipid metabolic process (GO:1903726),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of phospholipid metabolic process (GO:1903725),4,4,2.39,+,1.67,0.483,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
chalcone biosynthetic process (GO:0009715),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lignin catabolic process (GO:0046274),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chalcone metabolic process (GO:0009714),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phenylpropanoid catabolic process (GO:0046271),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
IRE1-mediated unfolded protein response (GO:0036498),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
membrane biogenesis (GO:0044091),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
carpel morphogenesis (GO:0048445),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of DNA demethylation (GO:1901537),4,4,2.39,+,1.67,0.483,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
nitrotoluene catabolic process (GO:0046263),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
trinitrotoluene catabolic process (GO:0046260),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"2,4,6-trinitrotoluene catabolic process (GO:0046256)",2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
abscisic acid-activated signaling pathway involved in stomatal movement (GO:1901527),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cell death in response to hydrogen peroxide (GO:0036474),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
salicylic acid catabolic process (GO:0046244),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of acylglycerol transport (GO:1901508),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of acylglycerol transport (GO:1901506),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
ether biosynthetic process (GO:1901503),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of protein binding (GO:0032092),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of autophagy in response to ER overload (GO:0034263),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of L-ascorbic acid biosynthetic process (GO:2000083),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nitric oxide metabolic process (GO:0046209),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of defense response by callose deposition (GO:2000071),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of defense response to insect (GO:2000068),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
positive regulation of translational initiation in response to stress (GO:0032058),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of translation in response to stress (GO:0032056),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
acquisition of nutrients from host (GO:0044002),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tRNA thio-modification (GO:0034227),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
quinolinate catabolic process (GO:0034213),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of trichome morphogenesis (GO:2000039),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of cell size (GO:0045793),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of stem cell division (GO:2000035),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cell size (GO:0045792),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detoxification of cobalt ion (GO:0010299),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to magnesium ion (GO:0032026),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to cobalt ion (GO:0032025),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of leaf formation (GO:2000025),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
homogalacturonan biosynthetic process (GO:0010289),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of arginine biosynthetic process via ornithine (GO:2000013),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
photosystem II oxygen evolving complex assembly (GO:0010270),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of fatty acid beta-oxidation (GO:0032000),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
box H/ACA snoRNA 3'-end processing (GO:0000495),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
box C/D snoRNA 3'-end processing (GO:0000494),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
box H/ACA snoRNP assembly (GO:0000493),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of adenylate cyclase activity (GO:0045761),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to selenium ion (GO:0010269),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"maturation of SSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA) (GO:0000489)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"maturation of LSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA) (GO:0000488)",1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of respiratory gaseous exchange (GO:0043576),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-threonine dephosphorylation (GO:0035970),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
UDP-rhamnose biosynthetic process (GO:0010253),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
maturation of 4.5S rRNA (GO:0000476),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
detection of phosphate ion (GO:0010247),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
rhamnogalacturonan I biosynthetic process (GO:0010246),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
radial microtubular system formation (GO:0010245),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of translational initiation in response to stress (GO:0043558),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
plastoquinone biosynthetic process (GO:0010236),6,6,3.59,+,1.67,0.383,1,5,2.15,+,2.32,0.173,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
alternative respiration (GO:0010230),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
wybutosine biosynthetic process (GO:0031591),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
wybutosine metabolic process (GO:0031590),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
stem vascular tissue pattern formation (GO:0010222),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of photorespiration (GO:0080093),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of raffinose metabolic process (GO:0080091),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
toluene-containing compound catabolic process (GO:0072491),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
toluene-containing compound metabolic process (GO:0072490),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
arginine catabolic process to proline (GO:0019493),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic cell size control checkpoint (GO:0031567),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
beta-alanine catabolic process (GO:0019484),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
N-acylethanolamine metabolic process (GO:0070291),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
4-alpha-methyl-delta7-sterol oxidation (GO:0080065),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"4,4-dimethyl-9beta,19-cyclopropylsterol oxidation (GO:0080064)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
L-lysine catabolic process (GO:0019477),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of triglyceride transport (GO:1905885),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of triglyceride transport (GO:1905883),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
L-lysine catabolic process to acetyl-CoA (GO:0019474),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to phenylalanine (GO:0080053),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to histidine (GO:0080052),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cutin transport (GO:0080051),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
methionine catabolic process via 2-oxobutanoate (GO:0019458),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
L-cysteine catabolic process to pyruvate (GO:0019450),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-serine dephosphorylation (GO:0070262),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cytokinin-activated signaling pathway (GO:0080038),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
L-cysteine catabolic process (GO:0019448),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chromoplast organization (GO:0009661),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nitrile biosynthetic process (GO:0080028),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of coenzyme A biosynthetic process (GO:0080020),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
triglyceride catabolic process (GO:0019433),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of defense response to virus by host (GO:0050691),6,6,3.59,+,1.67,0.383,1,5,2.15,+,2.32,0.173,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
positive regulation of transcription factor catabolic process (GO:1901485),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of transcription factor catabolic process (GO:1901483),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
1-deoxy-D-xylulose 5-phosphate biosynthetic process (GO:0052865),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
acetyl-CoA biosynthetic process from acetate (GO:0019427),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of mRNA processing (GO:0050686),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"sulfide oxidation, using siroheme sulfite reductase (GO:0019424)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pyruvate transmembrane transport (GO:1901475),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
sulfide oxidation (GO:0019418),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of chlorophyll catabolic process (GO:1903647),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of tetrapyrrole biosynthetic process (GO:1901464),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dolichol biosynthetic process (GO:0019408),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
D-gluconate catabolic process (GO:0046177),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
aldonic acid catabolic process (GO:0046176),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
response to symbiotic fungus (GO:0009610),4,4,2.39,+,1.67,0.483,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
glycerol-3-phosphate catabolic process (GO:0046168),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of syringal lignin biosynthetic process (GO:1901430),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to growth hormone (GO:0060416),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of syringal lignin biosynthetic process (GO:1901428),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization to spindle pole body (GO:0071988),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tetrahydrobiopterin metabolic process (GO:0046146),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,1,0.03,+,33.18,0.0392,1
mitochondrion distribution (GO:0048311),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of vitamin metabolic process (GO:0046137),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of vitamin metabolic process (GO:0046136),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
negative regulation of tetrapyrrole catabolic process (GO:1901405),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of tetrapyrrole metabolic process (GO:1901402),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
detection of oxygen (GO:0003032),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"2,4,6-trinitrotoluene metabolic process (GO:0018974)",2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
trinitrotoluene metabolic process (GO:0018973),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
xanthine metabolic process (GO:0046110),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
uridine metabolic process (GO:0046108),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
uracil biosynthetic process (GO:0046107),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to sterol depletion (GO:0006991),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
ER-nucleus signaling pathway (GO:0006984),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
ER overload response (GO:0006983),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
hypotonic response (GO:0006971),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
urea transmembrane transport (GO:0071918),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glyphosate metabolic process (GO:0018920),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular defense response (GO:0006968),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein serine/threonine kinase activity (GO:0071901),6,6,3.59,+,1.67,0.383,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
synergid death (GO:0010198),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
syncytium formation (GO:0006949),9,9,5.38,+,1.67,0.331,1,3,3.23,-,0.93,1,1,9,5.1,+,1.76,0.229,1,1,0.09,+,11.06,0.0952,1
cytokinin transport (GO:0010184),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of binding (GO:0051099),3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of DNA-binding transcription factor activity (GO:0051091),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
centriole assembly (GO:0098534),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
'de novo' cotranslational protein folding (GO:0051083),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
stress response to zinc ion (GO:1990359),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
galactomannan biosynthetic process (GO:0051070),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"RNA splicing, via transesterification reactions with guanosine as nucleophile (GO:0000376)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
galactomannan metabolic process (GO:0051069),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dihydrobiopterin metabolic process (GO:0051066),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
Group I intron splicing (GO:0000372),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of olefin biosynthetic process (GO:1900913),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
pinocytosis (GO:0006907),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of olefin metabolic process (GO:1900910),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to potassium ion (GO:0035865),3,3,1.79,+,1.67,0.678,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
cutin biosynthetic process (GO:0010143),8,8,4.78,+,1.67,0.311,1,2,2.87,-,0.7,1,1,8,4.53,+,1.76,0.299,1,0,0.08,-, < 0.01,1,1
"farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)",2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of small GTPase mediated signal transduction (GO:0051058),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of cellular respiration (GO:0043457),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
proline catabolic process to glutamate (GO:0010133),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
chromatin disassembly (GO:0031498),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of mating type switching (GO:0031494),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of secretion (GO:0051046),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
alkane catabolic process (GO:0043448),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
phenylacetate catabolic process (GO:0010124),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
arginine catabolic process to proline via ornithine (GO:0010121),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
camalexin biosynthetic process (GO:0010120),6,6,3.59,+,1.67,0.383,1,6,2.15,+,2.79,0.0942,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
response to peptide hormone (GO:0043434),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glyoxysome organization (GO:0010111),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"regulation of photosynthesis, dark reaction (GO:0010110)",3,3,1.79,+,1.67,0.678,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
nuclear envelope reassembly (GO:0031468),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
establishment of protein localization to chromosome (GO:0070199),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
meiotic attachment of telomere to nuclear envelope (GO:0070197),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of MAPK cascade (GO:0043409),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of MAP kinase activity (GO:0043407),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
epoxygenase P450 pathway (GO:0019373),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
N-terminal peptidyl-serine acetylation (GO:0017198),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of nutrient (GO:0009594),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of mRNA 3'-end processing (GO:0031441),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
arachidonic acid metabolic process (GO:0019369),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"fatty acid elongation, saturated fatty acid (GO:0019367)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyridine nucleotide salvage (GO:0019365),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pyridine nucleotide catabolic process (GO:0019364),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)",1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
chloroplast proton-transporting ATP synthase complex assembly (GO:0033614),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
oxalate catabolic process (GO:0033611),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nicotinamide nucleotide biosynthetic process from aspartate (GO:0019355),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
oxalate metabolic process (GO:0033609),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of ATP metabolic process (GO:1903580),3,3,1.79,+,1.67,0.678,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
polycistronic mRNA processing (GO:0031426),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
UDP-galactose transmembrane transport (GO:0072334),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
mitochondrial seryl-tRNA aminoacylation (GO:0070158),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitochondrial glycyl-tRNA aminoacylation (GO:0070150),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phenol-containing compound catabolic process (GO:0019336),6,6,3.59,+,1.67,0.383,1,5,2.15,+,2.32,0.173,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
chaperone-mediated protein transport (GO:0072321),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of exocytosis (GO:0017157),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
response to UV-A (GO:0070141),3,3,1.79,+,1.67,0.678,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
nitrotoluene metabolic process (GO:0019326),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
sequestering of actin monomers (GO:0042989),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pentose catabolic process (GO:0019323),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
pentose biosynthetic process (GO:0019322),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
indeterminate inflorescence morphogenesis (GO:0048283),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
stem cell division (GO:0017145),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
inflorescence morphogenesis (GO:0048281),4,4,2.39,+,1.67,0.483,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
inositol catabolic process (GO:0019310),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),2,2,1.2,+,1.67,0.633,1,2,0.72,+,2.79,0.285,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
dTDP-rhamnose biosynthetic process (GO:0019305),2,2,1.2,+,1.67,0.633,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
D-ribose catabolic process (GO:0019303),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
determination of dorsal identity (GO:0048263),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
thioredoxin reduction (GO:0042964),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
determination of dorsal/ventral asymmetry (GO:0048262),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein targeting (GO:1903533),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of secretion by cell (GO:1903530),6,6,3.59,+,1.67,0.383,1,3,2.15,+,1.39,0.706,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
adenosine biosynthetic process (GO:0046086),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glucosinolate transport (GO:1901349),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dUDP metabolic process (GO:0046077),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of secondary cell wall biogenesis (GO:1901347),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dTTP metabolic process (GO:0046075),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dTMP metabolic process (GO:0046073),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dTDP metabolic process (GO:0046072),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dGTP metabolic process (GO:0046070),2,2,1.2,+,1.67,0.633,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
glucoside transport (GO:0042946),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cGMP metabolic process (GO:0046068),1,1,0.6,+,1.67,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
peptidyl-serine autophosphorylation (GO:0036289),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to cytokine (GO:0034097),1,1,0.6,+,1.67,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
chorismate biosynthetic process (GO:0009423),7,7,4.19,+,1.67,0.409,1,1,2.51,-,0.4,0.69,1,7,3.97,+,1.76,0.281,1,0,0.07,-, < 0.01,1,1
toxin biosynthetic process (GO:0009403),7,7,4.19,+,1.67,0.409,1,7,2.51,+,2.79,0.064,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
phytoalexin biosynthetic process (GO:0052315),7,7,4.19,+,1.67,0.409,1,7,2.51,+,2.79,0.064,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
phytoalexin metabolic process (GO:0052314),7,7,4.19,+,1.67,0.409,1,7,2.51,+,2.79,0.064,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
negative regulation of protein kinase activity (GO:0006469),7,7,4.19,+,1.67,0.409,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
xanthophyll biosynthetic process (GO:0016123),7,7,4.19,+,1.67,0.409,1,6,2.51,+,2.39,0.119,1,7,3.97,+,1.76,0.281,1,0,0.07,-, < 0.01,1,1
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),7,7,4.19,+,1.67,0.409,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cell plate formation involved in plant-type cell wall biogenesis (GO:0009920),7,7,4.19,+,1.67,0.409,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
indole phytoalexin biosynthetic process (GO:0009700),7,7,4.19,+,1.67,0.409,1,7,2.51,+,2.79,0.064,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
indole phytoalexin metabolic process (GO:0046217),7,7,4.19,+,1.67,0.409,1,7,2.51,+,2.79,0.064,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
cellulose microfibril organization (GO:0010215),7,7,4.19,+,1.67,0.409,1,2,2.51,-,0.8,1,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
negative regulation of kinase activity (GO:0033673),7,7,4.19,+,1.67,0.409,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
gluconeogenesis (GO:0006094),19,18,11.36,+,1.58,0.175,1,12,6.81,+,1.76,0.151,1,18,10.77,+,1.67,0.125,1,1,0.19,+,5.24,0.181,1
"photosynthesis, light harvesting in photosystem I (GO:0009768)",16,15,9.57,+,1.57,0.264,1,13,5.74,+,2.27,0.0333,1,15,9.07,+,1.65,0.19,1,0,0.16,-, < 0.01,1,1
"photosynthesis, dark reaction (GO:0019685)",15,14,8.97,+,1.56,0.251,1,12,5.38,+,2.23,0.0466,1,14,8.5,+,1.65,0.18,1,0,0.15,-, < 0.01,1,1
reductive pentose-phosphate cycle (GO:0019253),14,13,8.37,+,1.55,0.319,1,11,5.02,+,2.19,0.0658,1,13,7.94,+,1.64,0.229,1,0,0.14,-, < 0.01,1,1
defense response by callose deposition (GO:0052542),14,13,8.37,+,1.55,0.319,1,10,5.02,+,1.99,0.104,1,12,7.94,+,1.51,0.311,1,0,0.14,-, < 0.01,1,1
chloroplast rRNA processing (GO:1901259),13,12,7.77,+,1.54,0.304,1,12,4.66,+,2.57,0.0213,1,12,7.37,+,1.63,0.219,1,0,0.13,-, < 0.01,1,1
pyrimidine nucleobase metabolic process (GO:0006206),13,12,7.77,+,1.54,0.304,1,6,4.66,+,1.29,0.606,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
photosynthetic electron transport in photosystem I (GO:0009773),13,12,7.77,+,1.54,0.304,1,8,4.66,+,1.72,0.222,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
energy quenching (GO:1990066),12,11,7.18,+,1.53,0.389,1,9,4.3,+,2.09,0.133,1,10,6.8,+,1.47,0.38,1,0,0.12,-, < 0.01,1,1
negative regulation of photosynthesis (GO:1905156),12,11,7.18,+,1.53,0.389,1,7,4.3,+,1.63,0.303,1,10,6.8,+,1.47,0.38,1,1,0.12,+,8.3,0.122,1
jasmonic acid and ethylene-dependent systemic resistance (GO:0009861),12,11,7.18,+,1.53,0.389,1,8,4.3,+,1.86,0.202,1,10,6.8,+,1.47,0.38,1,0,0.12,-, < 0.01,1,1
response to insect (GO:0009625),12,11,7.18,+,1.53,0.389,1,7,4.3,+,1.63,0.303,1,10,6.8,+,1.47,0.38,1,0,0.12,-, < 0.01,1,1
nonphotochemical quenching (GO:0010196),12,11,7.18,+,1.53,0.389,1,9,4.3,+,2.09,0.133,1,10,6.8,+,1.47,0.38,1,0,0.12,-, < 0.01,1,1
pentose metabolic process (GO:0019321),12,11,7.18,+,1.53,0.389,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
endosome organization (GO:0007032),11,10,6.58,+,1.52,0.37,1,6,3.94,+,1.52,0.413,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173),11,10,6.58,+,1.52,0.37,1,8,3.94,+,2.03,0.124,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
cellular response to light intensity (GO:0071484),11,10,6.58,+,1.52,0.37,1,9,3.94,+,2.28,0.0739,1,7,6.24,+,1.12,0.81,1,1,0.11,+,9.05,0.113,1
magnesium ion transport (GO:0015693),11,10,6.58,+,1.52,0.37,1,1,3.94,-,0.25,0.203,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
response to fructose (GO:0009750),11,10,6.58,+,1.52,0.37,1,8,3.94,+,2.03,0.124,1,11,6.24,+,1.76,0.188,1,0,0.11,-, < 0.01,1,1
carotenoid biosynthetic process (GO:0016117),21,19,12.56,+,1.51,0.194,1,13,7.53,+,1.73,0.122,1,18,11.9,+,1.51,0.242,1,0,0.21,-, < 0.01,1,1
tetraterpenoid biosynthetic process (GO:0016109),21,19,12.56,+,1.51,0.194,1,13,7.53,+,1.73,0.122,1,18,11.9,+,1.51,0.242,1,0,0.21,-, < 0.01,1,1
chlorophyll biosynthetic process (GO:0015995),31,28,18.54,+,1.51,0.138,1,24,11.12,+,2.16,0.00548,0.614,28,17.57,+,1.59,0.078,1,1,0.31,+,3.21,0.274,1
UMP metabolic process (GO:0046049),10,9,5.98,+,1.51,0.477,1,7,3.59,+,1.95,0.174,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
superoxide metabolic process (GO:0006801),10,9,5.98,+,1.51,0.477,1,7,3.59,+,1.95,0.174,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
negative regulation of protein phosphorylation (GO:0001933),10,9,5.98,+,1.51,0.477,1,7,3.59,+,1.95,0.174,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
phospholipid transport (GO:0015914),10,9,5.98,+,1.51,0.477,1,4,3.59,+,1.12,0.77,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
glutamine metabolic process (GO:0006541),10,9,5.98,+,1.51,0.477,1,6,3.59,+,1.67,0.392,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174),10,9,5.98,+,1.51,0.477,1,7,3.59,+,1.95,0.174,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
UMP biosynthetic process (GO:0006222),10,9,5.98,+,1.51,0.477,1,7,3.59,+,1.95,0.174,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
regulation of anion transmembrane transport (GO:1903959),10,9,5.98,+,1.51,0.477,1,6,3.59,+,1.67,0.392,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
negative regulation of carbohydrate metabolic process (GO:0045912),10,9,5.98,+,1.51,0.477,1,0,3.59,-, < 0.01,0.0723,1,9,5.67,+,1.59,0.343,1,0,0.1,-, < 0.01,1,1
photosystem II repair (GO:0010206),10,9,5.98,+,1.51,0.477,1,9,3.59,+,2.51,0.0631,1,9,5.67,+,1.59,0.343,1,0,0.1,-, < 0.01,1,1
"photosynthesis, light harvesting (GO:0009765)",29,26,17.34,+,1.5,0.162,1,24,10.4,+,2.31,0.00284,0.45,26,16.44,+,1.58,0.0926,1,0,0.29,-, < 0.01,1,1
"negative regulation of photosynthesis, light reaction (GO:0043155)",9,8,5.38,+,1.49,0.456,1,7,3.23,+,2.17,0.152,1,7,5.1,+,1.37,0.605,1,1,0.09,+,11.06,0.0952,1
tyrosine metabolic process (GO:0006570),9,8,5.38,+,1.49,0.456,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
extracellular structure organization (GO:0043062),9,8,5.38,+,1.49,0.456,1,3,3.23,-,0.93,1,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
"regulation of photosynthesis, light reaction (GO:0042548)",18,16,10.76,+,1.49,0.287,1,12,6.46,+,1.86,0.0986,1,15,10.2,+,1.47,0.28,1,1,0.18,+,5.53,0.173,1
cellular response to superoxide (GO:0071451),9,8,5.38,+,1.49,0.456,1,6,3.23,+,1.86,0.245,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
cellular response to oxygen radical (GO:0071450),9,8,5.38,+,1.49,0.456,1,6,3.23,+,1.86,0.245,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",9,8,5.38,+,1.49,0.456,1,9,3.23,+,2.79,0.0313,1,8,5.1,+,1.57,0.449,1,1,0.09,+,11.06,0.0952,1
extracellular matrix organization (GO:0030198),9,8,5.38,+,1.49,0.456,1,3,3.23,-,0.93,1,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
regulation of defense response to oomycetes (GO:1902288),9,8,5.38,+,1.49,0.456,1,6,3.23,+,1.86,0.245,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
lignin metabolic process (GO:0009808),36,32,21.53,+,1.49,0.104,1,23,12.91,+,1.78,0.0372,1,29,20.41,+,1.42,0.157,1,1,0.36,+,2.77,0.31,1
"regulation of DNA-templated transcription, initiation (GO:2000142)",9,8,5.38,+,1.49,0.456,1,3,3.23,-,0.93,1,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
photoinhibition (GO:0010205),9,8,5.38,+,1.49,0.456,1,7,3.23,+,2.17,0.152,1,7,5.1,+,1.37,0.605,1,1,0.09,+,11.06,0.0952,1
removal of superoxide radicals (GO:0019430),9,8,5.38,+,1.49,0.456,1,6,3.23,+,1.86,0.245,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
ether metabolic process (GO:0018904),9,8,5.38,+,1.49,0.456,1,7,3.23,+,2.17,0.152,1,8,5.1,+,1.57,0.449,1,1,0.09,+,11.06,0.0952,1
induced systemic resistance (GO:0009682),17,15,10.17,+,1.48,0.277,1,11,6.1,+,1.8,0.134,1,13,9.64,+,1.35,0.449,1,0,0.17,-, < 0.01,1,1
regulation of beta-glucan biosynthetic process (GO:0032951),8,7,4.78,+,1.46,0.595,1,1,2.87,-,0.35,0.461,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
regulation of beta-glucan metabolic process (GO:0032950),8,7,4.78,+,1.46,0.595,1,1,2.87,-,0.35,0.461,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
plant-type cell wall assembly (GO:0071668),8,7,4.78,+,1.46,0.595,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
farnesyl diphosphate metabolic process (GO:0045338),8,7,4.78,+,1.46,0.595,1,4,2.87,+,1.39,0.529,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
phospholipid translocation (GO:0045332),8,7,4.78,+,1.46,0.595,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
negative regulation of response to salt stress (GO:1901001),8,7,4.78,+,1.46,0.595,1,5,2.87,+,1.74,0.348,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
manganese ion homeostasis (GO:0055071),8,7,4.78,+,1.46,0.595,1,3,2.87,+,1.05,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
isoleucine metabolic process (GO:0006549),8,7,4.78,+,1.46,0.595,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
trehalose biosynthetic process (GO:0005992),8,7,4.78,+,1.46,0.595,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
isoleucine biosynthetic process (GO:0009097),8,7,4.78,+,1.46,0.595,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
indole-containing compound biosynthetic process (GO:0042435),24,21,14.35,+,1.46,0.218,1,17,8.61,+,1.98,0.0335,1,15,13.6,+,1.1,0.742,1,0,0.24,-, < 0.01,1,1
regulation of cellulose biosynthetic process (GO:2001006),8,7,4.78,+,1.46,0.595,1,1,2.87,-,0.35,0.461,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
cell wall assembly (GO:0070726),8,7,4.78,+,1.46,0.595,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",8,7,4.78,+,1.46,0.595,1,4,2.87,+,1.39,0.529,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
glucose metabolic process (GO:0006006),32,28,19.14,+,1.46,0.143,1,22,11.48,+,1.92,0.0203,1,26,18.14,+,1.43,0.173,1,1,0.32,+,3.11,0.281,1
regulation of anion channel activity (GO:0010359),8,7,4.78,+,1.46,0.595,1,6,2.87,+,2.09,0.22,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
embryonic axis specification (GO:0000578),8,7,4.78,+,1.46,0.595,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
photosystem II assembly (GO:0010207),24,21,14.35,+,1.46,0.218,1,18,8.61,+,2.09,0.0216,1,18,13.6,+,1.32,0.422,1,0,0.24,-, < 0.01,1,1
photosynthetic acclimation (GO:0009643),8,7,4.78,+,1.46,0.595,1,4,2.87,+,1.39,0.529,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
regulation of RNA stability (GO:0043487),8,7,4.78,+,1.46,0.595,1,6,2.87,+,2.09,0.22,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
regulation of photosynthesis (GO:0010109),31,27,18.54,+,1.46,0.174,1,15,11.12,+,1.35,0.32,1,25,17.57,+,1.42,0.21,1,1,0.31,+,3.21,0.274,1
hydrogen peroxide catabolic process (GO:0042744),15,13,8.97,+,1.45,0.334,1,7,5.38,+,1.3,0.628,1,13,8.5,+,1.53,0.325,1,1,0.15,+,6.64,0.148,1
carbon fixation (GO:0015977),15,13,8.97,+,1.45,0.334,1,11,5.38,+,2.04,0.0753,1,13,8.5,+,1.53,0.325,1,0,0.15,-, < 0.01,1,1
cell wall thickening (GO:0052386),15,13,8.97,+,1.45,0.334,1,11,5.38,+,2.04,0.0753,1,11,8.5,+,1.29,0.543,1,0,0.15,-, < 0.01,1,1
cellular oxidant detoxification (GO:0098869),15,13,8.97,+,1.45,0.334,1,9,5.38,+,1.67,0.246,1,12,8.5,+,1.41,0.424,1,0,0.15,-, < 0.01,1,1
plastid membrane organization (GO:0009668),44,38,26.31,+,1.44,0.109,1,29,15.78,+,1.84,0.0157,1,31,24.94,+,1.24,0.399,1,0,0.44,-, < 0.01,1,1
thylakoid membrane organization (GO:0010027),43,37,25.71,+,1.44,0.106,1,29,15.42,+,1.88,0.0104,0.959,30,24.37,+,1.23,0.394,1,0,0.43,-, < 0.01,1,1
intracellular sequestering of iron ion (GO:0006880),7,6,4.19,+,1.43,0.571,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
unsaturated fatty acid metabolic process (GO:0033559),14,12,8.37,+,1.43,0.418,1,8,5.02,+,1.59,0.332,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
NAD biosynthetic process (GO:0009435),7,6,4.19,+,1.43,0.571,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
mitochondrial ATP synthesis coupled proton transport (GO:0042776),7,6,4.19,+,1.43,0.571,1,5,2.51,+,1.99,0.322,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cell adhesion (GO:0007155),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
callose deposition in cell wall (GO:0052543),14,12,8.37,+,1.43,0.418,1,10,5.02,+,1.99,0.104,1,11,7.94,+,1.39,0.412,1,0,0.14,-, < 0.01,1,1
endoplasmic reticulum-plasma membrane tethering (GO:0061817),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
activation of immune response (GO:0002253),14,12,8.37,+,1.43,0.418,1,11,5.02,+,2.19,0.0658,1,11,7.94,+,1.39,0.412,1,0,0.14,-, < 0.01,1,1
activation of innate immune response (GO:0002218),14,12,8.37,+,1.43,0.418,1,11,5.02,+,2.19,0.0658,1,11,7.94,+,1.39,0.412,1,0,0.14,-, < 0.01,1,1
outer mitochondrial membrane organization (GO:0007008),7,6,4.19,+,1.43,0.571,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of vitamin metabolic process (GO:0030656),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
L-phenylalanine catabolic process (GO:0006559),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
glycine catabolic process (GO:0006546),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
cysteine biosynthetic process from serine (GO:0006535),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
indole-containing compound metabolic process (GO:0042430),35,30,20.93,+,1.43,0.158,1,24,12.55,+,1.91,0.0172,1,26,19.84,+,1.31,0.289,1,0,0.35,-, < 0.01,1,1
carotene biosynthetic process (GO:0016120),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
protein insertion into mitochondrial outer membrane (GO:0045040),7,6,4.19,+,1.43,0.571,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
endoplasmic reticulum localization (GO:0051643),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
biological adhesion (GO:0022610),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
negative regulation of phosphorus metabolic process (GO:0010563),14,12,8.37,+,1.43,0.418,1,8,5.02,+,1.59,0.332,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),7,6,4.19,+,1.43,0.571,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
negative regulation of phosphate metabolic process (GO:0045936),14,12,8.37,+,1.43,0.418,1,8,5.02,+,1.59,0.332,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
lignin biosynthetic process (GO:0009809),28,24,16.74,+,1.43,0.199,1,16,10.04,+,1.59,0.169,1,21,15.87,+,1.32,0.372,1,1,0.28,+,3.56,0.252,1
coumarin metabolic process (GO:0009804),7,6,4.19,+,1.43,0.571,1,6,2.51,+,2.39,0.119,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
cytochrome b6f complex assembly (GO:0010190),7,6,4.19,+,1.43,0.571,1,5,2.51,+,1.99,0.322,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
regulation of DNA-binding transcription factor activity (GO:0051090),7,6,4.19,+,1.43,0.571,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
membrane protein proteolysis (GO:0033619),7,6,4.19,+,1.43,0.571,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
hexose biosynthetic process (GO:0019319),21,18,12.56,+,1.43,0.32,1,12,7.53,+,1.59,0.234,1,18,11.9,+,1.51,0.242,1,1,0.21,+,4.74,0.198,1
carotenoid metabolic process (GO:0016116),27,23,16.15,+,1.42,0.242,1,15,9.68,+,1.55,0.218,1,23,15.31,+,1.5,0.184,1,0,0.27,-, < 0.01,1,1
tetraterpenoid metabolic process (GO:0016108),27,23,16.15,+,1.42,0.242,1,15,9.68,+,1.55,0.218,1,23,15.31,+,1.5,0.184,1,0,0.27,-, < 0.01,1,1
response to ozone (GO:0010193),20,17,11.96,+,1.42,0.309,1,12,7.17,+,1.67,0.162,1,17,11.34,+,1.5,0.232,1,0,0.2,-, < 0.01,1,1
unsaturated fatty acid biosynthetic process (GO:0006636),13,11,7.77,+,1.41,0.405,1,7,4.66,+,1.5,0.445,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
pyrimidine nucleoside monophosphate metabolic process (GO:0009129),13,11,7.77,+,1.41,0.405,1,9,4.66,+,1.93,0.145,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
branched-chain amino acid biosynthetic process (GO:0009082),13,11,7.77,+,1.41,0.405,1,5,4.66,+,1.07,1,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
photosystem I assembly (GO:0048564),13,11,7.77,+,1.41,0.405,1,11,4.66,+,2.36,0.0375,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
photosynthesis (GO:0015979),139,117,83.12,+,1.41,0.00633,1,98,49.85,+,1.97,5.17E-07,0.00295,114,78.79,+,1.45,0.0037,0.587,0,1.4,-, < 0.01,0.651,1
S-glycoside metabolic process (GO:0016143),25,21,14.95,+,1.4,0.286,1,11,8.97,+,1.23,0.572,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
glucosinolate metabolic process (GO:0019760),25,21,14.95,+,1.4,0.286,1,11,8.97,+,1.23,0.572,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
glycosinolate metabolic process (GO:0019757),25,21,14.95,+,1.4,0.286,1,11,8.97,+,1.23,0.572,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
"isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)",6,5,3.59,+,1.39,0.757,1,5,2.15,+,2.32,0.173,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
alditol phosphate metabolic process (GO:0052646),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
response to xenobiotic stimulus (GO:0009410),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
positive regulation of protein phosphorylation (GO:0001934),12,10,7.18,+,1.39,0.51,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
tryptophan biosynthetic process (GO:0000162),12,10,7.18,+,1.39,0.51,1,7,4.3,+,1.63,0.303,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130),12,10,7.18,+,1.39,0.51,1,8,4.3,+,1.86,0.202,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
plant-type cell wall cellulose biosynthetic process (GO:0052324),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
pyrimidine-containing compound salvage (GO:0008655),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
valine biosynthetic process (GO:0009099),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
aspartate family amino acid catabolic process (GO:0009068),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
cellular response to ATP (GO:0071318),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
positive regulation of innate immune response (GO:0045089),24,20,14.35,+,1.39,0.278,1,17,8.61,+,1.98,0.0335,1,17,13.6,+,1.25,0.516,1,0,0.24,-, < 0.01,1,1
xanthophyll metabolic process (GO:0016122),12,10,7.18,+,1.39,0.51,1,8,4.3,+,1.86,0.202,1,11,6.8,+,1.62,0.279,1,0,0.12,-, < 0.01,1,1
carotene metabolic process (GO:0016119),12,10,7.18,+,1.39,0.51,1,6,4.3,+,1.39,0.592,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
protein O-linked glycosylation via hydroxyproline (GO:0018258),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
lipid storage (GO:0019915),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
extracellular ATP signaling (GO:0106167),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
negative regulation of cellular carbohydrate metabolic process (GO:0010677),6,5,3.59,+,1.39,0.757,1,0,2.15,-, < 0.01,0.351,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
mitochondria-nucleus signaling pathway (GO:0031930),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
acetyl-CoA biosynthetic process from pyruvate (GO:0006086),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
glycerol-3-phosphate metabolic process (GO:0006072),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
glycerol metabolic process (GO:0006071),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
positive regulation of autophagy (GO:0010508),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
cellular response to sulfate starvation (GO:0009970),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
nitrogen utilization (GO:0019740),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
longitudinal axis specification (GO:0009942),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
phosphatidic acid metabolic process (GO:0046473),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
cell wall beta-glucan biosynthetic process (GO:0034410),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
oxidative photosynthetic carbon pathway (GO:0009854),6,5,3.59,+,1.39,0.757,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
magnesium ion transmembrane transport (GO:1903830),6,5,3.59,+,1.39,0.757,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
regulation of plant-type hypersensitive response (GO:0010363),12,10,7.18,+,1.39,0.51,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
regulation of salicylic acid biosynthetic process (GO:0080142),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
positive regulation of immune response (GO:0050778),24,20,14.35,+,1.39,0.278,1,17,8.61,+,1.98,0.0335,1,17,13.6,+,1.25,0.516,1,0,0.24,-, < 0.01,1,1
regulation of DNA demethylation (GO:1901535),6,5,3.59,+,1.39,0.757,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
regulation of anion transport (GO:0044070),12,10,7.18,+,1.39,0.51,1,6,4.3,+,1.39,0.592,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
indolalkylamine biosynthetic process (GO:0046219),12,10,7.18,+,1.39,0.51,1,7,4.3,+,1.63,0.303,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
regulation of stomatal complex development (GO:2000038),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
positive regulation of immune system process (GO:0002684),24,20,14.35,+,1.39,0.278,1,17,8.61,+,1.98,0.0335,1,17,13.6,+,1.25,0.516,1,0,0.24,-, < 0.01,1,1
chaperone-mediated protein complex assembly (GO:0051131),6,5,3.59,+,1.39,0.757,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
glycine decarboxylation via glycine cleavage system (GO:0019464),6,5,3.59,+,1.39,0.757,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
mucilage pectin metabolic process (GO:0048363),6,5,3.59,+,1.39,0.757,1,1,2.15,-,0.46,0.684,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
aldehyde biosynthetic process (GO:0046184),6,5,3.59,+,1.39,0.757,1,2,2.15,-,0.93,1,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
regulation of mRNA stability (GO:0043488),6,5,3.59,+,1.39,0.757,1,5,2.15,+,2.32,0.173,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of generation of precursor metabolites and energy (GO:0043467),24,20,14.35,+,1.39,0.278,1,13,8.61,+,1.51,0.261,1,18,13.6,+,1.32,0.422,1,1,0.24,+,4.15,0.221,1
cellularization (GO:0007349),6,5,3.59,+,1.39,0.757,1,1,2.15,-,0.46,0.684,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
"photosynthesis, light reaction (GO:0019684)",95,79,56.81,+,1.39,0.0334,1,68,34.07,+,2,2.23E-05,0.0255,76,53.85,+,1.41,0.0253,1,0,0.95,-, < 0.01,1,1
tetrapyrrole biosynthetic process (GO:0033014),41,34,24.52,+,1.39,0.188,1,28,14.7,+,1.9,0.0129,1,34,23.24,+,1.46,0.117,1,1,0.41,+,2.43,0.343,1
pyrimidine-containing compound biosynthetic process (GO:0072528),29,24,17.34,+,1.38,0.256,1,14,10.4,+,1.35,0.386,1,19,16.44,+,1.16,0.653,1,0,0.29,-, < 0.01,1,1
toxin metabolic process (GO:0009404),23,19,13.75,+,1.38,0.338,1,17,8.25,+,2.06,0.0295,1,18,13.04,+,1.38,0.33,1,0,0.23,-, < 0.01,1,1
positive regulation of phosphorylation (GO:0042327),17,14,10.17,+,1.38,0.458,1,6,6.1,-,0.98,1,1,12,9.64,+,1.25,0.566,1,0,0.17,-, < 0.01,1,1
detection of chemical stimulus (GO:0009593),17,14,10.17,+,1.38,0.458,1,10,6.1,+,1.64,0.272,1,12,9.64,+,1.25,0.566,1,0,0.17,-, < 0.01,1,1
monocarboxylic acid catabolic process (GO:0072329),51,42,30.5,+,1.38,0.133,1,21,18.29,+,1.15,0.593,1,48,28.91,+,1.66,0.0119,0.846,0,0.51,-, < 0.01,1,1
positive regulation of defense response (GO:0031349),45,37,26.91,+,1.37,0.17,1,26,16.14,+,1.61,0.0584,1,29,25.51,+,1.14,0.628,1,0,0.45,-, < 0.01,1,1
defense response to oomycetes (GO:0002229),28,23,16.74,+,1.37,0.31,1,17,10.04,+,1.69,0.0908,1,24,15.87,+,1.51,0.149,1,1,0.28,+,3.56,0.252,1
positive regulation of response to biotic stimulus (GO:0002833),39,32,23.32,+,1.37,0.219,1,24,13.99,+,1.72,0.044,1,27,22.11,+,1.22,0.443,1,0,0.39,-, < 0.01,1,1
reactive oxygen species biosynthetic process (GO:1903409),11,9,6.58,+,1.37,0.495,1,6,3.94,+,1.52,0.413,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
regulation of alcohol biosynthetic process (GO:1902930),11,9,6.58,+,1.37,0.495,1,6,3.94,+,1.52,0.413,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
hydrogen peroxide metabolic process (GO:0042743),22,18,13.16,+,1.37,0.33,1,11,7.89,+,1.39,0.428,1,18,12.47,+,1.44,0.252,1,1,0.22,+,4.52,0.206,1
trehalose metabolic process (GO:0005991),11,9,6.58,+,1.37,0.495,1,4,3.94,+,1.01,1,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
aromatic amino acid family catabolic process (GO:0009074),11,9,6.58,+,1.37,0.495,1,5,3.94,+,1.27,0.777,1,10,6.24,+,1.6,0.363,1,0,0.11,-, < 0.01,1,1
glutamine family amino acid catabolic process (GO:0009065),11,9,6.58,+,1.37,0.495,1,3,3.94,-,0.76,1,1,10,6.24,+,1.6,0.363,1,0,0.11,-, < 0.01,1,1
negative regulation of phosphorylation (GO:0042326),11,9,6.58,+,1.37,0.495,1,7,3.94,+,1.77,0.282,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
fructose 6-phosphate metabolic process (GO:0006002),11,9,6.58,+,1.37,0.495,1,8,3.94,+,2.03,0.124,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
"systemic acquired resistance, salicylic acid mediated signaling pathway (GO:0009862)",11,9,6.58,+,1.37,0.495,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
cell wall macromolecule catabolic process (GO:0016998),11,9,6.58,+,1.37,0.495,1,5,3.94,+,1.27,0.777,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
regulation of salicylic acid metabolic process (GO:0010337),11,9,6.58,+,1.37,0.495,1,7,3.94,+,1.77,0.282,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
NAD(P)H dehydrogenase complex assembly (GO:0010275),11,9,6.58,+,1.37,0.495,1,7,3.94,+,1.77,0.282,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
brassinosteroid homeostasis (GO:0010268),11,9,6.58,+,1.37,0.495,1,6,3.94,+,1.52,0.413,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
response to oxygen radical (GO:0000305),11,9,6.58,+,1.37,0.495,1,7,3.94,+,1.77,0.282,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
response to superoxide (GO:0000303),11,9,6.58,+,1.37,0.495,1,7,3.94,+,1.77,0.282,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
porphyrin-containing compound biosynthetic process (GO:0006779),38,31,22.72,+,1.36,0.213,1,25,13.63,+,1.83,0.0214,1,32,21.54,+,1.49,0.105,1,1,0.38,+,2.62,0.323,1
response to chitin (GO:0010200),75,61,44.85,+,1.36,0.0757,1,52,26.9,+,1.93,0.000362,0.103,52,42.51,+,1.22,0.267,1,0,0.75,-, < 0.01,1,1
reactive oxygen species metabolic process (GO:0072593),48,39,28.7,+,1.36,0.182,1,27,17.21,+,1.57,0.0658,1,36,27.21,+,1.32,0.212,1,1,0.48,+,2.07,0.388,1
benzene-containing compound metabolic process (GO:0042537),32,26,19.14,+,1.36,0.277,1,19,11.48,+,1.66,0.0816,1,22,18.14,+,1.21,0.482,1,0,0.32,-, < 0.01,1,1
"defense response to fungus, incompatible interaction (GO:0009817)",32,26,19.14,+,1.36,0.277,1,18,11.48,+,1.57,0.147,1,27,18.14,+,1.49,0.136,1,0,0.32,-, < 0.01,1,1
protein homooligomerization (GO:0051260),16,13,9.57,+,1.36,0.445,1,8,5.74,+,1.39,0.487,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
dicarboxylic acid biosynthetic process (GO:0043650),16,13,9.57,+,1.36,0.445,1,4,5.74,-,0.7,0.62,1,11,9.07,+,1.21,0.69,1,0,0.16,-, < 0.01,1,1
nucleotide-sugar biosynthetic process (GO:0009226),26,21,15.55,+,1.35,0.365,1,7,9.32,-,0.75,0.692,1,14,14.74,-,0.95,1,1,0,0.26,-, < 0.01,1,1
glucose 6-phosphate metabolic process (GO:0051156),26,21,15.55,+,1.35,0.365,1,16,9.32,+,1.72,0.113,1,20,14.74,+,1.36,0.357,1,2,0.26,+,7.66,0.0313,1
RNA capping (GO:0036260),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
negative regulation of plant-type hypersensitive response (GO:0034051),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
mitochondrial calcium ion transmembrane transport (GO:0006851),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
chloroplast fission (GO:0010020),20,16,11.96,+,1.34,0.393,1,13,7.17,+,1.81,0.112,1,16,11.34,+,1.41,0.303,1,0,0.2,-, < 0.01,1,1
7-methylguanosine RNA capping (GO:0009452),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
methylglyoxal metabolic process (GO:0009438),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
antisense RNA metabolic process (GO:0042868),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
osmosensory signaling pathway (GO:0007231),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
vitamin B6 metabolic process (GO:0042816),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
fat-soluble vitamin metabolic process (GO:0006775),10,8,5.98,+,1.34,0.628,1,5,3.59,+,1.39,0.561,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
callose localization (GO:0052545),20,16,11.96,+,1.34,0.393,1,13,7.17,+,1.81,0.112,1,14,11.34,+,1.23,0.593,1,0,0.2,-, < 0.01,1,1
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
icosanoid metabolic process (GO:0006690),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
phosphatidic acid biosynthetic process (GO:0006654),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
fatty acid beta-oxidation (GO:0006635),30,24,17.94,+,1.34,0.324,1,9,10.76,-,0.84,0.719,1,29,17.01,+,1.71,0.042,1,0,0.3,-, < 0.01,1,1
pattern recognition receptor signaling pathway (GO:0002221),10,8,5.98,+,1.34,0.628,1,7,3.59,+,1.95,0.174,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
tRNA pseudouridine synthesis (GO:0031119),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
tubulin complex assembly (GO:0007021),5,4,2.99,+,1.34,0.736,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
indolalkylamine metabolic process (GO:0006586),15,12,8.97,+,1.34,0.551,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
tyrosine catabolic process (GO:0006572),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
tryptophan metabolic process (GO:0006568),15,12,8.97,+,1.34,0.551,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
nucleobase transport (GO:0015851),10,8,5.98,+,1.34,0.628,1,5,3.59,+,1.39,0.561,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
cell wall pectin biosynthetic process (GO:0052325),10,8,5.98,+,1.34,0.628,1,4,3.59,+,1.12,0.77,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
tRNA wobble uridine modification (GO:0002098),15,12,8.97,+,1.34,0.551,1,6,5.38,+,1.12,0.806,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
leucine biosynthetic process (GO:0009098),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
indole-containing compound catabolic process (GO:0042436),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
protein geranylgeranylation (GO:0018344),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
cellular response to chitin (GO:0071323),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
protein import into chloroplast stroma (GO:0045037),20,16,11.96,+,1.34,0.393,1,10,7.17,+,1.39,0.408,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
fat-soluble vitamin biosynthetic process (GO:0042362),10,8,5.98,+,1.34,0.628,1,5,3.59,+,1.39,0.561,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
"base-excision repair, AP site formation (GO:0006285)",5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
methylglyoxal catabolic process (GO:0051596),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
negative regulation of RNA catabolic process (GO:1902369),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
mitochondrial calcium ion homeostasis (GO:0051560),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
purine nucleobase catabolic process (GO:0006145),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
TOR signaling (GO:0031929),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
ketone catabolic process (GO:0042182),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
cellular response to glucose starvation (GO:0042149),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
lactate metabolic process (GO:0006089),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
acetyl-CoA metabolic process (GO:0006084),20,16,11.96,+,1.34,0.393,1,12,7.17,+,1.67,0.162,1,14,11.34,+,1.23,0.593,1,0,0.2,-, < 0.01,1,1
response to mannitol (GO:0010555),10,8,5.98,+,1.34,0.628,1,6,3.59,+,1.67,0.392,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
hydrocarbon catabolic process (GO:0120253),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
ammonia assimilation cycle (GO:0019676),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
protein localization to plasma membrane (GO:0072659),10,8,5.98,+,1.34,0.628,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
monoterpene metabolic process (GO:0043692),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
negative regulation of proteolysis (GO:0045861),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
pH reduction (GO:0045851),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
protein tetramerization (GO:0051262),10,8,5.98,+,1.34,0.628,1,4,3.59,+,1.12,0.77,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
gibberellic acid homeostasis (GO:0010336),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
glycerol catabolic process (GO:0019563),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
negative regulation of response to water deprivation (GO:0080148),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
detection of endogenous stimulus (GO:0009726),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
detection of hormone stimulus (GO:0009720),5,4,2.99,+,1.34,0.736,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
de-etiolation (GO:0009704),10,8,5.98,+,1.34,0.628,1,5,3.59,+,1.39,0.561,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
calcium import into the mitochondrion (GO:0036444),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
regulation of salicylic acid mediated signaling pathway (GO:2000031),15,12,8.97,+,1.34,0.551,1,7,5.38,+,1.3,0.628,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
regulation of ARF protein signal transduction (GO:0032012),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
plastid fission (GO:0043572),20,16,11.96,+,1.34,0.393,1,13,7.17,+,1.81,0.112,1,16,11.34,+,1.41,0.303,1,0,0.2,-, < 0.01,1,1
salicylic acid biosynthetic process (GO:0009697),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
indolebutyric acid metabolic process (GO:0080024),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
positive regulation of mRNA processing (GO:0050685),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
alditol catabolic process (GO:0019405),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
mucilage metabolic process involved in seed coat development (GO:0048359),10,8,5.98,+,1.34,0.628,1,3,3.59,-,0.84,1,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
response to symbiont (GO:0009608),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
cytosolic calcium ion transport (GO:0060401),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
nuclear envelope organization (GO:0006998),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of binding (GO:0051098),5,4,2.99,+,1.34,0.736,1,0,1.79,-, < 0.01,0.335,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
RNA stabilization (GO:0043489),5,4,2.99,+,1.34,0.736,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
transpiration (GO:0010148),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
embryo sac cellularization (GO:0009558),5,4,2.99,+,1.34,0.736,1,1,1.79,-,0.56,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
tripeptide transport (GO:0042939),5,4,2.99,+,1.34,0.736,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),25,20,14.95,+,1.34,0.356,1,14,8.97,+,1.56,0.202,1,18,14.17,+,1.27,0.432,1,0,0.25,-, < 0.01,1,1
protein targeting to chloroplast (GO:0045036),35,28,20.93,+,1.34,0.297,1,19,12.55,+,1.51,0.163,1,26,19.84,+,1.31,0.289,1,0,0.35,-, < 0.01,1,1
chaperone-mediated protein folding (GO:0061077),45,36,26.91,+,1.34,0.206,1,22,16.14,+,1.36,0.266,1,32,25.51,+,1.25,0.343,1,1,0.45,+,2.21,0.369,1
establishment of protein localization to chloroplast (GO:0072596),35,28,20.93,+,1.34,0.297,1,19,12.55,+,1.51,0.163,1,26,19.84,+,1.31,0.289,1,0,0.35,-, < 0.01,1,1
cellular carbohydrate catabolic process (GO:0044275),34,27,20.33,+,1.33,0.29,1,19,12.19,+,1.56,0.12,1,28,19.27,+,1.45,0.147,1,2,0.34,+,5.86,0.0496,1
fatty acid oxidation (GO:0019395),34,27,20.33,+,1.33,0.29,1,10,12.19,-,0.82,0.732,1,31,19.27,+,1.61,0.0693,1,0,0.34,-, < 0.01,1,1
pigment biosynthetic process (GO:0046148),77,61,46.05,+,1.32,0.112,1,45,27.61,+,1.63,0.00995,0.947,59,43.65,+,1.35,0.0887,1,1,0.77,+,1.29,0.543,1
oligosaccharide biosynthetic process (GO:0009312),24,19,14.35,+,1.32,0.43,1,9,8.61,+,1.05,0.846,1,19,13.6,+,1.4,0.271,1,0,0.24,-, < 0.01,1,1
secondary metabolite biosynthetic process (GO:0044550),67,53,40.07,+,1.32,0.131,1,38,24.03,+,1.58,0.0262,1,45,37.98,+,1.18,0.376,1,1,0.67,+,1.49,0.494,1
cellular ketone metabolic process (GO:0042180),43,34,25.71,+,1.32,0.239,1,22,15.42,+,1.43,0.203,1,34,24.37,+,1.39,0.154,1,0,0.43,-, < 0.01,1,1
cell wall pectin metabolic process (GO:0052546),19,15,11.36,+,1.32,0.479,1,8,6.81,+,1.17,0.667,1,14,10.77,+,1.3,0.472,1,0,0.19,-, < 0.01,1,1
pyrimidine ribonucleotide biosynthetic process (GO:0009220),19,15,11.36,+,1.32,0.479,1,10,6.81,+,1.47,0.398,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
pyrimidine ribonucleotide metabolic process (GO:0009218),19,15,11.36,+,1.32,0.479,1,10,6.81,+,1.47,0.398,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
disaccharide biosynthetic process (GO:0046351),19,15,11.36,+,1.32,0.479,1,7,6.81,+,1.03,1,1,15,10.77,+,1.39,0.373,1,0,0.19,-, < 0.01,1,1
pyrimidine-containing compound metabolic process (GO:0072527),38,30,22.72,+,1.32,0.26,1,16,13.63,+,1.17,0.643,1,25,21.54,+,1.16,0.6,1,0,0.38,-, < 0.01,1,1
mucilage metabolic process (GO:0010191),19,15,11.36,+,1.32,0.479,1,5,6.81,-,0.73,0.648,1,16,10.77,+,1.49,0.29,1,0,0.19,-, < 0.01,1,1
aromatic amino acid family metabolic process (GO:0009072),52,41,31.1,+,1.32,0.198,1,25,18.65,+,1.34,0.243,1,37,29.48,+,1.26,0.32,1,1,0.52,+,1.91,0.412,1
fatty acid catabolic process (GO:0009062),33,26,19.73,+,1.32,0.346,1,10,11.83,-,0.84,0.731,1,31,18.71,+,1.66,0.05,1,0,0.33,-, < 0.01,1,1
ketone biosynthetic process (GO:0042181),33,26,19.73,+,1.32,0.346,1,18,11.83,+,1.52,0.154,1,26,18.71,+,1.39,0.223,1,0,0.33,-, < 0.01,1,1
chlorophyll metabolic process (GO:0015994),47,37,28.11,+,1.32,0.215,1,29,16.85,+,1.72,0.0259,1,40,26.64,+,1.5,0.0729,1,1,0.47,+,2.12,0.382,1
Golgi to plasma membrane transport (GO:0006893),14,11,8.37,+,1.31,0.538,1,7,5.02,+,1.39,0.463,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
isopentenyl diphosphate biosynthetic process (GO:0009240),14,11,8.37,+,1.31,0.538,1,12,5.02,+,2.39,0.0416,1,11,7.94,+,1.39,0.412,1,1,0.14,+,7.11,0.139,1
L-phenylalanine metabolic process (GO:0006558),14,11,8.37,+,1.31,0.538,1,6,5.02,+,1.2,0.8,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
intracellular receptor signaling pathway (GO:0030522),14,11,8.37,+,1.31,0.538,1,3,5.02,-,0.6,0.584,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),14,11,8.37,+,1.31,0.538,1,6,5.02,+,1.2,0.8,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
isopentenyl diphosphate metabolic process (GO:0046490),14,11,8.37,+,1.31,0.538,1,12,5.02,+,2.39,0.0416,1,11,7.94,+,1.39,0.412,1,1,0.14,+,7.11,0.139,1
positive regulation of response to external stimulus (GO:0032103),42,33,25.12,+,1.31,0.282,1,24,15.06,+,1.59,0.0697,1,29,23.81,+,1.22,0.458,1,0,0.42,-, < 0.01,1,1
blue light signaling pathway (GO:0009785),14,11,8.37,+,1.31,0.538,1,3,5.02,-,0.6,0.584,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
protein localization to chloroplast (GO:0072598),37,29,22.13,+,1.31,0.308,1,19,13.27,+,1.43,0.224,1,27,20.97,+,1.29,0.362,1,0,0.37,-, < 0.01,1,1
phenol-containing compound metabolic process (GO:0018958),23,18,13.75,+,1.31,0.421,1,15,8.25,+,1.82,0.0947,1,15,13.04,+,1.15,0.736,1,0,0.23,-, < 0.01,1,1
quinone biosynthetic process (GO:1901663),32,25,19.14,+,1.31,0.338,1,17,11.48,+,1.48,0.195,1,25,18.14,+,1.38,0.269,1,0,0.32,-, < 0.01,1,1
quinone metabolic process (GO:1901661),32,25,19.14,+,1.31,0.338,1,17,11.48,+,1.48,0.195,1,25,18.14,+,1.38,0.269,1,0,0.32,-, < 0.01,1,1
NADH metabolic process (GO:0006734),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
cellular glucose homeostasis (GO:0001678),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
nucleotide-sugar transmembrane transport (GO:0015780),18,14,10.76,+,1.3,0.469,1,7,6.46,+,1.08,0.823,1,8,10.2,-,0.78,0.685,1,1,0.18,+,5.53,0.173,1
"aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)",9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
monosaccharide transmembrane transport (GO:0015749),9,7,5.38,+,1.3,0.613,1,7,3.23,+,2.17,0.152,1,5,5.1,-,0.98,1,1,1,0.09,+,11.06,0.0952,1
protein prenylation (GO:0018342),9,7,5.38,+,1.3,0.613,1,6,3.23,+,1.86,0.245,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
vitamin E metabolic process (GO:0042360),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
DNA topological change (GO:0006265),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
prenylation (GO:0097354),9,7,5.38,+,1.3,0.613,1,6,3.23,+,1.86,0.245,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
heme metabolic process (GO:0042168),18,14,10.76,+,1.3,0.469,1,12,6.46,+,1.86,0.0986,1,12,10.2,+,1.18,0.705,1,0,0.18,-, < 0.01,1,1
phosphatidylcholine metabolic process (GO:0046470),9,7,5.38,+,1.3,0.613,1,5,3.23,+,1.55,0.543,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
regulation of shoot apical meristem development (GO:1902183),9,7,5.38,+,1.3,0.613,1,3,3.23,-,0.93,1,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
"induced systemic resistance, jasmonic acid mediated signaling pathway (GO:0009864)",9,7,5.38,+,1.3,0.613,1,7,3.23,+,2.17,0.152,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
monosaccharide catabolic process (GO:0046365),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
monosaccharide biosynthetic process (GO:0046364),36,28,21.53,+,1.3,0.303,1,21,12.91,+,1.63,0.0961,1,28,20.41,+,1.37,0.241,1,1,0.36,+,2.77,0.31,1
primary alcohol metabolic process (GO:0034308),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
positive regulation of protein kinase activity (GO:0045860),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
dicarboxylic acid catabolic process (GO:0043649),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
sequestering of metal ion (GO:0051238),9,7,5.38,+,1.3,0.613,1,2,3.23,-,0.62,0.739,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
cellular heat acclimation (GO:0070370),9,7,5.38,+,1.3,0.613,1,5,3.23,+,1.55,0.543,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
lipid translocation (GO:0034204),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
regulation of immune effector process (GO:0002697),9,7,5.38,+,1.3,0.613,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
regulation of defense response to virus (GO:0050688),9,7,5.38,+,1.3,0.613,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
nucleobase catabolic process (GO:0046113),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
vitamin E biosynthetic process (GO:0010189),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
cysteine biosynthetic process (GO:0019344),9,7,5.38,+,1.3,0.613,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
cellular detoxification (GO:1990748),27,21,16.15,+,1.3,0.373,1,15,9.68,+,1.55,0.218,1,20,15.31,+,1.31,0.365,1,0,0.27,-, < 0.01,1,1
hexose metabolic process (GO:0019318),54,42,32.29,+,1.3,0.206,1,32,19.37,+,1.65,0.027,1,40,30.61,+,1.31,0.198,1,1,0.54,+,1.84,0.424,1
response to amino acid (GO:0043200),22,17,13.16,+,1.29,0.414,1,14,7.89,+,1.77,0.0914,1,14,12.47,+,1.12,0.731,1,0,0.22,-, < 0.01,1,1
polysaccharide localization (GO:0033037),22,17,13.16,+,1.29,0.414,1,13,7.89,+,1.65,0.177,1,15,12.47,+,1.2,0.609,1,0,0.22,-, < 0.01,1,1
pyrimidine nucleotide biosynthetic process (GO:0006221),22,17,13.16,+,1.29,0.414,1,11,7.89,+,1.39,0.428,1,13,12.47,+,1.04,1,1,0,0.22,-, < 0.01,1,1
pyrimidine nucleotide metabolic process (GO:0006220),22,17,13.16,+,1.29,0.414,1,11,7.89,+,1.39,0.428,1,13,12.47,+,1.04,1,1,0,0.22,-, < 0.01,1,1
sulfur compound biosynthetic process (GO:0044272),79,61,47.24,+,1.29,0.137,1,38,28.33,+,1.34,0.141,1,53,44.78,+,1.18,0.364,1,1,0.79,+,1.26,0.552,1
protein autoubiquitination (GO:0051865),13,10,7.77,+,1.29,0.528,1,7,4.66,+,1.5,0.445,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
negative regulation of defense response to bacterium (GO:1900425),13,10,7.77,+,1.29,0.528,1,8,4.66,+,1.72,0.222,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
glycogen metabolic process (GO:0005977),13,10,7.77,+,1.29,0.528,1,8,4.66,+,1.72,0.222,1,8,7.37,+,1.09,0.824,1,2,0.13,+,15.31,0.00947,1
pigment metabolic process (GO:0042440),91,70,54.42,+,1.29,0.12,1,51,32.63,+,1.56,0.0126,1,68,51.58,+,1.32,0.0971,1,1,0.91,+,1.09,0.603,1
response to calcium ion (GO:0051592),13,10,7.77,+,1.29,0.528,1,6,4.66,+,1.29,0.606,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
energy reserve metabolic process (GO:0006112),13,10,7.77,+,1.29,0.528,1,8,4.66,+,1.72,0.222,1,8,7.37,+,1.09,0.824,1,2,0.13,+,15.31,0.00947,1
galactolipid metabolic process (GO:0019374),13,10,7.77,+,1.29,0.528,1,5,4.66,+,1.07,1,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
aromatic amino acid family biosynthetic process (GO:0009073),39,30,23.32,+,1.29,0.32,1,18,13.99,+,1.29,0.369,1,25,22.11,+,1.13,0.696,1,1,0.39,+,2.55,0.33,1
response to hexose (GO:0009746),43,33,25.71,+,1.28,0.287,1,21,15.42,+,1.36,0.256,1,30,24.37,+,1.23,0.394,1,1,0.43,+,2.31,0.356,1
heme biosynthetic process (GO:0006783),17,13,10.17,+,1.28,0.572,1,11,6.1,+,1.8,0.134,1,12,9.64,+,1.25,0.566,1,0,0.17,-, < 0.01,1,1
pectin biosynthetic process (GO:0045489),34,26,20.33,+,1.28,0.352,1,10,12.19,-,0.82,0.732,1,25,19.27,+,1.3,0.343,1,0,0.34,-, < 0.01,1,1
potassium ion homeostasis (GO:0055075),17,13,10.17,+,1.28,0.572,1,7,6.1,+,1.15,0.817,1,11,9.64,+,1.14,0.7,1,0,0.17,-, < 0.01,1,1
viral process (GO:0016032),17,13,10.17,+,1.28,0.572,1,7,6.1,+,1.15,0.817,1,13,9.64,+,1.35,0.449,1,0,0.17,-, < 0.01,1,1
cellular polysaccharide catabolic process (GO:0044247),17,13,10.17,+,1.28,0.572,1,10,6.1,+,1.64,0.272,1,13,9.64,+,1.35,0.449,1,2,0.17,+,11.71,0.015,1
protein repair (GO:0030091),17,13,10.17,+,1.28,0.572,1,12,6.1,+,1.97,0.0889,1,13,9.64,+,1.35,0.449,1,0,0.17,-, < 0.01,1,1
salicylic acid metabolic process (GO:0009696),17,13,10.17,+,1.28,0.572,1,11,6.1,+,1.8,0.134,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
nucleobase biosynthetic process (GO:0046112),17,13,10.17,+,1.28,0.572,1,8,6.1,+,1.31,0.502,1,11,9.64,+,1.14,0.7,1,0,0.17,-, < 0.01,1,1
pentose-phosphate shunt (GO:0006098),21,16,12.56,+,1.27,0.498,1,14,7.53,+,1.86,0.0826,1,16,11.9,+,1.34,0.394,1,2,0.21,+,9.48,0.0217,1
plastid organization (GO:0009657),231,176,138.14,+,1.27,0.015,1,121,82.84,+,1.46,0.000938,0.206,161,130.94,+,1.23,0.0437,1,1,2.32,-,0.43,0.732,1
steroid biosynthetic process (GO:0006694),29,22,17.34,+,1.27,0.389,1,16,10.4,+,1.54,0.176,1,19,16.44,+,1.16,0.653,1,0,0.29,-, < 0.01,1,1
peptidyl-serine modification (GO:0018209),58,44,34.68,+,1.27,0.259,1,28,20.8,+,1.35,0.219,1,32,32.88,-,0.97,1,1,0,0.58,-, < 0.01,1,1
calcium ion transmembrane transport (GO:0070588),29,22,17.34,+,1.27,0.389,1,17,10.4,+,1.63,0.13,1,23,16.44,+,1.4,0.248,1,0,0.29,-, < 0.01,1,1
flavonoid biosynthetic process (GO:0009813),29,22,17.34,+,1.27,0.389,1,14,10.4,+,1.35,0.386,1,19,16.44,+,1.16,0.653,1,0,0.29,-, < 0.01,1,1
secondary metabolic process (GO:0019748),120,91,71.76,+,1.27,0.0866,1,66,43.03,+,1.53,0.00573,0.629,83,68.02,+,1.22,0.164,1,1,1.21,-,0.83,1,1
phenylpropanoid metabolic process (GO:0009698),62,47,37.08,+,1.27,0.234,1,35,22.23,+,1.57,0.037,1,43,35.15,+,1.22,0.31,1,1,0.62,+,1.61,0.468,1
ATP generation from ADP (GO:0006757),33,25,19.73,+,1.27,0.415,1,16,11.83,+,1.35,0.331,1,26,18.71,+,1.39,0.223,1,2,0.33,+,6.03,0.0472,1
'de novo' protein folding (GO:0006458),33,25,19.73,+,1.27,0.415,1,18,11.83,+,1.52,0.154,1,21,18.71,+,1.12,0.673,1,1,0.33,+,3.02,0.288,1
glycolytic process (GO:0006096),33,25,19.73,+,1.27,0.415,1,16,11.83,+,1.35,0.331,1,26,18.71,+,1.39,0.223,1,2,0.33,+,6.03,0.0472,1
monosaccharide metabolic process (GO:0005996),78,59,46.64,+,1.26,0.184,1,43,27.97,+,1.54,0.0291,1,54,44.21,+,1.22,0.276,1,1,0.78,+,1.28,0.547,1
lipid oxidation (GO:0034440),41,31,24.52,+,1.26,0.331,1,13,14.7,-,0.88,0.76,1,37,23.24,+,1.59,0.0444,1,1,0.41,+,2.43,0.343,1
response to monosaccharide (GO:0034284),45,34,26.91,+,1.26,0.297,1,22,16.14,+,1.36,0.266,1,31,25.51,+,1.22,0.405,1,1,0.45,+,2.21,0.369,1
lateral root morphogenesis (GO:0010102),45,34,26.91,+,1.26,0.297,1,17,16.14,+,1.05,0.885,1,31,25.51,+,1.22,0.405,1,0,0.45,-, < 0.01,1,1
cell redox homeostasis (GO:0045454),53,40,31.69,+,1.26,0.283,1,32,19.01,+,1.68,0.0255,1,40,30.04,+,1.33,0.194,1,5,0.53,+,9.39,0.000271,0.515
tetrapyrrole metabolic process (GO:0033013),57,43,34.09,+,1.26,0.256,1,33,20.44,+,1.61,0.0308,1,46,32.31,+,1.42,0.0804,1,1,0.57,+,1.75,0.441,1
peptidyl-serine phosphorylation (GO:0018105),57,43,34.09,+,1.26,0.256,1,28,20.44,+,1.37,0.175,1,32,32.31,-,0.99,1,1,0,0.57,-, < 0.01,1,1
response to fungus (GO:0009620),198,149,118.41,+,1.26,0.0335,1,96,71.01,+,1.35,0.0162,1,142,112.24,+,1.27,0.035,1,1,1.99,-,0.5,0.726,1
defense response to fungus (GO:0050832),145,109,86.71,+,1.26,0.0779,1,71,52,+,1.37,0.0356,1,103,82.19,+,1.25,0.0838,1,1,1.46,-,0.69,1,1
glucan catabolic process (GO:0009251),20,15,11.96,+,1.25,0.491,1,13,7.17,+,1.81,0.112,1,16,11.34,+,1.41,0.303,1,3,0.2,+,14.93,0.00147,1
regulation of isoprenoid metabolic process (GO:0019747),20,15,11.96,+,1.25,0.491,1,8,7.17,+,1.12,0.83,1,14,11.34,+,1.23,0.593,1,0,0.2,-, < 0.01,1,1
response to glucose (GO:0009749),40,30,23.92,+,1.25,0.387,1,19,14.34,+,1.32,0.303,1,27,22.67,+,1.19,0.525,1,1,0.4,+,2.49,0.337,1
wax metabolic process (GO:0010166),20,15,11.96,+,1.25,0.491,1,7,7.17,-,0.98,1,1,16,11.34,+,1.41,0.303,1,0,0.2,-, < 0.01,1,1
chloroplast RNA processing (GO:0031425),20,15,11.96,+,1.25,0.491,1,9,7.17,+,1.25,0.534,1,15,11.34,+,1.32,0.482,1,0,0.2,-, < 0.01,1,1
stress granule assembly (GO:0034063),8,6,4.78,+,1.25,0.784,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
purine nucleobase transport (GO:0006863),8,6,4.78,+,1.25,0.784,1,5,2.87,+,1.74,0.348,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),4,3,2.39,+,1.25,0.718,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
calcium ion transport (GO:0006816),48,36,28.7,+,1.25,0.311,1,25,17.21,+,1.45,0.143,1,36,27.21,+,1.32,0.212,1,0,0.48,-, < 0.01,1,1
vegetative phase change (GO:0010050),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
regulation of nitrogen utilization (GO:0006808),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of mitotic spindle organization (GO:0060236),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
toxin catabolic process (GO:0009407),16,12,9.57,+,1.25,0.562,1,10,5.74,+,1.74,0.181,1,12,9.07,+,1.32,0.555,1,0,0.16,-, < 0.01,1,1
pyridoxal phosphate biosynthetic process (GO:0042823),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
pyridoxal phosphate metabolic process (GO:0042822),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
vitamin B6 biosynthetic process (GO:0042819),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
cuticle hydrocarbon biosynthetic process (GO:0006723),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
negative regulation of ion transport (GO:0043271),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
arabinan catabolic process (GO:0031222),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
arabinan metabolic process (GO:0031221),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
viral gene silencing in virus induced gene silencing (GO:0060145),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
plant-type cell wall cellulose metabolic process (GO:0052541),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
negative regulation of mRNA metabolic process (GO:1903312),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
defense response to nematode (GO:0002215),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
carbon utilization (GO:0015976),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
maltose metabolic process (GO:0000023),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
modulation by virus of host process (GO:0019048),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
deoxyribonucleotide catabolic process (GO:0009264),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cell cycle arrest (GO:0007050),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
nucleotide-sugar metabolic process (GO:0009225),32,24,19.14,+,1.25,0.409,1,9,11.48,-,0.78,0.598,1,18,18.14,-,0.99,1,1,0,0.32,-, < 0.01,1,1
vacuolar acidification (GO:0007035),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of response to reactive oxygen species (GO:1901031),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
hydrogen peroxide mediated signaling pathway (GO:0071588),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
proline metabolic process (GO:0006560),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
zinc ion homeostasis (GO:0055069),8,6,4.78,+,1.25,0.784,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
aspartate metabolic process (GO:0006531),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
malonyl-CoA biosynthetic process (GO:2001295),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
ATP transport (GO:0015867),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
ADP transport (GO:0015866),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
nucleoside transport (GO:0015858),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
urea transport (GO:0015840),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
pyrimidine nucleoside diphosphate metabolic process (GO:0009138),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
nucleoside diphosphate biosynthetic process (GO:0009133),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
pteridine-containing compound biosynthetic process (GO:0042559),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,7,6.8,+,1.03,1,1,1,0.12,+,8.3,0.122,1
protein O-linked glycosylation (GO:0006493),8,6,4.78,+,1.25,0.784,1,3,2.87,+,1.05,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
response to purine-containing compound (GO:0014074),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
hexose transmembrane transport (GO:0008645),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,1,0.04,+,24.89,0.0488,1
chloroplast disassembly (GO:1904821),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
UDP-glucose transmembrane transport (GO:0015786),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
glycogen biosynthetic process (GO:0005978),8,6,4.78,+,1.25,0.784,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
sequestering of iron ion (GO:0097577),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
terpenoid transport (GO:0046865),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
isoprenoid transport (GO:0046864),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
phosphoenolpyruvate transport (GO:0015714),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
"pentose-phosphate shunt, oxidative branch (GO:0009051)",8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,1,0.08,+,12.44,0.0861,1
negative regulation of cell division (GO:0051782),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cellular response to disaccharide stimulus (GO:0071324),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
brassinosteroid biosynthetic process (GO:0016132),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
phytosteroid biosynthetic process (GO:0016129),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
negative regulation of intracellular signal transduction (GO:1902532),16,12,9.57,+,1.25,0.562,1,8,5.74,+,1.39,0.487,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
carotene catabolic process (GO:0016121),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
reactive nitrogen species metabolic process (GO:2001057),8,6,4.78,+,1.25,0.784,1,5,2.87,+,1.74,0.348,1,5,4.53,+,1.1,1,1,1,0.08,+,12.44,0.0861,1
hydrogen sulfide biosynthetic process (GO:0070814),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,1,0.04,+,24.89,0.0488,1
regulation of transmembrane transport (GO:0034762),16,12,9.57,+,1.25,0.562,1,9,5.74,+,1.57,0.264,1,11,9.07,+,1.21,0.69,1,0,0.16,-, < 0.01,1,1
"regulation of defense response to bacterium, incompatible interaction (GO:1902477)",4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
transcription-coupled nucleotide-excision repair (GO:0006283),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
negative regulation of cell growth (GO:0030308),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
cellular response to misfolded protein (GO:0071218),16,12,9.57,+,1.25,0.562,1,7,5.74,+,1.22,0.64,1,12,9.07,+,1.32,0.555,1,0,0.16,-, < 0.01,1,1
detection of bacterium (GO:0016045),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
granum assembly (GO:0090391),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of shade avoidance (GO:1902446),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
protein glutathionylation (GO:0010731),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
pyrimidine nucleobase catabolic process (GO:0006208),4,3,2.39,+,1.25,0.718,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
mitotic spindle assembly (GO:0090307),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
response to copper ion (GO:0046688),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
root cap development (GO:0048829),8,6,4.78,+,1.25,0.784,1,0,2.87,-, < 0.01,0.12,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
Golgi calcium ion transport (GO:0032472),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
Golgi calcium ion homeostasis (GO:0032468),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
endosome to lysosome transport (GO:0008333),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of glutamine family amino acid metabolic process (GO:0000820),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
positive regulation of unidimensional cell growth (GO:0051512),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
positive regulation of histone H3-K9 dimethylation (GO:1900111),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
malate metabolic process (GO:0006108),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,10,6.8,+,1.47,0.38,1,0,0.12,-, < 0.01,1,1
uracil metabolic process (GO:0019860),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of spindle organization (GO:0090224),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
glycerolipid catabolic process (GO:0046503),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of COPII vesicle coating (GO:0003400),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of DNA-dependent DNA replication initiation (GO:0030174),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
protein localization to cell periphery (GO:1990778),12,9,7.18,+,1.25,0.654,1,3,4.3,-,0.7,0.772,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
tricarboxylic acid cycle (GO:0006099),24,18,14.35,+,1.25,0.524,1,7,8.61,-,0.81,0.838,1,20,13.6,+,1.47,0.211,1,1,0.24,+,4.15,0.221,1
intracellular pH reduction (GO:0051452),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of cellular response to hypoxia (GO:1900037),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
fructose metabolic process (GO:0006000),8,6,4.78,+,1.25,0.784,1,6,2.87,+,2.09,0.22,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
pyrimidine nucleotide salvage (GO:0032262),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
AMP salvage (GO:0044209),4,3,2.39,+,1.25,0.718,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
UMP salvage (GO:0044206),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cell wall beta-glucan metabolic process (GO:0034406),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
embryonic pattern specification (GO:0009880),16,12,9.57,+,1.25,0.562,1,7,5.74,+,1.22,0.64,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
"regulation of short-day photoperiodism, flowering (GO:0048587)",4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
"regulation of long-day photoperiodism, flowering (GO:0048586)",12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
steroid hormone biosynthetic process (GO:0120178),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
nucleoside transmembrane transport (GO:1901642),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
lignan biosynthetic process (GO:0009807),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
lignan metabolic process (GO:0009806),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of membrane lipid distribution (GO:0097035),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
regulation of fatty acid oxidation (GO:0046320),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
activation of protein kinase activity (GO:0032147),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
monoterpene biosynthetic process (GO:0043693),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
regulation of cell wall pectin metabolic process (GO:1902066),4,3,2.39,+,1.25,0.718,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of DNA-templated transcription in response to stress (GO:0043620),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
abscisic acid transport (GO:0080168),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
purine-containing compound transmembrane transport (GO:0072530),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
"photosynthesis, light harvesting in photosystem II (GO:0009769)",4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
response to paraquat (GO:1901562),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
stamen formation (GO:0048455),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
terpene catabolic process (GO:0046247),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of L-ascorbic acid biosynthetic process (GO:2000082),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
spermine catabolic process (GO:0046208),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
response to lead ion (GO:0010288),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of chlorophyll catabolic process (GO:0010271),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
NADH dehydrogenase complex (plastoquinone) assembly (GO:0010258),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
chloroplast mRNA processing (GO:0010239),8,6,4.78,+,1.25,0.784,1,5,2.87,+,1.74,0.348,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
regulation of response to endoplasmic reticulum stress (GO:1905897),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
beta-alanine metabolic process (GO:0019482),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
negative regulation of phosphorelay signal transduction system (GO:0070298),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
negative regulation of anthocyanin metabolic process (GO:0031538),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
indoleacetic acid metabolic process (GO:0009683),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
plasmodesma organization (GO:0009663),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
cellular response to boron-containing substance levels (GO:0080029),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
thigmotropism (GO:0009652),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
mucilage extrusion from seed coat (GO:0080001),8,6,4.78,+,1.25,0.784,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
phenol-containing compound biosynthetic process (GO:0046189),8,6,4.78,+,1.25,0.784,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
mucilage pectin biosynthetic process (GO:0048358),4,3,2.39,+,1.25,0.718,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of tetrapyrrole catabolic process (GO:1901404),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
ribulose bisphosphate carboxylase complex assembly (GO:0110102),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of cellular defense response (GO:0010185),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
detection of other organism (GO:0098543),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
response to potassium ion (GO:0035864),4,3,2.39,+,1.25,0.718,1,2,1.43,+,1.39,0.658,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
pyrimidine ribonucleotide salvage (GO:0010138),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
ureide catabolic process (GO:0010136),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
ureide metabolic process (GO:0010135),4,3,2.39,+,1.25,0.718,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
regulation of abscisic acid biosynthetic process (GO:0010115),8,6,4.78,+,1.25,0.784,1,5,2.87,+,1.74,0.348,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
protein deneddylation (GO:0000338),8,6,4.78,+,1.25,0.784,1,1,2.87,-,0.35,0.461,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
cellular response to iron ion starvation (GO:0010106),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
negative regulation of ethylene-activated signaling pathway (GO:0010105),12,9,7.18,+,1.25,0.654,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
adenosine metabolic process (GO:0046085),4,3,2.39,+,1.25,0.718,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
cellular response to reactive oxygen species (GO:0034614),28,21,16.74,+,1.25,0.461,1,12,10.04,+,1.2,0.593,1,20,15.87,+,1.26,0.454,1,0,0.28,-, < 0.01,1,1
cellular response to toxic substance (GO:0097237),28,21,16.74,+,1.25,0.461,1,16,10.04,+,1.59,0.169,1,20,15.87,+,1.26,0.454,1,0,0.28,-, < 0.01,1,1
divalent inorganic cation transport (GO:0072511),79,59,47.24,+,1.25,0.216,1,34,28.33,+,1.2,0.392,1,60,44.78,+,1.34,0.0924,1,0,0.79,-, < 0.01,1,1
response to oxygen levels (GO:0070482),154,115,92.09,+,1.25,0.0756,1,83,55.23,+,1.5,0.00369,0.479,107,87.3,+,1.23,0.105,1,1,1.55,-,0.65,1,1
lateral root development (GO:0048527),75,56,44.85,+,1.25,0.206,1,32,26.9,+,1.19,0.441,1,51,42.51,+,1.2,0.308,1,0,0.75,-, < 0.01,1,1
generation of precursor metabolites and energy (GO:0006091),244,182,145.91,+,1.25,0.0259,1,130,87.5,+,1.49,0.000291,0.0922,184,138.31,+,1.33,0.0037,0.572,7,2.45,+,2.86,0.0127,1
porphyrin-containing compound metabolic process (GO:0006778),55,41,32.89,+,1.25,0.292,1,31,19.72,+,1.57,0.0492,1,44,31.18,+,1.41,0.0935,1,1,0.55,+,1.81,0.429,1
response to hypoxia (GO:0001666),149,111,89.1,+,1.25,0.0816,1,80,53.43,+,1.5,0.00406,0.493,103,84.46,+,1.22,0.129,1,1,1.5,-,0.67,1,1
steroid metabolic process (GO:0008202),47,35,28.11,+,1.25,0.36,1,25,16.85,+,1.48,0.109,1,31,26.64,+,1.16,0.555,1,0,0.47,-, < 0.01,1,1
cellular response to carbohydrate stimulus (GO:0071322),39,29,23.32,+,1.24,0.381,1,17,13.99,+,1.22,0.543,1,23,22.11,+,1.04,0.895,1,0,0.39,-, < 0.01,1,1
divalent metal ion transport (GO:0070838),78,58,46.64,+,1.24,0.214,1,34,27.97,+,1.22,0.335,1,59,44.21,+,1.33,0.108,1,0,0.78,-, < 0.01,1,1
response to decreased oxygen levels (GO:0036293),152,113,90.9,+,1.24,0.0844,1,81,54.51,+,1.49,0.0044,0.513,105,86.16,+,1.22,0.117,1,1,1.53,-,0.65,1,1
chaperone cofactor-dependent protein refolding (GO:0051085),31,23,18.54,+,1.24,0.482,1,16,11.12,+,1.44,0.247,1,19,17.57,+,1.08,0.77,1,1,0.31,+,3.21,0.274,1
'de novo' posttranslational protein folding (GO:0051084),31,23,18.54,+,1.24,0.482,1,16,11.12,+,1.44,0.247,1,19,17.57,+,1.08,0.77,1,1,0.31,+,3.21,0.274,1
cellular response to abscisic acid stimulus (GO:0071215),85,63,50.83,+,1.24,0.202,1,41,30.48,+,1.35,0.128,1,60,48.18,+,1.25,0.194,1,2,0.85,+,2.34,0.214,1
cellular response to alcohol (GO:0097306),85,63,50.83,+,1.24,0.202,1,41,30.48,+,1.35,0.128,1,60,48.18,+,1.25,0.194,1,2,0.85,+,2.34,0.214,1
cellular response to oxygen levels (GO:0071453),135,100,80.73,+,1.24,0.104,1,75,48.41,+,1.55,0.0027,0.454,92,76.53,+,1.2,0.187,1,1,1.36,-,0.74,1,1
nucleobase metabolic process (GO:0009112),27,20,16.15,+,1.24,0.456,1,12,9.68,+,1.24,0.585,1,18,15.31,+,1.18,0.642,1,0,0.27,-, < 0.01,1,1
phenylpropanoid biosynthetic process (GO:0009699),50,37,29.9,+,1.24,0.32,1,26,17.93,+,1.45,0.15,1,32,28.34,+,1.13,0.645,1,1,0.5,+,1.99,0.4,1
negative regulation of defense response (GO:0031348),46,34,27.51,+,1.24,0.356,1,20,16.5,+,1.21,0.485,1,30,26.08,+,1.15,0.552,1,0,0.46,-, < 0.01,1,1
NADPH regeneration (GO:0006740),23,17,13.75,+,1.24,0.516,1,15,8.25,+,1.82,0.0947,1,17,13.04,+,1.3,0.414,1,2,0.23,+,8.66,0.0254,1
plant-type cell wall organization (GO:0009664),69,51,41.26,+,1.24,0.257,1,22,24.74,-,0.89,0.721,1,46,39.11,+,1.18,0.436,1,1,0.69,+,1.44,0.504,1
post-embryonic root morphogenesis (GO:0010101),46,34,27.51,+,1.24,0.356,1,17,16.5,+,1.03,0.887,1,31,26.08,+,1.19,0.477,1,0,0.46,-, < 0.01,1,1
cellular response to decreased oxygen levels (GO:0036294),134,99,80.13,+,1.24,0.117,1,74,48.05,+,1.54,0.00333,0.453,91,75.96,+,1.2,0.185,1,1,1.35,-,0.74,1,1
abscisic acid-activated signaling pathway (GO:0009738),65,48,38.87,+,1.23,0.284,1,30,23.31,+,1.29,0.245,1,45,36.85,+,1.22,0.32,1,1,0.65,+,1.53,0.484,1
wax biosynthetic process (GO:0010025),19,14,11.36,+,1.23,0.591,1,7,6.81,+,1.03,1,1,15,10.77,+,1.39,0.373,1,0,0.19,-, < 0.01,1,1
cellular response to blue light (GO:0071483),19,14,11.36,+,1.23,0.591,1,4,6.81,-,0.59,0.477,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
response to misfolded protein (GO:0051788),19,14,11.36,+,1.23,0.591,1,8,6.81,+,1.17,0.667,1,14,10.77,+,1.3,0.472,1,0,0.19,-, < 0.01,1,1
positive regulation of phosphorus metabolic process (GO:0010562),19,14,11.36,+,1.23,0.591,1,6,6.81,-,0.88,1,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
positive regulation of phosphate metabolic process (GO:0045937),19,14,11.36,+,1.23,0.591,1,6,6.81,-,0.88,1,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
primary root development (GO:0080022),19,14,11.36,+,1.23,0.591,1,8,6.81,+,1.17,0.667,1,13,10.77,+,1.21,0.586,1,0,0.19,-, < 0.01,1,1
regulation of defense response (GO:0031347),144,106,86.11,+,1.23,0.114,1,71,51.64,+,1.37,0.0292,1,92,81.63,+,1.13,0.376,1,0,1.45,-, < 0.01,0.408,1
chloroplast organization (GO:0009658),178,131,106.45,+,1.23,0.0754,1,91,63.83,+,1.43,0.00647,0.66,124,100.9,+,1.23,0.0801,1,1,1.79,-,0.56,1,1
ADP metabolic process (GO:0046031),34,25,20.33,+,1.23,0.423,1,16,12.19,+,1.31,0.421,1,26,19.27,+,1.35,0.282,1,2,0.34,+,5.86,0.0496,1
purine ribonucleoside diphosphate metabolic process (GO:0009179),34,25,20.33,+,1.23,0.423,1,16,12.19,+,1.31,0.421,1,26,19.27,+,1.35,0.282,1,2,0.34,+,5.86,0.0496,1
purine nucleoside diphosphate metabolic process (GO:0009135),34,25,20.33,+,1.23,0.423,1,16,12.19,+,1.31,0.421,1,26,19.27,+,1.35,0.282,1,2,0.34,+,5.86,0.0496,1
cellular response to hypoxia (GO:0071456),132,97,78.94,+,1.23,0.131,1,74,47.34,+,1.56,0.00245,0.423,89,74.83,+,1.19,0.206,1,1,1.33,-,0.75,1,1
G protein-coupled receptor signaling pathway (GO:0007186),15,11,8.97,+,1.23,0.686,1,10,5.38,+,1.86,0.17,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
regulation of defense response to bacterium (GO:1900424),30,22,17.94,+,1.23,0.476,1,16,10.76,+,1.49,0.24,1,21,17.01,+,1.23,0.468,1,0,0.3,-, < 0.01,1,1
starch catabolic process (GO:0005983),15,11,8.97,+,1.23,0.686,1,8,5.38,+,1.49,0.35,1,11,8.5,+,1.29,0.543,1,1,0.15,+,6.64,0.148,1
brassinosteroid metabolic process (GO:0016131),15,11,8.97,+,1.23,0.686,1,6,5.38,+,1.12,0.806,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
phytosteroid metabolic process (GO:0016128),15,11,8.97,+,1.23,0.686,1,6,5.38,+,1.12,0.806,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
regulation of ion transmembrane transport (GO:0034765),15,11,8.97,+,1.23,0.686,1,8,5.38,+,1.49,0.35,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
cellular response to amino acid stimulus (GO:0071230),15,11,8.97,+,1.23,0.686,1,7,5.38,+,1.3,0.628,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
positive regulation of cell population proliferation (GO:0008284),15,11,8.97,+,1.23,0.686,1,3,5.38,-,0.56,0.433,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
defense response to Gram-negative bacterium (GO:0050829),15,11,8.97,+,1.23,0.686,1,7,5.38,+,1.3,0.628,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
aldehyde catabolic process (GO:0046185),15,11,8.97,+,1.23,0.686,1,6,5.38,+,1.12,0.806,1,11,8.5,+,1.29,0.543,1,0,0.15,-, < 0.01,1,1
glycosyl compound metabolic process (GO:1901657),75,55,44.85,+,1.23,0.275,1,35,26.9,+,1.3,0.194,1,51,42.51,+,1.2,0.308,1,2,0.75,+,2.65,0.178,1
organic acid catabolic process (GO:0016054),119,87,71.16,+,1.22,0.169,1,45,42.68,+,1.05,0.789,1,100,67.46,+,1.48,0.00372,0.559,2,1.2,+,1.67,0.339,1
carbohydrate catabolic process (GO:0016052),119,87,71.16,+,1.22,0.169,1,55,42.68,+,1.29,0.12,1,89,67.46,+,1.32,0.0501,1,6,1.2,+,5.02,0.00154,1
carboxylic acid catabolic process (GO:0046395),119,87,71.16,+,1.22,0.169,1,45,42.68,+,1.05,0.789,1,100,67.46,+,1.48,0.00372,0.545,2,1.2,+,1.67,0.339,1
regulation of jasmonic acid mediated signaling pathway (GO:2000022),26,19,15.55,+,1.22,0.539,1,14,9.32,+,1.5,0.213,1,13,14.74,-,0.88,0.868,1,0,0.26,-, < 0.01,1,1
ribonucleoside diphosphate metabolic process (GO:0009185),37,27,22.13,+,1.22,0.44,1,17,13.27,+,1.28,0.439,1,27,20.97,+,1.29,0.362,1,2,0.37,+,5.38,0.0573,1
porphyrin-containing compound catabolic process (GO:0006787),11,8,6.58,+,1.22,0.645,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
ER-associated misfolded protein catabolic process (GO:0071712),11,8,6.58,+,1.22,0.645,1,6,3.94,+,1.52,0.413,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
proteasome assembly (GO:0043248),11,8,6.58,+,1.22,0.645,1,6,3.94,+,1.52,0.413,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
plastid transcription (GO:0042793),11,8,6.58,+,1.22,0.645,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
tRNA aminoacylation (GO:0043039),44,32,26.31,+,1.22,0.407,1,20,15.78,+,1.27,0.394,1,28,24.94,+,1.12,0.625,1,0,0.44,-, < 0.01,1,1
amino acid activation (GO:0043038),44,32,26.31,+,1.22,0.407,1,20,15.78,+,1.27,0.394,1,28,24.94,+,1.12,0.625,1,0,0.44,-, < 0.01,1,1
positive regulation of ATPase activity (GO:0032781),11,8,6.58,+,1.22,0.645,1,6,3.94,+,1.52,0.413,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
tetrapyrrole catabolic process (GO:0033015),11,8,6.58,+,1.22,0.645,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
negative regulation of cell population proliferation (GO:0008285),11,8,6.58,+,1.22,0.645,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
acetyl-CoA biosynthetic process (GO:0006085),11,8,6.58,+,1.22,0.645,1,5,3.94,+,1.27,0.777,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
peptidyl-lysine monomethylation (GO:0018026),11,8,6.58,+,1.22,0.645,1,7,3.94,+,1.77,0.282,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
galactose metabolic process (GO:0006012),11,8,6.58,+,1.22,0.645,1,5,3.94,+,1.27,0.777,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
regulation of response to biotic stimulus (GO:0002831),99,72,59.2,+,1.22,0.205,1,51,35.5,+,1.44,0.0403,1,65,56.12,+,1.16,0.37,1,0,0.99,-, < 0.01,0.629,1
fatty acid derivative biosynthetic process (GO:1901570),22,16,13.16,+,1.22,0.615,1,9,7.89,+,1.14,0.688,1,17,12.47,+,1.36,0.404,1,1,0.22,+,4.52,0.206,1
positive regulation of kinase activity (GO:0033674),11,8,6.58,+,1.22,0.645,1,4,3.94,+,1.01,1,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
galactolipid biosynthetic process (GO:0019375),11,8,6.58,+,1.22,0.645,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
pyruvate metabolic process (GO:0006090),55,40,32.89,+,1.22,0.341,1,29,19.72,+,1.47,0.106,1,40,31.18,+,1.28,0.24,1,2,0.55,+,3.62,0.11,1
purine nucleoside bisphosphate metabolic process (GO:0034032),40,29,23.92,+,1.21,0.455,1,21,14.34,+,1.46,0.189,1,26,22.67,+,1.15,0.609,1,1,0.4,+,2.49,0.337,1
cellular aldehyde metabolic process (GO:0006081),40,29,23.92,+,1.21,0.455,1,18,14.34,+,1.25,0.455,1,30,22.67,+,1.32,0.263,1,0,0.4,-, < 0.01,1,1
positive regulation of reproductive process (GO:2000243),40,29,23.92,+,1.21,0.455,1,16,14.34,+,1.12,0.761,1,27,22.67,+,1.19,0.525,1,0,0.4,-, < 0.01,1,1
ribonucleoside bisphosphate metabolic process (GO:0033875),40,29,23.92,+,1.21,0.455,1,21,14.34,+,1.46,0.189,1,26,22.67,+,1.15,0.609,1,1,0.4,+,2.49,0.337,1
nucleoside bisphosphate metabolic process (GO:0033865),40,29,23.92,+,1.21,0.455,1,21,14.34,+,1.46,0.189,1,26,22.67,+,1.15,0.609,1,1,0.4,+,2.49,0.337,1
water transport (GO:0006833),18,13,10.76,+,1.21,0.584,1,7,6.46,+,1.08,0.823,1,12,10.2,+,1.18,0.705,1,0,0.18,-, < 0.01,1,1
isoprenoid metabolic process (GO:0006720),108,78,64.58,+,1.21,0.223,1,44,38.73,+,1.14,0.461,1,84,61.22,+,1.37,0.0343,1,1,1.08,-,0.92,1,1
glutamate metabolic process (GO:0006536),18,13,10.76,+,1.21,0.584,1,8,6.46,+,1.24,0.656,1,13,10.2,+,1.27,0.575,1,0,0.18,-, < 0.01,1,1
tRNA wobble base modification (GO:0002097),18,13,10.76,+,1.21,0.584,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
fluid transport (GO:0042044),18,13,10.76,+,1.21,0.584,1,7,6.46,+,1.08,0.823,1,12,10.2,+,1.18,0.705,1,0,0.18,-, < 0.01,1,1
vesicle-mediated transport to the plasma membrane (GO:0098876),18,13,10.76,+,1.21,0.584,1,9,6.46,+,1.39,0.39,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
lateral root formation (GO:0010311),36,26,21.53,+,1.21,0.511,1,12,12.91,-,0.93,1,1,23,20.41,+,1.13,0.685,1,0,0.36,-, < 0.01,1,1
pyridine-containing compound metabolic process (GO:0072524),18,13,10.76,+,1.21,0.584,1,6,6.46,-,0.93,1,1,13,10.2,+,1.27,0.575,1,0,0.18,-, < 0.01,1,1
nucleotide phosphorylation (GO:0046939),43,31,25.71,+,1.21,0.471,1,22,15.42,+,1.43,0.203,1,31,24.37,+,1.27,0.333,1,2,0.43,+,4.63,0.0737,1
isoprenoid biosynthetic process (GO:0008299),86,62,51.43,+,1.21,0.268,1,39,30.84,+,1.26,0.223,1,65,48.75,+,1.33,0.0888,1,1,0.86,+,1.16,0.582,1
defense response to other organism (GO:0098542),468,337,279.87,+,1.2,0.00833,1,224,167.83,+,1.33,0.000359,0.108,314,265.29,+,1.18,0.0205,1,3,4.7,-,0.64,0.633,1
oligosaccharide metabolic process (GO:0009311),50,36,29.9,+,1.2,0.435,1,21,17.93,+,1.17,0.589,1,38,28.34,+,1.34,0.183,1,0,0.5,-, < 0.01,1,1
tRNA methylation (GO:0030488),25,18,14.95,+,1.2,0.533,1,11,8.97,+,1.23,0.572,1,13,14.17,-,0.92,0.867,1,0,0.25,-, < 0.01,1,1
glycosyl compound biosynthetic process (GO:1901659),25,18,14.95,+,1.2,0.533,1,12,8.97,+,1.34,0.455,1,15,14.17,+,1.06,0.87,1,0,0.25,-, < 0.01,1,1
regulation of innate immune response (GO:0045088),57,41,34.09,+,1.2,0.403,1,29,20.44,+,1.42,0.14,1,36,32.31,+,1.11,0.665,1,0,0.57,-, < 0.01,1,1
positive regulation of cellular catabolic process (GO:0031331),32,23,19.14,+,1.2,0.489,1,12,11.48,+,1.05,0.865,1,22,18.14,+,1.21,0.482,1,0,0.32,-, < 0.01,1,1
acyl-CoA metabolic process (GO:0006637),32,23,19.14,+,1.2,0.489,1,16,11.48,+,1.39,0.324,1,19,18.14,+,1.05,0.885,1,0,0.32,-, < 0.01,1,1
ribonucleoside monophosphate biosynthetic process (GO:0009156),32,23,19.14,+,1.2,0.489,1,16,11.48,+,1.39,0.324,1,20,18.14,+,1.1,0.773,1,0,0.32,-, < 0.01,1,1
thioester metabolic process (GO:0035383),32,23,19.14,+,1.2,0.489,1,16,11.48,+,1.39,0.324,1,19,18.14,+,1.05,0.885,1,0,0.32,-, < 0.01,1,1
regulation of response to external stimulus (GO:0032101),103,74,61.59,+,1.2,0.242,1,52,36.94,+,1.41,0.0444,1,68,58.39,+,1.16,0.338,1,0,1.03,-, < 0.01,0.629,1
response to oomycetes (GO:0002239),39,28,23.32,+,1.2,0.451,1,21,13.99,+,1.5,0.142,1,30,22.11,+,1.36,0.211,1,1,0.39,+,2.55,0.33,1
sterol metabolic process (GO:0016125),39,28,23.32,+,1.2,0.451,1,21,13.99,+,1.5,0.142,1,25,22.11,+,1.13,0.696,1,0,0.39,-, < 0.01,1,1
nucleoside diphosphate phosphorylation (GO:0006165),39,28,23.32,+,1.2,0.451,1,19,13.99,+,1.36,0.296,1,29,22.11,+,1.31,0.312,1,2,0.39,+,5.1,0.0626,1
systemic acquired resistance (GO:0009627),39,28,23.32,+,1.2,0.451,1,20,13.99,+,1.43,0.186,1,28,22.11,+,1.27,0.373,1,1,0.39,+,2.55,0.33,1
response to reactive oxygen species (GO:0000302),105,75,62.79,+,1.19,0.246,1,41,37.65,+,1.09,0.638,1,79,59.52,+,1.33,0.0641,1,0,1.05,-, < 0.01,0.629,1
host programmed cell death induced by symbiont (GO:0034050),35,25,20.93,+,1.19,0.506,1,22,12.55,+,1.75,0.0489,1,23,19.84,+,1.16,0.586,1,0,0.35,-, < 0.01,1,1
chloroplast-nucleus signaling pathway (GO:0010019),7,5,4.19,+,1.19,0.772,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
peroxisome fission (GO:0016559),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
xylan catabolic process (GO:0045493),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
sulfur amino acid biosynthetic process (GO:0000097),21,15,12.56,+,1.19,0.608,1,9,7.53,+,1.2,0.679,1,15,11.9,+,1.26,0.492,1,0,0.21,-, < 0.01,1,1
guanosine-containing compound metabolic process (GO:1901068),14,10,8.37,+,1.19,0.677,1,9,5.02,+,1.79,0.163,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
cell cycle G1/S phase transition (GO:0044843),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
formation of translation preinitiation complex (GO:0001731),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
formation of plant organ boundary (GO:0090691),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
cysteine metabolic process (GO:0006534),14,10,8.37,+,1.19,0.677,1,7,5.02,+,1.39,0.463,1,10,7.94,+,1.26,0.671,1,0,0.14,-, < 0.01,1,1
purine ribonucleotide transport (GO:0015868),7,5,4.19,+,1.19,0.772,1,5,2.51,+,1.99,0.322,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
DNA methylation on cytosine (GO:0032776),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular response to singlet oxygen (GO:0071452),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
tRNA aminoacylation for protein translation (GO:0006418),42,30,25.12,+,1.19,0.466,1,18,15.06,+,1.2,0.557,1,26,23.81,+,1.09,0.707,1,0,0.42,-, < 0.01,1,1
response to ATP (GO:0033198),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
disaccharide metabolic process (GO:0005984),42,30,25.12,+,1.19,0.466,1,18,15.06,+,1.2,0.557,1,31,23.81,+,1.3,0.273,1,0,0.42,-, < 0.01,1,1
L-phenylalanine biosynthetic process (GO:0009094),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
C4-dicarboxylate transport (GO:0015740),7,5,4.19,+,1.19,0.772,1,6,2.51,+,2.39,0.119,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
cellular response to glucose stimulus (GO:0071333),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular response to hexose stimulus (GO:0071331),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular response to sucrose stimulus (GO:0071329),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular response to monosaccharide stimulus (GO:0071326),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
"DNA-templated transcription, termination (GO:0006353)",7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
programmed cell death in response to reactive oxygen species (GO:0097468),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
polyprenol metabolic process (GO:0016093),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
peptidyl-threonine modification (GO:0018210),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
response to organophosphorus (GO:0046683),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
formation of anatomical boundary (GO:0048859),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
tetrahydrofolate biosynthetic process (GO:0046654),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,1,0.07,+,14.22,0.0769,1
peptidyl-threonine phosphorylation (GO:0018107),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
regulation of Ras protein signal transduction (GO:0046578),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
cell wall polysaccharide catabolic process (GO:0044347),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of leaf senescence (GO:1900055),28,20,16.74,+,1.19,0.553,1,10,10.04,-,1,1,1,19,15.87,+,1.2,0.546,1,0,0.28,-, < 0.01,1,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process (GO:1902223),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of cellular response to heat (GO:1900034),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
positive regulation of signal transduction (GO:0009967),56,40,33.49,+,1.19,0.399,1,20,20.08,-,1,1,1,38,31.74,+,1.2,0.391,1,0,0.56,-, < 0.01,1,1
positive regulation of gibberellic acid mediated signaling pathway (GO:0009939),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
negative regulation of hydrolase activity (GO:0051346),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
regulation of ribosome biogenesis (GO:0090069),7,5,4.19,+,1.19,0.772,1,5,2.51,+,1.99,0.322,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
response to salt (GO:1902074),14,10,8.37,+,1.19,0.677,1,7,5.02,+,1.39,0.463,1,8,7.94,+,1.01,1,1,1,0.14,+,7.11,0.139,1
response to nutrient (GO:0007584),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
carbohydrate mediated signaling (GO:0009756),28,20,16.74,+,1.19,0.553,1,13,10.04,+,1.29,0.478,1,17,15.87,+,1.07,0.877,1,0,0.28,-, < 0.01,1,1
fatty acid derivative metabolic process (GO:1901568),28,20,16.74,+,1.19,0.553,1,12,10.04,+,1.2,0.593,1,21,15.87,+,1.32,0.372,1,1,0.28,+,3.56,0.252,1
cellular response to hydrogen peroxide (GO:0070301),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
cell death in response to oxidative stress (GO:0036473),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
regulation of root morphogenesis (GO:2000067),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),21,15,12.56,+,1.19,0.608,1,7,7.53,-,0.93,1,1,14,11.9,+,1.18,0.725,1,0,0.21,-, < 0.01,1,1
regulation of stomatal complex patterning (GO:2000037),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
response to herbivore (GO:0080027),7,5,4.19,+,1.19,0.772,1,1,2.51,-,0.4,0.69,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
UV protection (GO:0009650),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,1,0.07,+,14.22,0.0769,1
shade avoidance (GO:0009641),7,5,4.19,+,1.19,0.772,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
hydrogen peroxide biosynthetic process (GO:0050665),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
alditol metabolic process (GO:0019400),7,5,4.19,+,1.19,0.772,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
plant-type hypersensitive response (GO:0009626),35,25,20.93,+,1.19,0.506,1,22,12.55,+,1.75,0.0489,1,23,19.84,+,1.16,0.586,1,0,0.35,-, < 0.01,1,1
mucilage biosynthetic process (GO:0010192),14,10,8.37,+,1.19,0.677,1,2,5.02,-,0.4,0.266,1,11,7.94,+,1.39,0.412,1,0,0.14,-, < 0.01,1,1
sugar mediated signaling pathway (GO:0010182),28,20,16.74,+,1.19,0.553,1,13,10.04,+,1.29,0.478,1,17,15.87,+,1.07,0.877,1,0,0.28,-, < 0.01,1,1
regulation of ATPase activity (GO:0043462),14,10,8.37,+,1.19,0.677,1,7,5.02,+,1.39,0.463,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
regulation of small GTPase mediated signal transduction (GO:0051056),7,5,4.19,+,1.19,0.772,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
regulation of MAPK cascade (GO:0043408),7,5,4.19,+,1.19,0.772,1,5,2.51,+,1.99,0.322,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
regulation of MAP kinase activity (GO:0043405),7,5,4.19,+,1.19,0.772,1,5,2.51,+,1.99,0.322,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
response to wounding (GO:0009611),139,99,83.12,+,1.19,0.2,1,71,49.85,+,1.42,0.0179,1,97,78.79,+,1.23,0.117,1,1,1.4,-,0.72,1,1
"defense response, incompatible interaction (GO:0009814)",111,79,66.38,+,1.19,0.259,1,58,39.81,+,1.46,0.0224,1,76,62.92,+,1.21,0.221,1,1,1.12,-,0.9,1,1
detoxification (GO:0098754),52,37,31.1,+,1.19,0.443,1,26,18.65,+,1.39,0.197,1,38,29.48,+,1.29,0.229,1,0,0.52,-, < 0.01,1,1
post-embryonic root development (GO:0048528),83,59,49.63,+,1.19,0.338,1,34,29.77,+,1.14,0.528,1,53,47.05,+,1.13,0.531,1,0,0.83,-, < 0.01,1,1
immune response (GO:0006955),190,135,113.62,+,1.19,0.133,1,98,68.14,+,1.44,0.00371,0.471,123,107.7,+,1.14,0.26,1,1,1.91,-,0.52,1,1
response to toxic substance (GO:0009636),69,49,41.26,+,1.19,0.391,1,32,24.74,+,1.29,0.257,1,48,39.11,+,1.23,0.289,1,0,0.69,-, < 0.01,1,1
response to organonitrogen compound (GO:0010243),155,110,92.69,+,1.19,0.18,1,85,55.59,+,1.53,0.0019,0.351,97,87.86,+,1.1,0.468,1,1,1.56,-,0.64,1,1
galacturonan metabolic process (GO:0010393),79,56,47.24,+,1.19,0.328,1,27,28.33,-,0.95,0.912,1,54,44.78,+,1.21,0.319,1,1,0.79,+,1.26,0.552,1
interspecies interaction between organisms (GO:0044419),642,455,383.92,+,1.19,0.00476,1,298,230.23,+,1.29,0.000191,0.0907,432,363.92,+,1.19,0.00499,0.619,3,6.45,-,0.47,0.219,1
cytochrome complex assembly (GO:0017004),24,17,14.35,+,1.18,0.629,1,9,8.61,+,1.05,0.846,1,16,13.6,+,1.18,0.624,1,0,0.24,-, < 0.01,1,1
aerobic respiration (GO:0009060),48,34,28.7,+,1.18,0.493,1,16,17.21,-,0.93,0.888,1,39,27.21,+,1.43,0.0946,1,1,0.48,+,2.07,0.388,1
regulation of immune system process (GO:0002682),72,51,43.06,+,1.18,0.352,1,36,25.82,+,1.39,0.102,1,46,40.81,+,1.13,0.564,1,0,0.72,-, < 0.01,1,1
innate immune response (GO:0045087),185,131,110.63,+,1.18,0.143,1,94,66.34,+,1.42,0.00615,0.639,119,104.87,+,1.13,0.28,1,1,1.86,-,0.54,1,1
response to carbohydrate (GO:0009743),106,75,63.39,+,1.18,0.28,1,45,38.01,+,1.18,0.354,1,71,60.09,+,1.18,0.272,1,3,1.06,+,2.82,0.0947,1
regulation of protein kinase activity (GO:0045859),41,29,24.52,+,1.18,0.536,1,11,14.7,-,0.75,0.435,1,27,23.24,+,1.16,0.531,1,0,0.41,-, < 0.01,1,1
response to biotic stimulus (GO:0009607),632,447,377.94,+,1.18,0.00545,1,293,226.65,+,1.29,0.000231,0.0824,423,358.25,+,1.18,0.00695,0.749,3,6.35,-,0.47,0.219,1
carbohydrate biosynthetic process (GO:0016051),198,140,118.41,+,1.18,0.126,1,69,71.01,-,0.97,0.889,1,134,112.24,+,1.19,0.12,1,2,1.99,+,1.01,1,1
response to external biotic stimulus (GO:0043207),631,446,377.34,+,1.18,0.00595,1,293,226.29,+,1.29,0.000228,0.0928,422,357.69,+,1.18,0.0076,0.736,3,6.34,-,0.47,0.219,1
response to other organism (GO:0051707),631,446,377.34,+,1.18,0.00595,1,293,226.29,+,1.29,0.000228,0.0867,422,357.69,+,1.18,0.0076,0.723,3,6.34,-,0.47,0.219,1
regulation of protein phosphorylation (GO:0001932),51,36,30.5,+,1.18,0.44,1,14,18.29,-,0.77,0.481,1,33,28.91,+,1.14,0.57,1,0,0.51,-, < 0.01,1,1
ribonucleoside monophosphate metabolic process (GO:0009161),34,24,20.33,+,1.18,0.587,1,17,12.19,+,1.39,0.267,1,21,19.27,+,1.09,0.779,1,0,0.34,-, < 0.01,1,1
positive regulation of cell death (GO:0010942),17,12,10.17,+,1.18,0.703,1,7,6.1,+,1.15,0.817,1,12,9.64,+,1.25,0.566,1,0,0.17,-, < 0.01,1,1
sterol biosynthetic process (GO:0016126),17,12,10.17,+,1.18,0.703,1,10,6.1,+,1.64,0.272,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
cellular response to metal ion (GO:0071248),17,12,10.17,+,1.18,0.703,1,7,6.1,+,1.15,0.817,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
cellulose biosynthetic process (GO:0030244),34,24,20.33,+,1.18,0.587,1,9,12.19,-,0.74,0.491,1,24,19.27,+,1.25,0.414,1,0,0.34,-, < 0.01,1,1
regulation of carbohydrate metabolic process (GO:0006109),51,36,30.5,+,1.18,0.44,1,14,18.29,-,0.77,0.481,1,35,28.91,+,1.21,0.431,1,2,0.51,+,3.9,0.0975,1
amino acid transmembrane transport (GO:0003333),17,12,10.17,+,1.18,0.703,1,9,6.1,+,1.48,0.373,1,12,9.64,+,1.25,0.566,1,0,0.17,-, < 0.01,1,1
abscission (GO:0009838),17,12,10.17,+,1.18,0.703,1,8,6.1,+,1.31,0.502,1,11,9.64,+,1.14,0.7,1,0,0.17,-, < 0.01,1,1
photosynthetic electron transport chain (GO:0009767),34,24,20.33,+,1.18,0.587,1,19,12.19,+,1.56,0.12,1,24,19.27,+,1.25,0.414,1,0,0.34,-, < 0.01,1,1
pectin metabolic process (GO:0045488),78,55,46.64,+,1.18,0.369,1,26,27.97,-,0.93,0.824,1,53,44.21,+,1.2,0.316,1,1,0.78,+,1.28,0.547,1
immune system process (GO:0002376),213,150,127.38,+,1.18,0.126,1,104,76.39,+,1.36,0.0101,0.944,137,120.74,+,1.13,0.262,1,1,2.14,-,0.47,0.727,1
positive regulation of signaling (GO:0023056),57,40,34.09,+,1.17,0.462,1,20,20.44,-,0.98,1,1,38,32.31,+,1.18,0.455,1,0,0.57,-, < 0.01,1,1
defense response to bacterium (GO:0042742),244,171,145.91,+,1.17,0.112,1,122,87.5,+,1.39,0.00325,0.452,166,138.31,+,1.2,0.0692,1,1,2.45,-,0.41,0.523,1
cellular response to organonitrogen compound (GO:0071417),30,21,17.94,+,1.17,0.566,1,14,10.76,+,1.3,0.396,1,17,17.01,-,1,1,1,0,0.3,-, < 0.01,1,1
phloem development (GO:0010088),10,7,5.98,+,1.17,0.804,1,3,3.59,-,0.84,1,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",20,14,11.96,+,1.17,0.723,1,6,7.17,-,0.84,0.826,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
glutathione metabolic process (GO:0006749),20,14,11.96,+,1.17,0.723,1,12,7.17,+,1.67,0.162,1,15,11.34,+,1.32,0.482,1,1,0.2,+,4.98,0.189,1
folic acid-containing compound biosynthetic process (GO:0009396),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,1,0.1,+,9.95,0.104,1
positive regulation of cellular protein catabolic process (GO:1903364),20,14,11.96,+,1.17,0.723,1,6,7.17,-,0.84,0.826,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
establishment or maintenance of cell polarity (GO:0007163),10,7,5.98,+,1.17,0.804,1,2,3.59,-,0.56,0.743,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
oligosaccharide catabolic process (GO:0009313),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
positive regulation of mRNA metabolic process (GO:1903313),10,7,5.98,+,1.17,0.804,1,5,3.59,+,1.39,0.561,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
chlorophyll catabolic process (GO:0015996),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
deoxyribonucleotide metabolic process (GO:0009262),10,7,5.98,+,1.17,0.804,1,5,3.59,+,1.39,0.561,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
endoplasmic reticulum organization (GO:0007029),20,14,11.96,+,1.17,0.723,1,8,7.17,+,1.12,0.83,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
sucrose biosynthetic process (GO:0005986),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),20,14,11.96,+,1.17,0.723,1,6,7.17,-,0.84,0.826,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
regulation of transmembrane transporter activity (GO:0022898),10,7,5.98,+,1.17,0.804,1,6,3.59,+,1.67,0.392,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
positive regulation of nuclear division (GO:0051785),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
respiratory chain complex IV assembly (GO:0008535),10,7,5.98,+,1.17,0.804,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
regulation of ion transmembrane transporter activity (GO:0032412),10,7,5.98,+,1.17,0.804,1,6,3.59,+,1.67,0.392,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
DNA endoreduplication (GO:0042023),10,7,5.98,+,1.17,0.804,1,3,3.59,-,0.84,1,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
root meristem growth (GO:0010449),10,7,5.98,+,1.17,0.804,1,3,3.59,-,0.84,1,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
negative regulation of transferase activity (GO:0051348),10,7,5.98,+,1.17,0.804,1,5,3.59,+,1.39,0.561,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
glyceraldehyde-3-phosphate metabolic process (GO:0019682),10,7,5.98,+,1.17,0.804,1,8,3.59,+,2.23,0.105,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
protein sumoylation (GO:0016925),10,7,5.98,+,1.17,0.804,1,5,3.59,+,1.39,0.561,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
regulation of mRNA catabolic process (GO:0061013),10,7,5.98,+,1.17,0.804,1,6,3.59,+,1.67,0.392,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
pigment catabolic process (GO:0046149),10,7,5.98,+,1.17,0.804,1,4,3.59,+,1.12,0.77,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
regulation of tetrapyrrole metabolic process (GO:1901401),20,14,11.96,+,1.17,0.723,1,12,7.17,+,1.67,0.162,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",10,7,5.98,+,1.17,0.804,1,5,3.59,+,1.39,0.561,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
response to singlet oxygen (GO:0000304),10,7,5.98,+,1.17,0.804,1,2,3.59,-,0.56,0.743,1,8,5.67,+,1.41,0.47,1,0,0.1,-, < 0.01,1,1
response to bacterium (GO:0009617),299,209,178.8,+,1.17,0.0858,1,145,107.23,+,1.35,0.00318,0.453,204,169.49,+,1.2,0.0432,1,1,3,-,0.33,0.376,1
dicarboxylic acid metabolic process (GO:0043648),63,44,37.67,+,1.17,0.425,1,25,22.59,+,1.11,0.716,1,46,35.71,+,1.29,0.195,1,1,0.63,+,1.58,0.473,1
regulation of immune response (GO:0050776),63,44,37.67,+,1.17,0.425,1,31,22.59,+,1.37,0.159,1,40,35.71,+,1.12,0.608,1,0,0.63,-, < 0.01,1,1
terpenoid metabolic process (GO:0006721),86,60,51.43,+,1.17,0.391,1,33,30.84,+,1.07,0.754,1,68,48.75,+,1.39,0.0432,1,0,0.86,-, < 0.01,1,1
auxin polar transport (GO:0009926),43,30,25.71,+,1.17,0.545,1,13,15.42,-,0.84,0.651,1,28,24.37,+,1.15,0.621,1,0,0.43,-, < 0.01,1,1
regulation of kinase activity (GO:0043549),43,30,25.71,+,1.17,0.545,1,11,15.42,-,0.71,0.357,1,28,24.37,+,1.15,0.621,1,0,0.43,-, < 0.01,1,1
monocarboxylic acid metabolic process (GO:0032787),294,205,175.81,+,1.17,0.0918,1,122,105.43,+,1.16,0.177,1,204,166.66,+,1.22,0.0264,1,4,2.95,+,1.35,0.544,1
regulation of carbohydrate biosynthetic process (GO:0043255),33,23,19.73,+,1.17,0.582,1,7,11.83,-,0.59,0.28,1,24,18.71,+,1.28,0.408,1,2,0.33,+,6.03,0.0472,1
small molecule catabolic process (GO:0044282),168,117,100.47,+,1.16,0.218,1,65,60.25,+,1.08,0.601,1,135,95.23,+,1.42,0.00257,0.488,4,1.69,+,2.37,0.0925,1
vitamin biosynthetic process (GO:0009110),46,32,27.51,+,1.16,0.558,1,23,16.5,+,1.39,0.217,1,30,26.08,+,1.15,0.552,1,1,0.46,+,2.16,0.375,1
terpene metabolic process (GO:0042214),23,16,13.75,+,1.16,0.624,1,9,8.25,+,1.09,0.841,1,18,13.04,+,1.38,0.33,1,0,0.23,-, < 0.01,1,1
protein refolding (GO:0042026),23,16,13.75,+,1.16,0.624,1,13,8.25,+,1.58,0.188,1,15,13.04,+,1.15,0.736,1,1,0.23,+,4.33,0.213,1
xyloglucan metabolic process (GO:0010411),23,16,13.75,+,1.16,0.624,1,6,8.25,-,0.73,0.673,1,13,13.04,-,1,1,1,1,0.23,+,4.33,0.213,1
response to ethylene (GO:0009723),92,64,55.02,+,1.16,0.362,1,45,32.99,+,1.36,0.0976,1,58,52.15,+,1.11,0.551,1,0,0.92,-, < 0.01,1,1
response to high light intensity (GO:0009644),46,32,27.51,+,1.16,0.558,1,27,16.5,+,1.64,0.0457,1,30,26.08,+,1.15,0.552,1,2,0.46,+,4.33,0.0824,1
cellular amino acid catabolic process (GO:0009063),69,48,41.26,+,1.16,0.444,1,26,24.74,+,1.05,0.816,1,56,39.11,+,1.43,0.0497,1,2,0.69,+,2.89,0.157,1
positive regulation of cell communication (GO:0010647),59,41,35.28,+,1.16,0.469,1,20,21.16,-,0.95,0.899,1,40,33.44,+,1.2,0.402,1,0,0.59,-, < 0.01,1,1
cellular response to osmotic stress (GO:0071470),36,25,21.53,+,1.16,0.597,1,17,12.91,+,1.32,0.351,1,27,20.41,+,1.32,0.294,1,1,0.36,+,2.77,0.31,1
cellulose metabolic process (GO:0030243),36,25,21.53,+,1.16,0.597,1,9,12.91,-,0.7,0.399,1,25,20.41,+,1.23,0.427,1,0,0.36,-, < 0.01,1,1
regulation of phosphate metabolic process (GO:0019220),88,61,52.62,+,1.16,0.396,1,26,31.56,-,0.82,0.455,1,56,49.88,+,1.12,0.488,1,0,0.88,-, < 0.01,1,1
defense response (GO:0006952),518,359,309.77,+,1.16,0.0296,1,240,185.76,+,1.29,0.001,0.212,337,293.63,+,1.15,0.0455,1,4,5.2,-,0.77,0.821,1
protein autophosphorylation (GO:0046777),127,88,75.95,+,1.16,0.289,1,61,45.54,+,1.34,0.0668,1,81,71.99,+,1.13,0.425,1,0,1.28,-, < 0.01,0.64,1
cellular calcium ion homeostasis (GO:0006874),39,27,23.32,+,1.16,0.611,1,19,13.99,+,1.36,0.296,1,27,22.11,+,1.22,0.443,1,0,0.39,-, < 0.01,1,1
mitochondrial transport (GO:0006839),65,45,38.87,+,1.16,0.489,1,27,23.31,+,1.16,0.553,1,34,36.85,-,0.92,0.754,1,0,0.65,-, < 0.01,1,1
response to iron ion (GO:0010039),13,9,7.77,+,1.16,0.826,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
carbohydrate derivative transport (GO:1901264),39,27,23.32,+,1.16,0.611,1,19,13.99,+,1.36,0.296,1,20,22.11,-,0.9,0.787,1,1,0.39,+,2.55,0.33,1
apocarotenoid metabolic process (GO:0043288),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
nucleotide salvage (GO:0043173),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
response to desiccation (GO:0009269),13,9,7.77,+,1.16,0.826,1,6,4.66,+,1.29,0.606,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
zinc ion transmembrane transport (GO:0071577),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
regulation of glucan biosynthetic process (GO:0010962),13,9,7.77,+,1.16,0.826,1,2,4.66,-,0.43,0.381,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
tertiary alcohol metabolic process (GO:1902644),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,5,7.37,-,0.68,0.625,1,0,0.13,-, < 0.01,1,1
cellular response to biotic stimulus (GO:0071216),13,9,7.77,+,1.16,0.826,1,7,4.66,+,1.5,0.445,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
cell plate assembly (GO:0000919),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
isoprenoid catabolic process (GO:0008300),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
regulation of meiotic cell cycle (GO:0051445),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
negative regulation of catabolic process (GO:0009895),13,9,7.77,+,1.16,0.826,1,6,4.66,+,1.29,0.606,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
response to karrikin (GO:0080167),78,54,46.64,+,1.16,0.417,1,35,27.97,+,1.25,0.284,1,52,44.21,+,1.18,0.361,1,0,0.78,-, < 0.01,1,1
anthocyanin-containing compound biosynthetic process (GO:0009718),13,9,7.77,+,1.16,0.826,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
abscisic acid metabolic process (GO:0009687),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
triglyceride biosynthetic process (GO:0019432),13,9,7.77,+,1.16,0.826,1,4,4.66,-,0.86,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
cellular lipid catabolic process (GO:0044242),68,47,40.66,+,1.16,0.441,1,20,24.39,-,0.82,0.47,1,58,38.55,+,1.5,0.0253,1,0,0.68,-, < 0.01,1,1
cellular response to oxidative stress (GO:0034599),55,38,32.89,+,1.16,0.52,1,23,19.72,+,1.17,0.522,1,41,31.18,+,1.32,0.201,1,1,0.55,+,1.81,0.429,1
anion homeostasis (GO:0055081),29,20,17.34,+,1.15,0.658,1,15,10.4,+,1.44,0.236,1,21,16.44,+,1.28,0.381,1,1,0.29,+,3.43,0.259,1
olefinic compound metabolic process (GO:0120254),29,20,17.34,+,1.15,0.658,1,14,10.4,+,1.35,0.386,1,19,16.44,+,1.16,0.653,1,0,0.29,-, < 0.01,1,1
protein peptidyl-prolyl isomerization (GO:0000413),29,20,17.34,+,1.15,0.658,1,10,10.4,-,0.96,1,1,17,16.44,+,1.03,1,1,0,0.29,-, < 0.01,1,1
leaf senescence (GO:0010150),74,51,44.25,+,1.15,0.459,1,43,26.54,+,1.62,0.015,1,52,41.95,+,1.24,0.264,1,3,0.74,+,4.04,0.0413,1
cell wall polysaccharide biosynthetic process (GO:0070592),45,31,26.91,+,1.15,0.554,1,12,16.14,-,0.74,0.452,1,27,25.51,+,1.06,0.807,1,0,0.45,-, < 0.01,1,1
positive regulation of response to stimulus (GO:0048584),141,97,84.32,+,1.15,0.282,1,59,50.56,+,1.17,0.333,1,88,79.93,+,1.1,0.489,1,1,1.42,-,0.71,1,1
cytidine to uridine editing (GO:0016554),16,11,9.57,+,1.15,0.696,1,7,5.74,+,1.22,0.64,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
acyl-CoA biosynthetic process (GO:0071616),16,11,9.57,+,1.15,0.696,1,7,5.74,+,1.22,0.64,1,6,9.07,-,0.66,0.507,1,0,0.16,-, < 0.01,1,1
thioester biosynthetic process (GO:0035384),16,11,9.57,+,1.15,0.696,1,7,5.74,+,1.22,0.64,1,6,9.07,-,0.66,0.507,1,0,0.16,-, < 0.01,1,1
branched-chain amino acid metabolic process (GO:0009081),32,22,19.14,+,1.15,0.673,1,9,11.48,-,0.78,0.598,1,25,18.14,+,1.38,0.269,1,1,0.32,+,3.11,0.281,1
actin nucleation (GO:0045010),16,11,9.57,+,1.15,0.696,1,4,5.74,-,0.7,0.62,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
regulation of cell size (GO:0008361),16,11,9.57,+,1.15,0.696,1,7,5.74,+,1.22,0.64,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
protein complex oligomerization (GO:0051259),32,22,19.14,+,1.15,0.673,1,12,11.48,+,1.05,0.865,1,18,18.14,-,0.99,1,1,0,0.32,-, < 0.01,1,1
protein insertion into mitochondrial membrane (GO:0051204),16,11,9.57,+,1.15,0.696,1,5,5.74,-,0.87,1,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
terpene biosynthetic process (GO:0046246),16,11,9.57,+,1.15,0.696,1,7,5.74,+,1.22,0.64,1,12,9.07,+,1.32,0.555,1,0,0.16,-, < 0.01,1,1
regulation of tetrapyrrole biosynthetic process (GO:1901463),16,11,9.57,+,1.15,0.696,1,10,5.74,+,1.74,0.181,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
nucleoside monophosphate biosynthetic process (GO:0009124),35,24,20.93,+,1.15,0.593,1,17,12.55,+,1.35,0.344,1,21,19.84,+,1.06,0.889,1,0,0.35,-, < 0.01,1,1
flavonoid metabolic process (GO:0009812),35,24,20.93,+,1.15,0.593,1,16,12.55,+,1.27,0.427,1,21,19.84,+,1.06,0.889,1,0,0.35,-, < 0.01,1,1
regulation of phosphorus metabolic process (GO:0051174),89,61,53.22,+,1.15,0.446,1,26,31.92,-,0.81,0.397,1,56,50.45,+,1.11,0.545,1,0,0.89,-, < 0.01,1,1
cell surface receptor signaling pathway (GO:0007166),19,13,11.36,+,1.14,0.717,1,9,6.81,+,1.32,0.52,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
plastid localization (GO:0051644),19,13,11.36,+,1.14,0.717,1,8,6.81,+,1.17,0.667,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
amino sugar metabolic process (GO:0006040),19,13,11.36,+,1.14,0.717,1,4,6.81,-,0.59,0.477,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
chloroplast localization (GO:0019750),19,13,11.36,+,1.14,0.717,1,8,6.81,+,1.17,0.667,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
regulation of phosphorylation (GO:0042325),60,41,35.88,+,1.14,0.537,1,17,21.52,-,0.79,0.439,1,38,34.01,+,1.12,0.599,1,0,0.6,-, < 0.01,1,1
calcium ion homeostasis (GO:0055074),41,28,24.52,+,1.14,0.619,1,21,14.7,+,1.43,0.194,1,28,23.24,+,1.2,0.453,1,0,0.41,-, < 0.01,1,1
polysaccharide catabolic process (GO:0000272),63,43,37.67,+,1.14,0.546,1,27,22.59,+,1.2,0.472,1,43,35.71,+,1.2,0.362,1,4,0.63,+,6.32,0.00441,1
response to abscisic acid (GO:0009737),315,215,188.37,+,1.14,0.134,1,132,112.96,+,1.17,0.128,1,211,178.56,+,1.18,0.0594,1,4,3.16,+,1.26,0.562,1
cellular amino acid metabolic process (GO:0006520),255,174,152.49,+,1.14,0.174,1,105,91.45,+,1.15,0.227,1,175,144.55,+,1.21,0.0538,1,3,2.56,+,1.17,0.745,1
endosome transport via multivesicular body sorting pathway (GO:0032509),22,15,13.16,+,1.14,0.735,1,12,7.89,+,1.52,0.245,1,16,12.47,+,1.28,0.5,1,0,0.22,-, < 0.01,1,1
detection of stimulus (GO:0051606),44,30,26.31,+,1.14,0.631,1,17,15.78,+,1.08,0.772,1,28,24.94,+,1.12,0.625,1,0,0.44,-, < 0.01,1,1
positive regulation of proteolysis (GO:0045862),22,15,13.16,+,1.14,0.735,1,7,7.89,-,0.89,1,1,14,12.47,+,1.12,0.731,1,0,0.22,-, < 0.01,1,1
multivesicular body sorting pathway (GO:0071985),22,15,13.16,+,1.14,0.735,1,12,7.89,+,1.52,0.245,1,16,12.47,+,1.28,0.5,1,0,0.22,-, < 0.01,1,1
negative regulation of translation (GO:0017148),22,15,13.16,+,1.14,0.735,1,9,7.89,+,1.14,0.688,1,12,12.47,-,0.96,1,1,0,0.22,-, < 0.01,1,1
organic hydroxy compound biosynthetic process (GO:1901617),91,62,54.42,+,1.14,0.451,1,43,32.63,+,1.32,0.14,1,58,51.58,+,1.12,0.494,1,1,0.91,+,1.09,0.603,1
plant-type cell wall organization or biogenesis (GO:0071669),138,94,82.52,+,1.14,0.34,1,41,49.49,-,0.83,0.307,1,91,78.23,+,1.16,0.269,1,1,1.39,-,0.72,1,1
aging (GO:0007568),94,64,56.21,+,1.14,0.458,1,50,33.71,+,1.48,0.0285,1,67,53.28,+,1.26,0.162,1,3,0.94,+,3.18,0.0723,1
response to alcohol (GO:0097305),319,217,190.76,+,1.14,0.148,1,133,114.4,+,1.16,0.144,1,213,180.83,+,1.18,0.061,1,4,3.2,+,1.25,0.566,1
regulation of cellular protein catabolic process (GO:1903362),25,17,14.95,+,1.14,0.75,1,8,8.97,-,0.89,1,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
cellular response to salt stress (GO:0071472),25,17,14.95,+,1.14,0.75,1,12,8.97,+,1.34,0.455,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),25,17,14.95,+,1.14,0.75,1,8,8.97,-,0.89,1,1,17,14.17,+,1.2,0.63,1,0,0.25,-, < 0.01,1,1
seed coat development (GO:0010214),25,17,14.95,+,1.14,0.75,1,9,8.97,+,1,1,1,15,14.17,+,1.06,0.87,1,0,0.25,-, < 0.01,1,1
metal ion transport (GO:0030001),156,106,93.29,+,1.14,0.305,1,63,55.94,+,1.13,0.44,1,110,88.43,+,1.24,0.0828,1,0,1.57,-, < 0.01,0.411,1
tRNA metabolic process (GO:0006399),134,91,80.13,+,1.14,0.368,1,59,48.05,+,1.23,0.189,1,68,75.96,-,0.9,0.508,1,0,1.35,-, < 0.01,0.646,1
protein dephosphorylation (GO:0006470),81,55,48.44,+,1.14,0.478,1,33,29.05,+,1.14,0.524,1,49,45.92,+,1.07,0.715,1,1,0.81,+,1.23,0.561,1
oxoacid metabolic process (GO:0043436),626,425,374.35,+,1.14,0.0393,1,260,224.49,+,1.16,0.042,1,417,354.85,+,1.18,0.00895,0.752,9,6.29,+,1.43,0.299,1
organic hydroxy compound metabolic process (GO:1901615),165,112,98.67,+,1.14,0.317,1,79,59.17,+,1.34,0.0402,1,109,93.53,+,1.17,0.229,1,1,1.66,-,0.6,1,1
starch biosynthetic process (GO:0019252),28,19,16.74,+,1.13,0.654,1,11,10.04,+,1.1,0.856,1,17,15.87,+,1.07,0.877,1,1,0.28,+,3.56,0.252,1
regulation of cellular catabolic process (GO:0031329),56,38,33.49,+,1.13,0.593,1,22,20.08,+,1.1,0.701,1,39,31.74,+,1.23,0.336,1,0,0.56,-, < 0.01,1,1
cellular response to chemical stress (GO:0062197),87,59,52.03,+,1.13,0.492,1,39,31.2,+,1.25,0.264,1,65,49.32,+,1.32,0.0909,1,2,0.87,+,2.29,0.222,1
response to acid chemical (GO:0001101),236,160,141.13,+,1.13,0.228,1,107,84.63,+,1.26,0.0475,1,160,133.78,+,1.2,0.0813,1,4,2.37,+,1.69,0.305,1
post-Golgi vesicle-mediated transport (GO:0006892),31,21,18.54,+,1.13,0.669,1,9,11.12,-,0.81,0.72,1,14,17.57,-,0.8,0.537,1,0,0.31,-, < 0.01,1,1
regulation of proteolysis (GO:0030162),31,21,18.54,+,1.13,0.669,1,10,11.12,-,0.9,0.861,1,21,17.57,+,1.2,0.564,1,0,0.31,-, < 0.01,1,1
alpha-amino acid catabolic process (GO:1901606),62,42,37.08,+,1.13,0.543,1,23,22.23,+,1.03,0.902,1,50,35.15,+,1.42,0.0754,1,2,0.62,+,3.21,0.133,1
organic acid metabolic process (GO:0006082),629,426,376.15,+,1.13,0.0429,1,261,225.57,+,1.16,0.0464,1,419,356.55,+,1.18,0.00909,0.752,9,6.32,+,1.42,0.3,1
protein transmembrane transport (GO:0071806),65,44,38.87,+,1.13,0.552,1,31,23.31,+,1.33,0.201,1,43,36.85,+,1.17,0.424,1,1,0.65,+,1.53,0.484,1
terpenoid biosynthetic process (GO:0016114),68,46,40.66,+,1.13,0.561,1,28,24.39,+,1.15,0.562,1,51,38.55,+,1.32,0.151,1,0,0.68,-, < 0.01,1,1
carboxylic acid transmembrane transport (GO:1905039),34,23,20.33,+,1.13,0.682,1,18,12.19,+,1.48,0.206,1,21,19.27,+,1.09,0.779,1,0,0.34,-, < 0.01,1,1
response to water deprivation (GO:0009414),210,142,125.58,+,1.13,0.267,1,93,75.31,+,1.23,0.0877,1,144,119.04,+,1.21,0.0835,1,4,2.11,+,1.9,0.165,1
nucleoside monophosphate metabolic process (GO:0009123),37,25,22.13,+,1.13,0.694,1,18,13.27,+,1.36,0.286,1,22,20.97,+,1.05,0.892,1,0,0.37,-, < 0.01,1,1
organelle localization by membrane tethering (GO:0140056),37,25,22.13,+,1.13,0.694,1,15,13.27,+,1.13,0.753,1,21,20.97,+,1,1,1,0,0.37,-, < 0.01,1,1
membrane docking (GO:0022406),37,25,22.13,+,1.13,0.694,1,15,13.27,+,1.13,0.753,1,21,20.97,+,1,1,1,0,0.37,-, < 0.01,1,1
seed maturation (GO:0010431),37,25,22.13,+,1.13,0.694,1,14,13.27,+,1.06,0.874,1,26,20.97,+,1.24,0.431,1,1,0.37,+,2.69,0.316,1
plant ovule development (GO:0048481),37,25,22.13,+,1.13,0.694,1,19,13.27,+,1.43,0.224,1,21,20.97,+,1,1,1,0,0.37,-, < 0.01,1,1
cellular response to topologically incorrect protein (GO:0035967),40,27,23.92,+,1.13,0.616,1,24,14.34,+,1.67,0.0473,1,26,22.67,+,1.15,0.609,1,0,0.4,-, < 0.01,1,1
regulation of cell population proliferation (GO:0042127),43,29,25.71,+,1.13,0.627,1,16,15.42,+,1.04,0.883,1,22,24.37,-,0.9,0.796,1,1,0.43,+,2.31,0.356,1
hydrocarbon metabolic process (GO:0120252),43,29,25.71,+,1.13,0.627,1,22,15.42,+,1.43,0.203,1,29,24.37,+,1.19,0.464,1,1,0.43,+,2.31,0.356,1
response to salicylic acid (GO:0009751),86,58,51.43,+,1.13,0.49,1,35,30.84,+,1.13,0.535,1,54,48.75,+,1.11,0.597,1,1,0.86,+,1.16,0.582,1
cellular divalent inorganic cation homeostasis (GO:0072503),43,29,25.71,+,1.13,0.627,1,20,15.42,+,1.3,0.32,1,30,24.37,+,1.23,0.394,1,0,0.43,-, < 0.01,1,1
response to topologically incorrect protein (GO:0035966),43,29,25.71,+,1.13,0.627,1,25,15.42,+,1.62,0.0718,1,28,24.37,+,1.15,0.621,1,0,0.43,-, < 0.01,1,1
response to external stimulus (GO:0009605),887,598,530.43,+,1.13,0.0194,1,379,318.09,+,1.19,0.00356,0.472,568,502.8,+,1.13,0.0187,1,7,8.91,-,0.79,0.603,1
ribonucleotide metabolic process (GO:0009259),147,99,87.91,+,1.13,0.354,1,67,52.72,+,1.27,0.102,1,94,83.33,+,1.13,0.381,1,3,1.48,+,2.03,0.188,1
organic anion transport (GO:0015711),101,68,60.4,+,1.13,0.473,1,50,36.22,+,1.38,0.0638,1,61,57.25,+,1.07,0.683,1,1,1.01,-,0.99,1,1
fatty acid metabolic process (GO:0006631),153,103,91.49,+,1.13,0.363,1,54,54.87,-,0.98,1,1,107,86.73,+,1.23,0.104,1,2,1.54,+,1.3,0.668,1
nucleoside diphosphate metabolic process (GO:0009132),52,35,31.1,+,1.13,0.581,1,23,18.65,+,1.23,0.431,1,34,29.48,+,1.15,0.503,1,2,0.52,+,3.83,0.101,1
programmed cell death (GO:0012501),52,35,31.1,+,1.13,0.581,1,28,18.65,+,1.5,0.0973,1,34,29.48,+,1.15,0.503,1,0,0.52,-, < 0.01,1,1
response to sucrose (GO:0009744),52,35,31.1,+,1.13,0.581,1,20,18.65,+,1.07,0.789,1,35,29.48,+,1.19,0.435,1,2,0.52,+,3.83,0.101,1
divalent inorganic cation homeostasis (GO:0072507),52,35,31.1,+,1.13,0.581,1,23,18.65,+,1.23,0.431,1,35,29.48,+,1.19,0.435,1,0,0.52,-, < 0.01,1,1
carboxylic acid metabolic process (GO:0019752),596,401,356.41,+,1.13,0.065,1,244,213.74,+,1.14,0.0775,1,398,337.85,+,1.18,0.0101,0.747,8,5.99,+,1.34,0.396,1
hormone transport (GO:0009914),55,37,32.89,+,1.12,0.59,1,16,19.72,-,0.81,0.503,1,35,31.18,+,1.12,0.584,1,0,0.55,-, < 0.01,1,1
tRNA modification (GO:0006400),64,43,38.27,+,1.12,0.55,1,26,22.95,+,1.13,0.631,1,30,36.28,-,0.83,0.452,1,0,0.64,-, < 0.01,1,1
endomembrane system organization (GO:0010256),67,45,40.07,+,1.12,0.558,1,24,24.03,-,1,1,1,36,37.98,-,0.95,0.838,1,1,0.67,+,1.49,0.494,1
small molecule metabolic process (GO:0044281),958,643,572.89,+,1.12,0.0193,1,418,343.56,+,1.22,0.000575,0.149,629,543.05,+,1.16,0.00301,0.537,14,9.62,+,1.45,0.175,1
plant organ senescence (GO:0090693),79,53,47.24,+,1.12,0.528,1,43,28.33,+,1.52,0.0302,1,53,44.78,+,1.18,0.364,1,3,0.79,+,3.78,0.0483,1
cellular metal ion homeostasis (GO:0006875),88,59,52.62,+,1.12,0.495,1,36,31.56,+,1.14,0.539,1,60,49.88,+,1.2,0.266,1,0,0.88,-, < 0.01,1,1
response to nitrogen compound (GO:1901698),185,124,110.63,+,1.12,0.343,1,93,66.34,+,1.4,0.00901,0.887,112,104.87,+,1.07,0.584,1,1,1.86,-,0.54,1,1
cellular carbohydrate biosynthetic process (GO:0034637),136,91,81.33,+,1.12,0.408,1,42,48.77,-,0.86,0.442,1,85,77.09,+,1.1,0.482,1,1,1.37,-,0.73,1,1
response to water (GO:0009415),214,143,127.97,+,1.12,0.321,1,93,76.74,+,1.21,0.117,1,146,121.31,+,1.2,0.0862,1,4,2.15,+,1.86,0.172,1
zinc ion transport (GO:0006829),15,10,8.97,+,1.11,0.837,1,5,5.38,-,0.93,1,1,12,8.5,+,1.41,0.424,1,0,0.15,-, < 0.01,1,1
protein secretion (GO:0009306),15,10,8.97,+,1.11,0.837,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
protein localization to extracellular region (GO:0071692),15,10,8.97,+,1.11,0.837,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
establishment of protein localization to extracellular region (GO:0035592),15,10,8.97,+,1.11,0.837,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
valine metabolic process (GO:0006573),15,10,8.97,+,1.11,0.837,1,3,5.38,-,0.56,0.433,1,12,8.5,+,1.41,0.424,1,0,0.15,-, < 0.01,1,1
methionine metabolic process (GO:0006555),15,10,8.97,+,1.11,0.837,1,5,5.38,-,0.93,1,1,11,8.5,+,1.29,0.543,1,0,0.15,-, < 0.01,1,1
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),15,10,8.97,+,1.11,0.837,1,4,5.38,-,0.74,0.796,1,12,8.5,+,1.41,0.424,1,1,0.15,+,6.64,0.148,1
organic hydroxy compound catabolic process (GO:1901616),30,20,17.94,+,1.11,0.77,1,14,10.76,+,1.3,0.396,1,21,17.01,+,1.23,0.468,1,0,0.3,-, < 0.01,1,1
peptide secretion (GO:0002790),15,10,8.97,+,1.11,0.837,1,8,5.38,+,1.49,0.35,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
regulation of chlorophyll biosynthetic process (GO:0010380),15,10,8.97,+,1.11,0.837,1,9,5.38,+,1.67,0.246,1,7,8.5,-,0.82,0.825,1,0,0.15,-, < 0.01,1,1
protein depolymerization (GO:0051261),15,10,8.97,+,1.11,0.837,1,4,5.38,-,0.74,0.796,1,12,8.5,+,1.41,0.424,1,0,0.15,-, < 0.01,1,1
pyridine-containing compound biosynthetic process (GO:0072525),15,10,8.97,+,1.11,0.837,1,5,5.38,-,0.93,1,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
gibberellin biosynthetic process (GO:0009686),15,10,8.97,+,1.11,0.837,1,7,5.38,+,1.3,0.628,1,11,8.5,+,1.29,0.543,1,0,0.15,-, < 0.01,1,1
UDP metabolic process (GO:0046048),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
GMP metabolic process (GO:0046037),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
zygote asymmetric cytokinesis in embryo sac (GO:0010069),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
xenobiotic metabolic process (GO:0006805),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
vernalization response (GO:0010048),6,4,3.59,+,1.11,1,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
mitochondrial fission (GO:0000266),12,8,7.18,+,1.11,0.82,1,3,4.3,-,0.7,0.772,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
response to metal ion (GO:0010038),285,190,170.43,+,1.11,0.25,1,122,102.21,+,1.19,0.0991,1,196,161.55,+,1.21,0.0388,1,7,2.86,+,2.44,0.0266,1
allantoin catabolic process (GO:0000256),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein unfolding (GO:0043335),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
histone H2B ubiquitination (GO:0033523),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
negative regulation of cellular catabolic process (GO:0031330),12,8,7.18,+,1.11,0.82,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
regulation of protein localization to chromatin (GO:1905634),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
glycolate metabolic process (GO:0009441),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of epithelial cell differentiation (GO:0030856),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
nuclear membrane organization (GO:0071763),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
histone ubiquitination (GO:0016574),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
protein autoprocessing (GO:0016540),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
ubiquinone biosynthetic process (GO:0006744),21,14,12.56,+,1.11,0.731,1,8,7.53,+,1.06,0.835,1,14,11.9,+,1.18,0.725,1,0,0.21,-, < 0.01,1,1
ubiquinone metabolic process (GO:0006743),21,14,12.56,+,1.11,0.731,1,8,7.53,+,1.06,0.835,1,14,11.9,+,1.18,0.725,1,0,0.21,-, < 0.01,1,1
intracellular protein transmembrane transport (GO:0065002),63,42,37.67,+,1.11,0.614,1,29,22.59,+,1.28,0.285,1,41,35.71,+,1.15,0.539,1,1,0.63,+,1.58,0.473,1
galactose catabolic process via UDP-galactose (GO:0033499),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
response to mannose (GO:1905582),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
2'-deoxyribonucleotide metabolic process (GO:0009394),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
tissue homeostasis (GO:0001894),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of exocyst localization (GO:0060178),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
very long-chain fatty acid biosynthetic process (GO:0042761),12,8,7.18,+,1.11,0.82,1,8,4.3,+,1.86,0.202,1,7,6.8,+,1.03,1,1,1,0.12,+,8.3,0.122,1
glycosphingolipid metabolic process (GO:0006687),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
glucosylceramide metabolic process (GO:0006678),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
glycosylceramide metabolic process (GO:0006677),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
triglyceride metabolic process (GO:0006641),18,12,10.76,+,1.11,0.851,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
stomatal opening (GO:1990069),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
G1/S transition of mitotic cell cycle (GO:0000082),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
specification of plant organ axis polarity (GO:0090708),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
purine-containing compound salvage (GO:0043101),6,4,3.59,+,1.11,1,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
GDP-mannose biosynthetic process (GO:0009298),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
snRNA pseudouridine synthesis (GO:0031120),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of microtubule depolymerization (GO:0031114),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
biological phase (GO:0044848),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
lysosomal transport (GO:0007041),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
pyrimidine deoxyribonucleotide metabolic process (GO:0009219),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of DNA endoreduplication (GO:0032876),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
formation of cytoplasmic translation initiation complex (GO:0001732),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
deoxyribonucleoside triphosphate catabolic process (GO:0009204),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
deoxyribonucleoside triphosphate metabolic process (GO:0009200),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
post-chaperonin tubulin folding pathway (GO:0007023),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
late nucleophagy (GO:0044805),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cell wall organization (GO:0071555),126,84,75.35,+,1.11,0.432,1,43,45.19,-,0.95,0.861,1,77,71.42,+,1.08,0.608,1,3,1.27,+,2.37,0.137,1
positive regulation of cell cycle G2/M phase transition (GO:1902751),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
tryptophan catabolic process (GO:0006569),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
proline biosynthetic process (GO:0006561),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
mitochondrion disassembly (GO:0061726),12,8,7.18,+,1.11,0.82,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
S-adenosylmethionine biosynthetic process (GO:0006556),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
glutamate catabolic process (GO:0006538),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
vitamin transmembrane transport (GO:0035461),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regeneration (GO:0031099),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
phosphate ion transmembrane transport (GO:0035435),6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
uracil transport (GO:0015857),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
pyrimidine nucleobase transport (GO:0015855),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
guanine transport (GO:0015854),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
adenine transport (GO:0015853),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
ribonucleoside diphosphate biosynthetic process (GO:0009188),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glyoxal metabolic process (GO:1903189),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
tRNA 5'-leader removal (GO:0001682),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
purine deoxyribonucleotide metabolic process (GO:0009151),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
deoxyribonucleoside metabolic process (GO:0009120),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
photosystem I stabilization (GO:0042550),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
tetrahydrofolylpolyglutamate metabolic process (GO:0046900),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
lipoate metabolic process (GO:0009106),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
cellular response to UV-B (GO:0071493),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
cellular response to xenobiotic stimulus (GO:0071466),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of auxin mediated signaling pathway (GO:0010929),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of translational elongation (GO:0006448),9,6,5.38,+,1.11,0.797,1,3,3.23,-,0.93,1,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
pyridoxine biosynthetic process (GO:0008615),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
pyridoxine metabolic process (GO:0008614),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cell-cell signaling involved in cell fate commitment (GO:0045168),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glutaminyl-tRNA aminoacylation (GO:0006425),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glutamyl-tRNA aminoacylation (GO:0006424),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
asparaginyl-tRNA aminoacylation (GO:0006421),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
alanyl-tRNA aminoacylation (GO:0006419),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
response to cycloheximide (GO:0046898),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of protein dephosphorylation (GO:0035304),18,12,10.76,+,1.11,0.851,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
positive regulation of RNA splicing (GO:0033120),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
malate transport (GO:0015743),6,4,3.59,+,1.11,1,1,5,2.15,+,2.32,0.173,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
aspartate family amino acid metabolic process (GO:0009066),42,28,25.12,+,1.11,0.711,1,20,15.06,+,1.33,0.312,1,30,23.81,+,1.26,0.329,1,0,0.42,-, < 0.01,1,1
monocarboxylic acid transport (GO:0015718),27,18,16.15,+,1.11,0.759,1,14,9.68,+,1.45,0.287,1,18,15.31,+,1.18,0.642,1,0,0.27,-, < 0.01,1,1
arsenite transport (GO:0015700),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
hormone biosynthetic process (GO:0042446),33,22,19.73,+,1.11,0.678,1,16,11.83,+,1.35,0.331,1,20,18.71,+,1.07,0.886,1,1,0.33,+,3.02,0.288,1
cellular response to fatty acid (GO:0071398),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of gene silencing by miRNA (GO:2000637),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of primary miRNA processing (GO:2000636),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of primary miRNA processing (GO:2000634),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of cell division (GO:0051781),12,8,7.18,+,1.11,0.82,1,2,4.3,-,0.46,0.38,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
positive regulation of secondary metabolite biosynthetic process (GO:1900378),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
termination of RNA polymerase II transcription (GO:0006369),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
transcription elongation from RNA polymerase II promoter (GO:0006368),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
regulation of mRNA polyadenylation (GO:1900363),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
terpenoid catabolic process (GO:0016115),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
DNA dealkylation involved in DNA repair (GO:0006307),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
ammonium transport (GO:0015696),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cadmium ion transport (GO:0015691),6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
positive regulation of photosynthesis (GO:1905157),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
water-soluble vitamin biosynthetic process (GO:0042364),36,24,21.53,+,1.11,0.69,1,18,12.91,+,1.39,0.278,1,22,20.41,+,1.08,0.785,1,1,0.36,+,2.77,0.31,1
regulation of iron ion transport (GO:0034756),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
iron ion transmembrane transport (GO:0034755),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
cellular response to mechanical stimulus (GO:0071260),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of ubiquitin protein ligase activity (GO:1904668),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
snoRNA catabolic process (GO:0016077),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
snRNA catabolic process (GO:0016076),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
"negative regulation of defense response to bacterium, incompatible interaction (GO:1902478)",3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to acid chemical (GO:0071229),36,24,21.53,+,1.11,0.69,1,17,12.91,+,1.32,0.351,1,21,20.41,+,1.03,0.891,1,0,0.36,-, < 0.01,1,1
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
establishment of plastid localization (GO:0051667),18,12,10.76,+,1.11,0.851,1,7,6.46,+,1.08,0.823,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
cellular response to external biotic stimulus (GO:0071217),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
mitochondrial DNA replication (GO:0006264),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
positive regulation of shade avoidance (GO:1902448),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
peptidyl-proline modification (GO:0018208),42,28,25.12,+,1.11,0.711,1,16,15.06,+,1.06,0.881,1,25,23.81,+,1.05,0.899,1,0,0.42,-, < 0.01,1,1
positive regulation of hydrogen peroxide metabolic process (GO:0010726),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
actin filament network formation (GO:0051639),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
UDP biosynthetic process (GO:0006225),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
preprophase band assembly (GO:0000913),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
uracil catabolic process (GO:0006212),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of gene silencing by miRNA (GO:0060964),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
homeostasis of number of cells within a tissue (GO:0048873),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
homeostasis of number of cells (GO:0048872),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of cutin biosynthetic process (GO:1901957),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
response to cadmium ion (GO:0046686),219,146,130.96,+,1.11,0.326,1,96,78.54,+,1.22,0.107,1,152,124.14,+,1.22,0.0563,1,7,2.2,+,3.18,0.00739,1
auxin transport (GO:0060918),54,36,32.29,+,1.11,0.663,1,16,19.37,-,0.83,0.587,1,34,30.61,+,1.11,0.657,1,0,0.54,-, < 0.01,1,1
cellular modified amino acid catabolic process (GO:0042219),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),18,12,10.76,+,1.11,0.851,1,4,6.46,-,0.62,0.475,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
DNA replication preinitiation complex assembly (GO:0071163),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of growth rate (GO:0040009),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
histone H4-R3 methylation (GO:0043985),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of mRNA catabolic process (GO:1902373),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of histone H3-K9 methylation (GO:0051574),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
histone H3-K9 acetylation (GO:0043970),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
GMP biosynthetic process (GO:0006177),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
AMP biosynthetic process (GO:0006167),6,4,3.59,+,1.11,1,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
protein K48-linked deubiquitination (GO:0071108),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
aerenchyma formation (GO:0010618),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
regulation of multi-organism process (GO:0043900),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
oxaloacetate metabolic process (GO:0006107),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
2-oxoglutarate metabolic process (GO:0006103),3,2,1.79,+,1.11,1,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of nucleus size (GO:0097298),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
root hair initiation (GO:0048766),9,6,5.38,+,1.11,0.797,1,0,3.23,-, < 0.01,0.124,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
negative regulation of protein catabolic process (GO:0042177),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
"guanine deglycation, glyoxal removal (GO:0106046)",3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
guanine deglycation (GO:0106044),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein maturation by [4Fe-4S] cluster transfer (GO:0106035),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nitrate assimilation (GO:0042128),6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,3,3.4,-,0.88,1,1,1,0.06,+,16.59,0.0676,1
nitrate metabolic process (GO:0042126),6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,3,3.4,-,0.88,1,1,1,0.06,+,16.59,0.0676,1
protein localization to chromosome (GO:0034502),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
polyadenylation-dependent mRNA catabolic process (GO:0071047),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
histone mRNA catabolic process (GO:0071044),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of defense response to oomycetes (GO:1902289),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
antisense RNA transcript catabolic process (GO:0071041),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
nuclear ncRNA surveillance (GO:0071029),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
basipetal auxin transport (GO:0010540),9,6,5.38,+,1.11,0.797,1,5,3.23,+,1.55,0.543,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
negative regulation of leaf senescence (GO:1900056),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
spermine metabolic process (GO:0008215),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,8,5.1,+,1.57,0.449,1,0,0.09,-, < 0.01,1,1
inositol biosynthetic process (GO:0006021),3,2,1.79,+,1.11,1,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
xyloglucan biosynthetic process (GO:0009969),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
response to 1-aminocyclopropane-1-carboxylic acid (GO:0009961),3,2,1.79,+,1.11,1,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
response to fatty acid (GO:0070542),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of heterochromatin organization (GO:0120261),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glyoxylate metabolic process (GO:0046487),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
anther wall tapetum cell differentiation (GO:0048657),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
anther wall tapetum formation (GO:0048656),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
calcium ion import (GO:0070509),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
phloem sucrose loading (GO:0009915),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of developmental growth (GO:0048640),9,6,5.38,+,1.11,0.797,1,3,3.23,-,0.93,1,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
acylglycerol catabolic process (GO:0046464),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
chloroplast relocation (GO:0009902),18,12,10.76,+,1.11,0.851,1,7,6.46,+,1.08,0.823,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
neutral lipid catabolic process (GO:0046461),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of developmental growth (GO:0048639),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
short-chain fatty acid metabolic process (GO:0046459),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein localization to phagophore assembly site (GO:0034497),6,4,3.59,+,1.11,1,1,0,2.15,-, < 0.01,0.351,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
U5 snRNA 3'-end processing (GO:0034476),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
U1 snRNA 3'-end processing (GO:0034473),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
purine nucleotide salvage (GO:0032261),6,4,3.59,+,1.11,1,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
response to jasmonic acid stimulus involved in jasmonic acid and ethylene-dependent systemic resistance (GO:0032260),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
CTP salvage (GO:0044211),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of proline metabolic process (GO:2000214),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
shoot apical meristem development (GO:1902182),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"positive regulation of development, heterochronic (GO:0045962)",6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of cell fate commitment (GO:0010453),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
cell cycle phase (GO:0022403),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of oxidoreductase activity (GO:0051354),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of mitotic cell cycle (GO:0045931),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
regulation of peptide transport (GO:0090087),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
deoxyribose phosphate metabolic process (GO:0019692),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
regulation of chlorophyll metabolic process (GO:0090056),18,12,10.76,+,1.11,0.851,1,10,6.46,+,1.55,0.284,1,9,10.2,-,0.88,0.843,1,0,0.18,-, < 0.01,1,1
positive regulation of catabolic process (GO:0009896),39,26,23.32,+,1.11,0.701,1,15,13.99,+,1.07,0.877,1,24,22.11,+,1.09,0.793,1,0,0.39,-, < 0.01,1,1
pollen tube adhesion (GO:0009865),3,2,1.79,+,1.11,1,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"negative regulation of long-day photoperiodism, flowering (GO:0048579)",6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
plant-type cell wall biogenesis (GO:0009832),93,62,55.61,+,1.11,0.506,1,26,33.35,-,0.78,0.297,1,63,52.72,+,1.2,0.278,1,0,0.93,-, < 0.01,1,1
plant-type cell wall modification (GO:0009827),27,18,16.15,+,1.11,0.759,1,8,9.68,-,0.83,0.706,1,16,15.31,+,1.05,0.875,1,1,0.27,+,3.69,0.244,1
deoxyribose phosphate catabolic process (GO:0046386),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
homeostasis of number of meristem cells (GO:0007639),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of vesicle-mediated transport (GO:0060627),18,12,10.76,+,1.11,0.851,1,7,6.46,+,1.08,0.823,1,13,10.2,+,1.27,0.575,1,0,0.18,-, < 0.01,1,1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
disaccharide catabolic process (GO:0046352),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
protein stabilization (GO:0050821),21,14,12.56,+,1.11,0.731,1,7,7.53,-,0.93,1,1,13,11.9,+,1.09,0.859,1,0,0.21,-, < 0.01,1,1
histone H3-K14 acetylation (GO:0044154),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"protein deglycation, glyoxal removal (GO:0036529)",3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein deglycation (GO:0036525),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of ERAD pathway (GO:1904292),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein K69-linked ufmylation (GO:1990592),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
primary alcohol biosynthetic process (GO:0034309),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of stomatal complex development (GO:2000122),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
potassium ion import across plasma membrane (GO:1990573),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of establishment of cell polarity (GO:2000114),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein polyufmylation (GO:1990564),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
mitochondrial transmembrane transport (GO:1990542),42,28,25.12,+,1.11,0.711,1,20,15.06,+,1.33,0.312,1,22,23.81,-,0.92,0.796,1,0,0.42,-, < 0.01,1,1
raffinose family oligosaccharide biosynthetic process (GO:0010325),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
polyadenylation-dependent ncRNA catabolic process (GO:0043634),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
polyadenylation-dependent RNA catabolic process (GO:0043633),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
regulation of protein transport (GO:0051223),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
floral organ senescence (GO:0080187),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
response to photooxidative stress (GO:0080183),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
plastoglobule organization (GO:0080177),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
cellular response to sucrose starvation (GO:0043617),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,1,0.03,+,33.18,0.0392,1
phragmoplast microtubule organization (GO:0080175),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of double fertilization forming a zygote and endosperm (GO:0080155),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of fertilization (GO:0080154),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
arabinose metabolic process (GO:0019566),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of abscisic acid-activated signaling pathway (GO:0009789),27,18,16.15,+,1.11,0.759,1,10,9.68,+,1.03,1,1,17,15.31,+,1.11,0.755,1,0,0.27,-, < 0.01,1,1
regulation of response to stress (GO:0080134),237,158,141.73,+,1.11,0.294,1,102,84.99,+,1.2,0.12,1,142,134.34,+,1.06,0.59,1,1,2.38,-,0.42,0.734,1
regulation of lipid localization (GO:1905952),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
hexose mediated signaling (GO:0009757),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
stigma development (GO:0048480),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
glycolate biosynthetic process (GO:0046295),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
formaldehyde catabolic process (GO:0046294),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
formaldehyde metabolic process (GO:0046292),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
tRNA 5'-end processing (GO:0099116),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
response to disaccharide (GO:0034285),54,36,32.29,+,1.11,0.663,1,20,19.37,+,1.03,0.895,1,36,30.61,+,1.18,0.444,1,2,0.54,+,3.69,0.107,1
indolalkylamine catabolic process (GO:0046218),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),18,12,10.76,+,1.11,0.851,1,5,6.46,-,0.77,0.813,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
hydrotropism (GO:0010274),6,4,3.59,+,1.11,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
response to silver ion (GO:0010272),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
somatic embryogenesis (GO:0010262),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of carotenoid biosynthetic process (GO:1904143),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
glucose mediated signaling pathway (GO:0010255),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cell-cell adhesion (GO:0098609),3,2,1.79,+,1.11,1,1,3,1.08,+,2.79,0.192,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
exonucleolytic trimming involved in rRNA processing (GO:0000459),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
stamen filament development (GO:0080086),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
ammonium transmembrane transport (GO:0072488),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
autophagy of mitochondrion (GO:0000422),12,8,7.18,+,1.11,0.82,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
beta-alanine biosynthetic process (GO:0019483),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of DNA binding (GO:0051101),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
indoleacetic acid biosynthetic process (GO:0009684),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
tryptophan catabolic process to kynurenine (GO:0019441),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
skotomorphogenesis (GO:0009647),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
homocysteine metabolic process (GO:0050667),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of establishment of protein localization (GO:0070201),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
alcohol catabolic process (GO:0046164),21,14,12.56,+,1.11,0.731,1,9,7.53,+,1.2,0.679,1,15,11.9,+,1.26,0.492,1,0,0.21,-, < 0.01,1,1
phloem loading (GO:0110126),6,4,3.59,+,1.11,1,1,4,2.15,+,1.86,0.304,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
pyrimidine deoxyribonucleoside metabolic process (GO:0046125),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
thymidine metabolic process (GO:0046104),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear pore organization (GO:0006999),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of cohesin loading (GO:0071922),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
detection of external biotic stimulus (GO:0098581),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
positive regulation of protein serine/threonine kinase activity (GO:0071902),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
regulation of protein serine/threonine kinase activity (GO:0071900),36,24,21.53,+,1.11,0.69,1,9,12.91,-,0.7,0.399,1,22,20.41,+,1.08,0.785,1,0,0.36,-, < 0.01,1,1
regulation of epidermis development (GO:0045682),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
response to microbial phytotoxin (GO:0010188),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of proton transport (GO:0010155),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of transport (GO:0051051),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
negative regulation of DNA-binding transcription factor activity (GO:0043433),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of epidermal cell differentiation (GO:0045604),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
microtubule severing (GO:0051013),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
galactose catabolic process (GO:0019388),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784),3,2,1.79,+,1.11,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
kynurenine metabolic process (GO:0070189),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
lipoxygenase pathway (GO:0019372),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
detection of biotic stimulus (GO:0009595),6,4,3.59,+,1.11,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of heterochromatin assembly (GO:0031445),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of mRNA 3'-end processing (GO:0031440),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
pyridine nucleotide metabolic process (GO:0019362),12,8,7.18,+,1.11,0.82,1,4,4.3,-,0.93,1,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
mitochondrial cytochrome c oxidase assembly (GO:0033617),9,6,5.38,+,1.11,0.797,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
transsulfuration (GO:0019346),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to aldehyde (GO:0110096),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
cellular detoxification of aldehyde (GO:0110095),9,6,5.38,+,1.11,0.797,1,4,3.23,+,1.24,0.754,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
mRNA stabilization (GO:0048255),3,2,1.79,+,1.11,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
endoplasmic reticulum to cytosol transport (GO:1903513),3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
dipeptide transport (GO:0042938),6,4,3.59,+,1.11,1,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
"retrograde protein transport, ER to cytosol (GO:0030970)",3,2,1.79,+,1.11,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
starch metabolic process (GO:0005982),51,34,30.5,+,1.11,0.654,1,21,18.29,+,1.15,0.593,1,33,28.91,+,1.14,0.57,1,2,0.51,+,3.9,0.0975,1
cellular response to phosphate starvation (GO:0016036),51,34,30.5,+,1.11,0.654,1,18,18.29,-,0.98,1,1,34,28.91,+,1.18,0.498,1,2,0.51,+,3.9,0.0975,1
response to oxygen-containing compound (GO:1901700),930,619,556.15,+,1.11,0.0332,1,392,333.51,+,1.18,0.00579,0.624,608,527.18,+,1.15,0.00485,0.643,10,9.34,+,1.07,0.734,1
sulfur compound metabolic process (GO:0006790),188,125,112.43,+,1.11,0.377,1,90,67.42,+,1.33,0.0279,1,122,106.57,+,1.14,0.258,1,5,1.89,+,2.65,0.0435,1
monocarboxylic acid biosynthetic process (GO:0072330),134,89,80.13,+,1.11,0.445,1,53,48.05,+,1.1,0.559,1,81,75.96,+,1.07,0.669,1,2,1.35,+,1.49,0.393,1
polysaccharide metabolic process (GO:0005976),232,154,138.74,+,1.11,0.313,1,77,83.2,-,0.93,0.602,1,147,131.51,+,1.12,0.305,1,6,2.33,+,2.57,0.0316,1
protein phosphorylation (GO:0006468),578,383,345.65,+,1.11,0.116,1,246,207.28,+,1.19,0.0233,1,358,327.64,+,1.09,0.186,1,3,5.81,-,0.52,0.386,1
ribose phosphate metabolic process (GO:0019693),154,102,92.09,+,1.11,0.436,1,70,55.23,+,1.27,0.109,1,96,87.3,+,1.1,0.467,1,3,1.55,+,1.94,0.205,1
cell wall polysaccharide metabolic process (GO:0010383),74,49,44.25,+,1.11,0.576,1,20,26.54,-,0.75,0.292,1,42,41.95,+,1,1,1,1,0.74,+,1.35,0.529,1
microtubule-based process (GO:0007017),142,94,84.92,+,1.11,0.457,1,39,50.92,-,0.77,0.15,1,96,80.49,+,1.19,0.197,1,1,1.43,-,0.7,1,1
oxidation-reduction process (GO:0055114),426,282,254.75,+,1.11,0.179,1,184,152.77,+,1.2,0.0353,1,294,241.48,+,1.22,0.0091,0.743,12,4.28,+,2.8,0.00139,1
carbohydrate metabolic process (GO:0005975),497,329,297.21,+,1.11,0.152,1,186,178.23,+,1.04,0.626,1,320,281.73,+,1.14,0.0744,1,10,4.99,+,2,0.0355,1
response to lipid (GO:0033993),417,276,249.37,+,1.11,0.188,1,173,149.54,+,1.16,0.106,1,267,236.38,+,1.13,0.115,1,4,4.19,-,0.95,1,1
glucan metabolic process (GO:0044042),127,84,75.95,+,1.11,0.475,1,43,45.54,-,0.94,0.793,1,82,71.99,+,1.14,0.385,1,5,1.28,+,3.92,0.0102,1
cellular glucan metabolic process (GO:0006073),124,82,74.15,+,1.11,0.47,1,40,44.47,-,0.9,0.594,1,79,70.29,+,1.12,0.42,1,4,1.25,+,3.21,0.0388,1
cellular carbohydrate metabolic process (GO:0044262),236,156,141.13,+,1.11,0.343,1,83,84.63,-,0.98,0.949,1,150,133.78,+,1.12,0.285,1,4,2.37,+,1.69,0.305,1
membrane organization (GO:0061024),174,115,104.05,+,1.11,0.426,1,73,62.4,+,1.17,0.275,1,98,98.63,-,0.99,1,1,1,1.75,-,0.57,1,1
nucleobase-containing small molecule metabolic process (GO:0055086),262,173,156.68,+,1.1,0.317,1,110,93.96,+,1.17,0.171,1,160,148.52,+,1.08,0.474,1,5,2.63,+,1.9,0.195,1
small molecule biosynthetic process (GO:0044283),432,285,258.34,+,1.1,0.195,1,187,154.92,+,1.21,0.0326,1,278,244.88,+,1.14,0.095,1,8,4.34,+,1.84,0.0837,1
nucleoside metabolic process (GO:0009116),47,31,28.11,+,1.1,0.725,1,23,16.85,+,1.36,0.223,1,32,26.64,+,1.2,0.414,1,2,0.47,+,4.24,0.0853,1
cellular component macromolecule biosynthetic process (GO:0070589),47,31,28.11,+,1.1,0.725,1,12,16.85,-,0.71,0.374,1,27,26.64,+,1.01,1,1,0,0.47,-, < 0.01,1,1
cell wall macromolecule biosynthetic process (GO:0044038),47,31,28.11,+,1.1,0.725,1,12,16.85,-,0.71,0.374,1,27,26.64,+,1.01,1,1,0,0.47,-, < 0.01,1,1
cellular response to chemical stimulus (GO:0070887),651,429,389.3,+,1.1,0.113,1,302,233.46,+,1.29,0.00018,0.0935,414,369.02,+,1.12,0.0618,1,5,6.54,-,0.76,0.687,1
cytoskeleton-dependent cytokinesis (GO:0061640),41,27,24.52,+,1.1,0.708,1,12,14.7,-,0.82,0.64,1,26,23.24,+,1.12,0.703,1,0,0.41,-, < 0.01,1,1
tRNA processing (GO:0008033),82,54,49.04,+,1.1,0.594,1,35,29.41,+,1.19,0.4,1,37,46.48,-,0.8,0.292,1,0,0.82,-, < 0.01,1,1
response to inorganic substance (GO:0010035),571,376,341.46,+,1.1,0.139,1,241,204.77,+,1.18,0.0307,1,387,323.67,+,1.2,0.00583,0.694,10,5.74,+,1.74,0.0827,1
anion transport (GO:0006820),161,106,96.28,+,1.1,0.445,1,76,57.74,+,1.32,0.0534,1,98,91.26,+,1.07,0.603,1,1,1.62,-,0.62,1,1
plant-type ovary development (GO:0035670),38,25,22.72,+,1.1,0.698,1,19,13.63,+,1.39,0.231,1,21,21.54,-,0.97,1,1,0,0.38,-, < 0.01,1,1
lipid catabolic process (GO:0016042),76,50,45.45,+,1.1,0.644,1,22,27.25,-,0.81,0.422,1,62,43.08,+,1.44,0.0332,1,0,0.76,-, < 0.01,1,1
negative regulation of molecular function (GO:0044092),38,25,22.72,+,1.1,0.698,1,15,13.63,+,1.1,0.756,1,24,21.54,+,1.11,0.692,1,0,0.38,-, < 0.01,1,1
protein ubiquitination (GO:0016567),377,248,225.45,+,1.1,0.24,1,136,135.2,+,1.01,0.959,1,214,213.7,+,1,1,1,2,3.79,-,0.53,0.593,1
cellular response to nutrient levels (GO:0031669),108,71,64.58,+,1.1,0.536,1,36,38.73,-,0.93,0.776,1,65,61.22,+,1.06,0.692,1,4,1.08,+,3.69,0.0255,1
protein transmembrane import into intracellular organelle (GO:0044743),35,23,20.93,+,1.1,0.786,1,16,12.55,+,1.27,0.427,1,24,19.84,+,1.21,0.498,1,0,0.35,-, < 0.01,1,1
cellular response to ethylene stimulus (GO:0071369),35,23,20.93,+,1.1,0.786,1,19,12.55,+,1.51,0.163,1,21,19.84,+,1.06,0.889,1,0,0.35,-, < 0.01,1,1
hydrocarbon biosynthetic process (GO:0120251),35,23,20.93,+,1.1,0.786,1,19,12.55,+,1.51,0.163,1,23,19.84,+,1.16,0.586,1,1,0.35,+,2.84,0.303,1
response to gibberellin (GO:0009739),67,44,40.07,+,1.1,0.624,1,25,24.03,+,1.04,0.906,1,41,37.98,+,1.08,0.689,1,0,0.67,-, < 0.01,1,1
lipid localization (GO:0010876),64,42,38.27,+,1.1,0.687,1,27,22.95,+,1.18,0.475,1,38,36.28,+,1.05,0.837,1,0,0.64,-, < 0.01,1,1
response to abiotic stimulus (GO:0009628),1344,882,803.72,+,1.1,0.0244,1,569,481.98,+,1.18,0.00053,0.144,844,761.85,+,1.11,0.0142,0.98,18,13.5,+,1.33,0.194,1
fatty acid biosynthetic process (GO:0006633),87,57,52.03,+,1.1,0.605,1,35,31.2,+,1.12,0.538,1,54,49.32,+,1.09,0.599,1,2,0.87,+,2.29,0.222,1
sulfur amino acid metabolic process (GO:0000096),29,19,17.34,+,1.1,0.767,1,12,10.4,+,1.15,0.723,1,20,16.44,+,1.22,0.552,1,0,0.29,-, < 0.01,1,1
cellular polysaccharide metabolic process (GO:0044264),168,110,100.47,+,1.09,0.455,1,53,60.25,-,0.88,0.443,1,103,95.23,+,1.08,0.525,1,4,1.69,+,2.37,0.0925,1
polysaccharide biosynthetic process (GO:0000271),136,89,81.33,+,1.09,0.533,1,36,48.77,-,0.74,0.117,1,84,77.09,+,1.09,0.526,1,1,1.37,-,0.73,1,1
ion transport (GO:0006811),379,248,226.64,+,1.09,0.276,1,168,135.92,+,1.24,0.0233,1,251,214.84,+,1.17,0.0528,1,6,3.81,+,1.58,0.285,1
positive regulation of molecular function (GO:0044093),81,53,48.44,+,1.09,0.654,1,33,29.05,+,1.14,0.524,1,42,45.92,-,0.91,0.707,1,0,0.81,-, < 0.01,1,1
cellular response to oxygen-containing compound (GO:1901701),321,210,191.96,+,1.09,0.318,1,144,115.12,+,1.25,0.0251,1,200,181.96,+,1.1,0.288,1,2,3.22,-,0.62,0.774,1
protein modification by small protein conjugation (GO:0032446),396,259,236.81,+,1.09,0.268,1,145,142.01,+,1.02,0.843,1,226,224.48,+,1.01,0.932,1,2,3.98,-,0.5,0.443,1
cellular protein catabolic process (GO:0044257),315,206,188.37,+,1.09,0.313,1,105,112.96,-,0.93,0.538,1,193,178.56,+,1.08,0.4,1,5,3.16,+,1.58,0.253,1
amine biosynthetic process (GO:0009309),26,17,15.55,+,1.09,0.755,1,13,9.32,+,1.39,0.363,1,13,14.74,-,0.88,0.868,1,0,0.26,-, < 0.01,1,1
response to molecule of bacterial origin (GO:0002237),26,17,15.55,+,1.09,0.755,1,13,9.32,+,1.39,0.363,1,17,14.74,+,1.15,0.637,1,0,0.26,-, < 0.01,1,1
sucrose metabolic process (GO:0005985),26,17,15.55,+,1.09,0.755,1,12,9.32,+,1.29,0.464,1,19,14.74,+,1.29,0.438,1,0,0.26,-, < 0.01,1,1
cellular biogenic amine biosynthetic process (GO:0042401),26,17,15.55,+,1.09,0.755,1,13,9.32,+,1.39,0.363,1,13,14.74,-,0.88,0.868,1,0,0.26,-, < 0.01,1,1
salicylic acid mediated signaling pathway (GO:0009863),26,17,15.55,+,1.09,0.755,1,8,9.32,-,0.86,0.846,1,16,14.74,+,1.09,0.872,1,0,0.26,-, < 0.01,1,1
regulation of protein stability (GO:0031647),26,17,15.55,+,1.09,0.755,1,8,9.32,-,0.86,0.846,1,16,14.74,+,1.09,0.872,1,0,0.26,-, < 0.01,1,1
negative regulation of cell death (GO:0060548),26,17,15.55,+,1.09,0.755,1,9,9.32,-,0.97,1,1,20,14.74,+,1.36,0.357,1,0,0.26,-, < 0.01,1,1
cellular response to starvation (GO:0009267),98,64,58.6,+,1.09,0.625,1,34,35.14,-,0.97,0.921,1,59,55.55,+,1.06,0.739,1,4,0.98,+,4.06,0.0188,1
cell death (GO:0008219),72,47,43.06,+,1.09,0.636,1,36,25.82,+,1.39,0.102,1,43,40.81,+,1.05,0.771,1,0,0.72,-, < 0.01,1,1
purine nucleoside bisphosphate biosynthetic process (GO:0034033),23,15,13.75,+,1.09,0.867,1,11,8.25,+,1.33,0.438,1,11,13.04,-,0.84,0.723,1,1,0.23,+,4.33,0.213,1
ribonucleoside bisphosphate biosynthetic process (GO:0034030),23,15,13.75,+,1.09,0.867,1,11,8.25,+,1.33,0.438,1,11,13.04,-,0.84,0.723,1,1,0.23,+,4.33,0.213,1
carbohydrate derivative catabolic process (GO:1901136),23,15,13.75,+,1.09,0.867,1,14,8.25,+,1.7,0.134,1,19,13.04,+,1.46,0.26,1,2,0.23,+,8.66,0.0254,1
very long-chain fatty acid metabolic process (GO:0000038),23,15,13.75,+,1.09,0.867,1,9,8.25,+,1.09,0.841,1,14,13.04,+,1.07,0.865,1,1,0.23,+,4.33,0.213,1
Golgi organization (GO:0007030),23,15,13.75,+,1.09,0.867,1,9,8.25,+,1.09,0.841,1,11,13.04,-,0.84,0.723,1,1,0.23,+,4.33,0.213,1
organelle disassembly (GO:1903008),23,15,13.75,+,1.09,0.867,1,6,8.25,-,0.73,0.673,1,15,13.04,+,1.15,0.736,1,0,0.23,-, < 0.01,1,1
cuticle development (GO:0042335),23,15,13.75,+,1.09,0.867,1,9,8.25,+,1.09,0.841,1,16,13.04,+,1.23,0.511,1,0,0.23,-, < 0.01,1,1
nucleoside bisphosphate biosynthetic process (GO:0033866),23,15,13.75,+,1.09,0.867,1,11,8.25,+,1.33,0.438,1,11,13.04,-,0.84,0.723,1,1,0.23,+,4.33,0.213,1
purine ribonucleoside metabolic process (GO:0046128),23,15,13.75,+,1.09,0.867,1,13,8.25,+,1.58,0.188,1,15,13.04,+,1.15,0.736,1,1,0.23,+,4.33,0.213,1
Group II intron splicing (GO:0000373),23,15,13.75,+,1.09,0.867,1,10,8.25,+,1.21,0.56,1,14,13.04,+,1.07,0.865,1,0,0.23,-, < 0.01,1,1
anion transmembrane transport (GO:0098656),66,43,39.47,+,1.09,0.692,1,35,23.67,+,1.48,0.0694,1,38,37.41,+,1.02,0.919,1,1,0.66,+,1.51,0.489,1
microtubule-based movement (GO:0007018),43,28,25.71,+,1.09,0.714,1,8,15.42,-,0.52,0.11,1,33,24.37,+,1.35,0.19,1,0,0.43,-, < 0.01,1,1
anatomical structure maturation (GO:0071695),106,69,63.39,+,1.09,0.584,1,33,38.01,-,0.87,0.562,1,67,60.09,+,1.12,0.476,1,1,1.06,-,0.94,1,1
response to chemical (GO:0042221),1601,1042,957.41,+,1.09,0.0238,1,677,574.15,+,1.18,0.000131,0.0749,1029,907.54,+,1.13,0.000802,0.286,22,16.08,+,1.37,0.139,1
protein catabolic process (GO:0030163),326,212,194.95,+,1.09,0.343,1,107,116.91,-,0.92,0.44,1,199,184.8,+,1.08,0.408,1,5,3.27,+,1.53,0.388,1
aromatic compound biosynthetic process (GO:0019438),506,329,302.59,+,1.09,0.228,1,202,181.46,+,1.11,0.192,1,285,286.83,-,0.99,0.94,1,6,5.08,+,1.18,0.646,1
regulation of cell differentiation (GO:0045595),20,13,11.96,+,1.09,0.858,1,11,7.17,+,1.53,0.306,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
sesquiterpenoid metabolic process (GO:0006714),20,13,11.96,+,1.09,0.858,1,4,7.17,-,0.56,0.358,1,14,11.34,+,1.23,0.593,1,0,0.2,-, < 0.01,1,1
protein targeting to mitochondrion (GO:0006626),40,26,23.92,+,1.09,0.799,1,15,14.34,+,1.05,0.879,1,19,22.67,-,0.84,0.589,1,0,0.4,-, < 0.01,1,1
DNA mediated transformation (GO:0009294),20,13,11.96,+,1.09,0.858,1,6,7.17,-,0.84,0.826,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
genetic transfer (GO:0009292),20,13,11.96,+,1.09,0.858,1,6,7.17,-,0.84,0.826,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
negative regulation of programmed cell death (GO:0043069),20,13,11.96,+,1.09,0.858,1,7,7.17,-,0.98,1,1,16,11.34,+,1.41,0.303,1,0,0.2,-, < 0.01,1,1
multi-organism cellular process (GO:0044764),20,13,11.96,+,1.09,0.858,1,6,7.17,-,0.84,0.826,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
cellular homeostasis (GO:0019725),180,117,107.64,+,1.09,0.507,1,79,64.55,+,1.22,0.136,1,119,102.03,+,1.17,0.203,1,5,1.81,+,2.77,0.0374,1
phosphorylation (GO:0016310),688,447,411.43,+,1.09,0.165,1,291,246.73,+,1.18,0.0169,1,425,390,+,1.09,0.158,1,5,6.91,-,0.72,0.691,1
nucleotide metabolic process (GO:0009117),191,124,114.22,+,1.09,0.482,1,85,68.5,+,1.24,0.0986,1,116,108.27,+,1.07,0.55,1,3,1.92,+,1.56,0.446,1
modification-dependent macromolecule catabolic process (GO:0043632),285,185,170.43,+,1.09,0.386,1,89,102.21,-,0.87,0.26,1,171,161.55,+,1.06,0.554,1,3,2.86,+,1.05,0.764,1
organonitrogen compound catabolic process (GO:1901565),450,292,269.1,+,1.09,0.279,1,157,161.38,-,0.97,0.779,1,293,255.09,+,1.15,0.0619,1,9,4.52,+,1.99,0.0489,1
cellular biogenic amine metabolic process (GO:0006576),37,24,22.13,+,1.08,0.792,1,18,13.27,+,1.36,0.286,1,22,20.97,+,1.05,0.892,1,0,0.37,-, < 0.01,1,1
regulation of protein catabolic process (GO:0042176),37,24,22.13,+,1.08,0.792,1,14,13.27,+,1.06,0.874,1,23,20.97,+,1.1,0.788,1,0,0.37,-, < 0.01,1,1
positive regulation of hydrolase activity (GO:0051345),37,24,22.13,+,1.08,0.792,1,16,13.27,+,1.21,0.534,1,16,20.97,-,0.76,0.394,1,0,0.37,-, < 0.01,1,1
cellular amine metabolic process (GO:0044106),37,24,22.13,+,1.08,0.792,1,18,13.27,+,1.36,0.286,1,22,20.97,+,1.05,0.892,1,0,0.37,-, < 0.01,1,1
modification-dependent protein catabolic process (GO:0019941),276,179,165.05,+,1.08,0.405,1,85,98.98,-,0.86,0.228,1,167,156.45,+,1.07,0.516,1,3,2.77,+,1.08,0.758,1
purine ribonucleotide metabolic process (GO:0009150),128,83,76.54,+,1.08,0.568,1,55,45.9,+,1.2,0.273,1,81,72.56,+,1.12,0.469,1,3,1.29,+,2.33,0.142,1
regulation of molecular function (GO:0065009),182,118,108.84,+,1.08,0.509,1,61,65.27,-,0.93,0.714,1,103,103.17,-,1,1,1,0,1.83,-, < 0.01,0.268,1
regulation of catabolic process (GO:0009894),71,46,42.46,+,1.08,0.702,1,28,25.46,+,1.1,0.649,1,47,40.25,+,1.17,0.442,1,0,0.71,-, < 0.01,1,1
energy derivation by oxidation of organic compounds (GO:0015980),88,57,52.62,+,1.08,0.667,1,31,31.56,-,0.98,1,1,62,49.88,+,1.24,0.201,1,3,0.88,+,3.39,0.0621,1
cell wall macromolecule metabolic process (GO:0044036),88,57,52.62,+,1.08,0.667,1,25,31.56,-,0.79,0.336,1,50,49.88,+,1,1,1,1,0.88,+,1.13,0.59,1
organic cyclic compound biosynthetic process (GO:1901362),573,371,342.66,+,1.08,0.228,1,232,205.49,+,1.13,0.111,1,325,324.81,+,1,1,1,7,5.76,+,1.22,0.521,1
response to osmotic stress (GO:0006970),329,213,196.74,+,1.08,0.368,1,131,117.98,+,1.11,0.309,1,216,186.5,+,1.16,0.0945,1,6,3.31,+,1.82,0.151,1
positive regulation of actin filament polymerization (GO:0030838),17,11,10.17,+,1.08,0.847,1,4,6.1,-,0.66,0.621,1,11,9.64,+,1.14,0.7,1,0,0.17,-, < 0.01,1,1
cellular modified amino acid biosynthetic process (GO:0042398),17,11,10.17,+,1.08,0.847,1,7,6.1,+,1.15,0.817,1,9,9.64,-,0.93,1,1,1,0.17,+,5.86,0.165,1
positive regulation of proteasomal protein catabolic process (GO:1901800),17,11,10.17,+,1.08,0.847,1,4,6.1,-,0.66,0.621,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
establishment of protein localization to mitochondrial membrane (GO:0090151),17,11,10.17,+,1.08,0.847,1,5,6.1,-,0.82,0.813,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
ethylene-activated signaling pathway (GO:0009873),34,22,20.33,+,1.08,0.783,1,18,12.19,+,1.48,0.206,1,20,19.27,+,1.04,0.888,1,0,0.34,-, < 0.01,1,1
anthocyanin-containing compound metabolic process (GO:0046283),17,11,10.17,+,1.08,0.847,1,7,6.1,+,1.15,0.817,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),17,11,10.17,+,1.08,0.847,1,7,6.1,+,1.15,0.817,1,7,9.64,-,0.73,0.531,1,0,0.17,-, < 0.01,1,1
heat acclimation (GO:0010286),34,22,20.33,+,1.08,0.783,1,13,12.19,+,1.07,0.869,1,23,19.27,+,1.19,0.581,1,0,0.34,-, < 0.01,1,1
cellular catabolic process (GO:0044248),708,458,423.39,+,1.08,0.18,1,243,253.9,-,0.96,0.57,1,467,401.33,+,1.16,0.0094,0.715,12,7.11,+,1.69,0.0776,1
cation transport (GO:0006812),232,150,138.74,+,1.08,0.455,1,100,83.2,+,1.2,0.131,1,160,131.51,+,1.22,0.056,1,5,2.33,+,2.15,0.0877,1
response to organic substance (GO:0010033),1007,651,602.19,+,1.08,0.106,1,422,361.13,+,1.17,0.00583,0.616,627,570.82,+,1.1,0.0565,1,10,10.12,-,0.99,1,1
proteolysis involved in cellular protein catabolic process (GO:0051603),308,199,184.19,+,1.08,0.403,1,101,110.45,-,0.91,0.461,1,186,174.59,+,1.07,0.507,1,5,3.09,+,1.62,0.244,1
root epidermal cell differentiation (GO:0010053),79,51,47.24,+,1.08,0.716,1,21,28.33,-,0.74,0.255,1,49,44.78,+,1.09,0.645,1,1,0.79,+,1.26,0.552,1
glucan biosynthetic process (GO:0009250),79,51,47.24,+,1.08,0.716,1,22,28.33,-,0.78,0.311,1,50,44.78,+,1.12,0.581,1,1,0.79,+,1.26,0.552,1
purine nucleotide metabolic process (GO:0006163),141,91,84.32,+,1.08,0.585,1,63,50.56,+,1.25,0.15,1,88,79.93,+,1.1,0.489,1,3,1.42,+,2.12,0.173,1
catabolic process (GO:0009056),829,535,495.75,+,1.08,0.156,1,290,297.29,-,0.98,0.726,1,549,469.92,+,1.17,0.00367,0.599,16,8.33,+,1.92,0.0112,1
amino acid transport (GO:0006865),31,20,18.54,+,1.08,0.774,1,18,11.12,+,1.62,0.106,1,18,17.57,+,1.02,1,1,0,0.31,-, < 0.01,1,1
NADP metabolic process (GO:0006739),31,20,18.54,+,1.08,0.774,1,18,11.12,+,1.62,0.106,1,20,17.57,+,1.14,0.663,1,2,0.31,+,6.42,0.0424,1
negative regulation of catalytic activity (GO:0043086),31,20,18.54,+,1.08,0.774,1,11,11.12,-,0.99,1,1,20,17.57,+,1.14,0.663,1,0,0.31,-, < 0.01,1,1
organophosphate ester transport (GO:0015748),31,20,18.54,+,1.08,0.774,1,15,11.12,+,1.35,0.32,1,18,17.57,+,1.02,1,1,0,0.31,-, < 0.01,1,1
regulation of cellular carbohydrate metabolic process (GO:0010675),31,20,18.54,+,1.08,0.774,1,7,11.12,-,0.63,0.356,1,21,17.57,+,1.2,0.564,1,1,0.31,+,3.21,0.274,1
response to nutrient levels (GO:0031667),138,89,82.52,+,1.08,0.582,1,48,49.49,-,0.97,0.933,1,82,78.23,+,1.05,0.725,1,4,1.39,+,2.89,0.0532,1
response to light stimulus (GO:0009416),484,312,289.44,+,1.08,0.296,1,207,173.57,+,1.19,0.0344,1,303,274.36,+,1.1,0.173,1,7,4.86,+,1.44,0.346,1
organic acid biosynthetic process (GO:0016053),301,194,180,+,1.08,0.424,1,121,107.94,+,1.12,0.288,1,184,170.62,+,1.08,0.416,1,5,3.02,+,1.65,0.235,1
carboxylic acid biosynthetic process (GO:0046394),301,194,180,+,1.08,0.424,1,121,107.94,+,1.12,0.288,1,184,170.62,+,1.08,0.416,1,5,3.02,+,1.65,0.235,1
cellular response to external stimulus (GO:0071496),135,87,80.73,+,1.08,0.578,1,49,48.41,+,1.01,0.933,1,82,76.53,+,1.07,0.62,1,4,1.36,+,2.95,0.0499,1
organic substance catabolic process (GO:1901575),762,491,455.68,+,1.08,0.185,1,269,273.27,-,0.98,0.856,1,503,431.94,+,1.16,0.00652,0.759,15,7.66,+,1.96,0.0133,1
alpha-amino acid metabolic process (GO:1901605),177,114,105.85,+,1.08,0.542,1,76,63.48,+,1.2,0.196,1,119,100.33,+,1.19,0.161,1,3,1.78,+,1.69,0.266,1
cellular response to light stimulus (GO:0071482),73,47,43.65,+,1.08,0.706,1,30,26.18,+,1.15,0.504,1,40,41.38,-,0.97,0.922,1,1,0.73,+,1.36,0.524,1
electron transport chain (GO:0022900),73,47,43.65,+,1.08,0.706,1,31,26.18,+,1.18,0.435,1,50,41.38,+,1.21,0.302,1,0,0.73,-, < 0.01,1,1
cellular polysaccharide biosynthetic process (GO:0033692),115,74,68.77,+,1.08,0.651,1,32,41.24,-,0.78,0.222,1,69,65.19,+,1.06,0.701,1,1,1.16,-,0.87,1,1
cellular response to extracellular stimulus (GO:0031668),129,83,77.14,+,1.08,0.618,1,46,46.26,-,0.99,1,1,78,73.12,+,1.07,0.663,1,4,1.3,+,3.09,0.0437,1
trichoblast differentiation (GO:0010054),70,45,41.86,+,1.08,0.7,1,18,25.1,-,0.72,0.227,1,42,39.68,+,1.06,0.768,1,0,0.7,-, < 0.01,1,1
microtubule cytoskeleton organization (GO:0000226),98,63,58.6,+,1.08,0.683,1,30,35.14,-,0.85,0.482,1,62,55.55,+,1.12,0.509,1,1,0.98,+,1.02,1,1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),28,18,16.74,+,1.08,0.879,1,4,10.04,-,0.4,0.106,1,19,15.87,+,1.2,0.546,1,0,0.28,-, < 0.01,1,1
activation of GTPase activity (GO:0090630),14,9,8.37,+,1.08,0.833,1,6,5.02,+,1.2,0.8,1,6,7.94,-,0.76,0.648,1,0,0.14,-, < 0.01,1,1
positive regulation of defense response to bacterium (GO:1900426),14,9,8.37,+,1.08,0.833,1,6,5.02,+,1.2,0.8,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
chloroplast avoidance movement (GO:0009903),14,9,8.37,+,1.08,0.833,1,4,5.02,-,0.8,0.796,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
stomatal lineage progression (GO:0010440),14,9,8.37,+,1.08,0.833,1,5,5.02,-,1,1,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
response to mechanical stimulus (GO:0009612),14,9,8.37,+,1.08,0.833,1,7,5.02,+,1.39,0.463,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
regulation of cyclin-dependent protein kinase activity (GO:1904029),28,18,16.74,+,1.08,0.879,1,4,10.04,-,0.4,0.106,1,19,15.87,+,1.2,0.546,1,0,0.28,-, < 0.01,1,1
ubiquitin-dependent protein catabolic process (GO:0006511),271,174,162.06,+,1.07,0.458,1,83,97.19,-,0.85,0.223,1,162,153.62,+,1.05,0.613,1,3,2.72,+,1.1,0.755,1
response to starvation (GO:0042594),120,77,71.76,+,1.07,0.657,1,44,43.03,+,1.02,0.929,1,71,68.02,+,1.04,0.763,1,4,1.21,+,3.32,0.0352,1
nucleoside phosphate metabolic process (GO:0006753),198,127,118.41,+,1.07,0.563,1,87,71.01,+,1.23,0.119,1,118,112.24,+,1.05,0.68,1,3,1.99,+,1.51,0.455,1
response to heat (GO:0009408),156,100,93.29,+,1.07,0.603,1,60,55.94,+,1.07,0.642,1,99,88.43,+,1.12,0.394,1,0,1.57,-, < 0.01,0.411,1
response to endogenous stimulus (GO:0009719),741,475,443.12,+,1.07,0.222,1,295,265.74,+,1.11,0.118,1,457,420.04,+,1.09,0.145,1,7,7.44,-,0.94,1,1
developmental maturation (GO:0021700),117,75,69.97,+,1.07,0.653,1,37,41.96,-,0.88,0.582,1,71,66.32,+,1.07,0.648,1,1,1.18,-,0.85,1,1
response to salt stress (GO:0009651),278,178,166.25,+,1.07,0.493,1,111,99.7,+,1.11,0.352,1,183,157.59,+,1.16,0.117,1,4,2.79,+,1.43,0.366,1
ribonucleoside metabolic process (GO:0009119),25,16,14.95,+,1.07,0.872,1,14,8.97,+,1.56,0.202,1,17,14.17,+,1.2,0.63,1,1,0.25,+,3.98,0.229,1
cellular response to lipid (GO:0071396),150,96,89.7,+,1.07,0.597,1,68,53.79,+,1.26,0.122,1,95,85.03,+,1.12,0.422,1,2,1.51,+,1.33,0.665,1
cytokinesis by cell plate formation (GO:0000911),50,32,29.9,+,1.07,0.819,1,13,17.93,-,0.73,0.39,1,29,28.34,+,1.02,0.907,1,0,0.5,-, < 0.01,1,1
purine nucleoside metabolic process (GO:0042278),25,16,14.95,+,1.07,0.872,1,15,8.97,+,1.67,0.149,1,17,14.17,+,1.2,0.63,1,2,0.25,+,7.96,0.0293,1
cellular response to nitrogen levels (GO:0043562),25,16,14.95,+,1.07,0.872,1,8,8.97,-,0.89,1,1,15,14.17,+,1.06,0.87,1,0,0.25,-, < 0.01,1,1
response to hormone (GO:0009725),719,460,429.97,+,1.07,0.251,1,285,257.85,+,1.11,0.14,1,446,407.57,+,1.09,0.124,1,7,7.22,-,0.97,1,1
seedling development (GO:0090351),86,55,51.43,+,1.07,0.727,1,35,30.84,+,1.13,0.535,1,55,48.75,+,1.13,0.483,1,0,0.86,-, < 0.01,1,1
regulation of hydrolase activity (GO:0051336),61,39,36.48,+,1.07,0.757,1,23,21.88,+,1.05,0.805,1,29,34.58,-,0.84,0.51,1,0,0.61,-, < 0.01,1,1
cell communication (GO:0007154),798,510,477.21,+,1.07,0.226,1,330,286.18,+,1.15,0.0254,1,487,452.35,+,1.08,0.187,1,8,8.02,-,1,1,1
response to temperature stimulus (GO:0009266),399,255,238.6,+,1.07,0.412,1,173,143.09,+,1.21,0.038,1,246,226.18,+,1.09,0.298,1,5,4.01,+,1.25,0.604,1
exocytosis (GO:0006887),36,23,21.53,+,1.07,0.789,1,14,12.91,+,1.08,0.751,1,19,20.41,-,0.93,0.889,1,0,0.36,-, < 0.01,1,1
pectin catabolic process (GO:0045490),36,23,21.53,+,1.07,0.789,1,11,12.91,-,0.85,0.742,1,23,20.41,+,1.13,0.685,1,1,0.36,+,2.77,0.31,1
iron ion homeostasis (GO:0055072),36,23,21.53,+,1.07,0.789,1,14,12.91,+,1.08,0.751,1,24,20.41,+,1.18,0.591,1,0,0.36,-, < 0.01,1,1
cell wall modification (GO:0042545),72,46,43.06,+,1.07,0.775,1,26,25.82,+,1.01,1,1,42,40.81,+,1.03,0.922,1,3,0.72,+,4.15,0.0387,1
cellular response to organic substance (GO:0071310),396,253,236.81,+,1.07,0.41,1,178,142.01,+,1.25,0.0122,1,239,224.48,+,1.06,0.45,1,3,3.98,-,0.75,0.801,1
organic acid transmembrane transport (GO:1903825),36,23,21.53,+,1.07,0.789,1,18,12.91,+,1.39,0.278,1,21,20.41,+,1.03,0.891,1,0,0.36,-, < 0.01,1,1
response to cold (GO:0009409),257,164,153.69,+,1.07,0.509,1,120,92.16,+,1.3,0.018,1,158,145.68,+,1.08,0.439,1,4,2.58,+,1.55,0.333,1
root morphogenesis (GO:0010015),163,104,97.48,+,1.07,0.611,1,45,58.45,-,0.77,0.132,1,98,92.4,+,1.06,0.65,1,1,1.64,-,0.61,1,1
lipid transport (GO:0006869),58,37,34.68,+,1.07,0.751,1,24,20.8,+,1.15,0.532,1,34,32.88,+,1.03,0.914,1,0,0.58,-, < 0.01,1,1
cellular component disassembly (GO:0022411),58,37,34.68,+,1.07,0.751,1,18,20.8,-,0.87,0.696,1,39,32.88,+,1.19,0.399,1,0,0.58,-, < 0.01,1,1
response to extracellular stimulus (GO:0009991),160,102,95.68,+,1.07,0.608,1,59,57.38,+,1.03,0.877,1,96,90.7,+,1.06,0.648,1,4,1.61,+,2.49,0.081,1
signaling (GO:0023052),647,412,386.91,+,1.06,0.312,1,270,232.03,+,1.16,0.0342,1,397,366.76,+,1.08,0.209,1,4,6.5,-,0.62,0.418,1
signal transduction (GO:0007165),641,408,383.32,+,1.06,0.31,1,269,229.87,+,1.17,0.0277,1,395,363.35,+,1.09,0.184,1,4,6.44,-,0.62,0.418,1
cellular iron ion homeostasis (GO:0006879),22,14,13.16,+,1.06,0.864,1,6,7.89,-,0.76,0.671,1,14,12.47,+,1.12,0.731,1,0,0.22,-, < 0.01,1,1
manganese ion transport (GO:0006828),11,7,6.58,+,1.06,1,1,4,3.94,+,1.01,1,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
vitamin metabolic process (GO:0006766),55,35,32.89,+,1.06,0.827,1,27,19.72,+,1.37,0.208,1,36,31.18,+,1.15,0.513,1,2,0.55,+,3.62,0.11,1
late endosome to vacuole transport (GO:0045324),33,21,19.73,+,1.06,0.888,1,13,11.83,+,1.1,0.74,1,21,18.71,+,1.12,0.673,1,0,0.33,-, < 0.01,1,1
snoRNA 3'-end processing (GO:0031126),11,7,6.58,+,1.06,1,1,5,3.94,+,1.27,0.777,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
autophagy of nucleus (GO:0044804),11,7,6.58,+,1.06,1,1,3,3.94,-,0.76,1,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
mitochondrial membrane organization (GO:0007006),22,14,13.16,+,1.06,0.864,1,8,7.89,+,1.01,1,1,10,12.47,-,0.8,0.713,1,0,0.22,-, < 0.01,1,1
genetic imprinting (GO:0071514),11,7,6.58,+,1.06,1,1,2,3.94,-,0.51,0.534,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
positive regulation of programmed cell death (GO:0043068),11,7,6.58,+,1.06,1,1,3,3.94,-,0.76,1,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
glucose homeostasis (GO:0042593),11,7,6.58,+,1.06,1,1,5,3.94,+,1.27,0.777,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148),11,7,6.58,+,1.06,1,1,4,3.94,+,1.01,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
cellular amino acid biosynthetic process (GO:0008652),132,84,78.94,+,1.06,0.672,1,51,47.34,+,1.08,0.673,1,83,74.83,+,1.11,0.476,1,2,1.33,+,1.51,0.386,1
carbohydrate transport (GO:0008643),33,21,19.73,+,1.06,0.888,1,17,11.83,+,1.44,0.26,1,20,18.71,+,1.07,0.886,1,2,0.33,+,6.03,0.0472,1
RNA 5'-end processing (GO:0000966),11,7,6.58,+,1.06,1,1,4,3.94,+,1.01,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
regulation of transporter activity (GO:0032409),11,7,6.58,+,1.06,1,1,6,3.94,+,1.52,0.413,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
L-ascorbic acid biosynthetic process (GO:0019853),11,7,6.58,+,1.06,1,1,6,3.94,+,1.52,0.413,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
nicotinamide nucleotide metabolic process (GO:0046496),11,7,6.58,+,1.06,1,1,3,3.94,-,0.76,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
olefinic compound biosynthetic process (GO:0120255),22,14,13.16,+,1.06,0.864,1,11,7.89,+,1.39,0.428,1,12,12.47,-,0.96,1,1,0,0.22,-, < 0.01,1,1
chloroplast accumulation movement (GO:0009904),11,7,6.58,+,1.06,1,1,2,3.94,-,0.51,0.534,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
beta-glucan biosynthetic process (GO:0051274),44,28,26.31,+,1.06,0.808,1,10,15.78,-,0.63,0.218,1,29,24.94,+,1.16,0.543,1,0,0.44,-, < 0.01,1,1
negative regulation of lipid metabolic process (GO:0045833),11,7,6.58,+,1.06,1,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
response to jasmonic acid (GO:0009753),110,70,65.78,+,1.06,0.699,1,48,39.45,+,1.22,0.276,1,71,62.35,+,1.14,0.394,1,0,1.11,-, < 0.01,0.631,1
response to low light intensity stimulus (GO:0009645),11,7,6.58,+,1.06,1,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
hyperosmotic response (GO:0006972),44,28,26.31,+,1.06,0.808,1,18,15.78,+,1.14,0.665,1,31,24.94,+,1.24,0.399,1,2,0.44,+,4.52,0.0765,1
regulation of stomatal movement (GO:0010119),66,42,39.47,+,1.06,0.765,1,33,23.67,+,1.39,0.136,1,47,37.41,+,1.26,0.239,1,0,0.66,-, < 0.01,1,1
pyridine nucleotide biosynthetic process (GO:0019363),11,7,6.58,+,1.06,1,1,4,3.94,+,1.01,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
purine-containing compound metabolic process (GO:0072521),162,103,96.88,+,1.06,0.655,1,76,58.1,+,1.31,0.0542,1,103,91.83,+,1.12,0.368,1,5,1.63,+,3.07,0.0256,1
ion transmembrane transport (GO:0034220),203,129,121.4,+,1.06,0.607,1,94,72.8,+,1.29,0.0397,1,135,115.07,+,1.17,0.154,1,6,2.04,+,2.94,0.0181,1
inorganic cation transmembrane transport (GO:0098662),137,87,81.93,+,1.06,0.677,1,61,49.13,+,1.24,0.168,1,97,77.66,+,1.25,0.1,1,5,1.38,+,3.63,0.0137,1
protein modification by small protein conjugation or removal (GO:0070647),460,292,275.08,+,1.06,0.42,1,159,164.96,-,0.96,0.71,1,258,260.75,-,0.99,0.906,1,2,4.62,-,0.43,0.334,1
hemicellulose metabolic process (GO:0010410),52,33,31.1,+,1.06,0.823,1,14,18.65,-,0.75,0.402,1,26,29.48,-,0.88,0.639,1,1,0.52,+,1.91,0.412,1
response to light intensity (GO:0009642),104,66,62.19,+,1.06,0.692,1,51,37.3,+,1.37,0.0675,1,64,58.95,+,1.09,0.629,1,3,1.04,+,2.87,0.0908,1
plant epidermal cell differentiation (GO:0090627),93,59,55.61,+,1.06,0.737,1,23,33.35,-,0.69,0.114,1,57,52.72,+,1.08,0.67,1,2,0.93,+,2.14,0.244,1
protein localization to mitochondrion (GO:0070585),41,26,24.52,+,1.06,0.802,1,15,14.7,+,1.02,1,1,19,23.24,-,0.82,0.504,1,0,0.41,-, < 0.01,1,1
establishment of protein localization to mitochondrion (GO:0072655),41,26,24.52,+,1.06,0.802,1,15,14.7,+,1.02,1,1,19,23.24,-,0.82,0.504,1,0,0.41,-, < 0.01,1,1
pollen-pistil interaction (GO:0009875),41,26,24.52,+,1.06,0.802,1,22,14.7,+,1.5,0.151,1,24,23.24,+,1.03,0.898,1,0,0.41,-, < 0.01,1,1
post-embryonic plant organ development (GO:0090696),112,71,66.98,+,1.06,0.702,1,45,40.17,+,1.12,0.525,1,65,63.49,+,1.02,0.875,1,1,1.13,-,0.89,1,1
metal ion homeostasis (GO:0055065),131,83,78.34,+,1.06,0.671,1,55,46.98,+,1.17,0.317,1,85,74.26,+,1.14,0.355,1,0,1.32,-, < 0.01,0.643,1
positive regulation of flower development (GO:0009911),30,19,17.94,+,1.06,0.883,1,11,10.76,+,1.02,1,1,19,17.01,+,1.12,0.766,1,0,0.3,-, < 0.01,1,1
cold acclimation (GO:0009631),30,19,17.94,+,1.06,0.883,1,14,10.76,+,1.3,0.396,1,19,17.01,+,1.12,0.766,1,0,0.3,-, < 0.01,1,1
ribonucleotide biosynthetic process (GO:0009260),90,57,53.82,+,1.06,0.733,1,38,32.28,+,1.18,0.421,1,50,51.02,-,0.98,0.93,1,1,0.9,+,1.11,0.599,1
regulation of catalytic activity (GO:0050790),158,100,94.49,+,1.06,0.651,1,50,56.66,-,0.88,0.477,1,87,89.56,-,0.97,0.841,1,0,1.59,-, < 0.01,0.412,1
response to radiation (GO:0009314),506,320,302.59,+,1.06,0.441,1,211,181.46,+,1.16,0.0628,1,311,286.83,+,1.08,0.265,1,7,5.08,+,1.38,0.36,1
phosphorus metabolic process (GO:0006793),1137,719,679.93,+,1.06,0.227,1,463,407.75,+,1.14,0.0173,1,689,644.52,+,1.07,0.153,1,13,11.42,+,1.14,0.639,1
root hair cell differentiation (GO:0048765),68,43,40.66,+,1.06,0.769,1,18,24.39,-,0.74,0.272,1,40,38.55,+,1.04,0.842,1,0,0.68,-, < 0.01,1,1
trichoblast maturation (GO:0048764),68,43,40.66,+,1.06,0.769,1,18,24.39,-,0.74,0.272,1,40,38.55,+,1.04,0.842,1,0,0.68,-, < 0.01,1,1
cell maturation (GO:0048469),68,43,40.66,+,1.06,0.769,1,18,24.39,-,0.74,0.272,1,40,38.55,+,1.04,0.842,1,0,0.68,-, < 0.01,1,1
root development (GO:0048364),310,196,185.38,+,1.06,0.546,1,93,111.17,-,0.84,0.137,1,182,175.73,+,1.04,0.704,1,2,3.11,-,0.64,0.773,1
external encapsulating structure organization (GO:0045229),152,96,90.9,+,1.06,0.692,1,51,54.51,-,0.94,0.749,1,90,86.16,+,1.04,0.737,1,3,1.53,+,1.96,0.2,1
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",19,12,11.36,+,1.06,0.855,1,7,6.81,+,1.03,1,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
nitrate transport (GO:0015706),19,12,11.36,+,1.06,0.855,1,9,6.81,+,1.32,0.52,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
autophagosome organization (GO:1905037),19,12,11.36,+,1.06,0.855,1,4,6.81,-,0.59,0.477,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
dormancy process (GO:0022611),19,12,11.36,+,1.06,0.855,1,4,6.81,-,0.59,0.477,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
cellular response to nitrogen starvation (GO:0006995),19,12,11.36,+,1.06,0.855,1,7,6.81,+,1.03,1,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
seed dormancy process (GO:0010162),19,12,11.36,+,1.06,0.855,1,4,6.81,-,0.59,0.477,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
cellular cation homeostasis (GO:0030003),103,65,61.59,+,1.06,0.749,1,39,36.94,+,1.06,0.775,1,66,58.39,+,1.13,0.469,1,0,1.03,-, < 0.01,0.629,1
leaf development (GO:0048366),222,140,132.76,+,1.05,0.622,1,87,79.61,+,1.09,0.474,1,128,125.84,+,1.02,0.867,1,3,2.23,+,1.35,0.492,1
beta-glucan metabolic process (GO:0051273),46,29,27.51,+,1.05,0.812,1,10,16.5,-,0.61,0.172,1,30,26.08,+,1.15,0.552,1,0,0.46,-, < 0.01,1,1
response to oxidative stress (GO:0006979),276,174,165.05,+,1.05,0.588,1,111,98.98,+,1.12,0.321,1,189,156.45,+,1.21,0.0453,1,3,2.77,+,1.08,0.758,1
root system development (GO:0022622),311,196,185.98,+,1.05,0.577,1,93,111.53,-,0.83,0.123,1,182,176.29,+,1.03,0.74,1,2,3.12,-,0.64,0.773,1
positive regulation of catalytic activity (GO:0043085),73,46,43.65,+,1.05,0.776,1,30,26.18,+,1.15,0.504,1,36,41.38,-,0.87,0.549,1,0,0.73,-, < 0.01,1,1
mitotic cytokinesis (GO:0000281),27,17,16.15,+,1.05,0.877,1,8,9.68,-,0.83,0.706,1,16,15.31,+,1.05,0.875,1,0,0.27,-, < 0.01,1,1
protein polyubiquitination (GO:0000209),54,34,32.29,+,1.05,0.826,1,18,19.37,-,0.93,0.894,1,30,30.61,-,0.98,1,1,1,0.54,+,1.84,0.424,1
regulation of ion transport (GO:0043269),27,17,16.15,+,1.05,0.877,1,12,9.68,+,1.24,0.585,1,15,15.31,-,0.98,1,1,1,0.27,+,3.69,0.244,1
cellular protein complex disassembly (GO:0043624),27,17,16.15,+,1.05,0.877,1,8,9.68,-,0.83,0.706,1,20,15.31,+,1.31,0.365,1,0,0.27,-, < 0.01,1,1
positive regulation of protein catabolic process (GO:0045732),27,17,16.15,+,1.05,0.877,1,9,9.68,-,0.93,1,1,15,15.31,-,0.98,1,1,0,0.27,-, < 0.01,1,1
positive regulation of developmental process (GO:0051094),81,51,48.44,+,1.05,0.787,1,30,29.05,+,1.03,0.914,1,51,45.92,+,1.11,0.586,1,0,0.81,-, < 0.01,1,1
protein-containing complex disassembly (GO:0032984),35,22,20.93,+,1.05,0.891,1,11,12.55,-,0.88,0.867,1,24,19.84,+,1.21,0.498,1,0,0.35,-, < 0.01,1,1
phosphate-containing compound metabolic process (GO:0006796),1109,697,663.19,+,1.05,0.285,1,455,397.71,+,1.14,0.0126,1,672,628.64,+,1.07,0.156,1,13,11.14,+,1.17,0.529,1
response to stimulus (GO:0050896),3178,1996,1900.46,+,1.05,0.0481,1,1256,1139.68,+,1.1,0.000797,0.182,1917,1801.47,+,1.06,0.0131,0.915,38,31.93,+,1.19,0.22,1
unidimensional cell growth (GO:0009826),164,103,98.07,+,1.05,0.703,1,58,58.81,-,0.99,1,1,103,92.96,+,1.11,0.406,1,3,1.65,+,1.82,0.231,1
carbohydrate derivative metabolic process (GO:1901135),446,280,266.71,+,1.05,0.532,1,168,159.94,+,1.05,0.576,1,256,252.82,+,1.01,0.873,1,8,4.48,+,1.79,0.093,1
ribose phosphate biosynthetic process (GO:0046390),94,59,56.21,+,1.05,0.802,1,40,33.71,+,1.19,0.376,1,52,53.28,-,0.98,0.931,1,1,0.94,+,1.06,0.614,1
secretion by cell (GO:0032940),51,32,30.5,+,1.05,0.821,1,21,18.29,+,1.15,0.593,1,26,28.91,-,0.9,0.722,1,1,0.51,+,1.95,0.406,1
negative regulation of protein metabolic process (GO:0051248),51,32,30.5,+,1.05,0.821,1,18,18.29,-,0.98,1,1,29,28.91,+,1,1,1,0,0.51,-, < 0.01,1,1
organonitrogen compound metabolic process (GO:1901564),2723,1708,1628.37,+,1.05,0.0827,1,1050,976.51,+,1.08,0.0256,1,1628,1543.55,+,1.05,0.0566,1,27,27.36,-,0.99,1,1
cellular respiration (GO:0045333),75,47,44.85,+,1.05,0.851,1,23,26.9,-,0.86,0.567,1,54,42.51,+,1.27,0.198,1,1,0.75,+,1.33,0.533,1
heterocycle biosynthetic process (GO:0018130),479,300,286.45,+,1.05,0.521,1,192,171.78,+,1.12,0.195,1,264,271.52,-,0.97,0.726,1,6,4.81,+,1.25,0.486,1
transmembrane transport (GO:0055085),491,307,293.62,+,1.05,0.551,1,212,176.08,+,1.2,0.0231,1,308,278.33,+,1.11,0.164,1,10,4.93,+,2.03,0.0338,1
cellular response to heat (GO:0034605),40,25,23.92,+,1.05,0.898,1,14,14.34,-,0.98,1,1,25,22.67,+,1.1,0.7,1,0,0.4,-, < 0.01,1,1
AMP metabolic process (GO:0046033),8,5,4.78,+,1.05,1,1,0,2.87,-, < 0.01,0.12,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
maintenance of root meristem identity (GO:0010078),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
N-terminal protein amino acid modification (GO:0031365),16,10,9.57,+,1.05,1,1,5,5.74,-,0.87,1,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0019288)",8,5,4.78,+,1.05,1,1,7,2.87,+,2.44,0.0834,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
carbohydrate homeostasis (GO:0033500),16,10,9.57,+,1.05,1,1,7,5.74,+,1.22,0.64,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
regulation of lipid metabolic process (GO:0019216),48,30,28.7,+,1.05,0.907,1,14,17.21,-,0.81,0.565,1,31,27.21,+,1.14,0.56,1,0,0.48,-, < 0.01,1,1
regulation of reactive oxygen species biosynthetic process (GO:1903426),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
xylan metabolic process (GO:0045491),32,20,19.14,+,1.05,0.887,1,8,11.48,-,0.7,0.473,1,15,18.14,-,0.83,0.649,1,0,0.32,-, < 0.01,1,1
amine catabolic process (GO:0009310),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
somatic cell DNA recombination (GO:0016444),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),8,5,4.78,+,1.05,1,1,5,2.87,+,1.74,0.348,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
mitotic spindle assembly checkpoint (GO:0007094),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
glucosamine-containing compound metabolic process (GO:1901071),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
regulation of plant organ formation (GO:1905428),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
regulation of microtubule-based process (GO:0032886),16,10,9.57,+,1.05,1,1,2,5.74,-,0.35,0.184,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
CAAX-box protein processing (GO:0071586),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
regulation of response to salt stress (GO:1901000),24,15,14.35,+,1.05,0.87,1,9,8.61,+,1.05,0.846,1,15,13.6,+,1.1,0.742,1,1,0.24,+,4.15,0.221,1
negative regulation of mitotic sister chromatid separation (GO:2000816),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
negative regulation of chromosome segregation (GO:0051985),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
multi-organism transport (GO:0044766),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
cellular response to endogenous stimulus (GO:0071495),312,195,186.58,+,1.05,0.642,1,135,111.89,+,1.21,0.0727,1,187,176.86,+,1.06,0.54,1,3,3.13,-,0.96,1,1
macroautophagy (GO:0016236),24,15,14.35,+,1.05,0.87,1,4,8.61,-,0.46,0.197,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
regulation of dephosphorylation (GO:0035303),24,15,14.35,+,1.05,0.87,1,8,8.61,-,0.93,1,1,13,13.6,-,0.96,1,1,0,0.24,-, < 0.01,1,1
cellular biogenic amine catabolic process (GO:0042402),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,7,4.53,+,1.54,0.427,1,0,0.08,-, < 0.01,1,1
multi-organism localization (GO:1902579),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
diterpenoid biosynthetic process (GO:0016102),16,10,9.57,+,1.05,1,1,7,5.74,+,1.22,0.64,1,12,9.07,+,1.32,0.555,1,0,0.16,-, < 0.01,1,1
negative regulation of mitotic sister chromatid segregation (GO:0033048),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
negative regulation of sister chromatid segregation (GO:0033046),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
transport of virus (GO:0046794),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
protein exit from endoplasmic reticulum (GO:0032527),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
tRNA catabolic process (GO:0016078),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
cellular response to unfolded protein (GO:0034620),24,15,14.35,+,1.05,0.87,1,17,8.61,+,1.98,0.0335,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
mitotic spindle checkpoint (GO:0071174),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
spindle assembly checkpoint (GO:0071173),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),16,10,9.57,+,1.05,1,1,3,5.74,-,0.52,0.435,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
asymmetric cell division (GO:0008356),16,10,9.57,+,1.05,1,1,2,5.74,-,0.35,0.184,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
adenine nucleotide transport (GO:0051503),8,5,4.78,+,1.05,1,1,5,2.87,+,1.74,0.348,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
calcium-mediated signaling (GO:0019722),32,20,19.14,+,1.05,0.887,1,13,11.48,+,1.13,0.735,1,17,18.14,-,0.94,0.883,1,0,0.32,-, < 0.01,1,1
plasmodesmata-mediated intercellular transport (GO:0010497),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
maintenance of shoot apical meristem identity (GO:0010492),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
regulation of transferase activity (GO:0051338),56,35,33.49,+,1.05,0.829,1,12,20.08,-,0.6,0.128,1,32,31.74,+,1.01,1,1,0,0.56,-, < 0.01,1,1
arabinogalactan protein metabolic process (GO:0010405),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
phototransduction (GO:0007602),16,10,9.57,+,1.05,1,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
negative regulation of mitotic nuclear division (GO:0045839),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
regulation of protein serine/threonine phosphatase activity (GO:0080163),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
CAAX-box protein maturation (GO:0080120),8,5,4.78,+,1.05,1,1,2,2.87,-,0.7,1,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
developmental growth involved in morphogenesis (GO:0060560),192,120,114.82,+,1.05,0.724,1,64,68.85,-,0.93,0.668,1,119,108.84,+,1.09,0.44,1,3,1.93,+,1.56,0.447,1
corolla development (GO:0048465),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,1,0.08,+,12.44,0.0861,1
petal development (GO:0048441),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,6,4.53,+,1.32,0.59,1,1,0.08,+,12.44,0.0861,1
carpel development (GO:0048440),48,30,28.7,+,1.05,0.907,1,22,17.21,+,1.28,0.343,1,25,27.21,-,0.92,0.808,1,0,0.48,-, < 0.01,1,1
regulation of DNA methylation (GO:0044030),16,10,9.57,+,1.05,1,1,4,5.74,-,0.7,0.62,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
negative regulation of cellular amide metabolic process (GO:0034249),24,15,14.35,+,1.05,0.87,1,9,8.61,+,1.05,0.846,1,13,13.6,-,0.96,1,1,0,0.24,-, < 0.01,1,1
regulation of response to water deprivation (GO:2000070),24,15,14.35,+,1.05,0.87,1,11,8.61,+,1.28,0.564,1,13,13.6,-,0.96,1,1,0,0.24,-, < 0.01,1,1
carbohydrate transmembrane transport (GO:0034219),16,10,9.57,+,1.05,1,1,11,5.74,+,1.92,0.123,1,7,9.07,-,0.77,0.668,1,1,0.16,+,6.22,0.156,1
regulation of leaf development (GO:2000024),16,10,9.57,+,1.05,1,1,6,5.74,+,1.05,1,1,6,9.07,-,0.66,0.507,1,1,0.16,+,6.22,0.156,1
floral organ abscission (GO:0010227),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
spindle checkpoint (GO:0031577),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
gibberellin metabolic process (GO:0009685),16,10,9.57,+,1.05,1,1,7,5.74,+,1.22,0.64,1,11,9.07,+,1.21,0.69,1,0,0.16,-, < 0.01,1,1
negative regulation of chromosome separation (GO:1905819),8,5,4.78,+,1.05,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
response to unfolded protein (GO:0006986),24,15,14.35,+,1.05,0.87,1,17,8.61,+,1.98,0.0335,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
photoprotection (GO:0010117),8,5,4.78,+,1.05,1,1,4,2.87,+,1.39,0.529,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
"red, far-red light phototransduction (GO:0009585)",16,10,9.57,+,1.05,1,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
acceptance of pollen (GO:0060321),8,5,4.78,+,1.05,1,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
cation transmembrane transport (GO:0098655),141,88,84.32,+,1.04,0.784,1,61,50.56,+,1.21,0.228,1,98,79.93,+,1.23,0.12,1,5,1.42,+,3.53,0.0153,1
post-embryonic plant organ morphogenesis (GO:0090697),77,48,46.05,+,1.04,0.853,1,30,27.61,+,1.09,0.741,1,45,43.65,+,1.03,0.925,1,1,0.77,+,1.29,0.543,1
positive regulation of cellular protein metabolic process (GO:0032270),77,48,46.05,+,1.04,0.853,1,24,27.61,-,0.87,0.651,1,44,43.65,+,1.01,1,1,0,0.77,-, < 0.01,1,1
seed germination (GO:0009845),69,43,41.26,+,1.04,0.845,1,28,24.74,+,1.13,0.565,1,45,39.11,+,1.15,0.494,1,0,0.69,-, < 0.01,1,1
regulation of cellular ketone metabolic process (GO:0010565),61,38,36.48,+,1.04,0.836,1,22,21.88,+,1.01,1,1,39,34.58,+,1.13,0.602,1,0,0.61,-, < 0.01,1,1
cellular response to hormone stimulus (GO:0032870),289,180,172.82,+,1.04,0.664,1,125,103.64,+,1.21,0.0802,1,176,163.82,+,1.07,0.464,1,3,2.9,+,1.03,0.767,1
response to organic cyclic compound (GO:0014070),159,99,95.08,+,1.04,0.747,1,63,57.02,+,1.1,0.491,1,95,90.13,+,1.05,0.694,1,1,1.6,-,0.63,1,1
protein modification process (GO:0036211),1487,925,889.24,+,1.04,0.324,1,540,533.26,+,1.01,0.789,1,852,842.92,+,1.01,0.801,1,7,14.94,-,0.47,0.0261,1
cellular protein modification process (GO:0006464),1487,925,889.24,+,1.04,0.324,1,540,533.26,+,1.01,0.789,1,852,842.92,+,1.01,0.801,1,7,14.94,-,0.47,0.0261,1
hyperosmotic salinity response (GO:0042538),37,23,22.13,+,1.04,0.894,1,16,13.27,+,1.21,0.534,1,27,20.97,+,1.29,0.362,1,2,0.37,+,5.38,0.0573,1
macromolecule catabolic process (GO:0009057),473,294,282.86,+,1.04,0.595,1,151,169.63,-,0.89,0.212,1,282,268.12,+,1.05,0.512,1,9,4.75,+,1.89,0.0585,1
lipid biosynthetic process (GO:0008610),317,197,189.57,+,1.04,0.678,1,130,113.68,+,1.14,0.192,1,195,179.69,+,1.09,0.376,1,4,3.18,+,1.26,0.564,1
proteolysis (GO:0006508),459,285,274.48,+,1.04,0.616,1,150,164.61,-,0.91,0.326,1,282,260.19,+,1.08,0.293,1,9,4.61,+,1.95,0.0524,1
regulation of response to osmotic stress (GO:0047484),29,18,17.34,+,1.04,0.881,1,11,10.4,+,1.06,0.858,1,18,16.44,+,1.09,0.763,1,1,0.29,+,3.43,0.259,1
nucleotide biosynthetic process (GO:0009165),116,72,69.37,+,1.04,0.82,1,49,41.6,+,1.18,0.33,1,64,65.76,-,0.97,0.938,1,1,1.17,-,0.86,1,1
mitochondrial respiratory chain complex assembly (GO:0033108),29,18,17.34,+,1.04,0.881,1,7,10.4,-,0.67,0.449,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
negative regulation of response to biotic stimulus (GO:0002832),29,18,17.34,+,1.04,0.881,1,13,10.4,+,1.25,0.487,1,18,16.44,+,1.09,0.763,1,0,0.29,-, < 0.01,1,1
negative regulation of response to external stimulus (GO:0032102),29,18,17.34,+,1.04,0.881,1,13,10.4,+,1.25,0.487,1,18,16.44,+,1.09,0.763,1,0,0.29,-, < 0.01,1,1
movement of cell or subcellular component (GO:0006928),58,36,34.68,+,1.04,0.915,1,13,20.8,-,0.63,0.138,1,42,32.88,+,1.28,0.251,1,0,0.58,-, < 0.01,1,1
vesicle docking (GO:0048278),29,18,17.34,+,1.04,0.881,1,10,10.4,-,0.96,1,1,15,16.44,-,0.91,0.876,1,0,0.29,-, < 0.01,1,1
cellular ion homeostasis (GO:0006873),108,67,64.58,+,1.04,0.814,1,41,38.73,+,1.06,0.78,1,69,61.22,+,1.13,0.433,1,0,1.08,-, < 0.01,0.63,1
cellular response to radiation (GO:0071478),79,49,47.24,+,1.04,0.855,1,31,28.33,+,1.09,0.665,1,43,44.78,-,0.96,0.851,1,1,0.79,+,1.26,0.552,1
negative regulation of cellular protein metabolic process (GO:0032269),50,31,29.9,+,1.04,0.909,1,17,17.93,-,0.95,1,1,28,28.34,-,0.99,1,1,0,0.5,-, < 0.01,1,1
inorganic ion transmembrane transport (GO:0098660),150,93,89.7,+,1.04,0.79,1,68,53.79,+,1.26,0.122,1,103,85.03,+,1.21,0.131,1,5,1.51,+,3.32,0.0193,1
carboxylic acid transport (GO:0046942),71,44,42.46,+,1.04,0.847,1,35,25.46,+,1.37,0.123,1,41,40.25,+,1.02,0.922,1,0,0.71,-, < 0.01,1,1
regulation of hormone levels (GO:0010817),134,83,80.13,+,1.04,0.833,1,50,48.05,+,1.04,0.801,1,78,75.96,+,1.03,0.886,1,1,1.35,-,0.74,1,1
base conversion or substitution editing (GO:0016553),21,13,12.56,+,1.04,1,1,8,7.53,+,1.06,0.835,1,10,11.9,-,0.84,0.712,1,0,0.21,-, < 0.01,1,1
cellular response to water deprivation (GO:0042631),21,13,12.56,+,1.04,1,1,10,7.53,+,1.33,0.423,1,13,11.9,+,1.09,0.859,1,0,0.21,-, < 0.01,1,1
response to hydrogen peroxide (GO:0042542),42,26,25.12,+,1.04,0.901,1,13,15.06,-,0.86,0.76,1,26,23.81,+,1.09,0.707,1,0,0.42,-, < 0.01,1,1
cellular response to water stimulus (GO:0071462),21,13,12.56,+,1.04,1,1,10,7.53,+,1.33,0.423,1,13,11.9,+,1.09,0.859,1,0,0.21,-, < 0.01,1,1
regulation of stomatal closure (GO:0090333),21,13,12.56,+,1.04,1,1,11,7.53,+,1.46,0.317,1,15,11.9,+,1.26,0.492,1,0,0.21,-, < 0.01,1,1
regulation of proteasomal protein catabolic process (GO:0061136),21,13,12.56,+,1.04,1,1,5,7.53,-,0.66,0.508,1,13,11.9,+,1.09,0.859,1,0,0.21,-, < 0.01,1,1
protein insertion into membrane (GO:0051205),21,13,12.56,+,1.04,1,1,6,7.53,-,0.8,0.827,1,10,11.9,-,0.84,0.712,1,0,0.21,-, < 0.01,1,1
response to stress (GO:0006950),1867,1155,1116.48,+,1.03,0.329,1,751,669.54,+,1.12,0.00421,0.501,1125,1058.32,+,1.06,0.0797,1,28,18.76,+,1.49,0.032,1
cell wall organization or biogenesis (GO:0071554),249,154,148.9,+,1.03,0.755,1,80,89.3,-,0.9,0.412,1,147,141.15,+,1.04,0.712,1,4,2.5,+,1.6,0.322,1
regulation of small molecule metabolic process (GO:0062012),76,47,45.45,+,1.03,0.852,1,28,27.25,+,1.03,0.911,1,48,43.08,+,1.11,0.574,1,1,0.76,+,1.31,0.538,1
cellular protein metabolic process (GO:0044267),1987,1228,1188.24,+,1.03,0.331,1,722,712.57,+,1.01,0.74,1,1140,1126.34,+,1.01,0.731,1,10,19.96,-,0.5,0.0137,1
lipid metabolic process (GO:0006629),531,328,317.54,+,1.03,0.64,1,198,190.43,+,1.04,0.637,1,341,301,+,1.13,0.0663,1,7,5.33,+,1.31,0.5,1
cytoplasmic microtubule organization (GO:0031122),34,21,20.33,+,1.03,0.89,1,10,12.19,-,0.82,0.732,1,22,19.27,+,1.14,0.677,1,0,0.34,-, < 0.01,1,1
cellular transition metal ion homeostasis (GO:0046916),34,21,20.33,+,1.03,0.89,1,11,12.19,-,0.9,0.866,1,23,19.27,+,1.19,0.581,1,0,0.34,-, < 0.01,1,1
regulation of translation (GO:0006417),68,42,40.66,+,1.03,0.921,1,23,24.39,-,0.94,0.905,1,38,38.55,-,0.99,1,1,0,0.68,-, < 0.01,1,1
translational initiation (GO:0006413),34,21,20.33,+,1.03,0.89,1,9,12.19,-,0.74,0.491,1,18,19.27,-,0.93,0.886,1,0,0.34,-, < 0.01,1,1
regulation of meristem development (GO:0048509),34,21,20.33,+,1.03,0.89,1,9,12.19,-,0.74,0.491,1,18,19.27,-,0.93,0.886,1,0,0.34,-, < 0.01,1,1
hormone-mediated signaling pathway (GO:0009755),251,155,150.1,+,1.03,0.756,1,108,90.01,+,1.2,0.116,1,151,142.28,+,1.06,0.564,1,2,2.52,-,0.79,1,1
response to red or far red light (GO:0009639),128,79,76.54,+,1.03,0.829,1,46,45.9,+,1,1,1,76,72.56,+,1.05,0.77,1,0,1.29,-, < 0.01,0.641,1
regulation of cell death (GO:0010941),60,37,35.88,+,1.03,0.916,1,21,21.52,-,0.98,1,1,41,34.01,+,1.21,0.352,1,0,0.6,-, < 0.01,1,1
cellular macromolecule catabolic process (GO:0044265),406,250,242.79,+,1.03,0.712,1,125,145.6,-,0.86,0.134,1,237,230.14,+,1.03,0.739,1,5,4.08,+,1.23,0.608,1
peptidyl-amino acid modification (GO:0018193),242,149,144.72,+,1.03,0.792,1,88,86.79,+,1.01,0.9,1,133,137.18,-,0.97,0.787,1,0,2.43,-, < 0.01,0.181,1
olefin biosynthetic process (GO:1900674),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
olefin metabolic process (GO:1900673),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
snoRNA processing (GO:0043144),13,8,7.77,+,1.03,1,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
leucine metabolic process (GO:0006551),13,8,7.77,+,1.03,1,1,4,4.66,-,0.86,1,1,10,7.37,+,1.36,0.517,1,1,0.13,+,7.66,0.131,1
cytoplasmic translational initiation (GO:0002183),13,8,7.77,+,1.03,1,1,3,4.66,-,0.64,0.584,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
methionine biosynthetic process (GO:0009086),13,8,7.77,+,1.03,1,1,5,4.66,+,1.07,1,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
meristem growth (GO:0035266),13,8,7.77,+,1.03,1,1,3,4.66,-,0.64,0.584,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
cellular hormone metabolic process (GO:0034754),26,16,15.55,+,1.03,1,1,13,9.32,+,1.39,0.363,1,15,14.74,+,1.02,1,1,0,0.26,-, < 0.01,1,1
snoRNA metabolic process (GO:0016074),13,8,7.77,+,1.03,1,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
stomatal closure (GO:0090332),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,10,7.37,+,1.36,0.517,1,1,0.13,+,7.66,0.131,1
cellular response to UV (GO:0034644),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,5,7.37,-,0.68,0.625,1,0,0.13,-, < 0.01,1,1
sulfur compound catabolic process (GO:0044273),13,8,7.77,+,1.03,1,1,4,4.66,-,0.86,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
cortical microtubule organization (GO:0043622),26,16,15.55,+,1.03,1,1,7,9.32,-,0.75,0.692,1,19,14.74,+,1.29,0.438,1,0,0.26,-, < 0.01,1,1
ethylene biosynthetic process (GO:0009693),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
ethylene metabolic process (GO:0009692),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
alkene biosynthetic process (GO:0043450),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
cellular alkene metabolic process (GO:0043449),13,8,7.77,+,1.03,1,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
cell morphogenesis (GO:0000902),221,136,132.16,+,1.03,0.783,1,72,79.25,-,0.91,0.504,1,133,125.28,+,1.06,0.577,1,4,2.22,+,1.8,0.289,1
cellular chemical homeostasis (GO:0055082),122,75,72.96,+,1.03,0.882,1,46,43.75,+,1.05,0.792,1,77,69.16,+,1.11,0.459,1,0,1.23,-, < 0.01,0.637,1
protein metabolic process (GO:0019538),2089,1283,1249.24,+,1.03,0.414,1,758,749.15,+,1.01,0.763,1,1202,1184.16,+,1.02,0.663,1,14,20.99,-,0.67,0.117,1
gynoecium development (GO:0048467),57,35,34.09,+,1.03,0.914,1,24,20.44,+,1.17,0.528,1,30,32.31,-,0.93,0.823,1,0,0.57,-, < 0.01,1,1
intracellular signal transduction (GO:0035556),202,124,120.8,+,1.03,0.818,1,76,72.44,+,1.05,0.732,1,119,114.5,+,1.04,0.77,1,2,2.03,-,0.99,1,1
biosynthetic process (GO:0009058),1768,1085,1057.28,+,1.03,0.478,1,640,634.03,+,1.01,0.823,1,1002,1002.2,-,1,1,1,16,17.76,-,0.9,0.797,1
cellular response to environmental stimulus (GO:0104004),132,81,78.94,+,1.03,0.887,1,54,47.34,+,1.14,0.404,1,79,74.83,+,1.06,0.719,1,2,1.33,+,1.51,0.386,1
cellular response to abiotic stimulus (GO:0071214),132,81,78.94,+,1.03,0.887,1,54,47.34,+,1.14,0.404,1,79,74.83,+,1.06,0.719,1,2,1.33,+,1.51,0.386,1
stomatal movement (GO:0010118),44,27,26.31,+,1.03,0.903,1,21,15.78,+,1.33,0.323,1,28,24.94,+,1.12,0.625,1,1,0.44,+,2.26,0.363,1
nucleoside phosphate biosynthetic process (GO:1901293),119,73,71.16,+,1.03,0.881,1,51,42.68,+,1.2,0.294,1,65,67.46,-,0.96,0.878,1,1,1.2,-,0.84,1,1
amine metabolic process (GO:0009308),62,38,37.08,+,1.02,0.918,1,28,22.23,+,1.26,0.337,1,36,35.15,+,1.02,0.916,1,0,0.62,-, < 0.01,1,1
export from cell (GO:0140352),62,38,37.08,+,1.02,0.918,1,23,22.23,+,1.03,0.902,1,33,35.15,-,0.94,0.831,1,1,0.62,+,1.61,0.468,1
aspartate family amino acid biosynthetic process (GO:0009067),31,19,18.54,+,1.02,1,1,13,11.12,+,1.17,0.61,1,22,17.57,+,1.25,0.474,1,0,0.31,-, < 0.01,1,1
anatomical structure formation involved in morphogenesis (GO:0048646),124,76,74.15,+,1.02,0.883,1,35,44.47,-,0.79,0.24,1,75,70.29,+,1.07,0.657,1,1,1.25,-,0.8,1,1
response to blue light (GO:0009637),62,38,37.08,+,1.02,0.918,1,17,22.23,-,0.76,0.372,1,36,35.15,+,1.02,0.916,1,0,0.62,-, < 0.01,1,1
immune effector process (GO:0002252),49,30,29.3,+,1.02,0.908,1,18,17.57,+,1.02,0.89,1,25,27.78,-,0.9,0.717,1,0,0.49,-, < 0.01,1,1
organelle localization (GO:0051640),98,60,58.6,+,1.02,0.934,1,38,35.14,+,1.08,0.696,1,52,55.55,-,0.94,0.734,1,0,0.98,-, < 0.01,1,1
phyllome development (GO:0048827),319,195,190.76,+,1.02,0.818,1,123,114.4,+,1.08,0.478,1,179,180.83,-,0.99,0.925,1,4,3.2,+,1.25,0.566,1
cortical cytoskeleton organization (GO:0030865),36,22,21.53,+,1.02,1,1,8,12.91,-,0.62,0.303,1,25,20.41,+,1.23,0.427,1,0,0.36,-, < 0.01,1,1
autophagosome assembly (GO:0000045),18,11,10.76,+,1.02,1,1,4,6.46,-,0.62,0.475,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
endosperm development (GO:0009960),18,11,10.76,+,1.02,1,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,1,0.18,+,5.53,0.173,1
negative regulation of innate immune response (GO:0045824),18,11,10.76,+,1.02,1,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
mitochondrial mRNA modification (GO:0080156),18,11,10.76,+,1.02,1,1,4,6.46,-,0.62,0.475,1,12,10.2,+,1.18,0.705,1,0,0.18,-, < 0.01,1,1
inflorescence development (GO:0010229),18,11,10.76,+,1.02,1,1,6,6.46,-,0.93,1,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
cell wall biogenesis (GO:0042546),131,80,78.34,+,1.02,0.886,1,38,46.98,-,0.81,0.292,1,78,74.26,+,1.05,0.718,1,1,1.32,-,0.76,1,1
organic substance biosynthetic process (GO:1901576),1707,1042,1020.8,+,1.02,0.582,1,617,612.16,+,1.01,0.86,1,962,967.62,-,0.99,0.897,1,14,17.15,-,0.82,0.514,1
regulation of anatomical structure morphogenesis (GO:0022603),82,50,49.04,+,1.02,0.928,1,25,29.41,-,0.85,0.511,1,47,46.48,+,1.01,1,1,0,0.82,-, < 0.01,1,1
cellular response to nitrogen compound (GO:1901699),41,25,24.52,+,1.02,1,1,16,14.7,+,1.09,0.764,1,21,23.24,-,0.9,0.792,1,0,0.41,-, < 0.01,1,1
cellular response to stimulus (GO:0051716),1437,876,859.34,+,1.02,0.632,1,562,515.33,+,1.09,0.0667,1,844,814.57,+,1.04,0.392,1,17,14.44,+,1.18,0.482,1
cation homeostasis (GO:0055080),151,92,90.3,+,1.02,0.894,1,61,54.15,+,1.13,0.433,1,94,85.6,+,1.1,0.504,1,0,1.52,-, < 0.01,0.409,1
localization (GO:0051179),1452,884,868.31,+,1.02,0.666,1,532,520.71,+,1.02,0.665,1,837,823.08,+,1.02,0.695,1,16,14.59,+,1.1,0.675,1
regulation of actin filament polymerization (GO:0030833),23,14,13.75,+,1.02,1,1,5,8.25,-,0.61,0.393,1,15,13.04,+,1.15,0.736,1,0,0.23,-, < 0.01,1,1
xylan biosynthetic process (GO:0045492),23,14,13.75,+,1.02,1,1,5,8.25,-,0.61,0.393,1,10,13.04,-,0.77,0.588,1,0,0.23,-, < 0.01,1,1
regulation of polysaccharide metabolic process (GO:0032881),23,14,13.75,+,1.02,1,1,5,8.25,-,0.61,0.393,1,14,13.04,+,1.07,0.865,1,0,0.23,-, < 0.01,1,1
positive regulation of growth (GO:0045927),23,14,13.75,+,1.02,1,1,8,8.25,-,0.97,1,1,14,13.04,+,1.07,0.865,1,0,0.23,-, < 0.01,1,1
ion homeostasis (GO:0050801),184,112,110.03,+,1.02,0.904,1,77,65.99,+,1.17,0.258,1,117,104.3,+,1.12,0.334,1,2,1.85,+,1.08,0.709,1
NADH dehydrogenase complex assembly (GO:0010257),23,14,13.75,+,1.02,1,1,8,8.25,-,0.97,1,1,12,13.04,-,0.92,0.862,1,0,0.23,-, < 0.01,1,1
response to nematode (GO:0009624),51,31,30.5,+,1.02,1,1,18,18.29,-,0.98,1,1,27,28.91,-,0.93,0.814,1,0,0.51,-, < 0.01,1,1
positive regulation of protein metabolic process (GO:0051247),84,51,50.23,+,1.02,0.929,1,27,30.12,-,0.9,0.667,1,46,47.62,-,0.97,0.927,1,0,0.84,-, < 0.01,1,1
"mRNA cis splicing, via spliceosome (GO:0045292)",28,17,16.74,+,1.02,1,1,6,10.04,-,0.6,0.33,1,17,15.87,+,1.07,0.877,1,0,0.28,-, < 0.01,1,1
secretion (GO:0046903),56,34,33.49,+,1.02,1,1,21,20.08,+,1.05,0.897,1,29,31.74,-,0.91,0.735,1,1,0.56,+,1.78,0.435,1
inorganic anion transport (GO:0015698),56,34,33.49,+,1.02,1,1,24,20.08,+,1.2,0.448,1,32,31.74,+,1.01,1,1,0,0.56,-, < 0.01,1,1
regulation of cell morphogenesis (GO:0022604),56,34,33.49,+,1.02,1,1,17,20.08,-,0.85,0.597,1,31,31.74,-,0.98,1,1,0,0.56,-, < 0.01,1,1
cell growth (GO:0016049),229,139,136.94,+,1.02,0.913,1,74,82.12,-,0.9,0.47,1,137,129.81,+,1.06,0.621,1,4,2.3,+,1.74,0.298,1
hormone metabolic process (GO:0042445),61,37,36.48,+,1.01,1,1,27,21.88,+,1.23,0.396,1,37,34.58,+,1.07,0.753,1,1,0.61,+,1.63,0.463,1
system development (GO:0048731),1176,713,703.26,+,1.01,0.765,1,414,421.73,-,0.98,0.743,1,670,666.62,+,1.01,0.919,1,10,11.81,-,0.85,0.758,1
mRNA modification (GO:0016556),33,20,19.73,+,1.01,1,1,10,11.83,-,0.84,0.731,1,17,18.71,-,0.91,0.883,1,0,0.33,-, < 0.01,1,1
lipid homeostasis (GO:0055088),33,20,19.73,+,1.01,1,1,12,11.83,+,1.01,1,1,21,18.71,+,1.12,0.673,1,0,0.33,-, < 0.01,1,1
plant epidermis development (GO:0090558),165,100,98.67,+,1.01,0.949,1,48,59.17,-,0.81,0.211,1,96,93.53,+,1.03,0.846,1,2,1.66,+,1.21,0.683,1
symbiotic process (GO:0044403),33,20,19.73,+,1.01,1,1,11,11.83,-,0.93,1,1,20,18.71,+,1.07,0.886,1,0,0.33,-, < 0.01,1,1
plant-type secondary cell wall biogenesis (GO:0009834),33,20,19.73,+,1.01,1,1,8,11.83,-,0.68,0.378,1,20,18.71,+,1.07,0.886,1,0,0.33,-, < 0.01,1,1
recognition of pollen (GO:0048544),33,20,19.73,+,1.01,1,1,16,11.83,+,1.35,0.331,1,19,18.71,+,1.02,1,1,0,0.33,-, < 0.01,1,1
jasmonic acid metabolic process (GO:0009694),33,20,19.73,+,1.01,1,1,14,11.83,+,1.18,0.62,1,22,18.71,+,1.18,0.575,1,1,0.33,+,3.02,0.288,1
macromolecule modification (GO:0043412),1733,1050,1036.35,+,1.01,0.72,1,607,621.48,-,0.98,0.597,1,972,982.36,-,0.99,0.78,1,7,17.41,-,0.4,0.00586,1
developmental growth (GO:0048589),228,138,136.35,+,1.01,0.913,1,75,81.76,-,0.92,0.554,1,134,129.24,+,1.04,0.741,1,3,2.29,+,1.31,0.502,1
regulation of lipid biosynthetic process (GO:0046890),38,23,22.72,+,1.01,1,1,10,13.63,-,0.73,0.512,1,22,21.54,+,1.02,1,1,0,0.38,-, < 0.01,1,1
regulation of unidimensional cell growth (GO:0051510),38,23,22.72,+,1.01,1,1,12,13.63,-,0.88,0.872,1,21,21.54,-,0.97,1,1,0,0.38,-, < 0.01,1,1
seed development (GO:0048316),493,298,294.82,+,1.01,0.881,1,180,176.8,+,1.02,0.824,1,277,279.46,-,0.99,0.939,1,4,4.95,-,0.81,1,1
establishment of localization (GO:0051234),1362,823,814.48,+,1.01,0.815,1,498,488.44,+,1.02,0.697,1,784,772.06,+,1.02,0.722,1,16,13.68,+,1.17,0.474,1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),144,87,86.11,+,1.01,0.946,1,40,51.64,-,0.77,0.178,1,86,81.63,+,1.05,0.73,1,2,1.45,+,1.38,0.658,1
plant organ development (GO:0099402),624,377,373.16,+,1.01,0.867,1,215,223.78,-,0.96,0.63,1,350,353.72,-,0.99,0.891,1,6,6.27,-,0.96,1,1
transport (GO:0006810),1336,807,798.94,+,1.01,0.814,1,491,479.11,+,1.02,0.633,1,769,757.32,+,1.02,0.719,1,16,13.42,+,1.19,0.467,1
fruit development (GO:0010154),510,308,304.98,+,1.01,0.883,1,186,182.89,+,1.02,0.861,1,285,289.1,-,0.99,0.88,1,4,5.12,-,0.78,0.82,1
cellular modified amino acid metabolic process (GO:0006575),53,32,31.69,+,1.01,1,1,22,19.01,+,1.16,0.599,1,35,30.04,+,1.16,0.505,1,3,0.53,+,5.63,0.0182,1
alpha-amino acid biosynthetic process (GO:1901607),116,70,69.37,+,1.01,0.94,1,49,41.6,+,1.18,0.33,1,69,65.76,+,1.05,0.759,1,2,1.17,+,1.72,0.328,1
cellular process (GO:0009987),7148,4312,4274.55,+,1.01,0.504,1,2627,2563.39,+,1.02,0.108,1,4118,4051.89,+,1.02,0.214,1,73,71.81,+,1.02,0.859,1
cellular nitrogen compound biosynthetic process (GO:0044271),776,468,464.05,+,1.01,0.88,1,291,278.29,+,1.05,0.496,1,414,439.88,-,0.94,0.32,1,5,7.8,-,0.64,0.453,1
organic acid transport (GO:0015849),73,44,43.65,+,1.01,1,1,35,26.18,+,1.34,0.156,1,41,41.38,-,0.99,1,1,0,0.73,-, < 0.01,1,1
cellular lipid metabolic process (GO:0044255),460,277,275.08,+,1.01,0.938,1,167,164.96,+,1.01,0.89,1,295,260.75,+,1.13,0.0969,1,5,4.62,+,1.08,0.81,1
metabolic process (GO:0008152),5256,3165,3143.12,+,1.01,0.692,1,1931,1884.89,+,1.02,0.242,1,3046,2979.4,+,1.02,0.205,1,52,52.8,-,0.98,0.928,1
regulation of cellular process (GO:0050794),2488,1498,1487.84,+,1.01,0.827,1,887,892.24,-,0.99,0.879,1,1420,1410.34,+,1.01,0.824,1,23,24.99,-,0.92,0.737,1
cellular biosynthetic process (GO:0044249),1636,984,978.34,+,1.01,0.88,1,585,586.7,-,1,0.959,1,909,927.38,-,0.98,0.612,1,15,16.44,-,0.91,0.792,1
protein folding (GO:0006457),138,83,82.52,+,1.01,1,1,54,49.49,+,1.09,0.566,1,73,78.23,-,0.93,0.666,1,3,1.39,+,2.16,0.166,1
proteasomal protein catabolic process (GO:0010498),153,92,91.49,+,1.01,1,1,47,54.87,-,0.86,0.376,1,92,86.73,+,1.06,0.688,1,3,1.54,+,1.95,0.203,1
inorganic ion homeostasis (GO:0098771),163,98,97.48,+,1.01,1,1,65,58.45,+,1.11,0.451,1,102,92.4,+,1.1,0.44,1,1,1.64,-,0.61,1,1
cytoskeleton organization (GO:0007010),173,104,103.46,+,1.01,1,1,53,62.04,-,0.85,0.362,1,109,98.07,+,1.11,0.383,1,1,1.74,-,0.58,1,1
plant organ morphogenesis (GO:1905392),258,155,154.29,+,1,0.959,1,77,92.52,-,0.83,0.168,1,144,146.25,-,0.98,0.917,1,2,2.59,-,0.77,1,1
regulation of biological process (GO:0050789),2867,1721,1714.48,+,1,0.89,1,1016,1028.15,-,0.99,0.726,1,1639,1625.18,+,1.01,0.765,1,27,28.8,-,0.94,0.751,1
CTP metabolic process (GO:0046036),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
response to anoxia (GO:0034059),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
cellular zinc ion homeostasis (GO:0006882),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
chloroplast RNA modification (GO:1900865),20,12,11.96,+,1,1,1,8,7.17,+,1.12,0.83,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
suspensor development (GO:0010098),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
phosphate ion transport (GO:0006817),15,9,8.97,+,1,1,1,6,5.38,+,1.12,0.806,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
response to boron-containing substance (GO:0010036),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
proton-transporting V-type ATPase complex assembly (GO:0070070),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
protein import into peroxisome matrix (GO:0016558),10,6,5.98,+,1,1,1,2,3.59,-,0.56,0.743,1,10,5.67,+,1.76,0.244,1,0,0.1,-, < 0.01,1,1
glutathione catabolic process (GO:0006751),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
activation of MAPK activity (GO:0000187),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
ceramide transport (GO:0035627),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),15,9,8.97,+,1,1,1,6,5.38,+,1.12,0.806,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
male meiosis cytokinesis (GO:0007112),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),15,9,8.97,+,1,1,1,4,5.38,-,0.74,0.796,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
sulfur amino acid catabolic process (GO:0000098),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of cell cycle G1/S phase transition (GO:1902806),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),15,9,8.97,+,1,1,1,6,5.38,+,1.12,0.806,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
cotranslational protein targeting to membrane (GO:0006613),15,9,8.97,+,1,1,1,6,5.38,+,1.12,0.806,1,8,8.5,-,0.94,1,1,1,0.15,+,6.64,0.148,1
amino acid salvage (GO:0043102),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of polysaccharide biosynthetic process (GO:0032885),15,9,8.97,+,1,1,1,2,5.38,-,0.37,0.269,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
regulation of cell fate specification (GO:0042659),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
polyamine catabolic process (GO:0006598),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
spermine biosynthetic process (GO:0006597),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
lysine metabolic process (GO:0006553),15,9,8.97,+,1,1,1,7,5.38,+,1.3,0.628,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
malonyl-CoA metabolic process (GO:2001293),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
cell-cell junction organization (GO:0045216),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
purine nucleotide transport (GO:0015865),10,6,5.98,+,1,1,1,5,3.59,+,1.39,0.561,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
lysosomal microautophagy (GO:0016237),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of translational fidelity (GO:0006450),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
response to nitrate starvation (GO:0090548),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
translational termination (GO:0006415),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
regulation of intracellular protein transport (GO:0033157),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
oligosaccharide transport (GO:0015772),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,7,5.67,+,1.23,0.801,1,1,0.1,+,9.95,0.104,1
sucrose transport (GO:0015770),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,7,5.67,+,1.23,0.801,1,1,0.1,+,9.95,0.104,1
disaccharide transport (GO:0015766),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,7,5.67,+,1.23,0.801,1,1,0.1,+,9.95,0.104,1
sucrose catabolic process (GO:0005987),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
sialic acid transport (GO:0015739),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
negative regulation of small molecule metabolic process (GO:0062014),15,9,8.97,+,1,1,1,5,5.38,-,0.93,1,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
pseudouridine synthesis (GO:0001522),20,12,11.96,+,1,1,1,7,7.17,-,0.98,1,1,6,11.34,-,0.53,0.22,1,0,0.2,-, < 0.01,1,1
response to redox state (GO:0051775),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,1,0.05,+,19.91,0.0582,1
regulation of gene expression by genetic imprinting (GO:0006349),10,6,5.98,+,1,1,1,2,3.59,-,0.56,0.743,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
lead ion transport (GO:0015692),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
hydrogen sulfide metabolic process (GO:0070813),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,5,2.83,+,1.76,0.512,1,2,0.05,+,39.82,0.002,1
piecemeal microautophagy of the nucleus (GO:0034727),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
cellular response to calcium ion (GO:0071277),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
protein N-linked glycosylation via asparagine (GO:0018279),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
L-methionine salvage (GO:0071267),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
cellular response to carbon dioxide (GO:0071244),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
mitochondrion localization (GO:0051646),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
CTP biosynthetic process (GO:0006241),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
pyrimidine nucleoside metabolic process (GO:0006213),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of mitotic cell cycle phase transition (GO:1901992),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
positive regulation of cell cycle phase transition (GO:1901989),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
peptidyl-asparagine modification (GO:0018196),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
regulation of meiotic nuclear division (GO:0040020),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
regulation of defense response to fungus (GO:1900150),20,12,11.96,+,1,1,1,11,7.17,+,1.53,0.306,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
Unclassified (UNCLASSIFIED),2140,1284,1279.73,+,1,0.923,1,750,767.44,-,0.98,0.564,1,1189,1213.07,-,0.98,0.554,1,15,21.5,-,0.7,0.153,1
regulation of histone H3-K9 dimethylation (GO:1900109),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of peroxisome size (GO:0044375),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
CUT metabolic process (GO:0071043),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
CUT catabolic process (GO:0071034),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
karyogamy (GO:0000741),20,12,11.96,+,1,1,1,12,7.17,+,1.67,0.162,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
positive regulation of cellular response to heat (GO:1900036),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
inositol metabolic process (GO:0006020),15,9,8.97,+,1,1,1,10,5.38,+,1.86,0.17,1,9,8.5,+,1.06,1,1,0,0.15,-, < 0.01,1,1
one-carbon compound transport (GO:0019755),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of flavonoid biosynthetic process (GO:0009963),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of lipid catabolic process (GO:0050994),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,5,2.83,+,1.76,0.512,1,0,0.05,-, < 0.01,1,1
regulation of microtubule cytoskeleton organization (GO:0070507),15,9,8.97,+,1,1,1,2,5.38,-,0.37,0.269,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
acylglycerol biosynthetic process (GO:0046463),15,9,8.97,+,1,1,1,5,5.38,-,0.93,1,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
neutral lipid biosynthetic process (GO:0046460),15,9,8.97,+,1,1,1,5,5.38,-,0.93,1,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
ncRNA 5'-end processing (GO:0034471),10,6,5.98,+,1,1,1,4,3.59,+,1.12,0.77,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
positive regulation of transferase activity (GO:0051347),20,12,11.96,+,1,1,1,5,7.17,-,0.7,0.65,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
regulation of organelle assembly (GO:1902115),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of morphogenesis of a branching structure (GO:0060688),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
determination of bilateral symmetry (GO:0009855),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
plant-type cell wall loosening (GO:0009828),15,9,8.97,+,1,1,1,4,5.38,-,0.74,0.796,1,11,8.5,+,1.29,0.543,1,1,0.15,+,6.64,0.148,1
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
cell junction organization (GO:0034330),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
rhamnogalacturonan I metabolic process (GO:0010395),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of gibberellin biosynthetic process (GO:0010371),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
post-translational protein modification (GO:0043687),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
leaf shaping (GO:0010358),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
singlet oxygen-mediated programmed cell death (GO:0010343),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of vegetative phase change (GO:0010321),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of mRNA catabolic process (GO:0061014),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
specification of symmetry (GO:0009799),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of seed growth (GO:0080113),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
negative regulation of immune response (GO:0050777),20,12,11.96,+,1,1,1,7,7.17,-,0.98,1,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
L-methionine salvage from methylthioadenosine (GO:0019509),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
intermembrane lipid transfer (GO:0120009),5,3,2.99,+,1,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
positive regulation of cellular amide metabolic process (GO:0034250),20,12,11.96,+,1,1,1,8,7.17,+,1.12,0.83,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
regulation of post-embryonic root development (GO:2000069),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
regulation of secondary shoot formation (GO:2000032),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
small nucleolar ribonucleoprotein complex assembly (GO:0000491),5,3,2.99,+,1,1,1,4,1.79,+,2.23,0.256,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
positive regulation of DNA repair (GO:0045739),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
guard mother cell cytokinesis (GO:0010235),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of translation (GO:0045727),20,12,11.96,+,1,1,1,8,7.17,+,1.12,0.83,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
positive regulation of GTPase activity (GO:0043547),20,12,11.96,+,1,1,1,9,7.17,+,1.25,0.534,1,8,11.34,-,0.71,0.439,1,0,0.2,-, < 0.01,1,1
integument development (GO:0080060),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
amyloplast organization (GO:0009660),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
response to herbicide (GO:0009635),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
mucilage biosynthetic process involved in seed coat development (GO:0048354),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
epithelium development (GO:0060429),15,9,8.97,+,1,1,1,4,5.38,-,0.74,0.796,1,11,8.5,+,1.29,0.543,1,0,0.15,-, < 0.01,1,1
organ boundary specification between lateral organs and the meristem (GO:0010199),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
polar nucleus fusion (GO:0010197),20,12,11.96,+,1,1,1,12,7.17,+,1.67,0.162,1,12,11.34,+,1.06,0.856,1,0,0.2,-, < 0.01,1,1
positive regulation of helicase activity (GO:0051096),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
anthocyanin accumulation in tissues in response to UV light (GO:0043481),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
pigment accumulation in tissues (GO:0043480),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
pigment accumulation in tissues in response to UV light (GO:0043479),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
"alternative mRNA splicing, via spliceosome (GO:0000380)",10,6,5.98,+,1,1,1,2,3.59,-,0.56,0.743,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
pigment accumulation in response to UV light (GO:0043478),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
pigment accumulation (GO:0043476),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
pigmentation (GO:0043473),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
negative regulation of lipid biosynthetic process (GO:0051055),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
cellular alkane metabolic process (GO:0043446),5,3,2.99,+,1,1,1,4,1.79,+,2.23,0.256,1,3,2.83,+,1.06,1,1,1,0.05,+,19.91,0.0582,1
positive regulation of MAPK cascade (GO:0043410),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
positive regulation of MAP kinase activity (GO:0043406),5,3,2.99,+,1,1,1,3,1.79,+,1.67,0.443,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
nicotinamide nucleotide biosynthetic process (GO:0019359),10,6,5.98,+,1,1,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
modified amino acid transport (GO:0072337),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of ATP metabolic process (GO:1903578),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
oxylipin metabolic process (GO:0031407),15,9,8.97,+,1,1,1,7,5.38,+,1.3,0.628,1,10,8.5,+,1.18,0.682,1,1,0.15,+,6.64,0.148,1
vesicle uncoating (GO:0072319),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
clathrin coat disassembly (GO:0072318),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
hexose catabolic process (GO:0019320),5,3,2.99,+,1,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
adenine biosynthetic process (GO:0046084),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
adenine metabolic process (GO:0046083),5,3,2.99,+,1,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
potassium ion transmembrane transport (GO:0071805),25,15,14.95,+,1,1,1,8,8.97,-,0.89,1,1,14,14.17,-,0.99,1,1,0,0.25,-, < 0.01,1,1
water-soluble vitamin metabolic process (GO:0006767),45,27,26.91,+,1,1,1,22,16.14,+,1.36,0.266,1,28,25.51,+,1.1,0.715,1,2,0.45,+,4.42,0.0794,1
mitochondrial ATP synthesis coupled electron transport (GO:0042775),25,15,14.95,+,1,1,1,9,8.97,+,1,1,1,16,14.17,+,1.13,0.746,1,0,0.25,-, < 0.01,1,1
transition metal ion transport (GO:0000041),45,27,26.91,+,1,1,1,17,16.14,+,1.05,0.885,1,32,25.51,+,1.25,0.343,1,0,0.45,-, < 0.01,1,1
cellular response to red or far red light (GO:0071489),35,21,20.93,+,1,1,1,15,12.55,+,1.2,0.525,1,19,19.84,-,0.96,1,1,0,0.35,-, < 0.01,1,1
regulation of auxin mediated signaling pathway (GO:0010928),25,15,14.95,+,1,1,1,9,8.97,+,1,1,1,13,14.17,-,0.92,0.867,1,0,0.25,-, < 0.01,1,1
regulation of cellular component size (GO:0032535),50,30,29.9,+,1,1,1,14,17.93,-,0.78,0.479,1,31,28.34,+,1.09,0.729,1,0,0.5,-, < 0.01,1,1
regulation of anatomical structure size (GO:0090066),50,30,29.9,+,1,1,1,14,17.93,-,0.78,0.479,1,31,28.34,+,1.09,0.729,1,0,0.5,-, < 0.01,1,1
jasmonic acid mediated signaling pathway (GO:0009867),50,30,29.9,+,1,1,1,23,17.93,+,1.28,0.351,1,31,28.34,+,1.09,0.729,1,0,0.5,-, < 0.01,1,1
cell recognition (GO:0008037),35,21,20.93,+,1,1,1,16,12.55,+,1.27,0.427,1,20,19.84,+,1.01,1,1,0,0.35,-, < 0.01,1,1
maintenance of location (GO:0051235),35,21,20.93,+,1,1,1,9,12.55,-,0.72,0.493,1,21,19.84,+,1.06,0.889,1,0,0.35,-, < 0.01,1,1
root hair cell development (GO:0080147),55,33,32.89,+,1,1,1,14,19.72,-,0.71,0.276,1,32,31.18,+,1.03,0.911,1,0,0.55,-, < 0.01,1,1
regulation of cellular amide metabolic process (GO:0034248),70,42,41.86,+,1,1,1,23,25.1,-,0.92,0.814,1,39,39.68,-,0.98,1,1,0,0.7,-, < 0.01,1,1
photoperiodism (GO:0009648),65,39,38.87,+,1,1,1,21,23.31,-,0.9,0.806,1,39,36.85,+,1.06,0.76,1,0,0.65,-, < 0.01,1,1
post-embryonic development (GO:0009791),977,586,584.25,+,1,0.957,1,359,350.37,+,1.02,0.675,1,559,553.82,+,1.01,0.868,1,6,9.81,-,0.61,0.244,1
shoot system development (GO:0048367),442,265,264.32,+,1,0.968,1,164,158.51,+,1.03,0.708,1,248,250.55,-,0.99,0.936,1,4,4.44,-,0.9,1,1
cellular metabolic process (GO:0044237),4763,2854,2848.3,+,1,0.917,1,1748,1708.09,+,1.02,0.303,1,2739,2699.94,+,1.01,0.457,1,43,47.85,-,0.9,0.41,1
organic substance metabolic process (GO:0071704),4814,2884,2878.8,+,1,0.929,1,1738,1726.38,+,1.01,0.763,1,2741,2728.85,+,1,0.82,1,40,48.36,-,0.83,0.144,1
organic substance transport (GO:0071702),626,375,374.35,+,1,0.973,1,239,224.49,+,1.06,0.406,1,347,354.85,-,0.98,0.758,1,7,6.29,+,1.11,0.682,1
protein targeting (GO:0006605),167,100,99.87,+,1,1,1,54,59.89,-,0.9,0.54,1,98,94.66,+,1.04,0.797,1,1,1.68,-,0.6,1,1
biological_process (GO:0008150),10701,6395,6399.27,-,1,0.923,1,3855,3837.56,+,1,0.564,1,6090,6065.93,+,1,0.554,1,114,107.5,+,1.06,0.153,1
macromolecule localization (GO:0033036),579,346,346.25,-,1,1,1,201,207.64,-,0.97,0.708,1,316,328.21,-,0.96,0.594,1,4,5.82,-,0.69,0.666,1
vacuolar transport (GO:0007034),77,46,46.05,-,1,1,1,25,27.61,-,0.91,0.736,1,39,43.65,-,0.89,0.628,1,0,0.77,-, < 0.01,1,1
biological regulation (GO:0065007),3191,1906,1908.24,-,1,0.973,1,1126,1144.35,-,0.98,0.605,1,1818,1808.84,+,1.01,0.852,1,27,32.06,-,0.84,0.356,1
chemical homeostasis (GO:0048878),248,148,148.31,-,1,1,1,97,88.94,+,1.09,0.46,1,153,140.58,+,1.09,0.402,1,2,2.49,-,0.8,1,1
regulation of biological quality (GO:0065008),585,349,349.83,-,1,1,1,216,209.79,+,1.03,0.712,1,348,331.61,+,1.05,0.464,1,8,5.88,+,1.36,0.391,1
endocytosis (GO:0006897),57,34,34.09,-,1,1,1,14,20.44,-,0.68,0.226,1,28,32.31,-,0.87,0.573,1,1,0.57,+,1.75,0.441,1
developmental process (GO:0032502),1835,1094,1097.34,-,1,0.934,1,651,658.06,-,0.99,0.806,1,1040,1040.18,-,1,1,1,18,18.43,-,0.98,1,1
response to UV-B (GO:0010224),52,31,31.1,-,1,1,1,24,18.65,+,1.29,0.299,1,30,29.48,+,1.02,1,1,1,0.52,+,1.91,0.412,1
multicellular organism development (GO:0007275),1545,921,923.92,-,1,0.947,1,554,554.06,-,1,1,1,866,875.79,-,0.99,0.786,1,12,15.52,-,0.77,0.414,1
regulation of response to stimulus (GO:0048583),458,273,273.89,-,1,1,1,170,164.25,+,1.04,0.712,1,266,259.62,+,1.02,0.753,1,2,4.6,-,0.43,0.333,1
protein import (GO:0017038),99,59,59.2,-,1,1,1,33,35.5,-,0.93,0.767,1,52,56.12,-,0.93,0.672,1,0,0.99,-, < 0.01,0.629,1
anatomical structure development (GO:0048856),1761,1049,1053.09,-,1,0.933,1,625,631.52,-,0.99,0.822,1,997,998.23,-,1,0.983,1,17,17.69,-,0.96,1,1
nitrogen compound transport (GO:0071705),539,321,322.33,-,1,0.971,1,199,193.29,+,1.03,0.733,1,295,305.54,-,0.97,0.633,1,5,5.41,-,0.92,1,1
ATP metabolic process (GO:0046034),84,50,50.23,-,1,1,1,32,30.12,+,1.06,0.752,1,56,47.62,+,1.18,0.377,1,2,0.84,+,2.37,0.211,1
regulation of cell division (GO:0051302),42,25,25.12,-,1,1,1,8,15.06,-,0.53,0.108,1,21,23.81,-,0.88,0.695,1,0,0.42,-, < 0.01,1,1
"regulation of mRNA splicing, via spliceosome (GO:0048024)",37,22,22.13,-,0.99,1,1,11,13.27,-,0.83,0.743,1,19,20.97,-,0.91,0.782,1,0,0.37,-, < 0.01,1,1
nucleus organization (GO:0006997),37,22,22.13,-,0.99,1,1,16,13.27,+,1.21,0.534,1,22,20.97,+,1.05,0.892,1,0,0.37,-, < 0.01,1,1
regulation of transport (GO:0051049),74,44,44.25,-,0.99,1,1,27,26.54,+,1.02,0.91,1,40,41.95,-,0.95,0.846,1,1,0.74,+,1.35,0.529,1
organonitrogen compound biosynthetic process (GO:1901566),850,505,508.31,-,0.99,0.931,1,319,304.82,+,1.05,0.471,1,468,481.83,-,0.97,0.614,1,7,8.54,-,0.82,0.722,1
multicellular organismal process (GO:0032501),1701,1010,1017.21,-,0.99,0.865,1,611,610.01,+,1,0.98,1,952,964.22,-,0.99,0.745,1,13,17.09,-,0.76,0.36,1
positive regulation of post-embryonic development (GO:0048582),59,35,35.28,-,0.99,1,1,22,21.16,+,1.04,0.9,1,36,33.44,+,1.08,0.749,1,0,0.59,-, < 0.01,1,1
protein localization (GO:0008104),484,287,289.44,-,0.99,0.94,1,161,173.57,-,0.93,0.413,1,263,274.36,-,0.96,0.587,1,4,4.86,-,0.82,1,1
primary metabolic process (GO:0044238),4436,2629,2652.76,-,0.99,0.66,1,1562,1590.82,-,0.98,0.448,1,2501,2514.57,-,0.99,0.793,1,36,44.56,-,0.81,0.136,1
positive regulation of protein-containing complex assembly (GO:0031334),27,16,16.15,-,0.99,1,1,7,9.68,-,0.72,0.56,1,16,15.31,+,1.05,0.875,1,0,0.27,-, < 0.01,1,1
negative regulation of response to stimulus (GO:0048585),152,90,90.9,-,0.99,1,1,55,54.51,+,1.01,0.937,1,90,86.16,+,1.04,0.737,1,1,1.53,-,0.65,1,1
plant organ formation (GO:1905393),66,39,39.47,-,0.99,1,1,19,23.67,-,0.8,0.46,1,37,37.41,-,0.99,1,1,0,0.66,-, < 0.01,1,1
mitochondrial RNA modification (GO:1900864),22,13,13.16,-,0.99,1,1,6,7.89,-,0.76,0.671,1,15,12.47,+,1.2,0.609,1,0,0.22,-, < 0.01,1,1
regulation of GTPase activity (GO:0043087),22,13,13.16,-,0.99,1,1,10,7.89,+,1.27,0.548,1,9,12.47,-,0.72,0.459,1,0,0.22,-, < 0.01,1,1
embryo sac central cell differentiation (GO:0009559),22,13,13.16,-,0.99,1,1,12,7.89,+,1.52,0.245,1,13,12.47,+,1.04,1,1,0,0.22,-, < 0.01,1,1
response to auxin (GO:0009733),166,98,99.27,-,0.99,0.949,1,61,59.53,+,1.02,0.88,1,94,94.1,-,1,1,1,3,1.67,+,1.8,0.237,1
regulation of intracellular signal transduction (GO:1902531),39,23,23.32,-,0.99,1,1,15,13.99,+,1.07,0.877,1,21,22.11,-,0.95,0.894,1,0,0.39,-, < 0.01,1,1
circadian rhythm (GO:0007623),78,46,46.64,-,0.99,1,1,24,27.97,-,0.86,0.574,1,45,44.21,+,1.02,0.925,1,3,0.78,+,3.83,0.0468,1
rhythmic process (GO:0048511),78,46,46.64,-,0.99,1,1,24,27.97,-,0.86,0.574,1,45,44.21,+,1.02,0.925,1,3,0.78,+,3.83,0.0468,1
positive regulation of protein modification process (GO:0031401),39,23,23.32,-,0.99,1,1,9,13.99,-,0.64,0.255,1,20,22.11,-,0.9,0.787,1,0,0.39,-, < 0.01,1,1
reproductive system development (GO:0061458),792,467,473.62,-,0.99,0.81,1,284,284.02,-,1,1,1,445,448.95,-,0.99,0.903,1,6,7.96,-,0.75,0.583,1
reproductive structure development (GO:0048608),792,467,473.62,-,0.99,0.81,1,284,284.02,-,1,1,1,445,448.95,-,0.99,0.903,1,6,7.96,-,0.75,0.583,1
regulation of cellular protein metabolic process (GO:0032268),212,125,126.78,-,0.99,0.955,1,60,76.03,-,0.79,0.111,1,119,120.17,-,0.99,0.954,1,0,2.13,-, < 0.01,0.279,1
organophosphate metabolic process (GO:0019637),397,234,237.41,-,0.99,0.867,1,158,142.37,+,1.11,0.261,1,233,225.04,+,1.04,0.674,1,7,3.99,+,1.76,0.125,1
homeostatic process (GO:0042592),336,198,200.93,-,0.99,0.892,1,135,120.5,+,1.12,0.266,1,202,190.46,+,1.06,0.524,1,7,3.38,+,2.07,0.0862,1
photomorphogenesis (GO:0009640),56,33,33.49,-,0.99,1,1,18,20.08,-,0.9,0.792,1,35,31.74,+,1.1,0.663,1,0,0.56,-, < 0.01,1,1
response to UV (GO:0009411),90,53,53.82,-,0.98,1,1,42,32.28,+,1.3,0.165,1,53,51.02,+,1.04,0.861,1,3,0.9,+,3.32,0.0655,1
amide biosynthetic process (GO:0043604),360,212,215.28,-,0.98,0.895,1,131,129.1,+,1.01,0.876,1,188,204.07,-,0.92,0.368,1,1,3.62,-,0.28,0.273,1
regulation of protein metabolic process (GO:0051246),226,133,135.15,-,0.98,0.912,1,66,81.05,-,0.81,0.141,1,126,128.11,-,0.98,0.911,1,0,2.27,-, < 0.01,0.177,1
proton transmembrane transport (GO:1902600),51,30,30.5,-,0.98,1,1,25,18.29,+,1.37,0.194,1,36,28.91,+,1.25,0.316,1,5,0.51,+,9.76,0.000229,0.654
endoplasmic reticulum unfolded protein response (GO:0030968),17,10,10.17,-,0.98,1,1,14,6.1,+,2.3,0.0239,1,9,9.64,-,0.93,1,1,0,0.17,-, < 0.01,1,1
oligopeptide transport (GO:0006857),17,10,10.17,-,0.98,1,1,7,6.1,+,1.15,0.817,1,13,9.64,+,1.35,0.449,1,0,0.17,-, < 0.01,1,1
red or far-red light signaling pathway (GO:0010017),34,20,20.33,-,0.98,1,1,14,12.19,+,1.15,0.626,1,19,19.27,-,0.99,1,1,0,0.34,-, < 0.01,1,1
process utilizing autophagic mechanism (GO:0061919),34,20,20.33,-,0.98,1,1,6,12.19,-,0.49,0.109,1,20,19.27,+,1.04,0.888,1,0,0.34,-, < 0.01,1,1
regulation of mitotic sister chromatid separation (GO:0010965),17,10,10.17,-,0.98,1,1,3,6.1,-,0.49,0.317,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
regulation of mitotic metaphase/anaphase transition (GO:0030071),17,10,10.17,-,0.98,1,1,3,6.1,-,0.49,0.317,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),17,10,10.17,-,0.98,1,1,3,6.1,-,0.49,0.317,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
import across plasma membrane (GO:0098739),17,10,10.17,-,0.98,1,1,6,6.1,-,0.98,1,1,9,9.64,-,0.93,1,1,0,0.17,-, < 0.01,1,1
import into cell (GO:0098657),17,10,10.17,-,0.98,1,1,6,6.1,-,0.98,1,1,9,9.64,-,0.93,1,1,0,0.17,-, < 0.01,1,1
auxin homeostasis (GO:0010252),17,10,10.17,-,0.98,1,1,4,6.1,-,0.66,0.621,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
regulation of chromosome separation (GO:1905818),17,10,10.17,-,0.98,1,1,3,6.1,-,0.49,0.317,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
autophagy (GO:0006914),34,20,20.33,-,0.98,1,1,6,12.19,-,0.49,0.109,1,20,19.27,+,1.04,0.888,1,0,0.34,-, < 0.01,1,1
anatomical structure morphogenesis (GO:0009653),551,324,329.5,-,0.98,0.83,1,171,197.6,-,0.87,0.0928,1,315,312.34,+,1.01,0.914,1,6,5.54,+,1.08,0.825,1
growth (GO:0040007),269,158,160.86,-,0.98,0.88,1,86,96.47,-,0.89,0.362,1,153,152.48,+,1,1,1,4,2.7,+,1.48,0.352,1
mitochondrion organization (GO:0007005),126,74,75.35,-,0.98,0.942,1,41,45.19,-,0.91,0.659,1,58,71.42,-,0.81,0.191,1,0,1.27,-, < 0.01,0.639,1
regulation of cellular response to stress (GO:0080135),63,37,37.67,-,0.98,1,1,20,22.59,-,0.89,0.709,1,33,35.71,-,0.92,0.75,1,0,0.63,-, < 0.01,1,1
cellular macromolecule metabolic process (GO:0044260),2698,1584,1613.42,-,0.98,0.523,1,905,967.55,-,0.94,0.051,1,1460,1529.38,-,0.95,0.111,1,16,27.1,-,0.59,0.0163,1
embryo development (GO:0009790),414,243,247.57,-,0.98,0.838,1,153,148.47,+,1.03,0.735,1,218,234.68,-,0.93,0.377,1,4,4.16,-,0.96,1,1
response to brassinosteroid (GO:0009741),46,27,27.51,-,0.98,1,1,21,16.5,+,1.27,0.404,1,25,26.08,-,0.96,0.902,1,0,0.46,-, < 0.01,1,1
embryo development ending in seed dormancy (GO:0009793),397,233,237.41,-,0.98,0.834,1,148,142.37,+,1.04,0.693,1,209,225.04,-,0.93,0.391,1,4,3.99,+,1,1,1
cytokinesis (GO:0000910),75,44,44.85,-,0.98,1,1,19,26.9,-,0.71,0.197,1,44,42.51,+,1.03,0.849,1,0,0.75,-, < 0.01,1,1
alcohol metabolic process (GO:0006066),75,44,44.85,-,0.98,1,1,32,26.9,+,1.19,0.441,1,47,42.51,+,1.11,0.637,1,1,0.75,+,1.33,0.533,1
nitrogen compound metabolic process (GO:0006807),3838,2251,2295.15,-,0.98,0.385,1,1367,1376.37,-,0.99,0.807,1,2118,2175.59,-,0.97,0.241,1,30,38.56,-,0.78,0.121,1
receptor-mediated endocytosis (GO:0006898),29,17,17.34,-,0.98,1,1,7,10.4,-,0.67,0.449,1,17,16.44,+,1.03,1,1,1,0.29,+,3.43,0.259,1
multidimensional cell growth (GO:0009825),29,17,17.34,-,0.98,1,1,7,10.4,-,0.67,0.449,1,15,16.44,-,0.91,0.876,1,1,0.29,+,3.43,0.259,1
axis specification (GO:0009798),29,17,17.34,-,0.98,1,1,9,10.4,-,0.87,0.854,1,14,16.44,-,0.85,0.751,1,0,0.29,-, < 0.01,1,1
regulation of primary metabolic process (GO:0080090),1446,847,864.72,-,0.98,0.631,1,488,518.56,-,0.94,0.229,1,788,819.67,-,0.96,0.35,1,14,14.53,-,0.96,1,1
glutamine family amino acid metabolic process (GO:0009064),41,24,24.52,-,0.98,1,1,15,14.7,+,1.02,1,1,26,23.24,+,1.12,0.703,1,0,0.41,-, < 0.01,1,1
carbohydrate derivative biosynthetic process (GO:1901137),294,172,175.81,-,0.98,0.846,1,97,105.43,-,0.92,0.487,1,147,166.66,-,0.88,0.229,1,3,2.95,+,1.02,0.771,1
cellular response to jasmonic acid stimulus (GO:0071395),53,31,31.69,-,0.98,1,1,23,19.01,+,1.21,0.436,1,32,30.04,+,1.07,0.821,1,0,0.53,-, < 0.01,1,1
floral whorl development (GO:0048438),118,69,70.56,-,0.98,0.94,1,46,42.32,+,1.09,0.656,1,65,66.89,-,0.97,0.877,1,1,1.19,-,0.84,1,1
positive regulation of biological process (GO:0048518),715,418,427.57,-,0.98,0.728,1,240,256.41,-,0.94,0.385,1,387,405.3,-,0.95,0.459,1,3,7.18,-,0.42,0.122,1
positive regulation of multicellular organismal process (GO:0051240),65,38,38.87,-,0.98,1,1,23,23.31,-,0.99,1,1,38,36.85,+,1.03,0.918,1,0,0.65,-, < 0.01,1,1
nucleobase-containing compound biosynthetic process (GO:0034654),337,197,201.53,-,0.98,0.821,1,111,120.85,-,0.92,0.448,1,166,191.03,-,0.87,0.145,1,2,3.39,-,0.59,0.777,1
regulation of cellular metabolic process (GO:0031323),1550,906,926.91,-,0.98,0.579,1,529,555.86,-,0.95,0.301,1,846,878.63,-,0.96,0.353,1,14,15.57,-,0.9,0.786,1
protein localization to membrane (GO:0072657),89,52,53.22,-,0.98,0.931,1,30,31.92,-,0.94,0.835,1,49,50.45,-,0.97,0.929,1,1,0.89,+,1.12,0.595,1
regulation of metabolic process (GO:0019222),1762,1028,1053.69,-,0.98,0.514,1,601,631.88,-,0.95,0.259,1,965,998.8,-,0.97,0.368,1,17,17.7,-,0.96,1,1
proton-transporting two-sector ATPase complex assembly (GO:0070071),12,7,7.18,-,0.98,1,1,3,4.3,-,0.7,0.772,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
cell-cell signaling (GO:0007267),12,7,7.18,-,0.98,1,1,2,4.3,-,0.46,0.38,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
phosphorelay signal transduction system (GO:0000160),48,28,28.7,-,0.98,1,1,20,17.21,+,1.16,0.582,1,25,27.21,-,0.92,0.808,1,0,0.48,-, < 0.01,1,1
sulfate assimilation (GO:0000103),12,7,7.18,-,0.98,1,1,8,4.3,+,1.86,0.202,1,10,6.8,+,1.47,0.38,1,4,0.12,+,33.18,1.55E-05,0.0885
regulation of protein localization (GO:0032880),24,14,14.35,-,0.98,1,1,6,8.61,-,0.7,0.536,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
phosphate ion homeostasis (GO:0055062),12,7,7.18,-,0.98,1,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
pyrimidine nucleoside triphosphate metabolic process (GO:0009147),12,7,7.18,-,0.98,1,1,4,4.3,-,0.93,1,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
"regulation of DNA-templated transcription, elongation (GO:0032784)",24,14,14.35,-,0.98,1,1,8,8.61,-,0.93,1,1,10,13.6,-,0.74,0.478,1,0,0.24,-, < 0.01,1,1
protein demethylation (GO:0006482),12,7,7.18,-,0.98,1,1,4,4.3,-,0.93,1,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
embryonic meristem initiation (GO:0090421),12,7,7.18,-,0.98,1,1,7,4.3,+,1.63,0.303,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
inorganic ion import across plasma membrane (GO:0099587),12,7,7.18,-,0.98,1,1,3,4.3,-,0.7,0.772,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
L-ascorbic acid metabolic process (GO:0019852),12,7,7.18,-,0.98,1,1,6,4.3,+,1.39,0.592,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
protein dealkylation (GO:0008214),12,7,7.18,-,0.98,1,1,4,4.3,-,0.93,1,1,9,6.8,+,1.32,0.506,1,0,0.12,-, < 0.01,1,1
regulation of autophagy (GO:0010506),12,7,7.18,-,0.98,1,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
trivalent inorganic anion homeostasis (GO:0072506),12,7,7.18,-,0.98,1,1,5,4.3,+,1.16,0.785,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
regulation of systemic acquired resistance (GO:0010112),12,7,7.18,-,0.98,1,1,3,4.3,-,0.7,0.772,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
peptide transport (GO:0015833),417,243,249.37,-,0.97,0.775,1,144,149.54,-,0.96,0.733,1,228,236.38,-,0.96,0.677,1,4,4.19,-,0.95,1,1
regulation of nitrogen compound metabolic process (GO:0051171),1392,811,832.42,-,0.97,0.545,1,475,499.19,-,0.95,0.331,1,748,789.06,-,0.95,0.216,1,12,13.98,-,0.86,0.67,1
regulation of biosynthetic process (GO:0009889),1253,730,749.3,-,0.97,0.574,1,434,449.35,-,0.97,0.523,1,676,710.27,-,0.95,0.284,1,15,12.59,+,1.19,0.456,1
protein transport (GO:0015031),400,233,239.2,-,0.97,0.77,1,137,143.45,-,0.96,0.655,1,215,226.74,-,0.95,0.551,1,4,4.02,-,1,1,1
amide transport (GO:0042886),431,251,257.74,-,0.97,0.748,1,146,154.56,-,0.94,0.565,1,234,244.32,-,0.96,0.622,1,4,4.33,-,0.92,1,1
regulation of RNA biosynthetic process (GO:2001141),1051,612,628.5,-,0.97,0.597,1,368,376.91,-,0.98,0.706,1,566,595.77,-,0.95,0.318,1,11,10.56,+,1.04,0.871,1
cell development (GO:0048468),189,110,113.02,-,0.97,0.857,1,57,67.78,-,0.84,0.275,1,104,107.14,-,0.97,0.854,1,1,1.9,-,0.53,1,1
"regulation of transcription, DNA-templated (GO:0006355)",1049,610,627.31,-,0.97,0.578,1,366,376.19,-,0.97,0.66,1,564,594.63,-,0.95,0.305,1,11,10.54,+,1.04,0.871,1
regulation of nucleic acid-templated transcription (GO:1903506),1049,610,627.31,-,0.97,0.578,1,366,376.19,-,0.97,0.66,1,564,594.63,-,0.95,0.305,1,11,10.54,+,1.04,0.871,1
regulation of cellular biosynthetic process (GO:0031326),1228,714,734.35,-,0.97,0.538,1,424,440.38,-,0.96,0.5,1,659,696.1,-,0.95,0.237,1,13,12.34,+,1.05,0.765,1
regulation of protein-containing complex assembly (GO:0043254),43,25,25.71,-,0.97,1,1,11,15.42,-,0.71,0.357,1,25,24.37,+,1.03,0.9,1,0,0.43,-, < 0.01,1,1
monovalent inorganic cation homeostasis (GO:0055067),43,25,25.71,-,0.97,1,1,15,15.42,-,0.97,1,1,24,24.37,-,0.98,1,1,0,0.43,-, < 0.01,1,1
cellular response to auxin stimulus (GO:0071365),43,25,25.71,-,0.97,1,1,16,15.42,+,1.04,0.883,1,24,24.37,-,0.98,1,1,1,0.43,+,2.31,0.356,1
establishment of protein localization (GO:0045184),406,236,242.79,-,0.97,0.74,1,138,145.6,-,0.95,0.621,1,218,230.14,-,0.95,0.526,1,4,4.08,-,0.98,1,1
vesicle-mediated transport (GO:0016192),320,186,191.36,-,0.97,0.78,1,105,114.76,-,0.91,0.436,1,164,181.39,-,0.9,0.293,1,4,3.21,+,1.24,0.567,1
cellular localization (GO:0051641),616,358,368.37,-,0.97,0.684,1,207,220.91,-,0.94,0.418,1,326,349.18,-,0.93,0.314,1,4,6.19,-,0.65,0.531,1
cellular response to stress (GO:0033554),756,439,452.09,-,0.97,0.622,1,291,271.11,+,1.07,0.294,1,425,428.54,-,0.99,0.901,1,13,7.59,+,1.71,0.0577,1
regulation of localization (GO:0032879),93,54,55.61,-,0.97,0.932,1,32,33.35,-,0.96,0.919,1,52,52.72,-,0.99,1,1,1,0.93,+,1.07,0.611,1
potassium ion transport (GO:0006813),31,18,18.54,-,0.97,1,1,10,11.12,-,0.9,0.861,1,18,17.57,+,1.02,1,1,0,0.31,-, < 0.01,1,1
transition metal ion homeostasis (GO:0055076),62,36,37.08,-,0.97,0.917,1,22,22.23,-,0.99,1,1,41,35.15,+,1.17,0.472,1,0,0.62,-, < 0.01,1,1
plant epidermis morphogenesis (GO:0090626),62,36,37.08,-,0.97,0.917,1,18,22.23,-,0.81,0.525,1,34,35.15,-,0.97,0.916,1,1,0.62,+,1.61,0.468,1
cellular response to salicylic acid stimulus (GO:0071446),31,18,18.54,-,0.97,1,1,10,11.12,-,0.9,0.861,1,17,17.57,-,0.97,1,1,1,0.31,+,3.21,0.274,1
cellular response to inorganic substance (GO:0071241),31,18,18.54,-,0.97,1,1,12,11.12,+,1.08,0.863,1,17,17.57,-,0.97,1,1,0,0.31,-, < 0.01,1,1
gene silencing by miRNA (GO:0035195),31,18,18.54,-,0.97,1,1,10,11.12,-,0.9,0.861,1,15,17.57,-,0.85,0.649,1,0,0.31,-, < 0.01,1,1
cotyledon development (GO:0048825),31,18,18.54,-,0.97,1,1,8,11.12,-,0.72,0.471,1,18,17.57,+,1.02,1,1,0,0.31,-, < 0.01,1,1
response to virus (GO:0009615),62,36,37.08,-,0.97,0.917,1,18,22.23,-,0.81,0.525,1,36,35.15,+,1.02,0.916,1,1,0.62,+,1.61,0.468,1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",31,18,18.54,-,0.97,1,1,9,11.12,-,0.81,0.72,1,15,17.57,-,0.85,0.649,1,0,0.31,-, < 0.01,1,1
reproductive shoot system development (GO:0090567),224,130,133.95,-,0.97,0.825,1,82,80.33,+,1.02,0.896,1,122,126.98,-,0.96,0.735,1,1,2.25,-,0.44,0.73,1
regulation of cellular macromolecule biosynthetic process (GO:2000112),1153,669,689.5,-,0.97,0.526,1,396,413.49,-,0.96,0.45,1,618,653.59,-,0.95,0.244,1,12,11.58,+,1.04,0.877,1
developmental process involved in reproduction (GO:0003006),919,533,549.57,-,0.97,0.574,1,322,329.57,-,0.98,0.738,1,506,520.94,-,0.97,0.607,1,6,9.23,-,0.65,0.387,1
regulation of signaling (GO:0023051),207,120,123.79,-,0.97,0.818,1,71,74.23,-,0.96,0.784,1,110,117.34,-,0.94,0.597,1,1,2.08,-,0.48,0.726,1
cellular macromolecule localization (GO:0070727),452,262,270.3,-,0.97,0.694,1,147,162.09,-,0.91,0.322,1,240,256.22,-,0.94,0.421,1,3,4.54,-,0.66,0.632,1
regulation of macromolecule biosynthetic process (GO:0010556),1160,672,693.69,-,0.97,0.511,1,398,416,-,0.96,0.434,1,623,657.55,-,0.95,0.267,1,12,11.65,+,1.03,0.877,1
regulation of RNA metabolic process (GO:0051252),1121,649,670.37,-,0.97,0.504,1,391,402.01,-,0.97,0.647,1,598,635.45,-,0.94,0.217,1,11,11.26,-,0.98,1,1
regulation of root meristem growth (GO:0010082),19,11,11.36,-,0.97,1,1,5,6.81,-,0.73,0.648,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),19,11,11.36,-,0.97,1,1,6,6.81,-,0.88,1,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
purine nucleoside monophosphate biosynthetic process (GO:0009127),19,11,11.36,-,0.97,1,1,6,6.81,-,0.88,1,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
branched-chain amino acid catabolic process (GO:0009083),19,11,11.36,-,0.97,1,1,4,6.81,-,0.59,0.477,1,14,10.77,+,1.3,0.472,1,1,0.19,+,5.24,0.181,1
mitochondrial translation (GO:0032543),19,11,11.36,-,0.97,1,1,9,6.81,+,1.32,0.52,1,12,10.77,+,1.11,0.852,1,0,0.19,-, < 0.01,1,1
plant-type primary cell wall biogenesis (GO:0009833),19,11,11.36,-,0.97,1,1,5,6.81,-,0.73,0.648,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
regulation of phosphorelay signal transduction system (GO:0070297),19,11,11.36,-,0.97,1,1,6,6.81,-,0.88,1,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
alcohol biosynthetic process (GO:0046165),38,22,22.72,-,0.97,1,1,17,13.63,+,1.25,0.445,1,22,21.54,+,1.02,1,1,1,0.38,+,2.62,0.323,1
regulation of ethylene-activated signaling pathway (GO:0010104),19,11,11.36,-,0.97,1,1,6,6.81,-,0.88,1,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
peptide biosynthetic process (GO:0043043),311,180,185.98,-,0.97,0.741,1,107,111.53,-,0.96,0.736,1,162,176.29,-,0.92,0.384,1,0,3.12,-, < 0.01,0.0787,1
cellular amide metabolic process (GO:0043603),439,254,262.52,-,0.97,0.69,1,164,157.43,+,1.04,0.639,1,243,248.85,-,0.98,0.777,1,3,4.41,-,0.68,0.804,1
peptide metabolic process (GO:0006518),346,200,206.91,-,0.97,0.72,1,122,124.08,-,0.98,0.915,1,186,196.13,-,0.95,0.583,1,1,3.48,-,0.29,0.268,1
regulation of macromolecule metabolic process (GO:0060255),1578,912,943.65,-,0.97,0.389,1,525,565.9,-,0.93,0.114,1,849,894.5,-,0.95,0.199,1,13,15.85,-,0.82,0.503,1
regulation of signal transduction (GO:0009966),206,119,123.19,-,0.97,0.773,1,70,73.88,-,0.95,0.731,1,110,116.77,-,0.94,0.637,1,1,2.07,-,0.48,0.726,1
flower development (GO:0009908),213,123,127.38,-,0.97,0.777,1,78,76.39,+,1.02,0.893,1,115,120.74,-,0.95,0.686,1,1,2.14,-,0.47,0.727,1
cell division (GO:0051301),149,86,89.1,-,0.97,0.839,1,40,53.43,-,0.75,0.115,1,80,84.46,-,0.95,0.73,1,0,1.5,-, < 0.01,0.409,1
auxin metabolic process (GO:0009850),26,15,15.55,-,0.96,1,1,11,9.32,+,1.18,0.709,1,18,14.74,+,1.22,0.532,1,1,0.26,+,3.83,0.237,1
macromolecule metabolic process (GO:0043170),3427,1977,2049.37,-,0.96,0.141,1,1159,1228.98,-,0.94,0.0445,1,1835,1942.62,-,0.94,0.0222,1,22,34.43,-,0.64,0.0122,1
translation (GO:0006412),307,177,183.59,-,0.96,0.704,1,104,110.1,-,0.94,0.651,1,159,174.02,-,0.91,0.38,1,0,3.08,-, < 0.01,0.0784,1
regulation of nucleobase-containing compound metabolic process (GO:0019219),1171,675,700.27,-,0.96,0.435,1,405,419.94,-,0.96,0.529,1,621,663.79,-,0.94,0.164,1,11,11.76,-,0.94,1,1
regulation of gene expression (GO:0010468),1364,786,815.68,-,0.96,0.397,1,463,489.15,-,0.95,0.287,1,729,773.19,-,0.94,0.178,1,12,13.7,-,0.88,0.773,1
regulation of cell communication (GO:0010646),210,121,125.58,-,0.96,0.775,1,71,75.31,-,0.94,0.733,1,112,119.04,-,0.94,0.64,1,1,2.11,-,0.47,0.727,1
monovalent inorganic cation transport (GO:0015672),92,53,55.02,-,0.96,0.864,1,40,32.99,+,1.21,0.322,1,60,52.15,+,1.15,0.398,1,5,0.92,+,5.41,0.0028,0.998
stomatal complex development (GO:0010374),33,19,19.73,-,0.96,1,1,11,11.83,-,0.93,1,1,18,18.71,-,0.96,1,1,0,0.33,-, < 0.01,1,1
positive regulation of cellular process (GO:0048522),561,323,335.48,-,0.96,0.594,1,178,201.18,-,0.88,0.159,1,302,318.01,-,0.95,0.469,1,1,5.64,-,0.18,0.0465,1
purine ribonucleotide biosynthetic process (GO:0009152),73,42,43.65,-,0.96,0.923,1,27,26.18,+,1.03,0.909,1,38,41.38,-,0.92,0.693,1,1,0.73,+,1.36,0.524,1
establishment of protein localization to membrane (GO:0090150),73,42,43.65,-,0.96,0.923,1,21,26.18,-,0.8,0.413,1,41,41.38,-,0.99,1,1,1,0.73,+,1.36,0.524,1
trichome morphogenesis (GO:0010090),47,27,28.11,-,0.96,0.905,1,13,16.85,-,0.77,0.465,1,26,26.64,-,0.98,1,1,1,0.47,+,2.12,0.382,1
posttranscriptional regulation of gene expression (GO:0010608),150,86,89.7,-,0.96,0.787,1,48,53.79,-,0.89,0.518,1,75,85.03,-,0.88,0.403,1,0,1.51,-, < 0.01,0.409,1
organophosphate biosynthetic process (GO:0090407),236,135,141.13,-,0.96,0.705,1,92,84.63,+,1.09,0.487,1,127,133.78,-,0.95,0.659,1,4,2.37,+,1.69,0.305,1
negative regulation of cellular metabolic process (GO:0031324),306,175,182.99,-,0.96,0.668,1,105,109.74,-,0.96,0.734,1,166,173.46,-,0.96,0.663,1,2,3.07,-,0.65,0.772,1
cellular protein localization (GO:0034613),432,247,258.34,-,0.96,0.6,1,135,154.92,-,0.87,0.16,1,226,244.88,-,0.92,0.343,1,3,4.34,-,0.69,0.803,1
acylglycerol metabolic process (GO:0006639),21,12,12.56,-,0.96,1,1,7,7.53,-,0.93,1,1,11,11.9,-,0.92,1,1,0,0.21,-, < 0.01,1,1
neutral lipid metabolic process (GO:0006638),21,12,12.56,-,0.96,1,1,7,7.53,-,0.93,1,1,11,11.9,-,0.92,1,1,0,0.21,-, < 0.01,1,1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),42,24,25.12,-,0.96,0.899,1,10,15.06,-,0.66,0.273,1,24,23.81,+,1.01,1,1,0,0.42,-, < 0.01,1,1
post-embryonic plant morphogenesis (GO:0090698),126,72,75.35,-,0.96,0.825,1,43,45.19,-,0.95,0.861,1,68,71.42,-,0.95,0.765,1,1,1.27,-,0.79,1,1
multi-multicellular organism process (GO:0044706),168,96,100.47,-,0.96,0.749,1,59,60.25,-,0.98,0.94,1,89,95.23,-,0.93,0.648,1,0,1.69,-, < 0.01,0.419,1
translational elongation (GO:0006414),21,12,12.56,-,0.96,1,1,11,7.53,+,1.46,0.317,1,10,11.9,-,0.84,0.712,1,0,0.21,-, < 0.01,1,1
supramolecular fiber organization (GO:0097435),98,56,58.6,-,0.96,0.803,1,27,35.14,-,0.77,0.262,1,61,55.55,+,1.1,0.563,1,0,0.98,-, < 0.01,1,1
purine nucleotide biosynthetic process (GO:0006164),77,44,46.05,-,0.96,0.851,1,29,27.61,+,1.05,0.825,1,40,43.65,-,0.92,0.7,1,1,0.77,+,1.29,0.543,1
polyol metabolic process (GO:0019751),42,24,25.12,-,0.96,0.899,1,22,15.06,+,1.46,0.156,1,26,23.81,+,1.09,0.707,1,1,0.42,+,2.37,0.35,1
positive regulation of protein polymerization (GO:0032273),21,12,12.56,-,0.96,1,1,4,7.53,-,0.53,0.362,1,12,11.9,+,1.01,1,1,0,0.21,-, < 0.01,1,1
pollination (GO:0009856),168,96,100.47,-,0.96,0.749,1,59,60.25,-,0.98,0.94,1,89,95.23,-,0.93,0.648,1,0,1.69,-, < 0.01,0.419,1
nucleotide transport (GO:0006862),14,8,8.37,-,0.96,1,1,7,5.02,+,1.39,0.463,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
amylopectin biosynthetic process (GO:0010021),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,3,3.97,-,0.76,1,1,1,0.07,+,14.22,0.0769,1
negative regulation of protein-containing complex assembly (GO:0031333),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
apocarotenoid biosynthetic process (GO:0043289),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
triterpenoid metabolic process (GO:0006722),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,7,3.97,+,1.76,0.281,1,0,0.07,-, < 0.01,1,1
positive regulation of posttranscriptional gene silencing (GO:0060148),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of response to oxidative stress (GO:1902882),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
sphingolipid metabolic process (GO:0006665),35,20,20.93,-,0.96,1,1,19,12.55,+,1.51,0.163,1,24,19.84,+,1.21,0.498,1,1,0.35,+,2.84,0.303,1
peptide catabolic process (GO:0043171),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
mRNA transcription (GO:0009299),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
coenzyme A metabolic process (GO:0015936),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,1,0.07,+,14.22,0.0769,1
deoxyribonucleotide biosynthetic process (GO:0009263),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
mitotic spindle organization (GO:0007052),14,8,8.37,-,0.96,1,1,4,5.02,-,0.8,0.796,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
amylopectin metabolic process (GO:2000896),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,3,3.97,-,0.76,1,1,1,0.07,+,14.22,0.0769,1
peroxisome organization (GO:0007031),28,16,16.74,-,0.96,1,1,5,10.04,-,0.5,0.169,1,21,15.87,+,1.32,0.372,1,0,0.28,-, < 0.01,1,1
positive regulation of establishment of protein localization (GO:1904951),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
monovalent inorganic anion homeostasis (GO:0055083),14,8,8.37,-,0.96,1,1,6,5.02,+,1.2,0.8,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
sodium ion homeostasis (GO:0055078),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
protein monoubiquitination (GO:0006513),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of histone methylation (GO:0031062),14,8,8.37,-,0.96,1,1,2,5.02,-,0.4,0.266,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
N-glycan processing (GO:0006491),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
manganese ion transmembrane transport (GO:0071421),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
tertiary alcohol biosynthetic process (GO:1902645),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
production of siRNA involved in chromatin silencing by small RNA (GO:0070919),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
positive regulation of small molecule metabolic process (GO:0062013),14,8,8.37,-,0.96,1,1,5,5.02,-,1,1,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
fatty acid elongation (GO:0030497),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
mRNA cleavage (GO:0006379),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of intracellular signal transduction (GO:1902533),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
intraspecies interaction between organisms (GO:0051703),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
positive regulation of response to DNA damage stimulus (GO:2001022),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular response to molecule of bacterial origin (GO:0071219),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
rRNA 5'-end processing (GO:0000967),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
defense response to virus (GO:0051607),35,20,20.93,-,0.96,1,1,9,12.55,-,0.72,0.493,1,16,19.84,-,0.81,0.56,1,0,0.35,-, < 0.01,1,1
positive regulation of intracellular protein transport (GO:0090316),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of mitotic sister chromatid separation (GO:1901970),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
purine nucleobase metabolic process (GO:0006144),14,8,8.37,-,0.96,1,1,6,5.02,+,1.2,0.8,1,8,7.94,+,1.01,1,1,0,0.14,-, < 0.01,1,1
positive regulation of reactive oxygen species metabolic process (GO:2000379),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cell population proliferation (GO:0008283),7,4,4.19,-,0.96,1,1,5,2.51,+,1.99,0.322,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
sulfate transport (GO:0008272),7,4,4.19,-,0.96,1,1,5,2.51,+,1.99,0.322,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
negative regulation of protein polymerization (GO:0032272),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of protein polymerization (GO:0032271),28,16,16.74,-,0.96,1,1,6,10.04,-,0.6,0.33,1,16,15.87,+,1.01,1,1,0,0.28,-, < 0.01,1,1
actin filament depolymerization (GO:0030042),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
actin polymerization or depolymerization (GO:0008154),14,8,8.37,-,0.96,1,1,4,5.02,-,0.8,0.796,1,11,7.94,+,1.39,0.412,1,0,0.14,-, < 0.01,1,1
guard mother cell differentiation (GO:0010444),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
regulation of oxidoreductase activity (GO:0051341),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
P-body assembly (GO:0033962),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
drought recovery (GO:0009819),7,4,4.19,-,0.96,1,1,4,2.51,+,1.59,0.496,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
"defense response to bacterium, incompatible interaction (GO:0009816)",28,16,16.74,-,0.96,1,1,16,10.04,+,1.59,0.169,1,16,15.87,+,1.01,1,1,0,0.28,-, < 0.01,1,1
lipid droplet organization (GO:0034389),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
stomatal complex patterning (GO:0010375),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of mitotic nuclear division (GO:0045840),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of protein transport (GO:0051222),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
developmental vegetative growth (GO:0080186),7,4,4.19,-,0.96,1,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
pyrimidine-containing compound catabolic process (GO:0072529),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,6,3.97,+,1.51,0.565,1,0,0.07,-, < 0.01,1,1
divalent inorganic anion homeostasis (GO:0072505),14,8,8.37,-,0.96,1,1,6,5.02,+,1.2,0.8,1,10,7.94,+,1.26,0.671,1,1,0.14,+,7.11,0.139,1
response to cytokinin (GO:0009735),56,32,33.49,-,0.96,0.912,1,14,20.08,-,0.7,0.277,1,28,31.74,-,0.88,0.65,1,0,0.56,-, < 0.01,1,1
abscisic acid biosynthetic process (GO:0009688),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
positive regulation of chromosome separation (GO:1905820),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
response to X-ray (GO:0010165),7,4,4.19,-,0.96,1,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
proton-transporting ATP synthase complex assembly (GO:0043461),7,4,4.19,-,0.96,1,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
sulfur compound transport (GO:0072348),14,8,8.37,-,0.96,1,1,7,5.02,+,1.39,0.463,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
oxylipin biosynthetic process (GO:0031408),14,8,8.37,-,0.96,1,1,6,5.02,+,1.2,0.8,1,10,7.94,+,1.26,0.671,1,1,0.14,+,7.11,0.139,1
intracellular protein transport (GO:0006886),361,206,215.88,-,0.95,0.598,1,117,129.46,-,0.9,0.344,1,191,204.64,-,0.93,0.445,1,3,3.63,-,0.83,1,1
positive regulation of cellular metabolic process (GO:0031325),398,227,238.01,-,0.95,0.585,1,129,142.73,-,0.9,0.34,1,206,225.61,-,0.91,0.302,1,1,4,-,0.25,0.192,1
positive regulation of nitrogen compound metabolic process (GO:0051173),360,205,215.28,-,0.95,0.597,1,116,129.1,-,0.9,0.343,1,184,204.07,-,0.9,0.258,1,0,3.62,-, < 0.01,0.0533,1
cellular component organization (GO:0016043),1596,908,954.42,-,0.95,0.201,1,527,572.35,-,0.92,0.0829,1,840,904.7,-,0.93,0.0652,1,8,16.03,-,0.5,0.0308,1
second-messenger-mediated signaling (GO:0019932),37,21,22.13,-,0.95,0.893,1,14,13.27,+,1.06,0.874,1,20,20.97,-,0.95,1,1,0,0.37,-, < 0.01,1,1
ERAD pathway (GO:0036503),37,21,22.13,-,0.95,0.893,1,16,13.27,+,1.21,0.534,1,20,20.97,-,0.95,1,1,1,0.37,+,2.69,0.316,1
ubiquitin-dependent ERAD pathway (GO:0030433),30,17,17.94,-,0.95,1,1,11,10.76,+,1.02,1,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
auxin-activated signaling pathway (GO:0009734),30,17,17.94,-,0.95,1,1,12,10.76,+,1.12,0.728,1,15,17.01,-,0.88,0.758,1,1,0.3,+,3.32,0.267,1
"photoperiodism, flowering (GO:0048573)",53,30,31.69,-,0.95,0.91,1,18,19.01,-,0.95,0.894,1,32,30.04,+,1.07,0.821,1,0,0.53,-, < 0.01,1,1
response to zinc ion (GO:0010043),23,13,13.75,-,0.95,1,1,5,8.25,-,0.61,0.393,1,14,13.04,+,1.07,0.865,1,0,0.23,-, < 0.01,1,1
regulation of programmed cell death (GO:0043067),46,26,27.51,-,0.95,0.903,1,14,16.5,-,0.85,0.662,1,31,26.08,+,1.19,0.477,1,0,0.46,-, < 0.01,1,1
establishment of protein localization to organelle (GO:0072594),184,104,110.03,-,0.95,0.668,1,55,65.99,-,0.83,0.268,1,96,104.3,-,0.92,0.532,1,1,1.85,-,0.54,1,1
detection of abiotic stimulus (GO:0009582),23,13,13.75,-,0.95,1,1,6,8.25,-,0.73,0.673,1,13,13.04,-,1,1,1,0,0.23,-, < 0.01,1,1
detection of external stimulus (GO:0009581),23,13,13.75,-,0.95,1,1,6,8.25,-,0.73,0.673,1,13,13.04,-,1,1,1,0,0.23,-, < 0.01,1,1
cell differentiation (GO:0030154),338,191,202.13,-,0.94,0.554,1,109,121.21,-,0.9,0.355,1,183,191.6,-,0.96,0.644,1,3,3.4,-,0.88,1,1
RNA biosynthetic process (GO:0032774),156,88,93.29,-,0.94,0.69,1,46,55.94,-,0.82,0.261,1,75,88.43,-,0.85,0.27,1,1,1.57,-,0.64,1,1
dephosphorylation (GO:0016311),126,71,75.35,-,0.94,0.712,1,46,45.19,+,1.02,0.931,1,71,71.42,-,0.99,1,1,2,1.27,+,1.58,0.365,1
cellular response to organic cyclic compound (GO:0071407),71,40,42.46,-,0.94,0.844,1,26,25.46,+,1.02,0.908,1,39,40.25,-,0.97,0.921,1,1,0.71,+,1.4,0.514,1
positive regulation of macromolecule metabolic process (GO:0010604),380,214,227.24,-,0.94,0.491,1,118,136.27,-,0.87,0.18,1,186,215.41,-,0.86,0.101,1,1,3.82,-,0.26,0.189,1
establishment of localization in cell (GO:0051649),515,290,307.97,-,0.94,0.414,1,171,184.69,-,0.93,0.401,1,267,291.93,-,0.91,0.239,1,4,5.17,-,0.77,0.821,1
"positive regulation of transcription, DNA-templated (GO:0045893)",240,135,143.52,-,0.94,0.59,1,75,86.07,-,0.87,0.333,1,117,136.05,-,0.86,0.183,1,0,2.41,-, < 0.01,0.18,1
negative regulation of reproductive process (GO:2000242),48,27,28.7,-,0.94,0.905,1,16,17.21,-,0.93,0.888,1,27,27.21,-,0.99,1,1,0,0.48,-, < 0.01,1,1
Golgi to vacuole transport (GO:0006896),16,9,9.57,-,0.94,1,1,2,5.74,-,0.35,0.184,1,5,9.07,-,0.55,0.266,1,0,0.16,-, < 0.01,1,1
positive regulation of seed germination (GO:0010030),16,9,9.57,-,0.94,1,1,7,5.74,+,1.22,0.64,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
regulation of mitotic nuclear division (GO:0007088),16,9,9.57,-,0.94,1,1,3,5.74,-,0.52,0.435,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
regulation of DNA endoreduplication (GO:0032875),16,9,9.57,-,0.94,1,1,5,5.74,-,0.87,1,1,7,9.07,-,0.77,0.668,1,1,0.16,+,6.22,0.156,1
response to endoplasmic reticulum stress (GO:0034976),64,36,38.27,-,0.94,0.836,1,33,22.95,+,1.44,0.105,1,37,36.28,+,1.02,0.918,1,4,0.64,+,6.22,0.00465,1
regulation of cell shape (GO:0008360),16,9,9.57,-,0.94,1,1,3,5.74,-,0.52,0.435,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
oxidative phosphorylation (GO:0006119),32,18,19.14,-,0.94,0.885,1,12,11.48,+,1.05,0.865,1,20,18.14,+,1.1,0.773,1,0,0.32,-, < 0.01,1,1
negative gravitropism (GO:0009959),16,9,9.57,-,0.94,1,1,6,5.74,+,1.05,1,1,6,9.07,-,0.66,0.507,1,0,0.16,-, < 0.01,1,1
modulation by symbiont of host process (GO:0044003),16,9,9.57,-,0.94,1,1,5,5.74,-,0.87,1,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
phototropism (GO:0009638),16,9,9.57,-,0.94,1,1,5,5.74,-,0.87,1,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
polyol catabolic process (GO:0046174),16,9,9.57,-,0.94,1,1,7,5.74,+,1.22,0.64,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
vesicle budding from membrane (GO:0006900),32,18,19.14,-,0.94,0.885,1,13,11.48,+,1.13,0.735,1,21,18.14,+,1.16,0.668,1,1,0.32,+,3.11,0.281,1
cellular component organization or biogenesis (GO:0071840),1850,1038,1106.31,-,0.94,0.0779,1,618,663.44,-,0.93,0.104,1,940,1048.68,-,0.9,0.00317,0.549,9,18.59,-,0.48,0.0156,1
mitochondrial RNA metabolic process (GO:0000959),41,23,24.52,-,0.94,0.897,1,13,14.7,-,0.88,0.76,1,24,23.24,+,1.03,0.898,1,0,0.41,-, < 0.01,1,1
lipid modification (GO:0030258),82,46,49.04,-,0.94,0.784,1,25,29.41,-,0.85,0.511,1,55,46.48,+,1.18,0.328,1,2,0.82,+,2.43,0.203,1
intracellular transport (GO:0046907),489,274,292.43,-,0.94,0.402,1,163,175.36,-,0.93,0.441,1,252,277.19,-,0.91,0.213,1,4,4.91,-,0.81,1,1
positive regulation of RNA metabolic process (GO:0051254),257,144,153.69,-,0.94,0.567,1,83,92.16,-,0.9,0.42,1,128,145.68,-,0.88,0.239,1,0,2.58,-, < 0.01,0.188,1
regulation of cytoskeleton organization (GO:0051493),50,28,29.9,-,0.94,0.816,1,8,17.93,-,0.45,0.0353,1,29,28.34,+,1.02,0.907,1,0,0.5,-, < 0.01,1,1
organic cyclic compound metabolic process (GO:1901360),1807,1011,1080.6,-,0.94,0.0683,1,623,648.02,-,0.96,0.372,1,927,1024.31,-,0.91,0.00793,0.708,14,18.15,-,0.77,0.372,1
negative regulation of biosynthetic process (GO:0009890),236,132,141.13,-,0.94,0.55,1,76,84.63,-,0.9,0.437,1,126,133.78,-,0.94,0.619,1,1,2.37,-,0.42,0.734,1
reproduction (GO:0000003),1089,609,651.23,-,0.94,0.173,1,367,390.53,-,0.94,0.291,1,583,617.31,-,0.94,0.253,1,7,10.94,-,0.64,0.265,1
respiratory electron transport chain (GO:0022904),34,19,20.33,-,0.93,0.888,1,11,12.19,-,0.9,0.866,1,22,19.27,+,1.14,0.677,1,0,0.34,-, < 0.01,1,1
cellular response to gibberellin stimulus (GO:0071370),34,19,20.33,-,0.93,0.888,1,14,12.19,+,1.15,0.626,1,20,19.27,+,1.04,0.888,1,0,0.34,-, < 0.01,1,1
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),272,152,162.66,-,0.93,0.51,1,88,97.54,-,0.9,0.432,1,134,154.18,-,0.87,0.192,1,0,2.73,-, < 0.01,0.118,1
regulation of protein modification process (GO:0031399),120,67,71.76,-,0.93,0.704,1,28,43.03,-,0.65,0.0392,1,64,68.02,-,0.94,0.758,1,0,1.21,-, < 0.01,0.635,1
protein processing (GO:0016485),43,24,25.71,-,0.93,0.899,1,11,15.42,-,0.71,0.357,1,27,24.37,+,1.11,0.709,1,0,0.43,-, < 0.01,1,1
anther development (GO:0048653),43,24,25.71,-,0.93,0.899,1,13,15.42,-,0.84,0.651,1,25,24.37,+,1.03,0.9,1,0,0.43,-, < 0.01,1,1
peptidyl-lysine modification (GO:0018205),95,53,56.81,-,0.93,0.733,1,33,34.07,-,0.97,0.92,1,53,53.85,-,0.98,1,1,0,0.95,-, < 0.01,1,1
positive regulation of RNA biosynthetic process (GO:1902680),242,135,144.72,-,0.93,0.555,1,75,86.79,-,0.86,0.275,1,119,137.18,-,0.87,0.204,1,0,2.43,-, < 0.01,0.181,1
positive regulation of nucleic acid-templated transcription (GO:1903508),242,135,144.72,-,0.93,0.555,1,75,86.79,-,0.86,0.275,1,119,137.18,-,0.87,0.204,1,0,2.43,-, < 0.01,0.181,1
protein-containing complex subunit organization (GO:0043933),427,238,255.35,-,0.93,0.392,1,140,153.13,-,0.91,0.358,1,205,242.05,-,0.85,0.0481,1,0,4.29,-, < 0.01,0.0232,1
cellular component assembly (GO:0022607),567,316,339.07,-,0.93,0.32,1,180,203.34,-,0.89,0.149,1,274,321.41,-,0.85,0.0278,1,0,5.7,-, < 0.01,0.00725,1
reproductive process (GO:0022414),1082,603,647.04,-,0.93,0.149,1,364,388.02,-,0.94,0.276,1,578,613.34,-,0.94,0.241,1,6,10.87,-,0.55,0.149,1
regulation of developmental process (GO:0050793),454,253,271.49,-,0.93,0.384,1,144,162.81,-,0.88,0.202,1,247,257.35,-,0.96,0.631,1,2,4.56,-,0.44,0.332,1
negative regulation of cellular process (GO:0048523),481,268,287.64,-,0.93,0.356,1,151,172.49,-,0.88,0.154,1,260,272.66,-,0.95,0.559,1,3,4.83,-,0.62,0.636,1
vesicle organization (GO:0016050),70,39,41.86,-,0.93,0.767,1,25,25.1,-,1,1,1,37,39.68,-,0.93,0.763,1,1,0.7,+,1.42,0.509,1
positive regulation of metabolic process (GO:0009893),438,244,261.93,-,0.93,0.376,1,139,157.07,-,0.88,0.212,1,219,248.28,-,0.88,0.127,1,1,4.4,-,0.23,0.136,1
regulation of cell cycle (GO:0051726),149,83,89.1,-,0.93,0.633,1,28,53.43,-,0.52,0.00106,0.208,79,84.46,-,0.94,0.678,1,3,1.5,+,2,0.193,1
negative regulation of nitrogen compound metabolic process (GO:0051172),264,147,157.87,-,0.93,0.504,1,89,94.67,-,0.94,0.669,1,141,149.65,-,0.94,0.601,1,1,2.65,-,0.38,0.526,1
negative regulation of biological process (GO:0048519),732,407,437.74,-,0.93,0.231,1,230,262.51,-,0.88,0.0769,1,389,414.94,-,0.94,0.306,1,3,7.35,-,0.41,0.123,1
protein-containing complex assembly (GO:0065003),376,209,224.85,-,0.93,0.41,1,123,134.84,-,0.91,0.382,1,175,213.14,-,0.82,0.0309,1,0,3.78,-, < 0.01,0.0561,1
negative regulation of supramolecular fiber organization (GO:1902904),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
negative regulation of transcription by RNA polymerase II (GO:0000122),18,10,10.76,-,0.93,1,1,6,6.46,-,0.93,1,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
response to molecule of fungal origin (GO:0002238),9,5,5.38,-,0.93,1,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
fatty acid transport (GO:0015908),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
guanosine-containing compound biosynthetic process (GO:1901070),9,5,5.38,-,0.93,1,1,4,3.23,+,1.24,0.754,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
valine catabolic process (GO:0006574),9,5,5.38,-,0.93,1,1,1,3.23,-,0.31,0.472,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
N-terminal protein amino acid acetylation (GO:0006474),9,5,5.38,-,0.93,1,1,1,3.23,-,0.31,0.472,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
regulation of translational initiation (GO:0006446),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
regulation of cell growth (GO:0001558),63,35,37.67,-,0.93,0.755,1,22,22.59,-,0.97,1,1,31,35.71,-,0.87,0.591,1,1,0.63,+,1.58,0.473,1
diterpenoid metabolic process (GO:0016101),18,10,10.76,-,0.93,1,1,7,6.46,+,1.08,0.823,1,13,10.2,+,1.27,0.575,1,0,0.18,-, < 0.01,1,1
organ growth (GO:0035265),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,2,5.1,-,0.39,0.347,1,0,0.09,-, < 0.01,1,1
protein insertion into mitochondrial inner membrane (GO:0045039),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
regulation of mitotic sister chromatid segregation (GO:0033047),9,5,5.38,-,0.93,1,1,1,3.23,-,0.31,0.472,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
regulation of sister chromatid segregation (GO:0033045),18,10,10.76,-,0.93,1,1,3,6.46,-,0.46,0.32,1,8,10.2,-,0.78,0.685,1,0,0.18,-, < 0.01,1,1
CDP-diacylglycerol biosynthetic process (GO:0016024),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
intracellular lipid transport (GO:0032365),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
protein import into mitochondrial matrix (GO:0030150),18,10,10.76,-,0.93,1,1,9,6.46,+,1.39,0.39,1,8,10.2,-,0.78,0.685,1,0,0.18,-, < 0.01,1,1
negative regulation of cytoskeleton organization (GO:0051494),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
glucuronoxylan biosynthetic process (GO:0010417),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
glucuronoxylan metabolic process (GO:0010413),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
cell wall hydroxyproline-rich glycoprotein metabolic process (GO:0010404),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
auxin biosynthetic process (GO:0009851),9,5,5.38,-,0.93,1,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,1,0.09,+,11.06,0.0952,1
glycosyl compound catabolic process (GO:1901658),9,5,5.38,-,0.93,1,1,7,3.23,+,2.17,0.152,1,8,5.1,+,1.57,0.449,1,2,0.09,+,22.12,0.00509,1
CDP-diacylglycerol metabolic process (GO:0046341),9,5,5.38,-,0.93,1,1,2,3.23,-,0.62,0.739,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
diol biosynthetic process (GO:0034312),9,5,5.38,-,0.93,1,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,1,0.09,+,11.06,0.0952,1
diol metabolic process (GO:0034311),9,5,5.38,-,0.93,1,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,1,0.09,+,11.06,0.0952,1
cell wall proteoglycan metabolic process (GO:0010384),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
positive regulation of isoprenoid metabolic process (GO:0045828),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
photosynthetic electron transport in photosystem II (GO:0009772),9,5,5.38,-,0.93,1,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
cytokinin biosynthetic process (GO:0009691),9,5,5.38,-,0.93,1,1,4,3.23,+,1.24,0.754,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
regulation of cytokinin-activated signaling pathway (GO:0080036),9,5,5.38,-,0.93,1,1,0,3.23,-, < 0.01,0.124,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
nitrogen cycle metabolic process (GO:0071941),9,5,5.38,-,0.93,1,1,4,3.23,+,1.24,0.754,1,4,5.1,-,0.78,0.78,1,1,0.09,+,11.06,0.0952,1
regulation of secondary metabolic process (GO:0043455),36,20,21.53,-,0.93,0.89,1,13,12.91,+,1.01,1,1,19,20.41,-,0.93,0.889,1,1,0.36,+,2.77,0.31,1
detection of light stimulus (GO:0009583),18,10,10.76,-,0.93,1,1,4,6.46,-,0.62,0.475,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
embryo sac development (GO:0009553),99,55,59.2,-,0.93,0.677,1,41,35.5,+,1.15,0.442,1,41,56.12,-,0.73,0.0938,1,1,0.99,+,1.01,1,1
"regulation of development, heterochronic (GO:0040034)",27,15,16.15,-,0.93,0.874,1,8,9.68,-,0.83,0.706,1,14,15.31,-,0.91,0.872,1,0,0.27,-, < 0.01,1,1
negative regulation of macromolecule biosynthetic process (GO:0010558),216,120,129.17,-,0.93,0.532,1,71,77.46,-,0.92,0.544,1,114,122.44,-,0.93,0.564,1,1,2.17,-,0.46,0.728,1
peptidyl-lysine methylation (GO:0018022),45,25,26.91,-,0.93,0.806,1,18,16.14,+,1.12,0.67,1,25,25.51,-,0.98,1,1,0,0.45,-, < 0.01,1,1
positive regulation of cell cycle (GO:0045787),27,15,16.15,-,0.93,0.874,1,8,9.68,-,0.83,0.706,1,14,15.31,-,0.91,0.872,1,1,0.27,+,3.69,0.244,1
response to far red light (GO:0010218),27,15,16.15,-,0.93,0.874,1,7,9.68,-,0.72,0.56,1,13,15.31,-,0.85,0.743,1,0,0.27,-, < 0.01,1,1
positive regulation of gene expression (GO:0010628),290,161,173.42,-,0.93,0.461,1,90,104,-,0.87,0.239,1,139,164.39,-,0.85,0.104,1,0,2.91,-, < 0.01,0.123,1
cellular aromatic compound metabolic process (GO:0006725),1741,966,1041.13,-,0.93,0.0451,1,593,624.35,-,0.95,0.256,1,886,986.9,-,0.9,0.00497,0.631,13,17.49,-,0.74,0.3,1
cellular developmental process (GO:0048869),393,218,235.02,-,0.93,0.373,1,128,140.94,-,0.91,0.364,1,211,222.77,-,0.95,0.547,1,3,3.95,-,0.76,1,1
negative regulation of RNA metabolic process (GO:0051253),184,102,110.03,-,0.93,0.58,1,63,65.99,-,0.95,0.827,1,100,104.3,-,0.96,0.756,1,1,1.85,-,0.54,1,1
ncRNA metabolic process (GO:0034660),341,189,203.92,-,0.93,0.413,1,142,122.29,+,1.16,0.129,1,146,193.3,-,0.76,0.00414,0.59,0,3.43,-, < 0.01,0.0522,1
purine-containing compound biosynthetic process (GO:0072522),83,46,49.63,-,0.93,0.716,1,32,29.77,+,1.08,0.75,1,43,47.05,-,0.91,0.71,1,1,0.83,+,1.2,0.569,1
actin cytoskeleton organization (GO:0030036),65,36,38.87,-,0.93,0.758,1,19,23.31,-,0.82,0.535,1,40,36.85,+,1.09,0.685,1,0,0.65,-, < 0.01,1,1
negative regulation of cellular biosynthetic process (GO:0031327),233,129,139.34,-,0.93,0.511,1,76,83.56,-,0.91,0.515,1,123,132.08,-,0.93,0.541,1,1,2.34,-,0.43,0.733,1
organelle organization (GO:0006996),1163,643,695.48,-,0.92,0.0979,1,373,417.07,-,0.89,0.0524,1,602,659.25,-,0.91,0.0584,1,5,11.68,-,0.43,0.0427,1
regulation of shoot system development (GO:0048831),114,63,68.17,-,0.92,0.64,1,34,40.88,-,0.83,0.399,1,61,64.62,-,0.94,0.752,1,0,1.15,-, < 0.01,0.632,1
nucleic acid-templated transcription (GO:0097659),152,84,90.9,-,0.92,0.589,1,44,54.51,-,0.81,0.222,1,72,86.16,-,0.84,0.234,1,1,1.53,-,0.65,1,1
"transcription, DNA-templated (GO:0006351)",152,84,90.9,-,0.92,0.589,1,44,54.51,-,0.81,0.222,1,72,86.16,-,0.84,0.234,1,1,1.53,-,0.65,1,1
positive regulation of macromolecule biosynthetic process (GO:0010557),268,148,160.27,-,0.92,0.443,1,82,96.11,-,0.85,0.221,1,131,151.92,-,0.86,0.171,1,1,2.69,-,0.37,0.528,1
leaf morphogenesis (GO:0009965),67,37,40.07,-,0.92,0.761,1,18,24.03,-,0.75,0.324,1,31,37.98,-,0.82,0.399,1,0,0.67,-, < 0.01,1,1
metallo-sulfur cluster assembly (GO:0031163),29,16,17.34,-,0.92,0.878,1,14,10.4,+,1.35,0.386,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
iron-sulfur cluster assembly (GO:0016226),29,16,17.34,-,0.92,0.878,1,14,10.4,+,1.35,0.386,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
cellular response to steroid hormone stimulus (GO:0071383),29,16,17.34,-,0.92,0.878,1,13,10.4,+,1.25,0.487,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
maintenance of location in cell (GO:0051651),29,16,17.34,-,0.92,0.878,1,6,10.4,-,0.58,0.253,1,17,16.44,+,1.03,1,1,0,0.29,-, < 0.01,1,1
response to steroid hormone (GO:0048545),29,16,17.34,-,0.92,0.878,1,13,10.4,+,1.25,0.487,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
brassinosteroid mediated signaling pathway (GO:0009742),29,16,17.34,-,0.92,0.878,1,13,10.4,+,1.25,0.487,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
androecium development (GO:0048466),58,32,34.68,-,0.92,0.745,1,18,20.8,-,0.87,0.696,1,32,32.88,-,0.97,1,1,0,0.58,-, < 0.01,1,1
stamen development (GO:0048443),58,32,34.68,-,0.92,0.745,1,18,20.8,-,0.87,0.696,1,32,32.88,-,0.97,1,1,0,0.58,-, < 0.01,1,1
floral organ development (GO:0048437),145,80,86.71,-,0.92,0.58,1,56,52,+,1.08,0.63,1,76,82.19,-,0.92,0.622,1,1,1.46,-,0.69,1,1
steroid hormone mediated signaling pathway (GO:0043401),29,16,17.34,-,0.92,0.878,1,13,10.4,+,1.25,0.487,1,16,16.44,-,0.97,1,1,0,0.29,-, < 0.01,1,1
regulation of flower development (GO:0009909),107,59,63.99,-,0.92,0.63,1,32,38.37,-,0.83,0.386,1,57,60.65,-,0.94,0.745,1,0,1.07,-, < 0.01,0.63,1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),214,118,127.97,-,0.92,0.493,1,69,76.74,-,0.9,0.455,1,112,121.31,-,0.92,0.523,1,1,2.15,-,0.47,0.727,1
regulation of abscisic acid-activated signaling pathway (GO:0009787),78,43,46.64,-,0.92,0.707,1,24,27.97,-,0.86,0.574,1,42,44.21,-,0.95,0.849,1,1,0.78,+,1.28,0.547,1
regulation of cellular response to alcohol (GO:1905957),78,43,46.64,-,0.92,0.707,1,24,27.97,-,0.86,0.574,1,42,44.21,-,0.95,0.849,1,1,0.78,+,1.28,0.547,1
regulation of response to alcohol (GO:1901419),78,43,46.64,-,0.92,0.707,1,24,27.97,-,0.86,0.574,1,42,44.21,-,0.95,0.849,1,1,0.78,+,1.28,0.547,1
cellular component biogenesis (GO:0044085),877,483,524.45,-,0.92,0.139,1,296,314.51,-,0.94,0.373,1,411,497.13,-,0.83,0.000972,0.292,1,8.81,-,0.11,0.00225,1
cell morphogenesis involved in differentiation (GO:0000904),138,76,82.52,-,0.92,0.619,1,39,49.49,-,0.79,0.199,1,73,78.23,-,0.93,0.666,1,1,1.39,-,0.72,1,1
trichome branching (GO:0010091),20,11,11.96,-,0.92,1,1,5,7.17,-,0.7,0.65,1,9,11.34,-,0.79,0.7,1,0,0.2,-, < 0.01,1,1
purine ribonucleoside monophosphate metabolic process (GO:0009167),20,11,11.96,-,0.92,1,1,6,7.17,-,0.84,0.826,1,9,11.34,-,0.79,0.7,1,0,0.2,-, < 0.01,1,1
purine nucleoside monophosphate metabolic process (GO:0009126),20,11,11.96,-,0.92,1,1,6,7.17,-,0.84,0.826,1,9,11.34,-,0.79,0.7,1,0,0.2,-, < 0.01,1,1
serine family amino acid metabolic process (GO:0009069),40,22,23.92,-,0.92,0.794,1,17,14.34,+,1.19,0.549,1,23,22.67,+,1.01,1,1,1,0.4,+,2.49,0.337,1
root hair elongation (GO:0048767),40,22,23.92,-,0.92,0.794,1,7,14.34,-,0.49,0.0957,1,23,22.67,+,1.01,1,1,0,0.4,-, < 0.01,1,1
jasmonic acid biosynthetic process (GO:0009695),20,11,11.96,-,0.92,1,1,7,7.17,-,0.98,1,1,14,11.34,+,1.23,0.593,1,1,0.2,+,4.98,0.189,1
response to red light (GO:0010114),40,22,23.92,-,0.92,0.794,1,14,14.34,-,0.98,1,1,23,22.67,+,1.01,1,1,0,0.4,-, < 0.01,1,1
double fertilization forming a zygote and endosperm (GO:0009567),20,11,11.96,-,0.92,1,1,5,7.17,-,0.7,0.65,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
fertilization (GO:0009566),20,11,11.96,-,0.92,1,1,5,7.17,-,0.7,0.65,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
protein localization to organelle (GO:0033365),220,121,131.56,-,0.92,0.464,1,63,78.9,-,0.8,0.118,1,113,124.71,-,0.91,0.421,1,1,2.21,-,0.45,0.729,1
meristem maintenance (GO:0010073),91,50,54.42,-,0.92,0.663,1,28,32.63,-,0.86,0.532,1,44,51.58,-,0.85,0.419,1,1,0.91,+,1.09,0.603,1
actin filament-based process (GO:0030029),71,39,42.46,-,0.92,0.694,1,20,25.46,-,0.79,0.404,1,43,40.25,+,1.07,0.77,1,0,0.71,-, < 0.01,1,1
gibberellin mediated signaling pathway (GO:0010476),31,17,18.54,-,0.92,0.882,1,12,11.12,+,1.08,0.863,1,18,17.57,+,1.02,1,1,0,0.31,-, < 0.01,1,1
negative regulation of RNA biosynthetic process (GO:1902679),177,97,105.85,-,0.92,0.53,1,59,63.48,-,0.93,0.656,1,96,100.33,-,0.96,0.752,1,1,1.78,-,0.56,1,1
negative regulation of nucleic acid-templated transcription (GO:1903507),177,97,105.85,-,0.92,0.53,1,59,63.48,-,0.93,0.656,1,96,100.33,-,0.96,0.752,1,1,1.78,-,0.56,1,1
multicellular organism reproduction (GO:0032504),115,63,68.77,-,0.92,0.641,1,36,41.24,-,0.87,0.517,1,66,65.19,+,1.01,0.938,1,1,1.16,-,0.87,1,1
macromolecule biosynthetic process (GO:0009059),853,467,510.1,-,0.92,0.119,1,242,305.9,-,0.79,0.000763,0.189,413,483.53,-,0.85,0.00654,0.746,3,8.57,-,0.35,0.0484,1
regulation of growth (GO:0040008),137,75,81.93,-,0.92,0.569,1,46,49.13,-,0.94,0.737,1,74,77.66,-,0.95,0.774,1,2,1.38,+,1.45,0.403,1
regulation of mRNA metabolic process (GO:1903311),53,29,31.69,-,0.91,0.733,1,17,19.01,-,0.89,0.786,1,25,30.04,-,0.83,0.481,1,0,0.53,-, < 0.01,1,1
positive regulation of cellular biosynthetic process (GO:0031328),291,159,174.02,-,0.91,0.375,1,93,104.36,-,0.89,0.349,1,142,164.96,-,0.86,0.143,1,1,2.92,-,0.34,0.375,1
negative regulation of metabolic process (GO:0009892),447,244,267.31,-,0.91,0.247,1,142,160.3,-,0.89,0.216,1,229,253.38,-,0.9,0.207,1,2,4.49,-,0.45,0.331,1
multi-organism process (GO:0051704),286,156,171.03,-,0.91,0.371,1,91,102.56,-,0.89,0.345,1,148,162.12,-,0.91,0.391,1,0,2.87,-, < 0.01,0.121,1
negative regulation of flower development (GO:0009910),33,18,19.73,-,0.91,0.885,1,11,11.83,-,0.93,1,1,16,18.71,-,0.86,0.658,1,0,0.33,-, < 0.01,1,1
negative regulation of developmental process (GO:0051093),99,54,59.2,-,0.91,0.616,1,35,35.5,-,0.99,1,1,57,56.12,+,1.02,0.933,1,0,0.99,-, < 0.01,0.629,1
response to carbon dioxide (GO:0010037),11,6,6.58,-,0.91,1,1,6,3.94,+,1.52,0.413,1,9,6.24,+,1.44,0.486,1,0,0.11,-, < 0.01,1,1
histone lysine demethylation (GO:0070076),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
histone demethylation (GO:0016577),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
flavin-containing compound biosynthetic process (GO:0042727),11,6,6.58,-,0.91,1,1,7,3.94,+,1.77,0.282,1,7,6.24,+,1.12,0.81,1,1,0.11,+,9.05,0.113,1
circadian regulation of gene expression (GO:0032922),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
ribosomal subunit export from nucleus (GO:0000054),11,6,6.58,-,0.91,1,1,8,3.94,+,2.03,0.124,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
anaphase-promoting complex-dependent catabolic process (GO:0031145),11,6,6.58,-,0.91,1,1,2,3.94,-,0.51,0.534,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
rRNA 3'-end processing (GO:0031125),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
polyamine biosynthetic process (GO:0006596),11,6,6.58,-,0.91,1,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
cellular metabolic compound salvage (GO:0043094),55,30,32.89,-,0.91,0.737,1,17,19.72,-,0.86,0.688,1,39,31.18,+,1.25,0.284,1,2,0.55,+,3.62,0.11,1
negative regulation of chromosome organization (GO:2001251),11,6,6.58,-,0.91,1,1,1,3.94,-,0.25,0.203,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
primary miRNA processing (GO:0031053),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),11,6,6.58,-,0.91,1,1,8,3.94,+,2.03,0.124,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
signal peptide processing (GO:0006465),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
lysine biosynthetic process via diaminopimelate (GO:0009089),11,6,6.58,-,0.91,1,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
actin filament bundle organization (GO:0061572),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
production of miRNAs involved in gene silencing by miRNA (GO:0035196),22,12,13.16,-,0.91,0.861,1,7,7.89,-,0.89,1,1,10,12.47,-,0.8,0.713,1,0,0.22,-, < 0.01,1,1
regulation of histone H3-K9 methylation (GO:0051570),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
sphingoid metabolic process (GO:0046519),11,6,6.58,-,0.91,1,1,6,3.94,+,1.52,0.413,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
diaminopimelate metabolic process (GO:0046451),11,6,6.58,-,0.91,1,1,5,3.94,+,1.27,0.777,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
vesicle transport along actin filament (GO:0030050),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
regulation of embryonic development (GO:0045995),11,6,6.58,-,0.91,1,1,2,3.94,-,0.51,0.534,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
gene expression (GO:0010467),1089,594,651.23,-,0.91,0.062,1,363,390.53,-,0.93,0.214,1,520,617.31,-,0.84,0.000793,0.302,1,10.94,-,0.09,0.000314,0.449
developmental cell growth (GO:0048588),110,60,65.78,-,0.91,0.579,1,32,39.45,-,0.81,0.339,1,58,62.35,-,0.93,0.687,1,0,1.11,-, < 0.01,0.631,1
inorganic cation import across plasma membrane (GO:0098659),11,6,6.58,-,0.91,1,1,3,3.94,-,0.76,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
negative regulation of immune system process (GO:0002683),22,12,13.16,-,0.91,0.861,1,7,7.89,-,0.89,1,1,13,12.47,+,1.04,1,1,0,0.22,-, < 0.01,1,1
ribosome localization (GO:0033750),11,6,6.58,-,0.91,1,1,8,3.94,+,2.03,0.124,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
pollen maturation (GO:0010152),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
actin filament bundle assembly (GO:0051017),11,6,6.58,-,0.91,1,1,4,3.94,+,1.01,1,1,8,6.24,+,1.28,0.636,1,0,0.11,-, < 0.01,1,1
cellular protein-containing complex assembly (GO:0034622),336,183,200.93,-,0.91,0.312,1,110,120.5,-,0.91,0.415,1,153,190.46,-,0.8,0.0223,1,0,3.38,-, < 0.01,0.0838,1
tissue development (GO:0009888),382,208,228.44,-,0.91,0.281,1,112,136.99,-,0.82,0.0622,1,200,216.54,-,0.92,0.381,1,5,3.84,+,1.3,0.44,1
regulation of reproductive process (GO:2000241),193,105,115.42,-,0.91,0.469,1,55,69.21,-,0.79,0.146,1,106,109.4,-,0.97,0.809,1,1,1.94,-,0.52,1,1
trichome differentiation (GO:0010026),57,31,34.09,-,0.91,0.741,1,15,20.44,-,0.73,0.348,1,29,32.31,-,0.9,0.736,1,1,0.57,+,1.75,0.441,1
actin filament organization (GO:0007015),57,31,34.09,-,0.91,0.741,1,16,20.44,-,0.78,0.427,1,35,32.31,+,1.08,0.745,1,0,0.57,-, < 0.01,1,1
positive regulation of biosynthetic process (GO:0009891),300,163,179.4,-,0.91,0.332,1,96,107.59,-,0.89,0.356,1,146,170.06,-,0.86,0.135,1,1,3.01,-,0.33,0.376,1
regulation of actin filament-based process (GO:0032970),35,19,20.93,-,0.91,0.78,1,7,12.55,-,0.56,0.165,1,20,19.84,+,1.01,1,1,0,0.35,-, < 0.01,1,1
"negative regulation of transcription, DNA-templated (GO:0045892)",175,95,104.65,-,0.91,0.486,1,57,62.76,-,0.91,0.55,1,94,99.2,-,0.95,0.702,1,1,1.76,-,0.57,1,1
positive regulation of cellular component biogenesis (GO:0044089),35,19,20.93,-,0.91,0.78,1,9,12.55,-,0.72,0.493,1,20,19.84,+,1.01,1,1,0,0.35,-, < 0.01,1,1
heterocycle metabolic process (GO:0046483),1684,914,1007.04,-,0.91,0.0119,1,563,603.91,-,0.93,0.124,1,841,954.59,-,0.88,0.00132,0.328,13,16.92,-,0.77,0.359,1
positive regulation of supramolecular fiber organization (GO:1902905),24,13,14.35,-,0.91,0.866,1,5,8.61,-,0.58,0.301,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
mRNA 3'-end processing (GO:0031124),24,13,14.35,-,0.91,0.866,1,11,8.61,+,1.28,0.564,1,10,13.6,-,0.74,0.478,1,0,0.24,-, < 0.01,1,1
sphingolipid biosynthetic process (GO:0030148),24,13,14.35,-,0.91,0.866,1,14,8.61,+,1.63,0.144,1,15,13.6,+,1.1,0.742,1,0,0.24,-, < 0.01,1,1
positive regulation of cytoskeleton organization (GO:0051495),24,13,14.35,-,0.91,0.866,1,5,8.61,-,0.58,0.301,1,14,13.6,+,1.03,1,1,0,0.24,-, < 0.01,1,1
cellular monovalent inorganic cation homeostasis (GO:0030004),24,13,14.35,-,0.91,0.866,1,5,8.61,-,0.58,0.301,1,13,13.6,-,0.96,1,1,0,0.24,-, < 0.01,1,1
polyol biosynthetic process (GO:0046173),24,13,14.35,-,0.91,0.866,1,13,8.61,+,1.51,0.261,1,15,13.6,+,1.1,0.742,1,1,0.24,+,4.15,0.221,1
multicellular organismal reproductive process (GO:0048609),109,59,65.18,-,0.91,0.576,1,33,39.09,-,0.84,0.445,1,63,61.79,+,1.02,0.937,1,1,1.1,-,0.91,1,1
cellular nitrogen compound metabolic process (GO:0034641),1955,1058,1169.1,-,0.9,0.00461,1,655,701.1,-,0.93,0.107,1,985,1108.2,-,0.89,0.00111,0.302,14,19.64,-,0.71,0.216,1
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),207,112,123.79,-,0.9,0.415,1,68,74.23,-,0.92,0.581,1,110,117.34,-,0.94,0.597,1,1,2.08,-,0.48,0.726,1
protein acylation (GO:0043543),61,33,36.48,-,0.9,0.671,1,17,21.88,-,0.78,0.44,1,32,34.58,-,0.93,0.747,1,0,0.61,-, < 0.01,1,1
protein maturation (GO:0051604),74,40,44.25,-,0.9,0.629,1,20,26.54,-,0.75,0.292,1,42,41.95,+,1,1,1,0,0.74,-, < 0.01,1,1
pollen tube development (GO:0048868),111,60,66.38,-,0.9,0.579,1,37,39.81,-,0.93,0.779,1,56,62.92,-,0.89,0.518,1,0,1.12,-, < 0.01,0.631,1
cell tip growth (GO:0009932),89,48,53.22,-,0.9,0.596,1,30,31.92,-,0.94,0.835,1,47,50.45,-,0.93,0.721,1,1,0.89,+,1.12,0.595,1
maintenance of meristem identity (GO:0010074),26,14,15.55,-,0.9,0.87,1,6,9.32,-,0.64,0.423,1,13,14.74,-,0.88,0.868,1,0,0.26,-, < 0.01,1,1
regulation of actin filament length (GO:0030832),26,14,15.55,-,0.9,0.87,1,5,9.32,-,0.54,0.226,1,16,14.74,+,1.09,0.872,1,0,0.26,-, < 0.01,1,1
phospholipid catabolic process (GO:0009395),13,7,7.77,-,0.9,1,1,4,4.66,-,0.86,1,1,10,7.37,+,1.36,0.517,1,0,0.13,-, < 0.01,1,1
protein targeting to peroxisome (GO:0006625),13,7,7.77,-,0.9,1,1,2,4.66,-,0.43,0.381,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
inner mitochondrial membrane organization (GO:0007007),13,7,7.77,-,0.9,1,1,4,4.66,-,0.86,1,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
lysine biosynthetic process (GO:0009085),13,7,7.77,-,0.9,1,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
exocytic process (GO:0140029),13,7,7.77,-,0.9,1,1,4,4.66,-,0.86,1,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
histone H3 acetylation (GO:0043966),13,7,7.77,-,0.9,1,1,2,4.66,-,0.43,0.381,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
regulation of root development (GO:2000280),26,14,15.55,-,0.9,0.87,1,11,9.32,+,1.18,0.709,1,12,14.74,-,0.81,0.615,1,0,0.26,-, < 0.01,1,1
establishment of protein localization to peroxisome (GO:0072663),13,7,7.77,-,0.9,1,1,2,4.66,-,0.43,0.381,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
protein localization to peroxisome (GO:0072662),13,7,7.77,-,0.9,1,1,2,4.66,-,0.43,0.381,1,11,7.37,+,1.49,0.395,1,0,0.13,-, < 0.01,1,1
regulation of actin polymerization or depolymerization (GO:0008064),26,14,15.55,-,0.9,0.87,1,5,9.32,-,0.54,0.226,1,16,14.74,+,1.09,0.872,1,0,0.26,-, < 0.01,1,1
regulation of phosphoprotein phosphatase activity (GO:0043666),13,7,7.77,-,0.9,1,1,3,4.66,-,0.64,0.584,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
vesicle docking involved in exocytosis (GO:0006904),13,7,7.77,-,0.9,1,1,4,4.66,-,0.86,1,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
regulation of mitotic cell cycle (GO:0007346),52,28,31.1,-,0.9,0.729,1,7,18.65,-,0.38,0.0111,0.986,26,29.48,-,0.88,0.639,1,0,0.52,-, < 0.01,1,1
regulation of actin filament organization (GO:0110053),26,14,15.55,-,0.9,0.87,1,5,9.32,-,0.54,0.226,1,16,14.74,+,1.09,0.872,1,0,0.26,-, < 0.01,1,1
regulation of meristem growth (GO:0010075),39,21,23.32,-,0.9,0.79,1,13,13.99,-,0.93,1,1,20,22.11,-,0.9,0.787,1,1,0.39,+,2.55,0.33,1
protein methylation (GO:0006479),65,35,38.87,-,0.9,0.679,1,21,23.31,-,0.9,0.806,1,33,36.85,-,0.9,0.674,1,0,0.65,-, < 0.01,1,1
protein alkylation (GO:0008213),65,35,38.87,-,0.9,0.679,1,21,23.31,-,0.9,0.806,1,33,36.85,-,0.9,0.674,1,0,0.65,-, < 0.01,1,1
nucleoside triphosphate biosynthetic process (GO:0009142),41,22,24.52,-,0.9,0.794,1,16,14.7,+,1.09,0.764,1,22,23.24,-,0.95,0.896,1,0,0.41,-, < 0.01,1,1
regulation of cellular component biogenesis (GO:0044087),82,44,49.04,-,0.9,0.581,1,25,29.41,-,0.85,0.511,1,45,46.48,-,0.97,0.926,1,0,0.82,-, < 0.01,1,1
regulation of developmental growth (GO:0048638),97,52,58.01,-,0.9,0.553,1,31,34.79,-,0.89,0.616,1,53,54.99,-,0.96,0.865,1,2,0.97,+,2.05,0.259,1
cellular macromolecule biosynthetic process (GO:0034645),821,440,490.96,-,0.9,0.0584,1,233,294.42,-,0.79,0.00103,0.21,386,465.39,-,0.83,0.0018,0.38,3,8.25,-,0.36,0.0668,1
ATP synthesis coupled electron transport (GO:0042773),28,15,16.74,-,0.9,0.875,1,9,10.04,-,0.9,0.854,1,18,15.87,+,1.13,0.759,1,0,0.28,-, < 0.01,1,1
cell cycle phase transition (GO:0044770),28,15,16.74,-,0.9,0.875,1,3,10.04,-,0.3,0.0394,1,15,15.87,-,0.95,1,1,0,0.28,-, < 0.01,1,1
regulation of nuclear division (GO:0051783),28,15,16.74,-,0.9,0.875,1,6,10.04,-,0.6,0.33,1,12,15.87,-,0.76,0.511,1,0,0.28,-, < 0.01,1,1
establishment of organelle localization (GO:0051656),56,30,33.49,-,0.9,0.657,1,20,20.08,-,1,1,1,27,31.74,-,0.85,0.567,1,0,0.56,-, < 0.01,1,1
ncRNA processing (GO:0034470),286,153,171.03,-,0.89,0.273,1,120,102.56,+,1.17,0.154,1,113,162.12,-,0.7,0.000898,0.285,0,2.87,-, < 0.01,0.121,1
organic cyclic compound catabolic process (GO:1901361),144,77,86.11,-,0.89,0.443,1,43,51.64,-,0.83,0.317,1,79,81.63,-,0.97,0.834,1,2,1.45,+,1.38,0.658,1
negative regulation of macromolecule metabolic process (GO:0010605),408,218,243.99,-,0.89,0.18,1,124,146.32,-,0.85,0.11,1,206,231.28,-,0.89,0.173,1,1,4.1,-,0.24,0.196,1
iron ion transport (GO:0006826),15,8,8.97,-,0.89,1,1,4,5.38,-,0.74,0.796,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
regulation of fatty acid metabolic process (GO:0019217),15,8,8.97,-,0.89,1,1,5,5.38,-,0.93,1,1,7,8.5,-,0.82,0.825,1,0,0.15,-, < 0.01,1,1
histone acetylation (GO:0016573),30,16,17.94,-,0.89,0.762,1,9,10.76,-,0.84,0.719,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
regulation of cell wall organization or biogenesis (GO:1903338),15,8,8.97,-,0.89,1,1,7,5.38,+,1.3,0.628,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
mitochondrial respiratory chain complex I assembly (GO:0032981),15,8,8.97,-,0.89,1,1,4,5.38,-,0.74,0.796,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
glycine metabolic process (GO:0006544),15,8,8.97,-,0.89,1,1,6,5.38,+,1.12,0.806,1,10,8.5,+,1.18,0.682,1,1,0.15,+,6.64,0.148,1
microgametogenesis (GO:0055046),30,16,17.94,-,0.89,0.762,1,11,10.76,+,1.02,1,1,15,17.01,-,0.88,0.758,1,1,0.3,+,3.32,0.267,1
nucleoside biosynthetic process (GO:0009163),15,8,8.97,-,0.89,1,1,7,5.38,+,1.3,0.628,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
internal protein amino acid acetylation (GO:0006475),30,16,17.94,-,0.89,0.762,1,9,10.76,-,0.84,0.719,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
ribonucleoside biosynthetic process (GO:0042455),15,8,8.97,-,0.89,1,1,7,5.38,+,1.3,0.628,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
purine nucleoside biosynthetic process (GO:0042451),15,8,8.97,-,0.89,1,1,7,5.38,+,1.3,0.628,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
peptidyl-lysine acetylation (GO:0018394),30,16,17.94,-,0.89,0.762,1,9,10.76,-,0.84,0.719,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
internal peptidyl-lysine acetylation (GO:0018393),30,16,17.94,-,0.89,0.762,1,9,10.76,-,0.84,0.719,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
cellular response to brassinosteroid stimulus (GO:0071367),30,16,17.94,-,0.89,0.762,1,13,10.76,+,1.21,0.603,1,16,17.01,-,0.94,0.879,1,0,0.3,-, < 0.01,1,1
"DNA-templated transcription, elongation (GO:0006354)",15,8,8.97,-,0.89,1,1,4,5.38,-,0.74,0.796,1,4,8.5,-,0.47,0.233,1,0,0.15,-, < 0.01,1,1
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),15,8,8.97,-,0.89,1,1,6,5.38,+,1.12,0.806,1,10,8.5,+,1.18,0.682,1,0,0.15,-, < 0.01,1,1
long-day photoperiodism (GO:0048571),15,8,8.97,-,0.89,1,1,2,5.38,-,0.37,0.269,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
purine ribonucleoside biosynthetic process (GO:0046129),15,8,8.97,-,0.89,1,1,7,5.38,+,1.3,0.628,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
positive regulation of DNA metabolic process (GO:0051054),15,8,8.97,-,0.89,1,1,5,5.38,-,0.93,1,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
nucleoside triphosphate metabolic process (GO:0009141),45,24,26.91,-,0.89,0.71,1,17,16.14,+,1.05,0.885,1,24,25.51,-,0.94,0.9,1,0,0.45,-, < 0.01,1,1
regulation of RNA splicing (GO:0043484),45,24,26.91,-,0.89,0.71,1,14,16.14,-,0.87,0.768,1,22,25.51,-,0.86,0.612,1,0,0.45,-, < 0.01,1,1
Golgi vesicle transport (GO:0048193),122,65,72.96,-,0.89,0.495,1,38,43.75,-,0.87,0.472,1,53,69.16,-,0.77,0.114,1,3,1.23,+,2.45,0.128,1
vegetative to reproductive phase transition of meristem (GO:0010228),124,66,74.15,-,0.89,0.453,1,36,44.47,-,0.81,0.281,1,69,70.29,-,0.98,0.94,1,1,1.25,-,0.8,1,1
shoot system morphogenesis (GO:0010016),111,59,66.38,-,0.89,0.475,1,30,39.81,-,0.75,0.18,1,52,62.92,-,0.83,0.287,1,0,1.12,-, < 0.01,0.631,1
purine nucleoside triphosphate metabolic process (GO:0009144),32,17,19.14,-,0.89,0.769,1,11,11.48,-,0.96,1,1,18,18.14,-,0.99,1,1,0,0.32,-, < 0.01,1,1
RNA processing (GO:0006396),584,310,349.24,-,0.89,0.0835,1,209,209.43,-,1,1,1,261,331.04,-,0.79,0.000992,0.283,0,5.87,-, < 0.01,0.00454,1
protein targeting to membrane (GO:0006612),49,26,29.3,-,0.89,0.72,1,15,17.57,-,0.85,0.671,1,29,27.78,+,1.04,0.906,1,1,0.49,+,2.03,0.394,1
mRNA metabolic process (GO:0016071),298,158,178.21,-,0.89,0.222,1,88,106.87,-,0.82,0.115,1,146,168.92,-,0.86,0.148,1,0,2.99,-, < 0.01,0.126,1
meristem initiation (GO:0010014),17,9,10.17,-,0.89,0.842,1,9,6.1,+,1.48,0.373,1,9,9.64,-,0.93,1,1,0,0.17,-, < 0.01,1,1
regulation of actin cytoskeleton organization (GO:0032956),34,18,20.33,-,0.89,0.775,1,6,12.19,-,0.49,0.109,1,20,19.27,+,1.04,0.888,1,0,0.34,-, < 0.01,1,1
pre-transcriptional gene silencing by RNA (GO:0140458),17,9,10.17,-,0.89,0.842,1,4,6.1,-,0.66,0.621,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
polyamine metabolic process (GO:0006595),17,9,10.17,-,0.89,0.842,1,7,6.1,+,1.15,0.817,1,11,9.64,+,1.14,0.7,1,0,0.17,-, < 0.01,1,1
regulation of phosphatase activity (GO:0010921),17,9,10.17,-,0.89,0.842,1,4,6.1,-,0.66,0.621,1,7,9.64,-,0.73,0.531,1,0,0.17,-, < 0.01,1,1
modulation of process of other organism involved in symbiotic interaction (GO:0051817),17,9,10.17,-,0.89,0.842,1,6,6.1,-,0.98,1,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
production of siRNA involved in RNA interference (GO:0030422),34,18,20.33,-,0.89,0.775,1,12,12.19,-,0.98,1,1,16,19.27,-,0.83,0.659,1,0,0.34,-, < 0.01,1,1
gene silencing by RNA-directed DNA methylation (GO:0080188),17,9,10.17,-,0.89,0.842,1,4,6.1,-,0.66,0.621,1,10,9.64,+,1.04,1,1,0,0.17,-, < 0.01,1,1
regulation of anthocyanin metabolic process (GO:0031537),17,9,10.17,-,0.89,0.842,1,6,6.1,-,0.98,1,1,7,9.64,-,0.73,0.531,1,1,0.17,+,5.86,0.165,1
modulation of process of other organism (GO:0035821),17,9,10.17,-,0.89,0.842,1,6,6.1,-,0.98,1,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
stomatal complex morphogenesis (GO:0010103),17,9,10.17,-,0.89,0.842,1,5,6.1,-,0.82,0.813,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
negative regulation of gene expression (GO:0010629),335,177,200.33,-,0.88,0.18,1,101,120.14,-,0.84,0.124,1,169,189.9,-,0.89,0.222,1,1,3.37,-,0.3,0.267,1
RNA methylation (GO:0001510),53,28,31.69,-,0.88,0.646,1,18,19.01,-,0.95,0.894,1,19,30.04,-,0.63,0.0865,1,0,0.53,-, < 0.01,1,1
ribonucleoside triphosphate biosynthetic process (GO:0009201),36,19,21.53,-,0.88,0.78,1,13,12.91,+,1.01,1,1,20,20.41,-,0.98,1,1,0,0.36,-, < 0.01,1,1
ribonucleoside triphosphate metabolic process (GO:0009199),36,19,21.53,-,0.88,0.78,1,13,12.91,+,1.01,1,1,20,20.41,-,0.98,1,1,0,0.36,-, < 0.01,1,1
RNA interference (GO:0016246),36,19,21.53,-,0.88,0.78,1,13,12.91,+,1.01,1,1,16,20.41,-,0.78,0.472,1,0,0.36,-, < 0.01,1,1
negative regulation of abscisic acid-activated signaling pathway (GO:0009788),36,19,21.53,-,0.88,0.78,1,10,12.91,-,0.77,0.615,1,21,20.41,+,1.03,0.891,1,1,0.36,+,2.77,0.31,1
negative regulation of cellular response to alcohol (GO:1905958),36,19,21.53,-,0.88,0.78,1,10,12.91,-,0.77,0.615,1,21,20.41,+,1.03,0.891,1,1,0.36,+,2.77,0.31,1
negative regulation of response to alcohol (GO:1901420),36,19,21.53,-,0.88,0.78,1,10,12.91,-,0.77,0.615,1,21,20.41,+,1.03,0.891,1,1,0.36,+,2.77,0.31,1
regulation of post-embryonic development (GO:0048580),220,116,131.56,-,0.88,0.281,1,68,78.9,-,0.86,0.312,1,123,124.71,-,0.99,0.955,1,0,2.21,-, < 0.01,0.285,1
mitotic cell cycle (GO:0000278),167,88,99.87,-,0.88,0.362,1,35,59.89,-,0.58,0.00287,0.443,80,94.66,-,0.85,0.231,1,1,1.68,-,0.6,1,1
regulation of plant organ morphogenesis (GO:1905421),19,10,11.36,-,0.88,0.849,1,5,6.81,-,0.73,0.648,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
regulation of chromosome segregation (GO:0051983),19,10,11.36,-,0.88,0.849,1,3,6.81,-,0.44,0.229,1,8,10.77,-,0.74,0.552,1,0,0.19,-, < 0.01,1,1
protein palmitoylation (GO:0018345),19,10,11.36,-,0.88,0.849,1,6,6.81,-,0.88,1,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
peptidyl-cysteine modification (GO:0018198),19,10,11.36,-,0.88,0.849,1,4,6.81,-,0.59,0.477,1,11,10.77,+,1.02,1,1,0,0.19,-, < 0.01,1,1
methylation (GO:0032259),152,80,90.9,-,0.88,0.375,1,49,54.51,-,0.9,0.573,1,71,86.16,-,0.82,0.184,1,0,1.53,-, < 0.01,0.41,1
positive regulation of cell cycle process (GO:0090068),19,10,11.36,-,0.88,0.849,1,6,6.81,-,0.88,1,1,11,10.77,+,1.02,1,1,1,0.19,+,5.24,0.181,1
pollen tube growth (GO:0009860),76,40,45.45,-,0.88,0.564,1,25,27.25,-,0.92,0.821,1,38,43.08,-,0.88,0.559,1,0,0.76,-, < 0.01,1,1
regulation of cellular protein localization (GO:1903827),19,10,11.36,-,0.88,0.849,1,5,6.81,-,0.73,0.648,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
cytokinin metabolic process (GO:0009690),19,10,11.36,-,0.88,0.849,1,8,6.81,+,1.17,0.667,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
regulation of multicellular organismal development (GO:2000026),230,121,137.54,-,0.88,0.266,1,70,82.48,-,0.85,0.235,1,126,130.38,-,0.97,0.781,1,0,2.31,-, < 0.01,0.178,1
RNA metabolic process (GO:0016070),926,487,553.75,-,0.88,0.018,1,302,332.08,-,0.91,0.14,1,436,524.91,-,0.83,0.000869,0.292,1,9.3,-,0.11,0.00154,0.98
protein acetylation (GO:0006473),40,21,23.92,-,0.88,0.692,1,10,14.34,-,0.7,0.34,1,20,22.67,-,0.88,0.689,1,0,0.4,-, < 0.01,1,1
base-excision repair (GO:0006284),21,11,12.56,-,0.88,0.855,1,6,7.53,-,0.8,0.827,1,12,11.9,+,1.01,1,1,0,0.21,-, < 0.01,1,1
nucleobase-containing compound metabolic process (GO:0006139),1491,781,891.63,-,0.88,0.00151,0.861,463,534.7,-,0.87,0.00389,0.483,707,845.18,-,0.84,3.12E-05,0.0446,8,14.98,-,0.53,0.0531,1
protein modification by small protein removal (GO:0070646),65,34,38.87,-,0.87,0.603,1,15,23.31,-,0.64,0.128,1,33,36.85,-,0.9,0.674,1,0,0.65,-, < 0.01,1,1
gene silencing by RNA (GO:0031047),88,46,52.62,-,0.87,0.475,1,23,31.56,-,0.73,0.195,1,40,49.88,-,0.8,0.269,1,0,0.88,-, < 0.01,1,1
regulation of mRNA processing (GO:0050684),44,23,26.31,-,0.87,0.705,1,12,15.78,-,0.76,0.451,1,20,24.94,-,0.8,0.438,1,0,0.44,-, < 0.01,1,1
aromatic compound catabolic process (GO:0019439),134,70,80.13,-,0.87,0.383,1,42,48.05,-,0.87,0.492,1,74,75.96,-,0.97,0.885,1,2,1.35,+,1.49,0.393,1
histone methylation (GO:0016571),46,24,27.51,-,0.87,0.623,1,14,16.5,-,0.85,0.662,1,23,26.08,-,0.88,0.707,1,0,0.46,-, < 0.01,1,1
clathrin-dependent endocytosis (GO:0072583),23,12,13.75,-,0.87,0.861,1,6,8.25,-,0.73,0.673,1,14,13.04,+,1.07,0.865,1,1,0.23,+,4.33,0.213,1
negative regulation of protein modification process (GO:0031400),23,12,13.75,-,0.87,0.861,1,7,8.25,-,0.85,0.837,1,11,13.04,-,0.84,0.723,1,0,0.23,-, < 0.01,1,1
RNA modification (GO:0009451),221,115,132.16,-,0.87,0.233,1,64,79.25,-,0.81,0.136,1,110,125.28,-,0.88,0.273,1,0,2.22,-, < 0.01,0.177,1
ATP biosynthetic process (GO:0006754),25,13,14.95,-,0.87,0.74,1,9,8.97,+,1,1,1,14,14.17,-,0.99,1,1,0,0.25,-, < 0.01,1,1
ATP synthesis coupled proton transport (GO:0015986),25,13,14.95,-,0.87,0.74,1,9,8.97,+,1,1,1,14,14.17,-,0.99,1,1,0,0.25,-, < 0.01,1,1
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",25,13,14.95,-,0.87,0.74,1,9,8.97,+,1,1,1,14,14.17,-,0.99,1,1,0,0.25,-, < 0.01,1,1
mitotic cell cycle checkpoint (GO:0007093),25,13,14.95,-,0.87,0.74,1,3,8.97,-,0.33,0.0829,1,10,14.17,-,0.71,0.384,1,0,0.25,-, < 0.01,1,1
pteridine-containing compound metabolic process (GO:0042558),25,13,14.95,-,0.87,0.74,1,8,8.97,-,0.89,1,1,15,14.17,+,1.06,0.87,1,2,0.25,+,7.96,0.0293,1
interaction with host (GO:0051701),25,13,14.95,-,0.87,0.74,1,6,8.97,-,0.67,0.54,1,14,14.17,-,0.99,1,1,0,0.25,-, < 0.01,1,1
regulation of cell cycle process (GO:0010564),75,39,44.85,-,0.87,0.499,1,16,26.9,-,0.59,0.0567,1,37,42.51,-,0.87,0.554,1,1,0.75,+,1.33,0.533,1
spindle assembly (GO:0051225),25,13,14.95,-,0.87,0.74,1,3,8.97,-,0.33,0.0829,1,12,14.17,-,0.85,0.733,1,0,0.25,-, < 0.01,1,1
mitotic cell cycle phase transition (GO:0044772),27,14,16.15,-,0.87,0.748,1,3,9.68,-,0.31,0.0392,1,15,15.31,-,0.98,1,1,0,0.27,-, < 0.01,1,1
negative regulation of mitotic cell cycle (GO:0045930),27,14,16.15,-,0.87,0.748,1,3,9.68,-,0.31,0.0392,1,11,15.31,-,0.72,0.402,1,0,0.27,-, < 0.01,1,1
nucleobase-containing compound transport (GO:0015931),83,43,49.63,-,0.87,0.462,1,30,29.77,+,1.01,1,1,32,47.05,-,0.68,0.0646,1,1,0.83,+,1.2,0.569,1
intra-Golgi vesicle-mediated transport (GO:0006891),29,15,17.34,-,0.86,0.756,1,9,10.4,-,0.87,0.854,1,13,16.44,-,0.79,0.524,1,1,0.29,+,3.43,0.259,1
RNA 3'-end processing (GO:0031123),58,30,34.68,-,0.86,0.581,1,20,20.8,-,0.96,1,1,23,32.88,-,0.7,0.165,1,0,0.58,-, < 0.01,1,1
mRNA processing (GO:0006397),205,106,122.59,-,0.86,0.238,1,63,73.52,-,0.86,0.295,1,98,116.21,-,0.84,0.166,1,0,2.06,-, < 0.01,0.274,1
regulation of multicellular organismal process (GO:0051239),267,138,159.67,-,0.86,0.162,1,80,95.75,-,0.84,0.158,1,142,151.35,-,0.94,0.568,1,1,2.68,-,0.37,0.527,1
regulation of supramolecular fiber organization (GO:1902903),33,17,19.73,-,0.86,0.663,1,6,11.83,-,0.51,0.146,1,19,18.71,+,1.02,1,1,0,0.33,-, < 0.01,1,1
protein targeting to vacuole (GO:0006623),33,17,19.73,-,0.86,0.663,1,6,11.83,-,0.51,0.146,1,13,18.71,-,0.69,0.286,1,0,0.33,-, < 0.01,1,1
positive regulation of cellular component organization (GO:0051130),66,34,39.47,-,0.86,0.535,1,15,23.67,-,0.63,0.129,1,35,37.41,-,0.94,0.836,1,0,0.66,-, < 0.01,1,1
macromolecule methylation (GO:0043414),134,69,80.13,-,0.86,0.343,1,41,48.05,-,0.85,0.39,1,60,75.96,-,0.79,0.134,1,0,1.35,-, < 0.01,0.646,1
regulation of organelle organization (GO:0033043),136,70,81.33,-,0.86,0.312,1,24,48.77,-,0.49,0.000789,0.188,67,77.09,-,0.87,0.379,1,1,1.37,-,0.73,1,1
glycosylation (GO:0070085),105,54,62.79,-,0.86,0.411,1,24,37.65,-,0.64,0.0449,1,49,59.52,-,0.82,0.275,1,0,1.05,-, < 0.01,0.629,1
spindle organization (GO:0007051),35,18,20.93,-,0.86,0.671,1,6,12.55,-,0.48,0.109,1,18,19.84,-,0.91,0.777,1,0,0.35,-, < 0.01,1,1
mitotic cell cycle process (GO:1903047),142,73,84.92,-,0.86,0.321,1,28,50.92,-,0.55,0.00282,0.46,66,80.49,-,0.82,0.192,1,0,1.43,-, < 0.01,0.408,1
cytoplasmic translation (GO:0002181),37,19,22.13,-,0.86,0.679,1,6,13.27,-,0.45,0.0814,1,16,20.97,-,0.76,0.394,1,0,0.37,-, < 0.01,1,1
regulation of mitotic cell cycle phase transition (GO:1901990),37,19,22.13,-,0.86,0.679,1,6,13.27,-,0.45,0.0814,1,17,20.97,-,0.81,0.571,1,0,0.37,-, < 0.01,1,1
establishment of protein localization to vacuole (GO:0072666),39,20,23.32,-,0.86,0.686,1,9,13.99,-,0.64,0.255,1,16,22.11,-,0.72,0.326,1,0,0.39,-, < 0.01,1,1
protein localization to vacuole (GO:0072665),39,20,23.32,-,0.86,0.686,1,9,13.99,-,0.64,0.255,1,16,22.11,-,0.72,0.326,1,0,0.39,-, < 0.01,1,1
pollen germination (GO:0009846),41,21,24.52,-,0.86,0.601,1,9,14.7,-,0.61,0.201,1,21,23.24,-,0.9,0.792,1,0,0.41,-, < 0.01,1,1
megagametogenesis (GO:0009561),45,23,26.91,-,0.85,0.616,1,19,16.14,+,1.18,0.57,1,22,25.51,-,0.86,0.612,1,1,0.45,+,2.21,0.369,1
vacuole organization (GO:0007033),47,24,28.11,-,0.85,0.623,1,10,16.85,-,0.59,0.174,1,24,26.64,-,0.9,0.712,1,0,0.47,-, < 0.01,1,1
negative regulation of cell cycle (GO:0045786),51,26,30.5,-,0.85,0.556,1,8,18.29,-,0.44,0.0257,1,21,28.91,-,0.73,0.269,1,0,0.51,-, < 0.01,1,1
organelle fusion (GO:0048284),53,27,31.69,-,0.85,0.563,1,20,19.01,+,1.05,0.894,1,25,30.04,-,0.83,0.481,1,0,0.53,-, < 0.01,1,1
posttranscriptional gene silencing (GO:0016441),71,36,42.46,-,0.85,0.483,1,21,25.46,-,0.82,0.479,1,29,40.25,-,0.72,0.145,1,0,0.71,-, < 0.01,1,1
gametophyte development (GO:0048229),290,147,173.42,-,0.85,0.0995,1,99,104,-,0.95,0.727,1,135,164.39,-,0.82,0.059,1,2,2.91,-,0.69,1,1
negative regulation of cell communication (GO:0010648),75,38,44.85,-,0.85,0.436,1,22,26.9,-,0.82,0.488,1,39,42.51,-,0.92,0.697,1,1,0.75,+,1.33,0.533,1
negative regulation of signaling (GO:0023057),75,38,44.85,-,0.85,0.436,1,22,26.9,-,0.82,0.488,1,39,42.51,-,0.92,0.697,1,1,0.75,+,1.33,0.533,1
tropism (GO:0009606),75,38,44.85,-,0.85,0.436,1,22,26.9,-,0.82,0.488,1,35,42.51,-,0.82,0.371,1,0,0.75,-, < 0.01,1,1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",164,83,98.07,-,0.85,0.234,1,52,58.81,-,0.88,0.485,1,78,92.96,-,0.84,0.226,1,0,1.65,-, < 0.01,0.416,1
"RNA splicing, via transesterification reactions (GO:0000375)",164,83,98.07,-,0.85,0.234,1,52,58.81,-,0.88,0.485,1,78,92.96,-,0.84,0.226,1,0,1.65,-, < 0.01,0.416,1
rRNA processing (GO:0006364),188,95,112.43,-,0.85,0.194,1,80,67.42,+,1.19,0.209,1,66,106.57,-,0.62,0.000607,0.267,0,1.89,-, < 0.01,0.268,1
heterocycle catabolic process (GO:0046700),129,65,77.14,-,0.84,0.265,1,35,46.26,-,0.76,0.154,1,68,73.12,-,0.93,0.655,1,2,1.3,+,1.54,0.375,1
meristem development (GO:0048507),141,71,84.32,-,0.84,0.254,1,45,50.56,-,0.89,0.558,1,66,79.93,-,0.83,0.216,1,2,1.42,+,1.41,0.655,1
RNA splicing (GO:0008380),197,99,117.81,-,0.84,0.164,1,63,70.65,-,0.89,0.478,1,93,111.67,-,0.83,0.157,1,0,1.98,-, < 0.01,0.271,1
regulation of cellular component organization (GO:0051128),253,127,151.3,-,0.84,0.109,1,59,90.73,-,0.65,0.00226,0.403,122,143.41,-,0.85,0.143,1,2,2.54,-,0.79,1,1
rRNA modification (GO:0000154),30,15,17.94,-,0.84,0.645,1,7,10.76,-,0.65,0.355,1,10,17.01,-,0.59,0.187,1,0,0.3,-, < 0.01,1,1
cellular component morphogenesis (GO:0032989),30,15,17.94,-,0.84,0.645,1,10,10.76,-,0.93,1,1,15,17.01,-,0.88,0.758,1,0,0.3,-, < 0.01,1,1
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),30,15,17.94,-,0.84,0.645,1,10,10.76,-,0.93,1,1,17,17.01,-,1,1,1,0,0.3,-, < 0.01,1,1
purine ribonucleoside triphosphate metabolic process (GO:0009205),30,15,17.94,-,0.84,0.645,1,10,10.76,-,0.93,1,1,17,17.01,-,1,1,1,0,0.3,-, < 0.01,1,1
purine nucleoside triphosphate biosynthetic process (GO:0009145),30,15,17.94,-,0.84,0.645,1,10,10.76,-,0.93,1,1,17,17.01,-,1,1,1,0,0.3,-, < 0.01,1,1
RNA (guanine-N7)-methylation (GO:0036265),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
7-methylguanosine cap hypermethylation (GO:0036261),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
CENP-A containing nucleosome assembly (GO:0034080),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
Golgi vesicle docking (GO:0048211),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
COPI coating of Golgi vesicle (GO:0048205),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
Golgi transport vesicle coating (GO:0048200),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
nectar secretion (GO:0071836),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cell volume homeostasis (GO:0006884),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
negative regulation of cell differentiation (GO:0045596),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
tricarboxylic acid transport (GO:0006842),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
embryonic root morphogenesis (GO:0010086),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
dicarboxylic acid transport (GO:0006835),12,6,7.18,-,0.84,0.811,1,6,4.3,+,1.39,0.592,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
primary shoot apical meristem specification (GO:0010072),8,4,4.78,-,0.84,1,1,4,2.87,+,1.39,0.529,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
zygote asymmetric cell division (GO:0010070),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of trichoblast fate specification (GO:0010061),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
sodium ion transport (GO:0006814),10,5,5.98,-,0.84,1,1,3,3.59,-,0.84,1,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
guard cell differentiation (GO:0010052),8,4,4.78,-,0.84,1,1,0,2.87,-, < 0.01,0.12,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
response to L-ascorbic acid (GO:0033591),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
M phase (GO:0000279),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
fruit dehiscence (GO:0010047),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
positive regulation of protein ubiquitination (GO:0031398),8,4,4.78,-,0.84,1,1,1,2.87,-,0.35,0.461,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
allantoin metabolic process (GO:0000255),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
regulation of cell projection organization (GO:0031344),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
gamma-aminobutyric acid catabolic process (GO:0009450),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
gamma-aminobutyric acid metabolic process (GO:0009448),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
putrescine biosynthetic process (GO:0009446),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
putrescine metabolic process (GO:0009445),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
lipooligosaccharide biosynthetic process (GO:1901271),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
aldonate transmembrane transport (GO:0042873),6,3,3.59,-,0.84,1,1,4,2.15,+,1.86,0.304,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
lipooligosaccharide metabolic process (GO:1901269),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
epithelial cell differentiation (GO:0030855),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
negative regulation of actin filament polymerization (GO:0030837),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
protein deubiquitination (GO:0016579),52,26,31.1,-,0.84,0.484,1,12,18.65,-,0.64,0.201,1,26,29.48,-,0.88,0.639,1,0,0.52,-, < 0.01,1,1
"protein import into peroxisome matrix, docking (GO:0016560)",4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
riboflavin metabolic process (GO:0006771),10,5,5.98,-,0.84,1,1,6,3.59,+,1.67,0.392,1,6,5.67,+,1.06,1,1,1,0.1,+,9.95,0.104,1
biotin metabolic process (GO:0006768),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
glutathione biosynthetic process (GO:0006750),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of alcohol biosynthetic process (GO:1902932),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
selective autophagy (GO:0061912),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
FAD biosynthetic process (GO:0006747),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of protein polyubiquitination (GO:1902916),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
stress response to copper ion (GO:1990169),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of protein polyubiquitination (GO:1902914),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
specification of axis polarity (GO:0065001),18,9,10.76,-,0.84,0.843,1,4,6.46,-,0.62,0.475,1,7,10.2,-,0.69,0.533,1,0,0.18,-, < 0.01,1,1
galacturonate biosynthetic process (GO:0033481),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"retrograde transport, endosome to plasma membrane (GO:1990126)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of protein-containing complex disassembly (GO:0043243),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
nonribosomal peptide biosynthetic process (GO:0019184),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein deacylation (GO:0035601),16,8,9.57,-,0.84,0.834,1,6,5.74,+,1.05,1,1,6,9.07,-,0.66,0.507,1,0,0.16,-, < 0.01,1,1
selenium compound metabolic process (GO:0001887),4,2,2.39,-,0.84,1,1,4,1.43,+,2.79,0.22,1,3,2.27,+,1.32,0.709,1,1,0.04,+,24.89,0.0488,1
negative regulation of cellular protein catabolic process (GO:1903363),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of camalexin biosynthetic process (GO:1901183),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of camalexin biosynthetic process (GO:1901182),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
L-ornithine transmembrane transport (GO:1903352),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
tRNA 3'-trailer cleavage (GO:0042779),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
cell part morphogenesis (GO:0032990),2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of vacuolar transport (GO:1903335),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
very long-chain fatty acid catabolic process (GO:0042760),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein insertion into mitochondrial inner membrane from matrix (GO:0032979),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein insertion into membrane from inner side (GO:0032978),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of nitrogen cycle metabolic process (GO:1903314),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
tRNA transcription (GO:0009304),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
inositol phosphate biosynthetic process (GO:0032958),10,5,5.98,-,0.84,1,1,4,3.59,+,1.12,0.77,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
fucosylation (GO:0036065),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
cytosolic transport (GO:0016482),24,12,14.35,-,0.84,0.731,1,5,8.61,-,0.58,0.301,1,11,13.6,-,0.81,0.603,1,0,0.24,-, < 0.01,1,1
regulation of starch metabolic process (GO:2000904),10,5,5.98,-,0.84,1,1,4,3.59,+,1.12,0.77,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
glucosylceramide catabolic process (GO:0006680),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cytoskeleton-dependent intracellular transport (GO:0030705),22,11,13.16,-,0.84,0.721,1,6,7.89,-,0.76,0.671,1,14,12.47,+,1.12,0.731,1,0,0.22,-, < 0.01,1,1
intrachromosomal DNA recombination (GO:1990067),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
vacuolar protein processing (GO:0006624),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
vacuolar sequestering (GO:0043181),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,1,0.08,+,12.44,0.0861,1
fruit valve development (GO:1990059),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
G2/M transition of mitotic cell cycle (GO:0000086),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
nucleoside salvage (GO:0043174),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
L-proline biosynthetic process (GO:0055129),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
putrescine biosynthetic process from arginine (GO:0033388),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
response to molecule of oomycetes origin (GO:0002240),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
ribosomal small subunit export from nucleus (GO:0000056),4,2,2.39,-,0.84,1,1,3,1.43,+,2.09,0.39,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
ribosomal large subunit export from nucleus (GO:0000055),6,3,3.59,-,0.84,1,1,5,2.15,+,2.32,0.173,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
urea cycle (GO:0000050),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
electron transport coupled proton transport (GO:0015990),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein storage vacuole organization (GO:1990019),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
maintenance of plant organ identity (GO:0090700),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
UDP-L-arabinose biosynthetic process (GO:0033358),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
UDP-L-arabinose metabolic process (GO:0033356),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
rRNA methylation (GO:0031167),20,10,11.96,-,0.84,0.709,1,5,7.17,-,0.7,0.65,1,6,11.34,-,0.53,0.22,1,0,0.2,-, < 0.01,1,1
maltose catabolic process (GO:0000025),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
diadenosine tetraphosphate metabolic process (GO:0015965),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
receptor metabolic process (GO:0043112),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
diadenosine polyphosphate metabolic process (GO:0015959),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
coenzyme A biosynthetic process (GO:0015937),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
response to pH (GO:0009268),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
2'-deoxyribonucleotide biosynthetic process (GO:0009265),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of microtubule depolymerization (GO:0031117),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of microtubule polymerization or depolymerization (GO:0031110),10,5,5.98,-,0.84,1,1,1,3.59,-,0.28,0.308,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
long-chain fatty acid import into peroxisome (GO:0015910),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
tetracycline transmembrane transport (GO:0015904),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,1,0.02,+,49.77,0.0295,1
lipid A biosynthetic process (GO:0009245),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of sister chromatid cohesion (GO:0007063),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
riboflavin biosynthetic process (GO:0009231),10,5,5.98,-,0.84,1,1,6,3.59,+,1.67,0.392,1,6,5.67,+,1.06,1,1,1,0.1,+,9.95,0.104,1
cell cycle G2/M phase transition (GO:0044839),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of establishment or maintenance of cell polarity (GO:0032878),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
detoxification of cadmium ion (GO:0071585),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
cell fate determination (GO:0001709),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
endoderm formation (GO:0001706),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
formation of primary germ layer (GO:0001704),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein ufmylation (GO:0071569),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cellular phosphate ion homeostasis (GO:0030643),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
polyketide biosynthetic process (GO:0030639),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
polyketide metabolic process (GO:0030638),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
threonine catabolic process (GO:0006567),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
S-adenosylmethioninamine biosynthetic process (GO:0006557),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
leucine catabolic process (GO:0006552),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
chloride ion homeostasis (GO:0055064),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
sulfate ion homeostasis (GO:0055063),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
endoplasmic reticulum membrane fusion (GO:0016320),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
glutamate decarboxylation to succinate (GO:0006540),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cytoplasmic translational termination (GO:0002184),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
reticulophagy (GO:0061709),2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of purine nucleotide metabolic process (GO:1900542),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
purine nucleobase salvage (GO:0043096),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
SNARE complex disassembly (GO:0035494),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
SNARE complex assembly (GO:0035493),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of apoptotic process (GO:0043066),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,4,2.27,+,1.76,0.471,1,0,0.04,-, < 0.01,1,1
capsule organization (GO:0045230),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to vitamin (GO:0033273),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
capsule polysaccharide biosynthetic process (GO:0045227),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
extracellular polysaccharide biosynthetic process (GO:0045226),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of cellular amine metabolic process (GO:0033240),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
organic hydroxy compound transport (GO:0015850),12,6,7.18,-,0.84,0.811,1,4,4.3,-,0.93,1,1,9,6.8,+,1.32,0.506,1,1,0.12,+,8.3,0.122,1
heterochromatin assembly by small RNA (GO:0031048),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
meiotic cytokinesis (GO:0033206),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,6,4.53,+,1.32,0.59,1,0,0.08,-, < 0.01,1,1
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
ornithine transport (GO:0015822),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
nucleotide catabolic process (GO:0009166),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
L-glutamate transmembrane transport (GO:0015813),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
basic amino acid transport (GO:0015802),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial protein processing (GO:0034982),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
nucleoside triphosphate catabolic process (GO:0009143),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
potassium ion export across plasma membrane (GO:0097623),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of mitochondrial gene expression (GO:0062125),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
nucleoside diphosphate catabolic process (GO:0009134),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
ribosome disassembly (GO:0032790),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
negative regulation of ATPase activity (GO:0032780),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
purine nucleobase biosynthetic process (GO:0009113),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
positive regulation of phytoalexin biosynthetic process (GO:0052322),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of phytoalexin metabolic process (GO:0052320),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
biotin biosynthetic process (GO:0009102),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of phytoalexin biosynthetic process (GO:0052319),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of phytoalexin metabolic process (GO:0052318),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to freezing (GO:0071497),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
collagen catabolic process (GO:0030574),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
cellular response to absence of light (GO:0071485),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to X-ray (GO:0071481),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to redox state (GO:0071461),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
detoxification of inorganic compound (GO:0061687),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
"protein localization to chromosome, centromeric region (GO:0071459)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),12,6,7.18,-,0.84,0.811,1,1,4.3,-,0.23,0.206,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
regulation of phosphate transport (GO:0010966),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
CENP-A containing chromatin organization (GO:0061641),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein ADP-ribosylation (GO:0006471),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to microtubule plus-end (GO:1904825),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
purine nucleobase transmembrane transport (GO:1904823),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
C-terminal protein amino acid modification (GO:0018410),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
positive regulation of brassinosteroid mediated signaling pathway (GO:1900459),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of translational termination (GO:0006449),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
assembly of large subunit precursor of preribosome (GO:1902626),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
valyl-tRNA aminoacylation (GO:0006438),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
threonyl-tRNA aminoacylation (GO:0006435),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
prolyl-tRNA aminoacylation (GO:0006433),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
leucyl-tRNA aminoacylation (GO:0006429),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
isoleucyl-tRNA aminoacylation (GO:0006428),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
histidyl-tRNA aminoacylation (GO:0006427),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cysteinyl-tRNA aminoacylation (GO:0006423),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to microtubule (GO:0035372),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to hydroperoxide (GO:0033194),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
oxidative demethylation (GO:0070989),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
demethylation (GO:0070988),24,12,14.35,-,0.84,0.731,1,7,8.61,-,0.81,0.838,1,12,13.6,-,0.88,0.863,1,0,0.24,-, < 0.01,1,1
mRNA catabolic process (GO:0006402),58,29,34.68,-,0.84,0.506,1,13,20.8,-,0.63,0.138,1,27,32.88,-,0.82,0.43,1,0,0.58,-, < 0.01,1,1
regulation of histone ubiquitination (GO:0033182),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein K11-linked ubiquitination (GO:0070979),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
myo-inositol transport (GO:0015798),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
polyol transport (GO:0015791),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
UDP-xylose transmembrane transport (GO:0015790),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
hypoxanthine transport (GO:0035344),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
long-chain fatty-acyl-CoA metabolic process (GO:0035336),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
polysaccharide transport (GO:0015774),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
glucose-6-phosphate transport (GO:0015760),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
organelle assembly (GO:0070925),116,58,69.37,-,0.84,0.272,1,27,41.6,-,0.65,0.045,1,48,65.76,-,0.73,0.0724,1,0,1.17,-, < 0.01,0.633,1
small RNA loading onto RISC (GO:0070922),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
homoserine metabolic process (GO:0009092),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
positive regulation of lipid biosynthetic process (GO:0046889),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
phosphoglycerate transmembrane transport (GO:0015713),6,3,3.59,-,0.84,1,1,4,2.15,+,1.86,0.304,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
hexose phosphate transport (GO:0015712),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
fatty acid alpha-oxidation (GO:0001561),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
modulation of RNA levels in other organism involved in symbiotic interaction (GO:0052249),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
cristae formation (GO:0042407),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
cellular response to indolebutyric acid stimulus (GO:0071366),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
endosomal transport (GO:0016197),52,26,31.1,-,0.84,0.484,1,19,18.65,+,1.02,1,1,26,29.48,-,0.88,0.639,1,0,0.52,-, < 0.01,1,1
multi-organism intercellular transport (GO:1902586),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of response to water deprivation (GO:1902584),8,4,4.78,-,0.84,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of triglyceride biosynthetic process (GO:0010866),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mRNA polyadenylation (GO:0006378),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,7,10.2,-,0.69,0.533,1,0,0.18,-, < 0.01,1,1
sesquiterpene metabolic process (GO:0051761),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of secondary metabolite biosynthetic process (GO:1900376),16,8,9.57,-,0.84,0.834,1,6,5.74,+,1.05,1,1,8,9.07,-,0.88,0.835,1,1,0.16,+,6.22,0.156,1
epidermis development (GO:0008544),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
"meiotic sister chromatid cohesion, centromeric (GO:0051754)",4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of mitochondrion organization (GO:0010821),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
sesquiterpenoid biosynthetic process (GO:0016106),12,6,7.18,-,0.84,0.811,1,2,4.3,-,0.46,0.38,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
triterpenoid biosynthetic process (GO:0016104),6,3,3.59,-,0.84,1,1,0,2.15,-, < 0.01,0.351,1,6,3.4,+,1.76,0.372,1,0,0.06,-, < 0.01,1,1
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein targeting to ER (GO:0045047),24,12,14.35,-,0.84,0.731,1,8,8.61,-,0.93,1,1,15,13.6,+,1.1,0.742,1,1,0.24,+,4.15,0.221,1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of protein exit from endoplasmic reticulum (GO:0070861),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of chromosome organization (GO:0033044),52,26,31.1,-,0.84,0.484,1,7,18.65,-,0.38,0.0111,1,23,29.48,-,0.78,0.338,1,0,0.52,-, < 0.01,1,1
export across plasma membrane (GO:0140115),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
[2Fe-2S] cluster assembly (GO:0044571),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"transport of virus in host, cell to cell (GO:0046740)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
transport of virus in multicellular host (GO:0046739),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
borate transport (GO:0046713),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
negative regulation of iron ion transport (GO:0034757),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
'de novo' GDP-L-fucose biosynthetic process (GO:0042351),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
movement in host environment (GO:0052126),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
taxis (GO:0042330),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
cellular response to zinc ion (GO:0071294),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
DNA replication-independent nucleosome organization (GO:0034724),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
iron incorporation into metallo-sulfur cluster (GO:0018283),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
metal incorporation into metallo-sulfur cluster (GO:0018282),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
L-methionine biosynthetic process (GO:0071265),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
cellular response to electrical stimulus (GO:0071257),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
rRNA catabolic process (GO:0016075),16,8,9.57,-,0.84,0.834,1,5,5.74,-,0.87,1,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
chloride transmembrane transport (GO:1902476),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of cell morphogenesis involved in differentiation (GO:0010769),16,8,9.57,-,0.84,0.834,1,4,5.74,-,0.7,0.62,1,5,9.07,-,0.55,0.266,1,0,0.16,-, < 0.01,1,1
L-alpha-amino acid transmembrane transport (GO:1902475),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
localization of cell (GO:0051674),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of histone H3-K27 trimethylation (GO:1902466),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of cell growth (GO:0030307),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
response to amino acid starvation (GO:1990928),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial mRNA catabolic process (GO:0000958),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial RNA catabolic process (GO:0000957),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
Golgi localization (GO:0051645),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
peptidyl-methionine modification (GO:0018206),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
peptidyl-histidine modification (GO:0018202),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of hydrogen peroxide biosynthetic process (GO:0010728),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of cytoplasmic translational elongation (GO:1900247),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
post-transcriptional gene silencing by RNA (GO:0035194),64,32,38.27,-,0.84,0.46,1,18,22.95,-,0.78,0.451,1,27,36.28,-,0.74,0.229,1,0,0.64,-, < 0.01,1,1
UTP biosynthetic process (GO:0006228),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of nitrate assimilation (GO:0090352),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
charged-tRNA amino acid modification (GO:0019988),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of cell aging (GO:0090342),2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to electrical stimulus (GO:0051602),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of superoxide metabolic process (GO:0090322),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial gene expression (GO:0140053),40,20,23.92,-,0.84,0.594,1,15,14.34,+,1.05,0.879,1,21,22.67,-,0.93,0.894,1,0,0.4,-, < 0.01,1,1
cyclic-nucleotide-mediated signaling (GO:0019935),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cAMP-mediated signaling (GO:0019933),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of cell cycle phase transition (GO:1901987),40,20,23.92,-,0.84,0.594,1,6,14.34,-,0.42,0.0434,1,19,22.67,-,0.84,0.589,1,0,0.4,-, < 0.01,1,1
multicellular organismal homeostasis (GO:0048871),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
cell motility (GO:0048870),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of cutin biosynthetic process (GO:1901959),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
autophagosome maturation (GO:0097352),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
specification of floral organ number (GO:0048833),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
specification of plant organ number (GO:0048832),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
adventitious root development (GO:0048830),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
vesicle cytoskeletal trafficking (GO:0099518),12,6,7.18,-,0.84,0.811,1,4,4.3,-,0.93,1,1,7,6.8,+,1.03,1,1,0,0.12,-, < 0.01,1,1
regulation of antifungal innate immune response (GO:1905034),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
error-prone translesion synthesis (GO:0042276),6,3,3.59,-,0.84,1,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
detection of molecule of bacterial origin (GO:0032490),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
modulation by symbiont of RNA levels in host (GO:0052018),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
regulation of peroxidase activity (GO:2000468),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
snRNA modification (GO:0040031),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
"regulation of molecular function, epigenetic (GO:0040030)",2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
locomotion (GO:0040011),20,10,11.96,-,0.84,0.709,1,8,7.17,+,1.12,0.83,1,13,11.34,+,1.15,0.719,1,0,0.2,-, < 0.01,1,1
purine nucleotide catabolic process (GO:0006195),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
histone H2A acetylation (GO:0043968),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
adenine salvage (GO:0006168),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
purine ribonucleoside salvage (GO:0006166),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
adenosine catabolic process (GO:0006154),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
inosine catabolic process (GO:0006148),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
regulation of nucleotide metabolic process (GO:0006140),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of gluconeogenesis (GO:0006111),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
lysine biosynthetic process via aminoadipic acid (GO:0019878),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of histone H4 acetylation (GO:0090239),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
succinyl-CoA metabolic process (GO:0006104),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of radial pattern formation (GO:0090213),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
stem cell population maintenance (GO:0019827),32,16,19.14,-,0.84,0.655,1,6,11.48,-,0.52,0.195,1,14,18.14,-,0.77,0.447,1,0,0.32,-, < 0.01,1,1
protein localization to cytoskeleton (GO:0044380),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
positive regulation of intracellular transport (GO:0032388),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
S-adenosylmethionine metabolic process (GO:0046500),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
RNA 3' uridylation (GO:0071076),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
protein localization to kinetochore (GO:0034501),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
green leaf volatile biosynthetic process (GO:0010597),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
sphingolipid catabolic process (GO:0030149),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
spermidine biosynthetic process (GO:0008295),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
floral meristem determinacy (GO:0010582),12,6,7.18,-,0.84,0.811,1,4,4.3,-,0.93,1,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
water homeostasis (GO:0030104),10,5,5.98,-,0.84,1,1,4,3.59,+,1.12,0.77,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
regulation of endocytosis (GO:0030100),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
tRNA N1-guanine methylation (GO:0002939),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of ubiquitin-protein transferase activity (GO:0051443),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
negative regulation of transposition (GO:0010529),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of transposition (GO:0010528),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"DNA catabolic process, exonucleolytic (GO:0000738)",2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of autophagy (GO:0010507),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
proteoglycan metabolic process (GO:0006029),10,5,5.98,-,0.84,1,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
telomere maintenance via recombination (GO:0000722),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
detoxification of nitrogen compound (GO:0051410),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of ruffle assembly (GO:1900027),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
mannose metabolic process (GO:0006013),4,2,2.39,-,0.84,1,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
centromere localization (GO:0072765),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrion morphogenesis (GO:0070584),2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular water homeostasis (GO:0009992),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
fucose metabolic process (GO:0006004),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cadmium ion transmembrane transport (GO:0070574),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cell-cell recognition (GO:0009988),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pentacyclic triterpenoid biosynthetic process (GO:0019745),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pentacyclic triterpenoid metabolic process (GO:0019742),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of proteasomal protein catabolic process (GO:1901799),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
negative regulation of signal transduction (GO:0009968),74,37,44.25,-,0.84,0.432,1,21,26.54,-,0.79,0.414,1,39,41.95,-,0.93,0.769,1,1,0.74,+,1.35,0.529,1
simple leaf morphogenesis (GO:0060776),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
leaf phyllotactic patterning (GO:0060772),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
phyllotactic patterning (GO:0060771),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of anion transmembrane transport (GO:1903961),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein K63-linked deubiquitination (GO:0070536),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
protein K63-linked ubiquitination (GO:0070534),10,5,5.98,-,0.84,1,1,1,3.59,-,0.28,0.308,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
radial axis specification (GO:0009945),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
S-adenosylmethioninamine metabolic process (GO:0046499),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
lipid A metabolic process (GO:0046493),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
glycosphingolipid catabolic process (GO:0046479),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
glycosylceramide catabolic process (GO:0046477),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
epidermal cell differentiation (GO:0009913),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
phosphatidylglycerol metabolic process (GO:0046471),10,5,5.98,-,0.84,1,1,1,3.59,-,0.28,0.308,1,7,5.67,+,1.23,0.801,1,0,0.1,-, < 0.01,1,1
membrane lipid catabolic process (GO:0046466),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,5,3.4,+,1.47,0.541,1,0,0.06,-, < 0.01,1,1
positive chemotaxis (GO:0050918),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
vacuolar transmembrane transport (GO:0034486),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
U4 snRNA 3'-end processing (GO:0034475),8,4,4.78,-,0.84,1,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
regulation of cellular amino acid biosynthetic process (GO:2000282),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
IMP salvage (GO:0032264),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
'de novo' CTP biosynthetic process (GO:0044210),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
'de novo' AMP biosynthetic process (GO:0044208),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
Lewis a epitope biosynthetic process (GO:0010493),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
actin filament polymerization (GO:0030041),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
pollen tube reception (GO:0010483),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of epidermal cell division (GO:0010482),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of telomere maintenance via telomerase (GO:0032211),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
microsporocyte differentiation (GO:0010480),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of telomere maintenance (GO:0032205),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of translational initiation (GO:0045948),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
response to iron ion starvation (GO:1990641),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
positive regulation of oxidoreductase activity (GO:0051353),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of glucosinolate biosynthetic process (GO:0010439),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,1,0.04,+,24.89,0.0488,1
cellular response to sulfur starvation (GO:0010438),2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,1,0.02,+,49.77,0.0295,1
negative regulation of growth (GO:0045926),20,10,11.96,-,0.84,0.709,1,7,7.17,-,0.98,1,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
positive regulation of fatty acid metabolic process (GO:0045923),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
negative regulation of fatty acid metabolic process (GO:0045922),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
DNA methylation on cytosine within a CG sequence (GO:0010424),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of ribosome biogenesis (GO:0090071),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to cortical microtubule cytoskeleton (GO:0072699),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to microtubule cytoskeleton (GO:0072698),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
protein localization to cell cortex (GO:0072697),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mannan metabolic process (GO:0010412),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of translational fidelity (GO:0045903),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
interphase (GO:0051325),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
prophase (GO:0051324),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
G2 phase (GO:0051319),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
NAD metabolic process (GO:0019674),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
GDP-mannose metabolic process (GO:0019673),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
rRNA (guanine-N7)-methylation (GO:0070476),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of plant epidermal cell differentiation (GO:1903888),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
aerobic electron transport chain (GO:0019646),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
"jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway (GO:0009868)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"induced systemic resistance, ethylene mediated signaling pathway (GO:0009866)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of systemic acquired resistance (GO:1901672),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
"negative regulation of short-day photoperiodism, flowering (GO:0048577)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
butyrate metabolic process (GO:0019605),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
deoxyribose phosphate biosynthetic process (GO:0046385),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
glycoside transport (GO:1901656),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
response to ketone (GO:1901654),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
cytokinin catabolic process (GO:0009823),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
response to peptide (GO:1901652),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
extracellular polysaccharide metabolic process (GO:0046379),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
L-glutamate biosynthetic process (GO:0097054),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of timing of transition from vegetative to reproductive phase (GO:0048510),18,9,10.76,-,0.84,0.843,1,4,6.46,-,0.62,0.475,1,9,10.2,-,0.88,0.843,1,0,0.18,-, < 0.01,1,1
regulation of timing of meristematic phase transition (GO:0048506),18,9,10.76,-,0.84,0.843,1,4,6.46,-,0.62,0.475,1,9,10.2,-,0.88,0.843,1,0,0.18,-, < 0.01,1,1
positive regulation of fatty acid oxidation (GO:0046321),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pre-mRNA cleavage required for polyadenylation (GO:0098789),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mRNA cleavage involved in mRNA processing (GO:0098787),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
Arp2/3 complex-mediated actin nucleation (GO:0034314),8,4,4.78,-,0.84,1,1,1,2.87,-,0.35,0.461,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
rhamnogalacturonan II metabolic process (GO:0010396),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of histone H3-K27 methylation (GO:0061087),6,3,3.59,-,0.84,1,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
histone monoubiquitination (GO:0010390),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein desumoylation (GO:0016926),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
COP9 signalosome assembly (GO:0010387),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
mitochondrial L-ornithine transmembrane transport (GO:1990575),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of response to nutrient levels (GO:0032107),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
stomatal complex formation (GO:0010376),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of response to extracellular stimulus (GO:0032104),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
positive regulation of gibberellin biosynthetic process (GO:0010372),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of nematode larval development (GO:0061062),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
macromolecule deacylation (GO:0098732),16,8,9.57,-,0.84,0.834,1,6,5.74,+,1.05,1,1,6,9.07,-,0.66,0.507,1,0,0.16,-, < 0.01,1,1
maintenance of cell number (GO:0098727),32,16,19.14,-,0.84,0.655,1,6,11.48,-,0.52,0.195,1,14,18.14,-,0.77,0.447,1,0,0.32,-, < 0.01,1,1
"negative regulation of molecular function, epigenetic (GO:0045857)",2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
uracil import across plasma membrane (GO:0098721),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to trehalose (GO:0010353),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
lithium ion transport (GO:0010351),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial fusion (GO:0008053),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
guanine import across plasma membrane (GO:0098710),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
adenine import across plasma membrane (GO:0098702),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
leaf formation (GO:0010338),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
membrane fusion (GO:0061025),40,20,23.92,-,0.84,0.594,1,12,14.34,-,0.84,0.64,1,17,22.67,-,0.75,0.338,1,0,0.4,-, < 0.01,1,1
spindle disassembly (GO:0051230),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
establishment of protein localization to endoplasmic reticulum (GO:0072599),24,12,14.35,-,0.84,0.731,1,8,8.61,-,0.93,1,1,15,13.6,+,1.1,0.742,1,1,0.24,+,4.15,0.221,1
RNA polyadenylation (GO:0043631),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,7,10.2,-,0.69,0.533,1,0,0.18,-, < 0.01,1,1
lateral growth (GO:0080190),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
nitrate import (GO:1902025),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
auxin efflux (GO:0010315),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
regulation of hydrogen peroxide metabolic process (GO:0010310),10,5,5.98,-,0.84,1,1,4,3.59,+,1.12,0.77,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
mitotic spindle disassembly (GO:0051228),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
rhamnogalacturonan II biosynthetic process (GO:0010306),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
male-female gamete recognition during double fertilization forming a zygote and endosperm (GO:0080173),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
hydrogen peroxide transmembrane transport (GO:0080170),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
callose deposition in phloem sieve plate (GO:0080165),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular amide catabolic process (GO:0043605),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),4,2,2.39,-,0.84,1,1,3,1.43,+,2.09,0.39,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
positive regulation of anion transport (GO:1903793),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
uracil transmembrane transport (GO:1903791),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
AMP transport (GO:0080121),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
maintenance of floral organ identity (GO:0048497),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
purine-containing compound catabolic process (GO:0072523),16,8,9.57,-,0.84,0.834,1,10,5.74,+,1.74,0.181,1,10,9.07,+,1.1,0.839,1,2,0.16,+,12.44,0.0135,1
sporopollenin biosynthetic process (GO:0080110),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
sucrose mediated signaling (GO:0009745),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
style development (GO:0048479),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular trivalent inorganic anion homeostasis (GO:0072502),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular divalent inorganic anion homeostasis (GO:0072501),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
detection of brassinosteroid stimulus (GO:0009729),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
petal formation (GO:0048451),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of vacuole organization (GO:0044090),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
petal morphogenesis (GO:0048446),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
guanine transmembrane transport (GO:1903716),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of plasma membrane bounded cell projection organization (GO:0120035),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of plasma membrane bounded cell projection assembly (GO:0120032),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of anion channel activity (GO:1901529),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
hydrogen peroxide mediated signaling pathway involved in stomatal movement (GO:1901528),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
spermidine catabolic process (GO:0046203),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"regulation of defense response to fungus, incompatible interaction (GO:2000072)",2,1,1.2,-,0.84,1,1,2,0.72,+,2.79,0.285,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
movement in host (GO:0044000),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
regulation of stem cell population maintenance (GO:2000036),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of proanthocyanidin biosynthetic process (GO:2000029),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
centromere clustering (GO:0098653),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mRNA pseudouridine synthesis (GO:1990481),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
regulation of lateral root development (GO:2000023),8,4,4.78,-,0.84,1,1,3,2.87,+,1.05,1,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
regulation of endosperm development (GO:2000014),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
positive regulation of TOR signaling (GO:0032008),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of TOR signaling (GO:0032006),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
respiratory burst involved in defense response (GO:0002679),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
detoxification of copper ion (GO:0010273),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of cellular amino acid metabolic process (GO:0045764),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
box C/D snoRNP assembly (GO:0000492),4,2,2.39,-,0.84,1,1,3,1.43,+,2.09,0.39,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
vitamin transport (GO:0051180),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
endodermal cell differentiation (GO:0035987),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to vitamin B1 (GO:0010266),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
SCF complex assembly (GO:0010265),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of sulfur metabolic process (GO:0051176),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
maturation of 5S rRNA (GO:0000481),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
peroxisomal transport (GO:0043574),16,8,9.57,-,0.84,0.834,1,2,5.74,-,0.35,0.184,1,12,9.07,+,1.32,0.555,1,0,0.16,-, < 0.01,1,1
positive regulation of DNA replication (GO:0045740),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,1,0.02,+,49.77,0.0295,1
COPI-coated vesicle budding (GO:0035964),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,6,10.2,-,0.59,0.294,1,0,0.18,-, < 0.01,1,1
respiratory burst (GO:0045730),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of translation in response to stress (GO:0043555),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of fatty acid biosynthetic process (GO:0045723),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of gluconeogenesis (GO:0045721),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to UV-C (GO:0010225),10,5,5.98,-,0.84,1,1,3,3.59,-,0.84,1,1,2,5.67,-,0.35,0.232,1,0,0.1,-, < 0.01,1,1
maintenance of DNA methylation (GO:0010216),8,4,4.78,-,0.84,1,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
positive regulation of actin nucleation (GO:0051127),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of actin nucleation (GO:0051125),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
response to continuous far red light stimulus by the high-irradiance response system (GO:0010201),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitophagy (GO:0000423),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
DNA ligation involved in DNA repair (GO:0051103),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
D-amino acid catabolic process (GO:0019478),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
regulation of cell projection assembly (GO:0060491),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
endoderm development (GO:0007492),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
etioplast organization (GO:0009662),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to indolebutyric acid (GO:0080026),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
entrainment of circadian clock (GO:0009649),16,8,9.57,-,0.84,0.834,1,3,5.74,-,0.52,0.435,1,10,9.07,+,1.1,0.839,1,0,0.16,-, < 0.01,1,1
photosystem stoichiometry adjustment (GO:0080005),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of tetrapyrrole biosynthetic process (GO:1901465),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
alditol biosynthetic process (GO:0019401),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein poly-ADP-ribosylation (GO:0070212),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein homotrimerization (GO:0070207),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
protein trimerization (GO:0070206),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
virus induced gene silencing (GO:0009616),12,6,7.18,-,0.84,0.811,1,3,4.3,-,0.7,0.772,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
glycerol-3-phosphate biosynthetic process (GO:0046167),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
siroheme metabolic process (GO:0046156),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular response to amino acid starvation (GO:0034198),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
acylglycerol transport (GO:0034196),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pyrimidine nucleoside catabolic process (GO:0046135),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
pyrimidine ribonucleoside catabolic process (GO:0046133),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of tetrapyrrole metabolic process (GO:1901403),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
pyrimidine ribonucleoside metabolic process (GO:0046131),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
phloem sucrose unloading (GO:0110128),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
phloem unloading (GO:0110127),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of embryo sac egg cell differentiation (GO:0045694),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
pyrimidine nucleobase transmembrane transport (GO:1904082),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of cellular defense response (GO:0010186),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
pollen tube guidance (GO:0010183),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
regulation of helicase activity (GO:0051095),6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
chemotaxis (GO:0006935),18,9,10.76,-,0.84,0.843,1,8,6.46,+,1.24,0.656,1,11,10.2,+,1.08,0.848,1,0,0.18,-, < 0.01,1,1
response to nitrate (GO:0010167),16,8,9.57,-,0.84,0.834,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
"nucleotide-excision repair, DNA incision (GO:0033683)",6,3,3.59,-,0.84,1,1,3,2.15,+,1.39,0.706,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
alkane biosynthetic process (GO:0043447),4,2,2.39,-,0.84,1,1,3,1.43,+,2.09,0.39,1,3,2.27,+,1.32,0.709,1,1,0.04,+,24.89,0.0488,1
negative regulation of systemic acquired resistance (GO:0010113),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
flavin adenine dinucleotide biosynthetic process (GO:0072388),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
actin filament severing (GO:0051014),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
glycolipid catabolic process (GO:0019377),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
peptidyl-diphthamide metabolic process (GO:0017182),6,3,3.59,-,0.84,1,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
rescue of stalled ribosome (GO:0072344),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
siroheme biosynthetic process (GO:0019354),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
dolichol metabolic process (GO:0019348),4,2,2.39,-,0.84,1,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
cysteine biosynthetic process via cystathionine (GO:0019343),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
megasporogenesis (GO:0009554),8,4,4.78,-,0.84,1,1,2,2.87,-,0.7,1,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
positive regulation of mitochondrial translation (GO:0070131),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
gastrulation (GO:0007369),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to microtubule end (GO:1905725),2,1,1.2,-,0.84,1,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of mitochondrial translation (GO:0070129),6,3,3.59,-,0.84,1,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
mitochondrial translational elongation (GO:0070125),4,2,2.39,-,0.84,1,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
clathrin coat assembly (GO:0048268),10,5,5.98,-,0.84,1,1,3,3.59,-,0.84,1,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
iron import into the mitochondrion (GO:0048250),2,1,1.2,-,0.84,1,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of lateral root development (GO:1901333),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
pollen sperm cell differentiation (GO:0048235),18,9,10.76,-,0.84,0.843,1,5,6.46,-,0.77,0.813,1,8,10.2,-,0.78,0.685,1,0,0.18,-, < 0.01,1,1
UTP metabolic process (GO:0046051),4,2,2.39,-,0.84,1,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
protein glycosylation (GO:0006486),100,50,59.8,-,0.84,0.311,1,21,35.86,-,0.59,0.0227,1,45,56.69,-,0.79,0.225,1,0,1,-, < 0.01,0.629,1
cellular component assembly involved in morphogenesis (GO:0010927),28,14,16.74,-,0.84,0.635,1,8,10.04,-,0.8,0.706,1,14,15.87,-,0.88,0.751,1,0,0.28,-, < 0.01,1,1
DNA packaging (GO:0006323),62,31,37.08,-,0.84,0.453,1,16,22.23,-,0.72,0.302,1,25,35.15,-,0.71,0.179,1,0,0.62,-, < 0.01,1,1
actin filament-based transport (GO:0099515),14,7,8.37,-,0.84,0.823,1,5,5.02,-,1,1,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
regulation of intracellular transport (GO:0032386),14,7,8.37,-,0.84,0.823,1,5,5.02,-,1,1,1,6,7.94,-,0.76,0.648,1,0,0.14,-, < 0.01,1,1
nuclear RNA surveillance (GO:0071027),14,7,8.37,-,0.84,0.823,1,5,5.02,-,1,1,1,6,7.94,-,0.76,0.648,1,0,0.14,-, < 0.01,1,1
regulation of flavonoid biosynthetic process (GO:0009962),14,7,8.37,-,0.84,0.823,1,6,5.02,+,1.2,0.8,1,7,7.94,-,0.88,1,1,1,0.14,+,7.11,0.139,1
cellular nitrogen compound catabolic process (GO:0044270),130,65,77.74,-,0.84,0.265,1,37,46.62,-,0.79,0.251,1,69,73.69,-,0.94,0.711,1,2,1.31,+,1.53,0.379,1
organophosphate catabolic process (GO:0046434),38,19,22.72,-,0.84,0.585,1,13,13.63,-,0.95,1,1,23,21.54,+,1.07,0.791,1,0,0.38,-, < 0.01,1,1
nucleobase-containing small molecule biosynthetic process (GO:0034404),28,14,16.74,-,0.84,0.635,1,11,10.04,+,1.1,0.856,1,14,15.87,-,0.88,0.751,1,0,0.28,-, < 0.01,1,1
intercellular transport (GO:0010496),14,7,8.37,-,0.84,0.823,1,4,5.02,-,0.8,0.796,1,9,7.94,+,1.13,0.829,1,0,0.14,-, < 0.01,1,1
actin filament-based movement (GO:0030048),14,7,8.37,-,0.84,0.823,1,5,5.02,-,1,1,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
rRNA base methylation (GO:0070475),14,7,8.37,-,0.84,0.823,1,4,5.02,-,0.8,0.796,1,4,7.94,-,0.5,0.326,1,0,0.14,-, < 0.01,1,1
positive regulation of lipid metabolic process (GO:0045834),14,7,8.37,-,0.84,0.823,1,4,5.02,-,0.8,0.796,1,5,7.94,-,0.63,0.477,1,0,0.14,-, < 0.01,1,1
gibberellic acid mediated signaling pathway (GO:0009740),28,14,16.74,-,0.84,0.635,1,11,10.04,+,1.1,0.856,1,15,15.87,-,0.95,1,1,0,0.28,-, < 0.01,1,1
inorganic anion transmembrane transport (GO:0098661),14,7,8.37,-,0.84,0.823,1,9,5.02,+,1.79,0.163,1,6,7.94,-,0.76,0.648,1,0,0.14,-, < 0.01,1,1
"regulation of photoperiodism, flowering (GO:2000028)",38,19,22.72,-,0.84,0.585,1,9,13.63,-,0.66,0.321,1,28,21.54,+,1.3,0.306,1,0,0.38,-, < 0.01,1,1
regulation of auxin polar transport (GO:2000012),14,7,8.37,-,0.84,0.823,1,5,5.02,-,1,1,1,3,7.94,-,0.38,0.134,1,0,0.14,-, < 0.01,1,1
macromolecule glycosylation (GO:0043413),100,50,59.8,-,0.84,0.311,1,21,35.86,-,0.59,0.0227,1,45,56.69,-,0.79,0.225,1,0,1,-, < 0.01,0.629,1
histone lysine methylation (GO:0034968),34,17,20.33,-,0.84,0.664,1,11,12.19,-,0.9,0.866,1,18,19.27,-,0.93,0.886,1,0,0.34,-, < 0.01,1,1
rRNA metabolic process (GO:0016072),195,97,116.61,-,0.83,0.144,1,81,69.93,+,1.16,0.271,1,70,110.54,-,0.63,0.000791,0.323,0,1.96,-, < 0.01,0.27,1
glycoprotein metabolic process (GO:0009100),109,54,65.18,-,0.83,0.291,1,22,39.09,-,0.56,0.0125,1,48,61.79,-,0.78,0.156,1,0,1.1,-, < 0.01,0.63,1
glycoprotein biosynthetic process (GO:0009101),101,50,60.4,-,0.83,0.311,1,21,36.22,-,0.58,0.0228,1,45,57.25,-,0.79,0.195,1,0,1.01,-, < 0.01,0.629,1
nucleic acid metabolic process (GO:0090304),1236,611,739.14,-,0.83,4.92E-05,0.281,360,443.25,-,0.81,0.000246,0.0825,550,700.63,-,0.79,6.25E-07,0.00357,3,12.42,-,0.24,0.00226,0.992
ribosome biogenesis (GO:0042254),255,126,152.49,-,0.83,0.078,1,101,91.45,+,1.1,0.395,1,87,144.55,-,0.6,2.47E-05,0.047,0,2.56,-, < 0.01,0.187,1
membrane lipid metabolic process (GO:0006643),83,41,49.63,-,0.83,0.352,1,34,29.77,+,1.14,0.528,1,44,47.05,-,0.94,0.781,1,2,0.83,+,2.4,0.207,1
regulation of transcription by RNA polymerase II (GO:0006357),245,121,146.51,-,0.83,0.091,1,63,87.86,-,0.72,0.0158,1,117,138.88,-,0.84,0.136,1,1,2.46,-,0.41,0.523,1
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),65,32,38.87,-,0.82,0.401,1,19,23.31,-,0.82,0.535,1,28,36.85,-,0.76,0.236,1,2,0.65,+,3.06,0.143,1
response to gravity (GO:0009629),65,32,38.87,-,0.82,0.401,1,19,23.31,-,0.82,0.535,1,31,36.85,-,0.84,0.458,1,0,0.65,-, < 0.01,1,1
regulation of seedling development (GO:1900140),63,31,37.67,-,0.82,0.395,1,20,22.59,-,0.89,0.709,1,34,35.71,-,0.95,0.916,1,0,0.63,-, < 0.01,1,1
covalent chromatin modification (GO:0016569),116,57,69.37,-,0.82,0.237,1,34,41.6,-,0.82,0.352,1,53,65.76,-,0.81,0.199,1,1,1.17,-,0.86,1,1
chromatin assembly or disassembly (GO:0006333),57,28,34.09,-,0.82,0.433,1,14,20.44,-,0.68,0.226,1,23,32.31,-,0.71,0.199,1,0,0.57,-, < 0.01,1,1
histone modification (GO:0016570),110,54,65.78,-,0.82,0.257,1,32,39.45,-,0.81,0.339,1,51,62.35,-,0.82,0.25,1,1,1.11,-,0.9,1,1
phospholipid biosynthetic process (GO:0008654),88,43,52.62,-,0.82,0.319,1,31,31.56,-,0.98,1,1,42,49.88,-,0.84,0.41,1,2,0.88,+,2.26,0.225,1
"mRNA splicing, via spliceosome (GO:0000398)",142,69,84.92,-,0.81,0.174,1,43,50.92,-,0.84,0.357,1,65,80.49,-,0.81,0.167,1,0,1.43,-, < 0.01,0.408,1
regulation of DNA replication (GO:0006275),33,16,19.73,-,0.81,0.556,1,8,11.83,-,0.68,0.378,1,13,18.71,-,0.69,0.286,1,1,0.33,+,3.02,0.288,1
gene silencing (GO:0016458),124,60,74.15,-,0.81,0.193,1,29,44.47,-,0.65,0.0344,1,51,70.29,-,0.73,0.0577,1,0,1.25,-, < 0.01,0.638,1
positive regulation of organelle organization (GO:0010638),60,29,35.88,-,0.81,0.381,1,11,21.52,-,0.51,0.042,1,30,34.01,-,0.88,0.66,1,0,0.6,-, < 0.01,1,1
phospholipid metabolic process (GO:0006644),145,70,86.71,-,0.81,0.156,1,46,52,-,0.88,0.509,1,75,82.19,-,0.91,0.573,1,2,1.46,+,1.37,0.659,1
serine family amino acid biosynthetic process (GO:0009070),29,14,17.34,-,0.81,0.636,1,11,10.4,+,1.06,0.858,1,14,16.44,-,0.85,0.751,1,1,0.29,+,3.43,0.259,1
nucleosome assembly (GO:0006334),27,13,16.15,-,0.81,0.625,1,6,9.68,-,0.62,0.329,1,9,15.31,-,0.59,0.223,1,0,0.27,-, < 0.01,1,1
negative regulation of multicellular organismal process (GO:0051241),79,38,47.24,-,0.8,0.293,1,25,28.33,-,0.88,0.656,1,41,44.78,-,0.92,0.703,1,0,0.79,-, < 0.01,1,1
chromatin assembly (GO:0031497),52,25,31.1,-,0.8,0.41,1,12,18.65,-,0.64,0.201,1,20,29.48,-,0.68,0.143,1,0,0.52,-, < 0.01,1,1
ribonucleoprotein complex biogenesis (GO:0022613),310,149,185.38,-,0.8,0.0281,1,113,111.17,+,1.02,0.867,1,108,175.73,-,0.61,5.66E-06,0.0162,0,3.11,-, < 0.01,0.0786,1
regulation of pH (GO:0006885),25,12,14.95,-,0.8,0.612,1,7,8.97,-,0.78,0.69,1,11,14.17,-,0.78,0.603,1,0,0.25,-, < 0.01,1,1
dsRNA processing (GO:0031050),50,24,29.9,-,0.8,0.402,1,15,17.93,-,0.84,0.672,1,22,28.34,-,0.78,0.39,1,0,0.5,-, < 0.01,1,1
production of small RNA involved in gene silencing by RNA (GO:0070918),50,24,29.9,-,0.8,0.402,1,15,17.93,-,0.84,0.672,1,22,28.34,-,0.78,0.39,1,0,0.5,-, < 0.01,1,1
negative regulation of organelle organization (GO:0010639),25,12,14.95,-,0.8,0.612,1,3,8.97,-,0.33,0.0829,1,12,14.17,-,0.85,0.733,1,0,0.25,-, < 0.01,1,1
ncRNA 3'-end processing (GO:0043628),25,12,14.95,-,0.8,0.612,1,9,8.97,+,1,1,1,10,14.17,-,0.71,0.384,1,0,0.25,-, < 0.01,1,1
regulation of DNA metabolic process (GO:0051052),73,35,43.65,-,0.8,0.319,1,16,26.18,-,0.61,0.0715,1,28,41.38,-,0.68,0.0783,1,0,0.73,-, < 0.01,1,1
pattern specification process (GO:0007389),121,58,72.36,-,0.8,0.187,1,33,43.39,-,0.76,0.169,1,50,68.59,-,0.73,0.0657,1,0,1.22,-, < 0.01,0.636,1
mitotic nuclear division (GO:0140014),48,23,28.7,-,0.8,0.461,1,12,17.21,-,0.7,0.306,1,19,27.21,-,0.7,0.204,1,0,0.48,-, < 0.01,1,1
folic acid-containing compound metabolic process (GO:0006760),23,11,13.75,-,0.8,0.599,1,7,8.25,-,0.85,0.837,1,13,13.04,-,1,1,1,2,0.23,+,8.66,0.0254,1
glutamine family amino acid biosynthetic process (GO:0009084),23,11,13.75,-,0.8,0.599,1,5,8.25,-,0.61,0.393,1,12,13.04,-,0.92,0.862,1,0,0.23,-, < 0.01,1,1
embryonic morphogenesis (GO:0048598),23,11,13.75,-,0.8,0.599,1,4,8.25,-,0.48,0.197,1,10,13.04,-,0.77,0.588,1,0,0.23,-, < 0.01,1,1
pollen development (GO:0009555),214,102,127.97,-,0.8,0.0608,1,66,76.74,-,0.86,0.305,1,98,121.31,-,0.81,0.0849,1,2,2.15,-,0.93,1,1
cellular response to cold (GO:0070417),21,10,12.56,-,0.8,0.711,1,8,7.53,+,1.06,0.835,1,12,11.9,+,1.01,1,1,0,0.21,-, < 0.01,1,1
male gamete generation (GO:0048232),42,20,25.12,-,0.8,0.433,1,13,15.06,-,0.86,0.76,1,22,23.81,-,0.92,0.796,1,0,0.42,-, < 0.01,1,1
chromatin organization (GO:0006325),225,107,134.55,-,0.8,0.0518,1,55,80.69,-,0.68,0.0093,0.9,101,127.54,-,0.79,0.055,1,1,2.26,-,0.44,0.73,1
regulation of seed germination (GO:0010029),61,29,36.48,-,0.79,0.328,1,18,21.88,-,0.82,0.524,1,32,34.58,-,0.93,0.747,1,0,0.61,-, < 0.01,1,1
nucleosome organization (GO:0034728),40,19,23.92,-,0.79,0.501,1,10,14.34,-,0.7,0.34,1,14,22.67,-,0.62,0.121,1,0,0.4,-, < 0.01,1,1
multi-organism reproductive process (GO:0044703),97,46,58.01,-,0.79,0.225,1,27,34.79,-,0.78,0.262,1,47,54.99,-,0.85,0.434,1,0,0.97,-, < 0.01,1,1
sexual reproduction (GO:0019953),97,46,58.01,-,0.79,0.225,1,27,34.79,-,0.78,0.262,1,47,54.99,-,0.85,0.434,1,0,0.97,-, < 0.01,1,1
L-serine metabolic process (GO:0006563),19,9,11.36,-,0.79,0.697,1,9,6.81,+,1.32,0.52,1,10,10.77,-,0.93,1,1,1,0.19,+,5.24,0.181,1
maintenance of protein location (GO:0045185),19,9,11.36,-,0.79,0.697,1,4,6.81,-,0.59,0.477,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
maintenance of protein location in cell (GO:0032507),19,9,11.36,-,0.79,0.697,1,4,6.81,-,0.59,0.477,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
establishment of vesicle localization (GO:0051650),19,9,11.36,-,0.79,0.697,1,4,6.81,-,0.59,0.477,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
vesicle localization (GO:0051648),19,9,11.36,-,0.79,0.697,1,4,6.81,-,0.59,0.477,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
regulation of gene silencing by RNA (GO:0060966),19,9,11.36,-,0.79,0.697,1,5,6.81,-,0.73,0.648,1,7,10.77,-,0.65,0.416,1,0,0.19,-, < 0.01,1,1
tetrahydrofolate metabolic process (GO:0046653),19,9,11.36,-,0.79,0.697,1,6,6.81,-,0.88,1,1,10,10.77,-,0.93,1,1,2,0.19,+,10.48,0.0182,1
pollen exine formation (GO:0010584),19,9,11.36,-,0.79,0.697,1,6,6.81,-,0.88,1,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),19,9,11.36,-,0.79,0.697,1,3,6.81,-,0.44,0.229,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
negative regulation of post-embryonic development (GO:0048581),72,34,43.06,-,0.79,0.27,1,23,25.82,-,0.89,0.726,1,37,40.81,-,0.91,0.69,1,0,0.72,-, < 0.01,1,1
phloem or xylem histogenesis (GO:0010087),68,32,40.66,-,0.79,0.3,1,18,24.39,-,0.74,0.272,1,34,38.55,-,0.88,0.606,1,0,0.68,-, < 0.01,1,1
cell cycle checkpoint (GO:0000075),34,16,20.33,-,0.79,0.468,1,4,12.19,-,0.33,0.026,1,13,19.27,-,0.67,0.287,1,0,0.34,-, < 0.01,1,1
positive regulation of histone modification (GO:0031058),17,8,10.17,-,0.79,0.682,1,2,6.1,-,0.33,0.189,1,9,9.64,-,0.93,1,1,0,0.17,-, < 0.01,1,1
regulation of phenylpropanoid metabolic process (GO:2000762),17,8,10.17,-,0.79,0.682,1,6,6.1,-,0.98,1,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
postreplication repair (GO:0006301),17,8,10.17,-,0.79,0.682,1,2,6.1,-,0.33,0.189,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
adaxial/abaxial axis specification (GO:0009943),17,8,10.17,-,0.79,0.682,1,3,6.1,-,0.49,0.317,1,7,9.64,-,0.73,0.531,1,0,0.17,-, < 0.01,1,1
organelle membrane fusion (GO:0090174),32,15,19.14,-,0.78,0.546,1,9,11.48,-,0.78,0.598,1,13,18.14,-,0.72,0.354,1,0,0.32,-, < 0.01,1,1
Golgi vesicle budding (GO:0048194),15,7,8.97,-,0.78,0.665,1,4,5.38,-,0.74,0.796,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
regulation of posttranscriptional gene silencing (GO:0060147),15,7,8.97,-,0.78,0.665,1,3,5.38,-,0.56,0.433,1,7,8.5,-,0.82,0.825,1,0,0.15,-, < 0.01,1,1
peroxisomal membrane transport (GO:0015919),15,7,8.97,-,0.78,0.665,1,2,5.38,-,0.37,0.269,1,12,8.5,+,1.41,0.424,1,0,0.15,-, < 0.01,1,1
microtubule polymerization or depolymerization (GO:0031109),15,7,8.97,-,0.78,0.665,1,2,5.38,-,0.37,0.269,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
protein deacetylation (GO:0006476),15,7,8.97,-,0.78,0.665,1,6,5.38,+,1.12,0.806,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
meiotic sister chromatid segregation (GO:0045144),15,7,8.97,-,0.78,0.665,1,3,5.38,-,0.56,0.433,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
serine family amino acid catabolic process (GO:0009071),15,7,8.97,-,0.78,0.665,1,6,5.38,+,1.12,0.806,1,11,8.5,+,1.29,0.543,1,1,0.15,+,6.64,0.148,1
RNA surveillance (GO:0071025),15,7,8.97,-,0.78,0.665,1,5,5.38,-,0.93,1,1,7,8.5,-,0.82,0.825,1,0,0.15,-, < 0.01,1,1
polarity specification of adaxial/abaxial axis (GO:0009944),15,7,8.97,-,0.78,0.665,1,2,5.38,-,0.37,0.269,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
production of ta-siRNAs involved in RNA interference (GO:0010267),15,7,8.97,-,0.78,0.665,1,5,5.38,-,0.93,1,1,7,8.5,-,0.82,0.825,1,0,0.15,-, < 0.01,1,1
meiotic sister chromatid cohesion (GO:0051177),15,7,8.97,-,0.78,0.665,1,3,5.38,-,0.56,0.433,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
"DNA-templated transcription, initiation (GO:0006352)",45,21,26.91,-,0.78,0.375,1,10,16.14,-,0.62,0.219,1,20,25.51,-,0.78,0.438,1,0,0.45,-, < 0.01,1,1
IMP metabolic process (GO:0046040),13,6,7.77,-,0.77,0.813,1,4,4.66,-,0.86,1,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
nucleoside phosphate catabolic process (GO:1901292),13,6,7.77,-,0.77,0.813,1,4,4.66,-,0.86,1,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
flavin-containing compound metabolic process (GO:0042726),13,6,7.77,-,0.77,0.813,1,7,4.66,+,1.5,0.445,1,7,7.37,-,0.95,1,1,1,0.13,+,7.66,0.131,1
DNA replication checkpoint (GO:0000076),13,6,7.77,-,0.77,0.813,1,2,4.66,-,0.43,0.381,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
cell cycle DNA replication (GO:0044786),26,12,15.55,-,0.77,0.506,1,4,9.32,-,0.43,0.145,1,4,14.74,-,0.27,0.00748,0.749,0,0.26,-, < 0.01,1,1
regulation of secondary cell wall biogenesis (GO:2000652),13,6,7.77,-,0.77,0.813,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
negative regulation of nuclear division (GO:0051784),13,6,7.77,-,0.77,0.813,1,1,4.66,-,0.21,0.133,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
regulation of DNA-dependent DNA replication (GO:0090329),26,12,15.55,-,0.77,0.506,1,7,9.32,-,0.75,0.692,1,9,14.74,-,0.61,0.222,1,1,0.26,+,3.83,0.237,1
regulation of hormone metabolic process (GO:0032350),13,6,7.77,-,0.77,0.813,1,5,4.66,+,1.07,1,1,7,7.37,-,0.95,1,1,1,0.13,+,7.66,0.131,1
nuclear mRNA surveillance (GO:0071028),13,6,7.77,-,0.77,0.813,1,5,4.66,+,1.07,1,1,5,7.37,-,0.68,0.625,1,0,0.13,-, < 0.01,1,1
response to freezing (GO:0050826),13,6,7.77,-,0.77,0.813,1,7,4.66,+,1.5,0.445,1,9,7.37,+,1.22,0.661,1,0,0.13,-, < 0.01,1,1
pollen wall assembly (GO:0010208),26,12,15.55,-,0.77,0.506,1,7,9.32,-,0.75,0.692,1,13,14.74,-,0.88,0.868,1,0,0.26,-, < 0.01,1,1
cellular response to virus (GO:0098586),13,6,7.77,-,0.77,0.813,1,3,4.66,-,0.64,0.584,1,6,7.37,-,0.81,0.813,1,0,0.13,-, < 0.01,1,1
regulation of reactive oxygen species metabolic process (GO:2000377),39,18,23.32,-,0.77,0.412,1,13,13.99,-,0.93,1,1,20,22.11,-,0.9,0.787,1,0,0.39,-, < 0.01,1,1
nuclear-transcribed mRNA catabolic process (GO:0000956),50,23,29.9,-,0.77,0.333,1,11,17.93,-,0.61,0.148,1,23,28.34,-,0.81,0.465,1,0,0.5,-, < 0.01,1,1
regulation of gene silencing (GO:0060968),50,23,29.9,-,0.77,0.333,1,12,17.93,-,0.67,0.249,1,18,28.34,-,0.64,0.101,1,0,0.5,-, < 0.01,1,1
ribonucleoprotein complex export from nucleus (GO:0071426),37,17,22.13,-,0.77,0.401,1,14,13.27,+,1.06,0.874,1,13,20.97,-,0.62,0.143,1,0,0.37,-, < 0.01,1,1
ribonucleoprotein complex localization (GO:0071166),37,17,22.13,-,0.77,0.401,1,14,13.27,+,1.06,0.874,1,13,20.97,-,0.62,0.143,1,0,0.37,-, < 0.01,1,1
cell cycle (GO:0007049),320,147,191.36,-,0.77,0.00774,1,64,114.76,-,0.56,5.96E-06,0.0113,138,181.39,-,0.76,0.00676,0.743,1,3.21,-,0.31,0.383,1
membrane lipid biosynthetic process (GO:0046467),70,32,41.86,-,0.76,0.22,1,28,25.1,+,1.12,0.646,1,33,39.68,-,0.83,0.412,1,1,0.7,+,1.42,0.509,1
cell cycle process (GO:0022402),300,137,179.4,-,0.76,0.00805,1,59,107.59,-,0.55,6.94E-06,0.00991,129,170.06,-,0.76,0.0082,0.72,0,3.01,-, < 0.01,0.0784,1
DNA modification (GO:0006304),33,15,19.73,-,0.76,0.456,1,5,11.83,-,0.42,0.0665,1,14,18.71,-,0.75,0.448,1,0,0.33,-, < 0.01,1,1
regulation of response to red or far red light (GO:2000030),33,15,19.73,-,0.76,0.456,1,11,11.83,-,0.93,1,1,19,18.71,+,1.02,1,1,0,0.33,-, < 0.01,1,1
threonine metabolic process (GO:0006566),11,5,6.58,-,0.76,0.797,1,3,3.94,-,0.76,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
regulation of brassinosteroid mediated signaling pathway (GO:1900457),11,5,6.58,-,0.76,0.797,1,4,3.94,+,1.01,1,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
transcription by RNA polymerase II (GO:0006366),44,20,26.31,-,0.76,0.365,1,12,15.78,-,0.76,0.451,1,12,24.94,-,0.48,0.025,1,0,0.44,-, < 0.01,1,1
DNA methylation (GO:0006306),22,10,13.16,-,0.76,0.584,1,4,7.89,-,0.51,0.267,1,10,12.47,-,0.8,0.713,1,0,0.22,-, < 0.01,1,1
DNA alkylation (GO:0006305),22,10,13.16,-,0.76,0.584,1,4,7.89,-,0.51,0.267,1,10,12.47,-,0.8,0.713,1,0,0.22,-, < 0.01,1,1
protein maturation by iron-sulfur cluster transfer (GO:0097428),11,5,6.58,-,0.76,0.797,1,5,3.94,+,1.27,0.777,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
anther dehiscence (GO:0009901),11,5,6.58,-,0.76,0.797,1,2,3.94,-,0.51,0.534,1,7,6.24,+,1.12,0.81,1,0,0.11,-, < 0.01,1,1
"long-day photoperiodism, flowering (GO:0048574)",11,5,6.58,-,0.76,0.797,1,2,3.94,-,0.51,0.534,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
protein-containing complex localization (GO:0031503),44,20,26.31,-,0.76,0.365,1,15,15.78,-,0.95,1,1,15,24.94,-,0.6,0.103,1,0,0.44,-, < 0.01,1,1
RNA catabolic process (GO:0006401),73,33,43.65,-,0.76,0.192,1,14,26.18,-,0.53,0.028,1,33,41.38,-,0.8,0.311,1,0,0.73,-, < 0.01,1,1
organelle fission (GO:0048285),155,70,92.69,-,0.76,0.0523,1,41,55.59,-,0.74,0.0869,1,68,87.86,-,0.77,0.0798,1,0,1.56,-, < 0.01,0.411,1
positive regulation of transcription by RNA polymerase II (GO:0045944),82,37,49.04,-,0.75,0.183,1,21,29.41,-,0.71,0.18,1,33,46.48,-,0.71,0.0986,1,0,0.82,-, < 0.01,1,1
protein export from nucleus (GO:0006611),40,18,23.92,-,0.75,0.344,1,15,14.34,+,1.05,0.879,1,14,22.67,-,0.62,0.121,1,0,0.4,-, < 0.01,1,1
regulation of cell cycle G2/M phase transition (GO:1902749),20,9,11.96,-,0.75,0.567,1,3,7.17,-,0.42,0.234,1,10,11.34,-,0.88,0.85,1,0,0.2,-, < 0.01,1,1
protein localization to endoplasmic reticulum (GO:0070972),40,18,23.92,-,0.75,0.344,1,9,14.34,-,0.63,0.256,1,22,22.67,-,0.97,1,1,1,0.4,+,2.49,0.337,1
positive gravitropism (GO:0009958),20,9,11.96,-,0.75,0.567,1,6,7.17,-,0.84,0.826,1,8,11.34,-,0.71,0.439,1,0,0.2,-, < 0.01,1,1
regulation of gibberellic acid mediated signaling pathway (GO:0009937),20,9,11.96,-,0.75,0.567,1,5,7.17,-,0.7,0.65,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
inositol phosphate metabolic process (GO:0043647),20,9,11.96,-,0.75,0.567,1,8,7.17,+,1.12,0.83,1,11,11.34,-,0.97,1,1,0,0.2,-, < 0.01,1,1
gravitropism (GO:0009630),58,26,34.68,-,0.75,0.259,1,17,20.8,-,0.82,0.514,1,25,32.88,-,0.76,0.303,1,0,0.58,-, < 0.01,1,1
vesicle fusion (GO:0006906),29,13,17.34,-,0.75,0.428,1,8,10.4,-,0.77,0.58,1,11,16.44,-,0.67,0.323,1,0,0.29,-, < 0.01,1,1
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),9,4,5.38,-,0.74,0.778,1,1,3.23,-,0.31,0.472,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
phosphatidylglycerol biosynthetic process (GO:0006655),9,4,5.38,-,0.74,0.778,1,1,3.23,-,0.31,0.472,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
rRNA pseudouridine synthesis (GO:0031118),9,4,5.38,-,0.74,0.778,1,2,3.23,-,0.62,0.739,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
vesicle cargo loading (GO:0035459),9,4,5.38,-,0.74,0.778,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),9,4,5.38,-,0.74,0.778,1,0,3.23,-, < 0.01,0.124,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920),9,4,5.38,-,0.74,0.778,1,3,3.23,-,0.93,1,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
threonine biosynthetic process (GO:0009088),9,4,5.38,-,0.74,0.778,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
histone H3-K4 methylation (GO:0051568),9,4,5.38,-,0.74,0.778,1,3,3.23,-,0.93,1,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
histone H4 acetylation (GO:0043967),9,4,5.38,-,0.74,0.778,1,2,3.23,-,0.62,0.739,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
ceramide biosynthetic process (GO:0046513),9,4,5.38,-,0.74,0.778,1,5,3.23,+,1.55,0.543,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
COPII-coated vesicle cargo loading (GO:0090110),9,4,5.38,-,0.74,0.778,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
regulation of cellular localization (GO:0060341),27,12,16.15,-,0.74,0.508,1,7,9.68,-,0.72,0.56,1,14,15.31,-,0.91,0.872,1,0,0.27,-, < 0.01,1,1
protein localization to nucleus (GO:0034504),43,19,25.71,-,0.74,0.295,1,8,15.42,-,0.52,0.11,1,13,24.37,-,0.53,0.0505,1,0,0.43,-, < 0.01,1,1
adaxial/abaxial pattern specification (GO:0009955),25,11,14.95,-,0.74,0.491,1,4,8.97,-,0.45,0.143,1,9,14.17,-,0.64,0.286,1,0,0.25,-, < 0.01,1,1
regionalization (GO:0003002),100,44,59.8,-,0.74,0.1,1,23,35.86,-,0.64,0.0515,1,39,56.69,-,0.69,0.051,1,0,1,-, < 0.01,0.629,1
gamete generation (GO:0007276),48,21,28.7,-,0.73,0.263,1,14,17.21,-,0.81,0.565,1,22,27.21,-,0.81,0.456,1,0,0.48,-, < 0.01,1,1
glycolipid metabolic process (GO:0006664),48,21,28.7,-,0.73,0.263,1,15,17.21,-,0.87,0.775,1,20,27.21,-,0.74,0.258,1,1,0.48,+,2.07,0.388,1
regulation of cellular pH (GO:0030641),16,7,9.57,-,0.73,0.667,1,3,5.74,-,0.52,0.435,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
regulation of cellular amino acid metabolic process (GO:0006521),16,7,9.57,-,0.73,0.667,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
regulation of cellular amine metabolic process (GO:0033238),16,7,9.57,-,0.73,0.667,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
glycerolipid biosynthetic process (GO:0045017),80,35,47.84,-,0.73,0.123,1,22,28.69,-,0.77,0.311,1,36,45.35,-,0.79,0.286,1,1,0.8,+,1.24,0.556,1
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),16,7,9.57,-,0.73,0.667,1,3,5.74,-,0.52,0.435,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
peptidyl-L-cysteine S-palmitoylation (GO:0018230),16,7,9.57,-,0.73,0.667,1,3,5.74,-,0.52,0.435,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
regulation of intracellular pH (GO:0051453),16,7,9.57,-,0.73,0.667,1,3,5.74,-,0.52,0.435,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
dehiscence (GO:0009900),16,7,9.57,-,0.73,0.667,1,4,5.74,-,0.7,0.62,1,9,9.07,-,0.99,1,1,0,0.16,-, < 0.01,1,1
phloem transport (GO:0010233),16,7,9.57,-,0.73,0.667,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
vascular transport (GO:0010232),16,7,9.57,-,0.73,0.667,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
vascular process in circulatory system (GO:0003018),16,7,9.57,-,0.73,0.667,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
circulatory system process (GO:0003013),16,7,9.57,-,0.73,0.667,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
system process (GO:0003008),16,7,9.57,-,0.73,0.667,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
liposaccharide metabolic process (GO:1903509),48,21,28.7,-,0.73,0.263,1,15,17.21,-,0.87,0.775,1,20,27.21,-,0.74,0.258,1,1,0.48,+,2.07,0.388,1
glycerolipid metabolic process (GO:0046486),124,54,74.15,-,0.73,0.0518,1,35,44.47,-,0.79,0.24,1,57,70.29,-,0.81,0.214,1,1,1.25,-,0.8,1,1
negative regulation of DNA metabolic process (GO:0051053),23,10,13.75,-,0.73,0.474,1,5,8.25,-,0.61,0.393,1,10,13.04,-,0.77,0.588,1,0,0.23,-, < 0.01,1,1
microsporogenesis (GO:0009556),23,10,13.75,-,0.73,0.474,1,6,8.25,-,0.73,0.673,1,9,13.04,-,0.69,0.462,1,0,0.23,-, < 0.01,1,1
negative regulation of cell cycle process (GO:0010948),30,13,17.94,-,0.72,0.35,1,5,10.76,-,0.46,0.125,1,10,17.01,-,0.59,0.187,1,0,0.3,-, < 0.01,1,1
floral organ morphogenesis (GO:0048444),30,13,17.94,-,0.72,0.35,1,12,10.76,+,1.12,0.728,1,13,17.01,-,0.76,0.525,1,1,0.3,+,3.32,0.267,1
regulation of circadian rhythm (GO:0042752),44,19,26.31,-,0.72,0.244,1,7,15.78,-,0.44,0.0389,1,26,24.94,+,1.04,0.901,1,1,0.44,+,2.26,0.363,1
xylem and phloem pattern formation (GO:0010051),51,22,30.5,-,0.72,0.226,1,13,18.29,-,0.71,0.321,1,18,28.91,-,0.62,0.102,1,0,0.51,-, < 0.01,1,1
nuclear transport (GO:0051169),79,34,47.24,-,0.72,0.119,1,22,28.33,-,0.78,0.311,1,24,44.78,-,0.54,0.0072,0.747,0,0.79,-, < 0.01,1,1
nucleocytoplasmic transport (GO:0006913),79,34,47.24,-,0.72,0.119,1,22,28.33,-,0.78,0.311,1,24,44.78,-,0.54,0.0072,0.734,0,0.79,-, < 0.01,1,1
nucleobase-containing compound catabolic process (GO:0034655),98,42,58.6,-,0.72,0.0793,1,22,35.14,-,0.63,0.0479,1,46,55.55,-,0.83,0.298,1,2,0.98,+,2.03,0.262,1
sister chromatid segregation (GO:0000819),49,21,29.3,-,0.72,0.217,1,11,17.57,-,0.63,0.187,1,17,27.78,-,0.61,0.0946,1,0,0.49,-, < 0.01,1,1
cellular copper ion homeostasis (GO:0006878),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
meristem determinacy (GO:0010022),14,6,8.37,-,0.72,0.645,1,6,5.02,+,1.2,0.8,1,4,7.94,-,0.5,0.326,1,0,0.14,-, < 0.01,1,1
regulation of sulfur amino acid metabolic process (GO:0031335),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
histone deacetylation (GO:0016575),14,6,8.37,-,0.72,0.645,1,5,5.02,-,1,1,1,4,7.94,-,0.5,0.326,1,0,0.14,-, < 0.01,1,1
regulation of lignin biosynthetic process (GO:1901141),7,3,4.19,-,0.72,0.753,1,4,2.51,+,1.59,0.496,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
phosphatidylethanolamine biosynthetic process (GO:0006646),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
mitotic chromosome condensation (GO:0007076),7,3,4.19,-,0.72,0.753,1,1,2.51,-,0.4,0.69,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
regulation of chromatin assembly or disassembly (GO:0001672),7,3,4.19,-,0.72,0.753,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
cellular response to red light (GO:0071491),7,3,4.19,-,0.72,0.753,1,4,2.51,+,1.59,0.496,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
protein neddylation (GO:0045116),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
phosphatidylinositol phosphorylation (GO:0046854),14,6,8.37,-,0.72,0.645,1,5,5.02,-,1,1,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
carbohydrate phosphorylation (GO:0046835),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
lipid phosphorylation (GO:0046834),14,6,8.37,-,0.72,0.645,1,5,5.02,-,1,1,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
transcription by RNA polymerase III (GO:0006383),14,6,8.37,-,0.72,0.645,1,3,5.02,-,0.6,0.584,1,7,7.94,-,0.88,1,1,0,0.14,-, < 0.01,1,1
transcription initiation from RNA polymerase II promoter (GO:0006367),21,9,12.56,-,0.72,0.455,1,5,7.53,-,0.66,0.508,1,6,11.9,-,0.5,0.162,1,0,0.21,-, < 0.01,1,1
DNA methylation-dependent heterochromatin assembly (GO:0006346),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
snRNA metabolic process (GO:0016073),21,9,12.56,-,0.72,0.455,1,7,7.53,-,0.93,1,1,7,11.9,-,0.59,0.244,1,0,0.21,-, < 0.01,1,1
translesion synthesis (GO:0019985),7,3,4.19,-,0.72,0.753,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
histone H3-K27 methylation (GO:0070734),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
cellular protein-containing complex localization (GO:0034629),7,3,4.19,-,0.72,0.753,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
peptidyl-arginine modification (GO:0018195),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,1,3.97,-,0.25,0.272,1,0,0.07,-, < 0.01,1,1
protein hydroxylation (GO:0018126),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
sporulation (GO:0043934),28,12,16.74,-,0.72,0.414,1,7,10.04,-,0.7,0.449,1,11,15.87,-,0.69,0.323,1,0,0.28,-, < 0.01,1,1
intracellular mRNA localization (GO:0008298),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
nuclear retention of pre-mRNA at the site of transcription (GO:0071033),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
spermidine metabolic process (GO:0008216),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,5,3.97,+,1.26,0.767,1,0,0.07,-, < 0.01,1,1
regulation of telomere maintenance (GO:0032204),7,3,4.19,-,0.72,0.753,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
phosphatidylethanolamine metabolic process (GO:0046337),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
regulation of ethylene biosynthetic process (GO:0010364),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
protein polymerization (GO:0051258),21,9,12.56,-,0.72,0.455,1,4,7.53,-,0.53,0.362,1,9,11.9,-,0.76,0.571,1,0,0.21,-, < 0.01,1,1
response to gamma radiation (GO:0010332),14,6,8.37,-,0.72,0.645,1,5,5.02,-,1,1,1,5,7.94,-,0.63,0.477,1,0,0.14,-, < 0.01,1,1
peptidyl-proline hydroxylation (GO:0019511),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
stamen morphogenesis (GO:0048448),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
sexual sporulation (GO:0034293),28,12,16.74,-,0.72,0.414,1,7,10.04,-,0.7,0.449,1,11,15.87,-,0.69,0.323,1,0,0.28,-, < 0.01,1,1
maturation of 5.8S rRNA (GO:0000460),28,12,16.74,-,0.72,0.414,1,10,10.04,-,1,1,1,9,15.87,-,0.57,0.17,1,0,0.28,-, < 0.01,1,1
methylguanosine-cap decapping (GO:0110156),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
seed morphogenesis (GO:0048317),7,3,4.19,-,0.72,0.753,1,3,2.51,+,1.2,0.73,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of olefin biosynthetic process (GO:1900911),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
regulation of olefin metabolic process (GO:1900908),7,3,4.19,-,0.72,0.753,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
plant-type sporogenesis (GO:0048236),28,12,16.74,-,0.72,0.414,1,7,10.04,-,0.7,0.449,1,11,15.87,-,0.69,0.323,1,0,0.28,-, < 0.01,1,1
"regulation of gene expression, epigenetic (GO:0040029)",61,26,36.48,-,0.71,0.151,1,12,21.88,-,0.55,0.0616,1,26,34.58,-,0.75,0.263,1,0,0.61,-, < 0.01,1,1
anatomical structure arrangement (GO:0048532),40,17,23.92,-,0.71,0.274,1,17,14.34,+,1.19,0.549,1,17,22.67,-,0.75,0.338,1,1,0.4,+,2.49,0.337,1
sister chromatid cohesion (GO:0007062),33,14,19.73,-,0.71,0.296,1,7,11.83,-,0.59,0.28,1,10,18.71,-,0.53,0.0821,1,0,0.33,-, < 0.01,1,1
photorespiration (GO:0009853),33,14,19.73,-,0.71,0.296,1,11,11.83,-,0.93,1,1,24,18.71,+,1.28,0.408,1,2,0.33,+,6.03,0.0472,1
regulation of histone methylation (GO:0031060),26,11,15.55,-,0.71,0.397,1,4,9.32,-,0.43,0.145,1,11,14.74,-,0.75,0.495,1,0,0.26,-, < 0.01,1,1
ribosomal large subunit biogenesis (GO:0042273),71,30,42.46,-,0.71,0.122,1,26,25.46,+,1.02,0.908,1,18,40.25,-,0.45,0.00128,0.332,0,0.71,-, < 0.01,1,1
ribosomal small subunit biogenesis (GO:0042274),57,24,34.09,-,0.7,0.168,1,21,20.44,+,1.03,0.898,1,13,32.31,-,0.4,0.0017,0.387,0,0.57,-, < 0.01,1,1
RNA phosphodiester bond hydrolysis (GO:0090501),38,16,22.72,-,0.7,0.262,1,13,13.63,-,0.95,1,1,10,21.54,-,0.46,0.034,1,0,0.38,-, < 0.01,1,1
positive regulation of chromatin organization (GO:1905269),19,8,11.36,-,0.7,0.435,1,2,6.81,-,0.29,0.0866,1,9,10.77,-,0.84,0.844,1,0,0.19,-, < 0.01,1,1
negative regulation of mitotic cell cycle phase transition (GO:1901991),19,8,11.36,-,0.7,0.435,1,3,6.81,-,0.44,0.229,1,7,10.77,-,0.65,0.416,1,0,0.19,-, < 0.01,1,1
negative regulation of cell cycle phase transition (GO:1901988),19,8,11.36,-,0.7,0.435,1,3,6.81,-,0.44,0.229,1,7,10.77,-,0.65,0.416,1,0,0.19,-, < 0.01,1,1
ncRNA catabolic process (GO:0034661),19,8,11.36,-,0.7,0.435,1,6,6.81,-,0.88,1,1,10,10.77,-,0.93,1,1,0,0.19,-, < 0.01,1,1
"retrograde transport, endosome to Golgi (GO:0042147)",19,8,11.36,-,0.7,0.435,1,5,6.81,-,0.73,0.648,1,7,10.77,-,0.65,0.416,1,0,0.19,-, < 0.01,1,1
embryonic meristem development (GO:0048508),19,8,11.36,-,0.7,0.435,1,7,6.81,+,1.03,1,1,8,10.77,-,0.74,0.552,1,0,0.19,-, < 0.01,1,1
import into nucleus (GO:0051170),38,16,22.72,-,0.7,0.262,1,6,13.63,-,0.44,0.0593,1,12,21.54,-,0.56,0.0779,1,0,0.38,-, < 0.01,1,1
positive regulation of transport (GO:0051050),19,8,11.36,-,0.7,0.435,1,5,6.81,-,0.73,0.648,1,8,10.77,-,0.74,0.552,1,0,0.19,-, < 0.01,1,1
DNA methylation or demethylation (GO:0044728),31,13,18.54,-,0.7,0.35,1,5,11.12,-,0.45,0.127,1,12,17.57,-,0.68,0.34,1,0,0.31,-, < 0.01,1,1
maturation of LSU-rRNA (GO:0000470),31,13,18.54,-,0.7,0.35,1,13,11.12,+,1.17,0.61,1,6,17.57,-,0.34,0.01,0.751,0,0.31,-, < 0.01,1,1
small GTPase mediated signal transduction (GO:0007264),12,5,7.18,-,0.7,0.62,1,3,4.3,-,0.7,0.772,1,6,6.8,-,0.88,1,1,1,0.12,+,8.3,0.122,1
protein import into nucleus (GO:0006606),36,15,21.53,-,0.7,0.251,1,5,12.91,-,0.39,0.049,1,11,20.41,-,0.54,0.0698,1,0,0.36,-, < 0.01,1,1
DNA dealkylation (GO:0035510),12,5,7.18,-,0.7,0.62,1,1,4.3,-,0.23,0.206,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),24,10,14.35,-,0.7,0.379,1,5,8.61,-,0.58,0.301,1,7,13.6,-,0.51,0.136,1,0,0.24,-, < 0.01,1,1
mRNA export from nucleus (GO:0006406),24,10,14.35,-,0.7,0.379,1,5,8.61,-,0.58,0.301,1,7,13.6,-,0.51,0.136,1,0,0.24,-, < 0.01,1,1
regulation of stomatal opening (GO:1902456),12,5,7.18,-,0.7,0.62,1,4,4.3,-,0.93,1,1,8,6.8,+,1.18,0.817,1,0,0.12,-, < 0.01,1,1
IMP biosynthetic process (GO:0006188),12,5,7.18,-,0.7,0.62,1,4,4.3,-,0.93,1,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
COPII-coated vesicle budding (GO:0090114),12,5,7.18,-,0.7,0.62,1,3,4.3,-,0.7,0.772,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
DNA conformation change (GO:0071103),99,41,59.2,-,0.69,0.0535,1,23,35.5,-,0.65,0.0632,1,37,56.12,-,0.66,0.0314,1,0,0.99,-, < 0.01,0.629,1
cellular response to cytokinin stimulus (GO:0071368),29,12,17.34,-,0.69,0.334,1,4,10.4,-,0.38,0.0741,1,10,16.44,-,0.61,0.186,1,0,0.29,-, < 0.01,1,1
glycerophospholipid metabolic process (GO:0006650),102,42,61,-,0.69,0.0465,1,28,36.58,-,0.77,0.231,1,46,57.82,-,0.8,0.229,1,1,1.02,-,0.98,1,1
protein N-linked glycosylation (GO:0006487),34,14,20.33,-,0.69,0.296,1,8,12.19,-,0.66,0.38,1,13,19.27,-,0.67,0.287,1,0,0.34,-, < 0.01,1,1
chromatin organization involved in regulation of transcription (GO:0034401),51,21,30.5,-,0.69,0.179,1,8,18.29,-,0.44,0.0257,1,19,28.91,-,0.66,0.135,1,0,0.51,-, < 0.01,1,1
chromosome organization (GO:0051276),360,148,215.28,-,0.69,7.72E-05,0.221,81,129.1,-,0.63,7.73E-05,0.0491,137,204.07,-,0.67,4.59E-05,0.0437,1,3.62,-,0.28,0.273,1
DNA metabolic process (GO:0006259),339,139,202.72,-,0.69,0.000126,0.18,65,121.57,-,0.53,7.89E-07,0.00225,126,192.16,-,0.66,3.15E-05,0.036,2,3.41,-,0.59,0.778,1
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",22,9,13.16,-,0.68,0.361,1,8,7.89,+,1.01,1,1,8,12.47,-,0.64,0.344,1,1,0.22,+,4.52,0.206,1
glycolipid biosynthetic process (GO:0009247),44,18,26.31,-,0.68,0.19,1,13,15.78,-,0.82,0.652,1,16,24.94,-,0.64,0.14,1,1,0.44,+,2.26,0.363,1
RNA export from nucleus (GO:0006405),44,18,26.31,-,0.68,0.19,1,15,15.78,-,0.95,1,1,14,24.94,-,0.56,0.0565,1,0,0.44,-, < 0.01,1,1
DNA replication initiation (GO:0006270),22,9,13.16,-,0.68,0.361,1,6,7.89,-,0.76,0.671,1,5,12.47,-,0.4,0.07,1,0,0.22,-, < 0.01,1,1
ribosome assembly (GO:0042255),54,22,32.29,-,0.68,0.154,1,15,19.37,-,0.77,0.415,1,15,30.61,-,0.49,0.0119,0.836,0,0.54,-, < 0.01,1,1
ribonucleoprotein complex assembly (GO:0022618),108,44,64.58,-,0.68,0.0351,1,26,38.73,-,0.67,0.076,1,34,61.22,-,0.56,0.00208,0.424,0,1.08,-, < 0.01,0.63,1
ribonucleoprotein complex subunit organization (GO:0071826),111,45,66.38,-,0.68,0.0305,1,27,39.81,-,0.68,0.0803,1,35,62.92,-,0.56,0.0018,0.394,0,1.12,-, < 0.01,0.631,1
maturation of SSU-rRNA (GO:0030490),37,15,22.13,-,0.68,0.251,1,17,13.27,+,1.28,0.439,1,7,20.97,-,0.33,0.00432,0.601,0,0.37,-, < 0.01,1,1
cellular process involved in reproduction in multicellular organism (GO:0022412),42,17,25.12,-,0.68,0.181,1,11,15.06,-,0.73,0.436,1,19,23.81,-,0.8,0.505,1,0,0.42,-, < 0.01,1,1
nuclear export (GO:0051168),47,19,28.11,-,0.68,0.162,1,16,16.85,-,0.95,1,1,15,26.64,-,0.56,0.0629,1,0,0.47,-, < 0.01,1,1
GTP metabolic process (GO:0046039),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
response to aluminum ion (GO:0010044),10,4,5.98,-,0.67,0.59,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
response to nitric oxide (GO:0071731),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
one-carbon metabolic process (GO:0006730),15,6,8.97,-,0.67,0.502,1,4,5.38,-,0.74,0.796,1,9,8.5,+,1.06,1,1,1,0.15,+,6.64,0.148,1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",10,4,5.98,-,0.67,0.59,1,1,3.59,-,0.28,0.308,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
"posttranslational protein targeting to membrane, translocation (GO:0031204)",5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,1,0.05,+,19.91,0.0582,1
tRNA 3'-end processing (GO:0042780),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
positive regulation of circadian rhythm (GO:0042753),10,4,5.98,-,0.67,0.59,1,2,3.59,-,0.56,0.743,1,5,5.67,-,0.88,1,1,1,0.1,+,9.95,0.104,1
ribosomal small subunit assembly (GO:0000028),20,8,11.96,-,0.67,0.435,1,5,7.17,-,0.7,0.65,1,4,11.34,-,0.35,0.0549,1,0,0.2,-, < 0.01,1,1
nuclear migration (GO:0007097),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
regulation of microtubule polymerization (GO:0031113),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
long-chain fatty acid transport (GO:0015909),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
protein lipoylation (GO:0009249),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
morphogenesis of a branching structure (GO:0001763),10,4,5.98,-,0.67,0.59,1,2,3.59,-,0.56,0.743,1,6,5.67,+,1.06,1,1,0,0.1,-, < 0.01,1,1
L-serine biosynthetic process (GO:0006564),5,2,2.99,-,0.67,1,1,3,1.79,+,1.67,0.443,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
lipid X metabolic process (GO:2001289),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
acidic amino acid transport (GO:0015800),5,2,2.99,-,0.67,1,1,3,1.79,+,1.67,0.443,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
histone arginine methylation (GO:0034969),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
histone H3-K9 modification (GO:0061647),10,4,5.98,-,0.67,0.59,1,2,3.59,-,0.56,0.743,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
homoserine biosynthetic process (GO:0009090),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of hormone biosynthetic process (GO:0046885),10,4,5.98,-,0.67,0.59,1,4,3.59,+,1.12,0.77,1,4,5.67,-,0.71,0.782,1,1,0.1,+,9.95,0.104,1
response to drug (GO:0042493),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,1,0.05,+,19.91,0.0582,1
regulation of nucleocytoplasmic transport (GO:0046822),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
ribonucleoside catabolic process (GO:0042454),5,2,2.99,-,0.67,1,1,3,1.79,+,1.67,0.443,1,4,2.83,+,1.41,0.731,1,1,0.05,+,19.91,0.0582,1
hormone catabolic process (GO:0042447),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
sesquiterpene biosynthetic process (GO:0051762),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
DNA replication-independent nucleosome assembly (GO:0006336),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
protein retention in Golgi apparatus (GO:0045053),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
leaf pavement cell development (GO:0090436),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
maintenance of dormancy (GO:0097437),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
positive regulation of transmembrane transport (GO:0034764),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of fatty acid biosynthetic process (GO:0042304),10,4,5.98,-,0.67,0.59,1,1,3.59,-,0.28,0.308,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
cellular response to nitrate (GO:0071249),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of ubiquitin protein ligase activity (GO:1904666),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
localization within membrane (GO:0051668),10,4,5.98,-,0.67,0.59,1,3,3.59,-,0.84,1,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
DNA ligation (GO:0006266),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
mitochondrial RNA 3'-end processing (GO:0000965),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
nucleus localization (GO:0051647),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
cotyledon morphogenesis (GO:0048826),15,6,8.97,-,0.67,0.502,1,2,5.38,-,0.37,0.269,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
negative regulation of organ growth (GO:0046621),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
chromosome condensation (GO:0030261),15,6,8.97,-,0.67,0.502,1,3,5.38,-,0.56,0.433,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
autophagy of peroxisome (GO:0030242),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
'de novo' IMP biosynthetic process (GO:0006189),10,4,5.98,-,0.67,0.59,1,4,3.59,+,1.12,0.77,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
GTP biosynthetic process (GO:0006183),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of histone H3-K4 methylation (GO:0051569),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
histone mRNA metabolic process (GO:0008334),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
purine nucleoside catabolic process (GO:0006152),5,2,2.99,-,0.67,1,1,4,1.79,+,2.23,0.256,1,4,2.83,+,1.41,0.731,1,2,0.05,+,39.82,0.002,1
positive regulation of chlorophyll biosynthetic process (GO:1902326),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
centromeric sister chromatid cohesion (GO:0070601),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
miRNA metabolic process (GO:0010586),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of starch biosynthetic process (GO:0010581),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
(1->3)-beta-D-glucan biosynthetic process (GO:0006075),10,4,5.98,-,0.67,0.59,1,1,3.59,-,0.28,0.308,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
(1->3)-beta-D-glucan metabolic process (GO:0006074),10,4,5.98,-,0.67,0.59,1,1,3.59,-,0.28,0.308,1,5,5.67,-,0.88,1,1,0,0.1,-, < 0.01,1,1
regulation of reciprocal meiotic recombination (GO:0010520),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
N-acetylglucosamine metabolic process (GO:0006044),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
photoreactive repair (GO:0000719),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,1,0.05,+,19.91,0.0582,1
epidermal cell fate specification (GO:0009957),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of meristem structural organization (GO:0009934),15,6,8.97,-,0.67,0.502,1,5,5.38,-,0.93,1,1,7,8.5,-,0.82,0.825,1,2,0.15,+,13.27,0.0121,1
anther wall tapetum development (GO:0048658),10,4,5.98,-,0.67,0.59,1,4,3.59,+,1.12,0.77,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
anther wall tapetum morphogenesis (GO:0048655),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
anther morphogenesis (GO:0048654),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of production of siRNA involved in RNA interference (GO:0090065),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
nucleotide transmembrane transport (GO:1901679),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
poly(A)+ mRNA export from nucleus (GO:0016973),10,4,5.98,-,0.67,0.59,1,2,3.59,-,0.56,0.743,1,2,5.67,-,0.35,0.232,1,0,0.1,-, < 0.01,1,1
positive regulation of wax biosynthetic process (GO:1904278),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of wax biosynthetic process (GO:1904276),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
suberin biosynthetic process (GO:0010345),10,4,5.98,-,0.67,0.59,1,2,3.59,-,0.56,0.743,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
anisotropic cell growth (GO:0051211),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
floral organ formation (GO:0048449),15,6,8.97,-,0.67,0.502,1,6,5.38,+,1.12,0.806,1,6,8.5,-,0.71,0.65,1,0,0.15,-, < 0.01,1,1
maintenance of seed dormancy (GO:0010231),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
enzyme-directed rRNA pseudouridine synthesis (GO:0000455),5,2,2.99,-,0.67,1,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
replication-born double-strand break repair via sister chromatid exchange (GO:1990414),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
regulation of anthocyanin biosynthetic process (GO:0031540),10,4,5.98,-,0.67,0.59,1,4,3.59,+,1.12,0.77,1,4,5.67,-,0.71,0.782,1,1,0.1,+,9.95,0.104,1
regulation of cation transmembrane transport (GO:1904062),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
regulation of apoptotic process (GO:0042981),5,2,2.99,-,0.67,1,1,1,1.79,-,0.56,1,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
response to ammonium ion (GO:0060359),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
inositol phosphorylation (GO:0052746),5,2,2.99,-,0.67,1,1,2,1.79,+,1.12,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
chromatin organization involved in negative regulation of transcription (GO:0097549),50,20,29.9,-,0.67,0.138,1,7,17.93,-,0.39,0.0152,1,18,28.34,-,0.64,0.101,1,0,0.5,-, < 0.01,1,1
response to ionizing radiation (GO:0010212),25,10,14.95,-,0.67,0.301,1,5,8.97,-,0.56,0.301,1,7,14.17,-,0.49,0.1,1,0,0.25,-, < 0.01,1,1
heterochromatin assembly (GO:0031507),25,10,14.95,-,0.67,0.301,1,5,8.97,-,0.56,0.301,1,10,14.17,-,0.71,0.384,1,0,0.25,-, < 0.01,1,1
mRNA transport (GO:0051028),25,10,14.95,-,0.67,0.301,1,5,8.97,-,0.56,0.301,1,7,14.17,-,0.49,0.1,1,0,0.25,-, < 0.01,1,1
cellular response to DNA damage stimulus (GO:0006974),272,108,162.66,-,0.66,0.000216,0.206,54,97.54,-,0.55,2.61E-05,0.0249,99,154.18,-,0.64,0.000103,0.0841,2,2.73,-,0.73,1,1
DNA repair (GO:0006281),246,97,147.11,-,0.66,0.00038,0.31,48,88.22,-,0.54,4.34E-05,0.031,88,139.45,-,0.63,0.000143,0.0819,2,2.47,-,0.81,1,1
protein-DNA complex subunit organization (GO:0071824),74,29,44.25,-,0.66,0.0528,1,15,26.54,-,0.57,0.0405,1,20,41.95,-,0.48,0.00242,0.476,0,0.74,-, < 0.01,1,1
DNA replication (GO:0006260),97,38,58.01,-,0.66,0.0257,1,20,34.79,-,0.57,0.0206,1,24,54.99,-,0.44,0.000127,0.0805,0,0.97,-, < 0.01,1,1
cleavage involved in rRNA processing (GO:0000469),23,9,13.75,-,0.65,0.361,1,9,8.25,+,1.09,0.841,1,5,13.04,-,0.38,0.0487,1,0,0.23,-, < 0.01,1,1
DNA-dependent DNA replication (GO:0006261),87,34,52.03,-,0.65,0.0378,1,17,31.2,-,0.54,0.0189,1,20,49.32,-,0.41,0.000107,0.0762,0,0.87,-, < 0.01,1,1
glycerophospholipid biosynthetic process (GO:0046474),64,25,38.27,-,0.65,0.0786,1,16,22.95,-,0.7,0.206,1,27,36.28,-,0.74,0.229,1,1,0.64,+,1.56,0.479,1
male meiotic nuclear division (GO:0007140),18,7,10.76,-,0.65,0.411,1,6,6.46,-,0.93,1,1,10,10.2,-,0.98,1,1,0,0.18,-, < 0.01,1,1
negative regulation of DNA recombination (GO:0045910),18,7,10.76,-,0.65,0.411,1,4,6.46,-,0.62,0.475,1,7,10.2,-,0.69,0.533,1,0,0.18,-, < 0.01,1,1
RNA localization (GO:0006403),54,21,32.29,-,0.65,0.0953,1,17,19.37,-,0.88,0.688,1,17,30.61,-,0.56,0.0349,1,0,0.54,-, < 0.01,1,1
lipoprotein metabolic process (GO:0042157),54,21,32.29,-,0.65,0.0953,1,13,19.37,-,0.67,0.214,1,20,30.61,-,0.65,0.115,1,1,0.54,+,1.84,0.424,1
"negative regulation of gene expression, epigenetic (GO:0045814)",31,12,18.54,-,0.65,0.211,1,3,11.12,-,0.27,0.0183,1,10,17.57,-,0.57,0.143,1,0,0.31,-, < 0.01,1,1
response to absence of light (GO:0009646),31,12,18.54,-,0.65,0.211,1,10,11.12,-,0.9,0.861,1,17,17.57,-,0.97,1,1,1,0.31,+,3.21,0.274,1
regulation of protein ubiquitination (GO:0031396),13,5,7.77,-,0.64,0.472,1,2,4.66,-,0.43,0.381,1,5,7.37,-,0.68,0.625,1,0,0.13,-, < 0.01,1,1
copper ion homeostasis (GO:0055070),13,5,7.77,-,0.64,0.472,1,5,4.66,+,1.07,1,1,8,7.37,+,1.09,0.824,1,0,0.13,-, < 0.01,1,1
"positive regulation of gene expression, epigenetic (GO:0045815)",13,5,7.77,-,0.64,0.472,1,3,4.66,-,0.64,0.584,1,5,7.37,-,0.68,0.625,1,0,0.13,-, < 0.01,1,1
cytokinin-activated signaling pathway (GO:0009736),26,10,15.55,-,0.64,0.301,1,4,9.32,-,0.43,0.145,1,9,14.74,-,0.61,0.222,1,0,0.26,-, < 0.01,1,1
regulation of seed maturation (GO:2000034),13,5,7.77,-,0.64,0.472,1,2,4.66,-,0.43,0.381,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
regulation of pollen tube growth (GO:0080092),13,5,7.77,-,0.64,0.472,1,2,4.66,-,0.43,0.381,1,3,7.37,-,0.41,0.195,1,0,0.13,-, < 0.01,1,1
protein-DNA complex assembly (GO:0065004),60,23,35.88,-,0.64,0.0696,1,10,21.52,-,0.46,0.0204,1,15,34.01,-,0.44,0.00356,0.597,0,0.6,-, < 0.01,1,1
establishment of RNA localization (GO:0051236),47,18,28.11,-,0.64,0.123,1,15,16.85,-,0.89,0.774,1,14,26.64,-,0.53,0.0326,1,0,0.47,-, < 0.01,1,1
RNA transport (GO:0050658),47,18,28.11,-,0.64,0.123,1,15,16.85,-,0.89,0.774,1,14,26.64,-,0.53,0.0326,1,0,0.47,-, < 0.01,1,1
nucleic acid transport (GO:0050657),47,18,28.11,-,0.64,0.123,1,15,16.85,-,0.89,0.774,1,14,26.64,-,0.53,0.0326,1,0,0.47,-, < 0.01,1,1
meristem structural organization (GO:0009933),34,13,20.33,-,0.64,0.178,1,13,12.19,+,1.07,0.869,1,15,19.27,-,0.78,0.46,1,1,0.34,+,2.93,0.296,1
positive regulation of chromosome organization (GO:2001252),21,8,12.56,-,0.64,0.339,1,2,7.53,-,0.27,0.0584,1,9,11.9,-,0.76,0.571,1,0,0.21,-, < 0.01,1,1
ribosomal large subunit assembly (GO:0000027),29,11,17.34,-,0.63,0.252,1,7,10.4,-,0.67,0.449,1,8,16.44,-,0.49,0.0854,1,0,0.29,-, < 0.01,1,1
regulation of response to DNA damage stimulus (GO:2001020),29,11,17.34,-,0.63,0.252,1,6,10.4,-,0.58,0.253,1,9,16.44,-,0.55,0.129,1,0,0.29,-, < 0.01,1,1
regulation of histone modification (GO:0031056),37,14,22.13,-,0.63,0.15,1,6,13.27,-,0.45,0.0814,1,16,20.97,-,0.76,0.394,1,0,0.37,-, < 0.01,1,1
protein lipidation (GO:0006497),53,20,31.69,-,0.63,0.0894,1,13,19.01,-,0.68,0.263,1,19,30.04,-,0.63,0.0865,1,1,0.53,+,1.88,0.418,1
lipoprotein biosynthetic process (GO:0042158),53,20,31.69,-,0.63,0.0894,1,13,19.01,-,0.68,0.263,1,19,30.04,-,0.63,0.0865,1,1,0.53,+,1.88,0.418,1
nuclear division (GO:0000280),122,46,72.96,-,0.63,0.00645,1,26,43.75,-,0.59,0.0146,1,47,69.16,-,0.68,0.0242,1,0,1.23,-, < 0.01,0.637,1
maintenance of inflorescence meristem identity (GO:0010077),8,3,4.78,-,0.63,0.553,1,2,2.87,-,0.7,1,1,1,4.53,-,0.22,0.17,1,0,0.08,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",16,6,9.57,-,0.63,0.384,1,6,5.74,+,1.05,1,1,7,9.07,-,0.77,0.668,1,0,0.16,-, < 0.01,1,1
histidine biosynthetic process (GO:0000105),8,3,4.78,-,0.63,0.553,1,7,2.87,+,2.44,0.0834,1,4,4.53,-,0.88,1,1,1,0.08,+,12.44,0.0861,1
protein retention in ER lumen (GO:0006621),8,3,4.78,-,0.63,0.553,1,0,2.87,-, < 0.01,0.12,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
mitotic DNA replication checkpoint (GO:0033314),8,3,4.78,-,0.63,0.553,1,2,2.87,-,0.7,1,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
histidine metabolic process (GO:0006547),8,3,4.78,-,0.63,0.553,1,7,2.87,+,2.44,0.0834,1,4,4.53,-,0.88,1,1,1,0.08,+,12.44,0.0861,1
sulfation (GO:0051923),8,3,4.78,-,0.63,0.553,1,0,2.87,-, < 0.01,0.12,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
arginine metabolic process (GO:0006525),16,6,9.57,-,0.63,0.384,1,4,5.74,-,0.7,0.62,1,8,9.07,-,0.88,0.835,1,0,0.16,-, < 0.01,1,1
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),8,3,4.78,-,0.63,0.553,1,1,2.87,-,0.35,0.461,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
stress response to metal ion (GO:0097501),8,3,4.78,-,0.63,0.553,1,1,2.87,-,0.35,0.461,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
organic cation transport (GO:0015695),8,3,4.78,-,0.63,0.553,1,3,2.87,+,1.05,1,1,5,4.53,+,1.1,1,1,0,0.08,-, < 0.01,1,1
regulation of organ growth (GO:0046620),8,3,4.78,-,0.63,0.553,1,2,2.87,-,0.7,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",8,3,4.78,-,0.63,0.553,1,3,2.87,+,1.05,1,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
sphingoid biosynthetic process (GO:0046520),8,3,4.78,-,0.63,0.553,1,4,2.87,+,1.39,0.529,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
regulation of ubiquitin-protein transferase activity (GO:0051438),8,3,4.78,-,0.63,0.553,1,1,2.87,-,0.35,0.461,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
DNA synthesis involved in DNA repair (GO:0000731),8,3,4.78,-,0.63,0.553,1,0,2.87,-, < 0.01,0.12,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
leaf vascular tissue pattern formation (GO:0010305),24,9,14.35,-,0.63,0.281,1,4,8.61,-,0.46,0.197,1,8,13.6,-,0.59,0.204,1,0,0.24,-, < 0.01,1,1
RNA decapping (GO:0110154),8,3,4.78,-,0.63,0.553,1,2,2.87,-,0.7,1,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
imidazole-containing compound metabolic process (GO:0052803),8,3,4.78,-,0.63,0.553,1,7,2.87,+,2.44,0.0834,1,4,4.53,-,0.88,1,1,1,0.08,+,12.44,0.0861,1
mitotic sister chromatid segregation (GO:0000070),35,13,20.93,-,0.62,0.178,1,8,12.55,-,0.64,0.3,1,11,19.84,-,0.55,0.0918,1,0,0.35,-, < 0.01,1,1
xylem development (GO:0010089),27,10,16.15,-,0.62,0.235,1,6,9.68,-,0.62,0.329,1,15,15.31,-,0.98,1,1,0,0.27,-, < 0.01,1,1
chromatin silencing (GO:0006342),27,10,16.15,-,0.62,0.235,1,2,9.68,-,0.21,0.0181,1,8,15.31,-,0.52,0.114,1,0,0.27,-, < 0.01,1,1
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",27,10,16.15,-,0.62,0.235,1,12,9.68,+,1.24,0.585,1,4,15.31,-,0.26,0.00764,0.692,0,0.27,-, < 0.01,1,1
meiosis II cell cycle process (GO:0061983),19,7,11.36,-,0.62,0.315,1,3,6.81,-,0.44,0.229,1,6,10.77,-,0.56,0.297,1,0,0.19,-, < 0.01,1,1
regulation of sulfur metabolic process (GO:0042762),19,7,11.36,-,0.62,0.315,1,4,6.81,-,0.59,0.477,1,9,10.77,-,0.84,0.844,1,1,0.19,+,5.24,0.181,1
meiosis II (GO:0007135),19,7,11.36,-,0.62,0.315,1,3,6.81,-,0.44,0.229,1,6,10.77,-,0.56,0.297,1,0,0.19,-, < 0.01,1,1
mitochondrial RNA processing (GO:0000963),19,7,11.36,-,0.62,0.315,1,5,6.81,-,0.73,0.648,1,8,10.77,-,0.74,0.552,1,0,0.19,-, < 0.01,1,1
regulation of chromatin silencing (GO:0031935),19,7,11.36,-,0.62,0.315,1,4,6.81,-,0.59,0.477,1,5,10.77,-,0.46,0.139,1,0,0.19,-, < 0.01,1,1
chromatin remodeling (GO:0006338),68,25,40.66,-,0.61,0.0408,1,12,24.39,-,0.49,0.0214,1,30,38.55,-,0.78,0.292,1,0,0.68,-, < 0.01,1,1
negative regulation of cellular component organization (GO:0051129),49,18,29.3,-,0.61,0.0775,1,5,17.57,-,0.28,0.00291,0.437,20,27.78,-,0.72,0.259,1,0,0.49,-, < 0.01,1,1
heterochromatin organization (GO:0070828),30,11,17.94,-,0.61,0.196,1,5,10.76,-,0.46,0.125,1,12,17.01,-,0.71,0.339,1,0,0.3,-, < 0.01,1,1
regulation of chromatin organization (GO:1902275),60,22,35.88,-,0.61,0.0517,1,10,21.52,-,0.46,0.0204,1,21,34.01,-,0.62,0.0632,1,0,0.6,-, < 0.01,1,1
regulation of shoot system morphogenesis (GO:1900618),11,4,6.58,-,0.61,0.439,1,1,3.94,-,0.25,0.203,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
regulation of metal ion transport (GO:0010959),11,4,6.58,-,0.61,0.439,1,3,3.94,-,0.76,1,1,5,6.24,-,0.8,0.799,1,1,0.11,+,9.05,0.113,1
cell fate commitment (GO:0045165),33,12,19.73,-,0.61,0.165,1,7,11.83,-,0.59,0.28,1,12,18.71,-,0.64,0.215,1,1,0.33,+,3.02,0.288,1
phosphorylated carbohydrate dephosphorylation (GO:0046838),11,4,6.58,-,0.61,0.439,1,3,3.94,-,0.76,1,1,6,6.24,-,0.96,1,1,0,0.11,-, < 0.01,1,1
transcription preinitiation complex assembly (GO:0070897),11,4,6.58,-,0.61,0.439,1,2,3.94,-,0.51,0.534,1,2,6.24,-,0.32,0.153,1,0,0.11,-, < 0.01,1,1
snRNA 3'-end processing (GO:0034472),11,4,6.58,-,0.61,0.439,1,4,3.94,+,1.01,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",11,4,6.58,-,0.61,0.439,1,4,3.94,+,1.01,1,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
maintenance of protein localization in organelle (GO:0072595),11,4,6.58,-,0.61,0.439,1,0,3.94,-, < 0.01,0.0784,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
DNA integrity checkpoint (GO:0031570),22,8,13.16,-,0.61,0.261,1,3,7.89,-,0.38,0.116,1,8,12.47,-,0.64,0.344,1,0,0.22,-, < 0.01,1,1
regulation of leaf morphogenesis (GO:1901371),11,4,6.58,-,0.61,0.439,1,1,3.94,-,0.25,0.203,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
chromosome segregation (GO:0007059),89,32,53.22,-,0.6,0.014,1,17,31.92,-,0.53,0.0147,1,29,50.45,-,0.57,0.00919,0.739,0,0.89,-, < 0.01,1,1
mitotic DNA integrity checkpoint (GO:0044774),14,5,8.37,-,0.6,0.355,1,2,5.02,-,0.4,0.266,1,5,7.94,-,0.63,0.477,1,0,0.14,-, < 0.01,1,1
snRNA processing (GO:0016180),14,5,8.37,-,0.6,0.355,1,4,5.02,-,0.8,0.796,1,6,7.94,-,0.76,0.648,1,0,0.14,-, < 0.01,1,1
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),14,5,8.37,-,0.6,0.355,1,4,5.02,-,0.8,0.796,1,4,7.94,-,0.5,0.326,1,0,0.14,-, < 0.01,1,1
double-strand break repair via homologous recombination (GO:0000724),70,25,41.86,-,0.6,0.0255,1,11,25.1,-,0.44,0.00759,0.761,20,39.68,-,0.5,0.00571,0.694,0,0.7,-, < 0.01,1,1
mitotic sister chromatid cohesion (GO:0007064),17,6,10.17,-,0.59,0.29,1,4,6.1,-,0.66,0.621,1,4,9.64,-,0.42,0.116,1,0,0.17,-, < 0.01,1,1
chromosome separation (GO:0051304),17,6,10.17,-,0.59,0.29,1,3,6.1,-,0.49,0.317,1,8,9.64,-,0.83,0.836,1,0,0.17,-, < 0.01,1,1
spliceosomal snRNP assembly (GO:0000387),17,6,10.17,-,0.59,0.29,1,3,6.1,-,0.49,0.317,1,7,9.64,-,0.73,0.531,1,0,0.17,-, < 0.01,1,1
nucleotide-excision repair (GO:0006289),37,13,22.13,-,0.59,0.108,1,8,13.27,-,0.6,0.236,1,13,20.97,-,0.62,0.143,1,0,0.37,-, < 0.01,1,1
regulation of protein modification by small protein conjugation or removal (GO:1903320),15,5,8.97,-,0.56,0.356,1,2,5.38,-,0.37,0.269,1,5,8.5,-,0.59,0.358,1,0,0.15,-, < 0.01,1,1
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",15,5,8.97,-,0.56,0.356,1,6,5.38,+,1.12,0.806,1,3,8.5,-,0.35,0.0918,1,0,0.15,-, < 0.01,1,1
regulation of seed development (GO:0080050),15,5,8.97,-,0.56,0.356,1,2,5.38,-,0.37,0.269,1,8,8.5,-,0.94,1,1,0,0.15,-, < 0.01,1,1
maintenance of meiotic sister chromatid cohesion (GO:0034090),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
"regulation of vesicle targeting, to, from or within Golgi (GO:0048209)",3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein localization to Golgi apparatus (GO:0034067),6,2,3.59,-,0.56,0.718,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
cellular sodium ion homeostasis (GO:0006883),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of cell differentiation (GO:0045597),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
drug transmembrane transport (GO:0006855),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,1,0.03,+,33.18,0.0392,1
regulation of photomorphogenesis (GO:0010099),24,8,14.35,-,0.56,0.2,1,7,8.61,-,0.81,0.838,1,12,13.6,-,0.88,0.863,1,0,0.24,-, < 0.01,1,1
maintenance of floral meristem identity (GO:0010076),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
root meristem specification (GO:0010071),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
sodium ion transmembrane transport (GO:0035725),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
myo-inositol hexakisphosphate metabolic process (GO:0033517),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
negative regulation of sulfur amino acid metabolic process (GO:0031336),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
arachidonic acid secretion (GO:0050482),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protein-tetrapyrrole linkage (GO:0017006),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,4,3.4,+,1.18,0.755,1,0,0.06,-, < 0.01,1,1
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nucleosome positioning (GO:0016584),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,2,5.1,-,0.39,0.347,1,0,0.09,-, < 0.01,1,1
mitotic DNA replication (GO:1902969),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,0,5.1,-, < 0.01,0.0312,1,0,0.09,-, < 0.01,1,1
icosanoid transport (GO:0071715),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
fusion of sperm to egg plasma membrane involved in double fertilization forming a zygote and endosperm (GO:0061936),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
stress response to cadmium ion (GO:1990170),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
peroxisome localization (GO:0060151),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
ribonucleoprotein complex disassembly (GO:0032988),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
rRNA transcription (GO:0009303),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
collagen metabolic process (GO:0032963),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of response to oxidative stress (GO:1902884),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
ceramide metabolic process (GO:0006672),18,6,10.76,-,0.56,0.291,1,7,6.46,+,1.08,0.823,1,12,10.2,+,1.18,0.705,1,0,0.18,-, < 0.01,1,1
sphingosine metabolic process (GO:0006670),6,2,3.59,-,0.56,0.718,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
diacylglycerol biosynthetic process (GO:0006651),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein processing involved in protein targeting to mitochondrion (GO:0006627),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
DNA repair complex assembly (GO:0090735),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
NLS-bearing protein import into nucleus (GO:0006607),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
response to cation stress (GO:0043157),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of SNARE complex assembly (GO:0035542),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
NAD transport (GO:0043132),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
meiotic cell cycle checkpoint (GO:0033313),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
response to humidity (GO:0009270),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of microtubule polymerization or depolymerization (GO:0031112),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
sterol transport (GO:0015918),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
plasma membrane organization (GO:0007009),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
ubiquinone-6 biosynthetic process (GO:1901006),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
ubiquinone-6 metabolic process (GO:1901004),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,3,1.7,+,1.76,0.674,1,0,0.03,-, < 0.01,1,1
positive regulation of response to salt stress (GO:1901002),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
inositol phosphate catabolic process (GO:0071545),9,3,5.38,-,0.56,0.553,1,3,3.23,-,0.93,1,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
cadmium ion homeostasis (GO:0055073),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glycine biosynthetic process (GO:0006545),9,3,5.38,-,0.56,0.553,1,3,3.23,-,0.93,1,1,5,5.1,-,0.98,1,1,1,0.09,+,11.06,0.0952,1
translation reinitiation (GO:0002188),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
glutamate biosynthetic process (GO:0006537),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
amino acid import (GO:0043090),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
C-terminal protein lipidation (GO:0006501),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
tRNA wobble adenosine to inosine editing (GO:0002100),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
chromatin remodeling at centromere (GO:0031055),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nuclear migration along microfilament (GO:0031022),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nucleoside catabolic process (GO:0009164),6,2,3.59,-,0.56,0.718,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,2,0.06,+,33.18,0.00264,1
deoxyribonucleoside monophosphate metabolic process (GO:0009162),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
long-chain fatty acid metabolic process (GO:0001676),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,6,5.1,+,1.18,0.791,1,0,0.09,-, < 0.01,1,1
L-amino acid transport (GO:0015807),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,0,3.4,-, < 0.01,0.0935,1,0,0.06,-, < 0.01,1,1
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to UV-C (GO:0071494),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to far red light (GO:0071490),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to ionizing radiation (GO:0071479),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
secondary alcohol metabolic process (GO:1902652),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
phenylalanyl-tRNA aminoacylation (GO:0006432),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of glucose metabolic process (GO:0010906),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
tRNA export from nucleus (GO:0006409),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of cellular response to phosphate starvation (GO:0140255),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
fatty-acyl-CoA metabolic process (GO:0035337),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
cysteine catabolic process (GO:0009093),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
endonucleolytic cleavage involved in tRNA processing (GO:1905267),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
inositol phosphate dephosphorylation (GO:0046855),9,3,5.38,-,0.56,0.553,1,3,3.23,-,0.93,1,1,4,5.1,-,0.78,0.78,1,0,0.09,-, < 0.01,1,1
microtubule bundle formation (GO:0001578),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of protein export from nucleus (GO:0046825),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of chromatin assembly (GO:0010847),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
positive regulation of RNA interference (GO:1900370),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
transcription by RNA polymerase I (GO:0006360),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of transcription by RNA polymerase I (GO:0006356),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
mRNA cleavage involved in gene silencing by miRNA (GO:0035279),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein localization to nuclear envelope (GO:0090435),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
plasma membrane fusion (GO:0045026),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
quaternary ammonium group transport (GO:0015697),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
microtubule polymerization (GO:0046785),12,4,7.18,-,0.56,0.44,1,1,4.3,-,0.23,0.206,1,3,6.8,-,0.44,0.283,1,0,0.12,-, < 0.01,1,1
GDP-L-fucose biosynthetic process (GO:0042350),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
"nucleotide-excision repair, DNA gap filling (GO:0006297)",3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
stabilization of membrane potential (GO:0030322),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
cellular monovalent inorganic anion homeostasis (GO:0030320),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
pyrimidine dimer repair (GO:0006290),9,3,5.38,-,0.56,0.553,1,2,3.23,-,0.62,0.739,1,4,5.1,-,0.78,0.78,1,1,0.09,+,11.06,0.0952,1
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),6,2,3.59,-,0.56,0.718,1,3,2.15,+,1.39,0.706,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
DNA strand elongation involved in DNA replication (GO:0006271),12,4,7.18,-,0.56,0.44,1,2,4.3,-,0.46,0.38,1,1,6.8,-,0.15,0.0403,1,0,0.12,-, < 0.01,1,1
negative regulation of stomatal opening (GO:1902457),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
peptidyl-arginine methylation (GO:0018216),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
double-strand break repair involved in meiotic recombination (GO:1990918),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nucleic acid phosphodiester bond hydrolysis (GO:0090305),63,21,37.67,-,0.56,0.0177,1,18,22.59,-,0.8,0.449,1,19,35.71,-,0.53,0.0151,1,0,0.63,-, < 0.01,1,1
response to arsenic-containing substance (GO:0046685),9,3,5.38,-,0.56,0.553,1,2,3.23,-,0.62,0.739,1,7,5.1,+,1.37,0.605,1,0,0.09,-, < 0.01,1,1
mature ribosome assembly (GO:0042256),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
nucleobase-containing small molecule catabolic process (GO:0034656),6,2,3.59,-,0.56,0.718,1,4,2.15,+,1.86,0.304,1,5,3.4,+,1.47,0.541,1,2,0.06,+,33.18,0.00264,1
endocytic recycling (GO:0032456),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
positive regulation of ion transmembrane transporter activity (GO:0032414),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of transporter activity (GO:0032411),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
DNA strand elongation (GO:0022616),12,4,7.18,-,0.56,0.44,1,2,4.3,-,0.46,0.38,1,1,6.8,-,0.15,0.0403,1,0,0.12,-, < 0.01,1,1
positive regulation of histone H3-K4 methylation (GO:0051571),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
response to strigolactone (GO:1902347),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
programmed cell death involved in cell development (GO:0010623),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of symbiotic process (GO:0043903),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
isocitrate metabolic process (GO:0006102),6,2,3.59,-,0.56,0.718,1,2,2.15,-,0.93,1,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
citrate metabolic process (GO:0006101),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of chromatin silencing (GO:0031936),12,4,7.18,-,0.56,0.44,1,2,4.3,-,0.46,0.38,1,4,6.8,-,0.59,0.442,1,0,0.12,-, < 0.01,1,1
regulation of triglyceride metabolic process (GO:0090207),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of protein depolymerization (GO:1901881),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of protein depolymerization (GO:1901880),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
regulation of protein depolymerization (GO:1901879),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
root hair cell tip growth (GO:0048768),12,4,7.18,-,0.56,0.44,1,1,4.3,-,0.23,0.206,1,6,6.8,-,0.88,1,1,0,0.12,-, < 0.01,1,1
sphingosine biosynthetic process (GO:0046512),6,2,3.59,-,0.56,0.718,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
intracellular sterol transport (GO:0032366),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
centromere complex assembly (GO:0034508),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
production of lsiRNA involved in RNA interference (GO:0010599),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
leaf proximal/distal pattern formation (GO:0010589),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
icosanoid secretion (GO:0032309),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
peptidyl-lysine dimethylation (GO:0018027),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
peptidyl-lysine trimethylation (GO:0018023),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
tRNA N2-guanine methylation (GO:0002940),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
uronic acid metabolic process (GO:0006063),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
monopolar spindle attachment to meiosis I kinetochore (GO:0051455),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of meiotic cell cycle (GO:0051447),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
DNA recombinase assembly (GO:0000730),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
recombinational repair (GO:0000725),75,25,44.85,-,0.56,0.00951,1,11,26.9,-,0.41,0.00304,0.445,21,42.51,-,0.49,0.00282,0.519,0,0.75,-, < 0.01,1,1
arachidonate transport (GO:1903963),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
ammonium ion metabolic process (GO:0097164),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
FAD metabolic process (GO:0046443),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
D-amino acid metabolic process (GO:0046416),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of DNA biosynthetic process (GO:2000279),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
metal incorporation into metallo-molybdopterin complex (GO:0042040),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
"tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)",3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of rRNA processing (GO:2000232),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of telomere maintenance via telomerase (GO:0032210),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of telomere maintenance via telomere lengthening (GO:1904356),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
cellular response to reactive nitrogen species (GO:1902170),9,3,5.38,-,0.56,0.553,1,2,3.23,-,0.62,0.739,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
negative regulation of DNA replication (GO:0008156),12,4,7.18,-,0.56,0.44,1,3,4.3,-,0.7,0.772,1,2,6.8,-,0.29,0.101,1,0,0.12,-, < 0.01,1,1
cellular anion homeostasis (GO:0030002),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of transcription by RNA polymerase I (GO:0045943),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to potassium ion starvation (GO:0051365),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
response to acidic pH (GO:0010447),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
choline metabolic process (GO:0019695),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
protoxylem development (GO:0090059),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
multicellular organismal water homeostasis (GO:0050891),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
urea metabolic process (GO:0019627),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of body fluid levels (GO:0050878),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
GDP-L-fucose metabolic process (GO:0046368),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
sporocyte differentiation (GO:0048533),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
strigolactone biosynthetic process (GO:1901601),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
strigolactone metabolic process (GO:1901600),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
mRNA cleavage involved in gene silencing (GO:0098795),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of histone H3-K27 methylation (GO:0061085),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
positive regulation of response to nutrient levels (GO:0032109),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
positive regulation of response to extracellular stimulus (GO:0032106),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of DNA-dependent DNA replication (GO:2000104),12,4,7.18,-,0.56,0.44,1,3,4.3,-,0.7,0.772,1,2,6.8,-,0.29,0.101,1,0,0.12,-, < 0.01,1,1
negative regulation of ethylene biosynthetic process (GO:0010366),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
sodium ion import across plasma membrane (GO:0098719),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
shoot axis formation (GO:0010346),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
RNA virus induced gene silencing (GO:0051214),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
galacturonate metabolic process (GO:0019586),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
lytic vacuole organization (GO:0080171),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
fatty acid transmembrane transport (GO:1902001),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of asymmetric cell division (GO:0009786),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
pyrimidine-containing compound transmembrane transport (GO:0072531),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of viral process (GO:0050792),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
secondary growth (GO:0080117),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
fatty acid derivative transport (GO:1901571),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
proton export across plasma membrane (GO:0120029),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of seed dormancy process (GO:2000033),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
regulation of adaxial/abaxial pattern formation (GO:2000011),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,3,1.7,+,1.76,0.674,1,1,0.03,+,33.18,0.0392,1
myo-inositol hexakisphosphate biosynthetic process (GO:0010264),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
negative regulation of sulfur metabolic process (GO:0051175),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
response to low fluence blue light stimulus by blue low-fluence system (GO:0010244),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
secondary shoot formation (GO:0010223),9,3,5.38,-,0.56,0.553,1,1,3.23,-,0.31,0.472,1,5,5.1,-,0.98,1,1,0,0.09,-, < 0.01,1,1
positive regulation of vernalization response (GO:0010220),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
negative regulation of fatty acid biosynthetic process (GO:0045717),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of vernalization response (GO:0010219),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cyanide metabolic process (GO:0019499),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of cellular response to phosphate starvation (GO:0080040),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of cytokinin-activated signaling pathway (GO:0080037),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
mRNA methylation (GO:0080009),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
sulfate reduction (GO:0019419),3,1,1.79,-,0.56,1,1,3,1.08,+,2.79,0.192,1,3,1.7,+,1.76,0.674,1,2,0.03,+,66.36,0.000963,1
purine ribonucleoside catabolic process (GO:0046130),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
inosine metabolic process (GO:0046102),3,1,1.79,-,0.56,1,1,2,1.08,+,1.86,0.613,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
histone H3-K27 trimethylation (GO:0098532),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
spliceosomal complex disassembly (GO:0000390),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
red light signaling pathway (GO:0010161),6,2,3.59,-,0.56,0.718,1,3,2.15,+,1.39,0.706,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
abaxial cell fate specification (GO:0010158),6,2,3.59,-,0.56,0.718,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
negative regulation of olefin biosynthetic process (GO:1900912),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
vesicle targeting (GO:0006903),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
negative regulation of olefin metabolic process (GO:1900909),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
generation of catalytic spliceosome for first transesterification step (GO:0000349),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
positive regulation of abscisic acid biosynthetic process (GO:0010116),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of photomorphogenesis (GO:0010100),12,4,7.18,-,0.56,0.44,1,4,4.3,-,0.93,1,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
N-terminal peptidyl-methionine acetylation (GO:0017196),6,2,3.59,-,0.56,0.718,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
detection of gravity (GO:0009590),3,1,1.79,-,0.56,1,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
lactone biosynthetic process (GO:1901336),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
lactone metabolic process (GO:1901334),3,1,1.79,-,0.56,1,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
nuclear chromosome segregation (GO:0098813),79,26,47.24,-,0.55,0.00824,1,15,28.33,-,0.53,0.019,1,24,44.78,-,0.54,0.0072,0.761,0,0.79,-, < 0.01,1,1
meiotic cell cycle process (GO:1903046),119,39,71.16,-,0.55,0.000902,0.644,23,42.68,-,0.54,0.00533,0.609,42,67.46,-,0.62,0.0082,0.709,0,1.2,-, < 0.01,0.635,1
double-strand break repair (GO:0006302),98,32,58.6,-,0.55,0.00256,0.913,13,35.14,-,0.37,0.000208,0.0915,25,55.55,-,0.45,0.000153,0.0793,0,0.98,-, < 0.01,1,1
regulation of DNA recombination (GO:0000018),25,8,14.95,-,0.54,0.149,1,5,8.97,-,0.56,0.301,1,10,14.17,-,0.71,0.384,1,0,0.25,-, < 0.01,1,1
ATP-dependent chromatin remodeling (GO:0043044),22,7,13.16,-,0.53,0.179,1,3,7.89,-,0.38,0.116,1,8,12.47,-,0.64,0.344,1,0,0.22,-, < 0.01,1,1
regulation of DNA repair (GO:0006282),22,7,13.16,-,0.53,0.179,1,4,7.89,-,0.51,0.267,1,7,12.47,-,0.56,0.245,1,0,0.22,-, < 0.01,1,1
chromosome organization involved in meiotic cell cycle (GO:0070192),41,13,24.52,-,0.53,0.0481,1,8,14.7,-,0.54,0.143,1,12,23.24,-,0.52,0.0446,1,0,0.41,-, < 0.01,1,1
nuclear DNA replication (GO:0033260),16,5,9.57,-,0.52,0.261,1,1,5.74,-,0.17,0.0564,1,1,9.07,-,0.11,0.00926,0.724,0,0.16,-, < 0.01,1,1
regulation of protein-containing complex disassembly (GO:0043244),13,4,7.77,-,0.51,0.318,1,2,4.66,-,0.43,0.381,1,7,7.37,-,0.95,1,1,0,0.13,-, < 0.01,1,1
double-strand break repair via nonhomologous end joining (GO:0006303),13,4,7.77,-,0.51,0.318,1,2,4.66,-,0.43,0.381,1,3,7.37,-,0.41,0.195,1,0,0.13,-, < 0.01,1,1
meiotic nuclear division (GO:0140013),82,25,49.04,-,0.51,0.0025,0.954,15,29.41,-,0.51,0.0147,1,30,46.48,-,0.65,0.0385,1,0,0.82,-, < 0.01,1,1
meiotic cell cycle (GO:0051321),128,39,76.54,-,0.51,0.000144,0.165,23,45.9,-,0.5,0.00151,0.287,42,72.56,-,0.58,0.00169,0.403,0,1.29,-, < 0.01,0.641,1
cell fate specification (GO:0001708),23,7,13.75,-,0.51,0.132,1,5,8.25,-,0.61,0.393,1,9,13.04,-,0.69,0.462,1,1,0.23,+,4.33,0.213,1
anatomical structure homeostasis (GO:0060249),30,9,17.94,-,0.5,0.0693,1,5,10.76,-,0.46,0.125,1,7,17.01,-,0.41,0.0382,1,0,0.3,-, < 0.01,1,1
mitotic G2/M transition checkpoint (GO:0044818),10,3,5.98,-,0.5,0.394,1,2,3.59,-,0.56,0.743,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
negative regulation of cell cycle G2/M phase transition (GO:1902750),10,3,5.98,-,0.5,0.394,1,2,3.59,-,0.56,0.743,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),10,3,5.98,-,0.5,0.394,1,2,3.59,-,0.56,0.743,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
regulation of auxin metabolic process (GO:0090354),10,3,5.98,-,0.5,0.394,1,5,3.59,+,1.39,0.561,1,4,5.67,-,0.71,0.782,1,1,0.1,+,9.95,0.104,1
negative regulation of gene silencing (GO:0060969),20,6,11.96,-,0.5,0.157,1,2,7.17,-,0.28,0.0874,1,7,11.34,-,0.62,0.32,1,0,0.2,-, < 0.01,1,1
ncRNA transcription (GO:0098781),10,3,5.98,-,0.5,0.394,1,2,3.59,-,0.56,0.743,1,3,5.67,-,0.53,0.399,1,0,0.1,-, < 0.01,1,1
DNA demethylation (GO:0080111),10,3,5.98,-,0.5,0.394,1,1,3.59,-,0.28,0.308,1,2,5.67,-,0.35,0.232,1,0,0.1,-, < 0.01,1,1
tricarboxylic acid metabolic process (GO:0072350),10,3,5.98,-,0.5,0.394,1,3,3.59,-,0.84,1,1,4,5.67,-,0.71,0.782,1,0,0.1,-, < 0.01,1,1
DNA recombination (GO:0006310),120,35,71.76,-,0.49,8.29E-05,0.158,16,43.03,-,0.37,3.54E-05,0.0289,36,68.02,-,0.53,0.000561,0.267,0,1.21,-, < 0.01,0.635,1
negative regulation of chromatin organization (GO:1905268),21,6,12.56,-,0.48,0.114,1,2,7.53,-,0.27,0.0584,1,7,11.9,-,0.59,0.244,1,0,0.21,-, < 0.01,1,1
positive regulation of ion transport (GO:0043270),7,2,4.19,-,0.48,0.498,1,1,2.51,-,0.4,0.69,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
negative regulation of protein-containing complex disassembly (GO:0043242),7,2,4.19,-,0.48,0.498,1,0,2.51,-, < 0.01,0.201,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
negative regulation of peptidyl-lysine acetylation (GO:2000757),7,2,4.19,-,0.48,0.498,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
protein localization to endoplasmic reticulum exit site (GO:0070973),7,2,4.19,-,0.48,0.498,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
histone H3-K9 demethylation (GO:0033169),7,2,4.19,-,0.48,0.498,1,1,2.51,-,0.4,0.69,1,4,3.97,+,1.01,1,1,0,0.07,-, < 0.01,1,1
regulation of RNA interference (GO:1900368),7,2,4.19,-,0.48,0.498,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),7,2,4.19,-,0.48,0.498,1,2,2.51,-,0.8,1,1,3,3.97,-,0.76,1,1,0,0.07,-, < 0.01,1,1
negative regulation of protein acetylation (GO:1901984),7,2,4.19,-,0.48,0.498,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
folic acid metabolic process (GO:0046655),7,2,4.19,-,0.48,0.498,1,2,2.51,-,0.8,1,1,4,3.97,+,1.01,1,1,1,0.07,+,14.22,0.0769,1
histone H3-K9 methylation (GO:0051567),7,2,4.19,-,0.48,0.498,1,2,2.51,-,0.8,1,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
negative regulation of histone acetylation (GO:0035067),7,2,4.19,-,0.48,0.498,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
non-recombinational repair (GO:0000726),14,4,8.37,-,0.48,0.228,1,2,5.02,-,0.4,0.266,1,3,7.94,-,0.38,0.134,1,0,0.14,-, < 0.01,1,1
regulation of vacuole organization (GO:0044088),7,2,4.19,-,0.48,0.498,1,1,2.51,-,0.4,0.69,1,5,3.97,+,1.26,0.767,1,1,0.07,+,14.22,0.0769,1
vesicle fusion with Golgi apparatus (GO:0048280),7,2,4.19,-,0.48,0.498,1,1,2.51,-,0.4,0.69,1,1,3.97,-,0.25,0.272,1,0,0.07,-, < 0.01,1,1
spliceosomal complex assembly (GO:0000245),18,5,10.76,-,0.46,0.136,1,3,6.46,-,0.46,0.32,1,5,10.2,-,0.49,0.193,1,0,0.18,-, < 0.01,1,1
negative regulation of seed germination (GO:0010187),18,5,10.76,-,0.46,0.136,1,4,6.46,-,0.62,0.475,1,7,10.2,-,0.69,0.533,1,0,0.18,-, < 0.01,1,1
inositol lipid-mediated signaling (GO:0048017),11,3,6.58,-,0.46,0.276,1,1,3.94,-,0.25,0.203,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
arginine biosynthetic process (GO:0006526),11,3,6.58,-,0.46,0.276,1,2,3.94,-,0.51,0.534,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
regulation of peptidyl-lysine acetylation (GO:2000756),11,3,6.58,-,0.46,0.276,1,1,3.94,-,0.25,0.203,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
tracheary element differentiation (GO:1905177),11,3,6.58,-,0.46,0.276,1,2,3.94,-,0.51,0.534,1,4,6.24,-,0.64,0.594,1,0,0.11,-, < 0.01,1,1
regulation of protein acetylation (GO:1901983),11,3,6.58,-,0.46,0.276,1,1,3.94,-,0.25,0.203,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
regulation of histone acetylation (GO:0035065),11,3,6.58,-,0.46,0.276,1,1,3.94,-,0.25,0.203,1,5,6.24,-,0.8,0.799,1,0,0.11,-, < 0.01,1,1
cotyledon vascular tissue pattern formation (GO:0010588),11,3,6.58,-,0.46,0.276,1,1,3.94,-,0.25,0.203,1,3,6.24,-,0.48,0.404,1,0,0.11,-, < 0.01,1,1
double-strand break repair via break-induced replication (GO:0000727),11,3,6.58,-,0.46,0.276,1,2,3.94,-,0.51,0.534,1,1,6.24,-,0.16,0.0669,1,0,0.11,-, < 0.01,1,1
meiotic chromosome segregation (GO:0045132),48,13,28.7,-,0.45,0.0111,1,7,17.21,-,0.41,0.0208,1,14,27.21,-,0.51,0.0247,1,0,0.48,-, < 0.01,1,1
phosphatidylinositol metabolic process (GO:0046488),63,17,37.67,-,0.45,0.00244,0.997,14,22.59,-,0.62,0.119,1,18,35.71,-,0.5,0.0103,0.755,1,0.63,+,1.58,0.473,1
meiosis I cell cycle process (GO:0061982),60,15,35.88,-,0.42,0.00169,0.878,10,21.52,-,0.46,0.0204,1,17,34.01,-,0.5,0.00889,0.757,0,0.6,-, < 0.01,1,1
chloride transport (GO:0006821),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
primary meristem tissue development (GO:0010065),8,2,4.78,-,0.42,0.339,1,1,2.87,-,0.35,0.461,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
circumnutation (GO:0010031),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
spliceosomal tri-snRNP complex assembly (GO:0000244),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
meiotic spindle organization (GO:0000212),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
female gamete generation (GO:0007292),8,2,4.78,-,0.42,0.339,1,1,2.87,-,0.35,0.461,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
"vesicle targeting, to, from or within Golgi (GO:0048199)",4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
cellular response to nitric oxide (GO:0071732),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
mitotic DNA replication initiation (GO:1902975),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
Mo-molybdopterin cofactor biosynthetic process (GO:0006777),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
gibberellin catabolic process (GO:0045487),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
telomere maintenance in response to DNA damage (GO:0043247),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
single strand break repair (GO:0000012),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
mitochondrial genome maintenance (GO:0000002),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of microtubule polymerization (GO:0031116),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
microtubule nucleation (GO:0007020),8,2,4.78,-,0.42,0.339,1,1,2.87,-,0.35,0.461,1,1,4.53,-,0.22,0.17,1,0,0.08,-, < 0.01,1,1
drug transport (GO:0015893),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,1,0.04,+,24.89,0.0488,1
triose phosphate transmembrane transport (GO:0035436),4,1,2.39,-,0.42,0.657,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
negative regulation of cellular amine metabolic process (GO:0033239),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
metaphase/anaphase transition of cell cycle (GO:0044784),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
cellular response to gamma radiation (GO:0071480),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
negative regulation of reciprocal meiotic recombination (GO:0045128),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
triose phosphate transport (GO:0015717),4,1,2.39,-,0.42,0.657,1,2,1.43,+,1.39,0.658,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
mannosylation (GO:0097502),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
chromosome localization (GO:0050000),8,2,4.78,-,0.42,0.339,1,1,2.87,-,0.35,0.461,1,3,4.53,-,0.66,0.756,1,0,0.08,-, < 0.01,1,1
adenosine to inosine editing (GO:0006382),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
mRNA splice site selection (GO:0006376),8,2,4.78,-,0.42,0.339,1,2,2.87,-,0.7,1,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
diterpenoid catabolic process (GO:0016103),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
heterochromatin organization involved in chromatin silencing (GO:0070868),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
heterochromatin maintenance (GO:0070829),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of membrane potential (GO:0042391),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of ion transmembrane transport (GO:0034767),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
actin filament capping (GO:0051693),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of histone H3-K27 trimethylation (GO:1902464),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
lagging strand elongation (GO:0006273),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
regulation of membrane lipid metabolic process (GO:1905038),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
histone H4-K5 acetylation (GO:0043981),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
nuclear cell cycle DNA replication initiation (GO:1902315),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
regulation of auxin biosynthetic process (GO:0010600),8,2,4.78,-,0.42,0.339,1,4,2.87,+,1.39,0.529,1,2,4.53,-,0.44,0.346,1,1,0.08,+,12.44,0.0861,1
xylem vessel member cell differentiation (GO:0048759),8,2,4.78,-,0.42,0.339,1,1,2.87,-,0.35,0.461,1,4,4.53,-,0.88,1,1,0,0.08,-, < 0.01,1,1
ceramide catabolic process (GO:0046514),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
miRNA catabolic process (GO:0010587),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
cell cycle DNA replication initiation (GO:1902292),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
resolution of meiotic recombination intermediates (GO:0000712),12,3,7.18,-,0.42,0.192,1,1,4.3,-,0.23,0.206,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
proximal/distal pattern formation (GO:0009954),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
Mo-molybdopterin cofactor metabolic process (GO:0019720),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
negative regulation of gibberellic acid mediated signaling pathway (GO:0009938),12,3,7.18,-,0.42,0.192,1,2,4.3,-,0.46,0.38,1,5,6.8,-,0.74,0.624,1,0,0.12,-, < 0.01,1,1
positive regulation of DNA recombination (GO:0045911),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
multicellular organismal movement (GO:0050879),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,0,0.04,-, < 0.01,1,1
diacylglycerol metabolic process (GO:0046339),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
regulation of jasmonic acid biosynthetic process (GO:0080141),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
regulation of jasmonic acid metabolic process (GO:0080140),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
prosthetic group metabolic process (GO:0051189),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
negative regulation of cellular amino acid metabolic process (GO:0045763),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
molybdopterin cofactor metabolic process (GO:0043545),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
intra-S DNA damage checkpoint (GO:0031573),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of anthocyanin metabolic process (GO:0031539),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
mRNA 5'-splice site recognition (GO:0000395),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
vesicle coating (GO:0006901),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
tRNA transport (GO:0051031),4,1,2.39,-,0.42,0.657,1,1,1.43,-,0.7,1,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
barbed-end actin filament capping (GO:0051016),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
detection of visible light (GO:0009584),4,1,2.39,-,0.42,0.657,1,0,1.43,-, < 0.01,0.579,1,2,2.27,-,0.88,1,1,0,0.04,-, < 0.01,1,1
DNA biosynthetic process (GO:0071897),20,5,11.96,-,0.42,0.0964,1,1,7.17,-,0.14,0.0235,1,2,11.34,-,0.18,0.00675,0.756,0,0.2,-, < 0.01,1,1
meiosis I (GO:0007127),56,14,33.49,-,0.42,0.0027,0.907,10,20.08,-,0.5,0.0362,1,17,31.74,-,0.54,0.0206,1,0,0.56,-, < 0.01,1,1
telomere maintenance (GO:0000723),26,6,15.55,-,0.39,0.0286,1,4,9.32,-,0.43,0.145,1,5,14.74,-,0.34,0.0233,1,0,0.26,-, < 0.01,1,1
telomere organization (GO:0032200),26,6,15.55,-,0.39,0.0286,1,4,9.32,-,0.43,0.145,1,5,14.74,-,0.34,0.0233,1,0,0.26,-, < 0.01,1,1
reciprocal homologous recombination (GO:0140527),44,10,26.31,-,0.38,0.00437,1,7,15.78,-,0.44,0.0389,1,13,24.94,-,0.52,0.0381,1,0,0.44,-, < 0.01,1,1
reciprocal meiotic recombination (GO:0007131),44,10,26.31,-,0.38,0.00437,1,7,15.78,-,0.44,0.0389,1,13,24.94,-,0.52,0.0381,1,0,0.44,-, < 0.01,1,1
homologous recombination (GO:0035825),44,10,26.31,-,0.38,0.00437,1,7,15.78,-,0.44,0.0389,1,13,24.94,-,0.52,0.0381,1,0,0.44,-, < 0.01,1,1
phosphatidylinositol-mediated signaling (GO:0048015),9,2,5.38,-,0.37,0.228,1,1,3.23,-,0.31,0.472,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
negative regulation of histone modification (GO:0031057),9,2,5.38,-,0.37,0.228,1,0,3.23,-, < 0.01,0.124,1,3,5.1,-,0.59,0.555,1,0,0.09,-, < 0.01,1,1
phosphatidylinositol dephosphorylation (GO:0046856),18,4,10.76,-,0.37,0.077,1,3,6.46,-,0.46,0.32,1,5,10.2,-,0.49,0.193,1,0,0.18,-, < 0.01,1,1
histone exchange (GO:0043486),9,2,5.38,-,0.37,0.228,1,1,3.23,-,0.31,0.472,1,2,5.1,-,0.39,0.347,1,0,0.09,-, < 0.01,1,1
DNA damage checkpoint (GO:0000077),14,3,8.37,-,0.36,0.131,1,2,5.02,-,0.4,0.266,1,2,7.94,-,0.25,0.0658,1,0,0.14,-, < 0.01,1,1
radial pattern formation (GO:0009956),14,3,8.37,-,0.36,0.131,1,1,5.02,-,0.2,0.138,1,3,7.94,-,0.38,0.134,1,0,0.14,-, < 0.01,1,1
meiotic chromosome separation (GO:0051307),14,3,8.37,-,0.36,0.131,1,1,5.02,-,0.2,0.138,1,5,7.94,-,0.63,0.477,1,0,0.14,-, < 0.01,1,1
interstrand cross-link repair (GO:0036297),14,3,8.37,-,0.36,0.131,1,0,5.02,-, < 0.01,0.0281,1,3,7.94,-,0.38,0.134,1,0,0.14,-, < 0.01,1,1
phosphatidylinositol biosynthetic process (GO:0006661),34,7,20.33,-,0.34,0.00584,1,6,12.19,-,0.49,0.109,1,7,19.27,-,0.36,0.0092,0.729,1,0.34,+,2.93,0.296,1
maintenance of sister chromatid cohesion (GO:0034086),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
copper ion transport (GO:0006825),5,1,2.99,-,0.33,0.421,1,2,1.79,+,1.12,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
negative regulation of actin filament depolymerization (GO:0030835),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
histone phosphorylation (GO:0016572),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
female meiotic nuclear division (GO:0007143),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
long-chain fatty acid biosynthetic process (GO:0042759),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
synaptonemal complex assembly (GO:0007130),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
inositol trisphosphate metabolic process (GO:0032957),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
entrainment of circadian clock by photoperiod (GO:0043153),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
ornithine metabolic process (GO:0006591),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
neutral amino acid transport (GO:0015804),5,1,2.99,-,0.33,0.421,1,4,1.79,+,2.23,0.256,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
phospholipid dephosphorylation (GO:0046839),20,4,11.96,-,0.33,0.0358,1,4,7.17,-,0.56,0.358,1,6,11.34,-,0.53,0.22,1,1,0.2,+,4.98,0.189,1
transcription initiation from RNA polymerase III promoter (GO:0006384),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,4,2.83,+,1.41,0.731,1,0,0.05,-, < 0.01,1,1
chromatin maintenance (GO:0070827),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
cellular component maintenance (GO:0043954),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
positive regulation of photomorphogenesis (GO:2000306),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,3,2.83,+,1.06,1,1,0,0.05,-, < 0.01,1,1
regulation of DNA biosynthetic process (GO:2000278),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
ncRNA export from nucleus (GO:0097064),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
negative regulation of meiotic nuclear division (GO:0045835),5,1,2.99,-,0.33,0.421,1,0,1.79,-, < 0.01,0.335,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
tetrahydrofolate interconversion (GO:0035999),10,2,5.98,-,0.33,0.231,1,2,3.59,-,0.56,0.743,1,5,5.67,-,0.88,1,1,1,0.1,+,9.95,0.104,1
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",5,1,2.99,-,0.33,0.421,1,2,1.79,+,1.12,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
flavin adenine dinucleotide metabolic process (GO:0072387),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,2,2.83,-,0.71,1,1,0,0.05,-, < 0.01,1,1
synaptonemal complex organization (GO:0070193),5,1,2.99,-,0.33,0.421,1,1,1.79,-,0.56,1,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
GPI anchor biosynthetic process (GO:0006506),27,5,16.15,-,0.31,0.00994,1,5,9.68,-,0.52,0.227,1,4,15.31,-,0.26,0.00764,0.715,1,0.27,+,3.69,0.244,1
GPI anchor metabolic process (GO:0006505),27,5,16.15,-,0.31,0.00994,1,5,9.68,-,0.52,0.227,1,4,15.31,-,0.26,0.00764,0.704,1,0.27,+,3.69,0.244,1
specification of floral organ identity (GO:0010093),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
glycine biosynthetic process from serine (GO:0019264),6,1,3.59,-,0.28,0.268,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
regulation of actin filament depolymerization (GO:0030834),6,1,3.59,-,0.28,0.268,1,0,2.15,-, < 0.01,0.351,1,3,3.4,-,0.88,1,1,0,0.06,-, < 0.01,1,1
negative regulation of posttranscriptional gene silencing (GO:0060149),6,1,3.59,-,0.28,0.268,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
L-serine catabolic process (GO:0006565),6,1,3.59,-,0.28,0.268,1,2,2.15,-,0.93,1,1,4,3.4,+,1.18,0.755,1,1,0.06,+,16.59,0.0676,1
attachment of GPI anchor to protein (GO:0016255),6,1,3.59,-,0.28,0.268,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
telomere capping (GO:0016233),6,1,3.59,-,0.28,0.268,1,0,2.15,-, < 0.01,0.351,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
negative regulation of brassinosteroid mediated signaling pathway (GO:1900458),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
attachment of spindle microtubules to kinetochore (GO:0008608),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,1,3.4,-,0.29,0.434,1,0,0.06,-, < 0.01,1,1
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",18,3,10.76,-,0.28,0.0395,1,5,6.46,-,0.77,0.813,1,3,10.2,-,0.29,0.0404,1,0,0.18,-, < 0.01,1,1
mismatch repair (GO:0006298),18,3,10.76,-,0.28,0.0395,1,3,6.46,-,0.46,0.32,1,4,10.2,-,0.39,0.118,1,0,0.18,-, < 0.01,1,1
meiotic mismatch repair (GO:0000710),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,0,3.4,-, < 0.01,0.0935,1,0,0.06,-, < 0.01,1,1
establishment of chromosome localization (GO:0051303),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
RNA polymerase II preinitiation complex assembly (GO:0051123),6,1,3.59,-,0.28,0.268,1,1,2.15,-,0.46,0.684,1,0,3.4,-, < 0.01,0.0935,1,0,0.06,-, < 0.01,1,1
spliceosomal conformational changes to generate catalytic conformation (GO:0000393),6,1,3.59,-,0.28,0.268,1,2,2.15,-,0.93,1,1,0,3.4,-, < 0.01,0.0935,1,0,0.06,-, < 0.01,1,1
procambium histogenesis (GO:0010067),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
regulation of potassium ion transport (GO:0043266),7,1,4.19,-,0.24,0.272,1,2,2.51,-,0.8,1,1,2,3.97,-,0.5,0.503,1,1,0.07,+,14.22,0.0769,1
specification of plant organ identity (GO:0090701),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
homologous chromosome segregation (GO:0045143),28,4,16.74,-,0.24,0.0029,0.871,4,10.04,-,0.4,0.106,1,5,15.87,-,0.32,0.0107,0.774,0,0.28,-, < 0.01,1,1
DNA catabolic process (GO:0006308),7,1,4.19,-,0.24,0.272,1,0,2.51,-, < 0.01,0.201,1,2,3.97,-,0.5,0.503,1,0,0.07,-, < 0.01,1,1
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,0,3.97,-, < 0.01,0.0539,1,0,0.07,-, < 0.01,1,1
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,0,3.97,-, < 0.01,0.0539,1,0,0.07,-, < 0.01,1,1
maintenance of DNA repeat elements (GO:0043570),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,0,3.97,-, < 0.01,0.0539,1,0,0.07,-, < 0.01,1,1
pre-replicative complex assembly (GO:0036388),7,1,4.19,-,0.24,0.272,1,1,2.51,-,0.4,0.69,1,0,3.97,-, < 0.01,0.0539,1,0,0.07,-, < 0.01,1,1
regulation of double-strand break repair (GO:2000779),8,1,4.78,-,0.21,0.167,1,0,2.87,-, < 0.01,0.12,1,2,4.53,-,0.44,0.346,1,0,0.08,-, < 0.01,1,1
homologous chromosome pairing at meiosis (GO:0007129),25,3,14.95,-,0.2,0.00274,0.87,3,8.97,-,0.33,0.0829,1,3,14.17,-,0.21,0.00483,0.656,0,0.25,-, < 0.01,1,1
DNA duplex unwinding (GO:0032508),26,3,15.55,-,0.19,0.00173,0.761,3,9.32,-,0.32,0.0565,1,4,14.74,-,0.27,0.00748,0.736,0,0.26,-, < 0.01,1,1
mitotic DNA damage checkpoint (GO:0044773),9,1,5.38,-,0.19,0.102,1,0,3.23,-, < 0.01,0.124,1,1,5.1,-,0.2,0.106,1,0,0.09,-, < 0.01,1,1
telomere maintenance via telomere lengthening (GO:0010833),9,1,5.38,-,0.19,0.102,1,1,3.23,-,0.31,0.472,1,1,5.1,-,0.2,0.106,1,0,0.09,-, < 0.01,1,1
mitotic recombination (GO:0006312),9,1,5.38,-,0.19,0.102,1,2,3.23,-,0.62,0.739,1,1,5.1,-,0.2,0.106,1,0,0.09,-, < 0.01,1,1
DNA geometric change (GO:0032392),28,3,16.74,-,0.18,0.00115,0.73,3,10.04,-,0.3,0.0394,1,4,15.87,-,0.25,0.00492,0.638,0,0.28,-, < 0.01,1,1
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",10,1,5.98,-,0.17,0.0626,1,3,3.59,-,0.84,1,1,1,5.67,-,0.18,0.111,1,0,0.1,-, < 0.01,1,1
endonucleolytic cleavage involved in rRNA processing (GO:0000478),11,1,6.58,-,0.15,0.0387,1,3,3.94,-,0.76,1,1,1,6.24,-,0.16,0.0669,1,0,0.11,-, < 0.01,1,1
DNA unwinding involved in DNA replication (GO:0006268),16,1,9.57,-,0.1,0.00508,1,2,5.74,-,0.35,0.184,1,1,9.07,-,0.11,0.00926,0.714,0,0.16,-, < 0.01,1,1
plasma membrane to endosome transport (GO:0048227),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maintenance of mitotic sister chromatid cohesion (GO:0034088),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
inter-Golgi cisterna vesicle-mediated transport (GO:0048219),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
COPII vesicle coating (GO:0048208),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
endosomal vesicle fusion (GO:0034058),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
protein localization to nuclear inner membrane (GO:0036228),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
purine nucleoside bisphosphate catabolic process (GO:0034034),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
ribonucleoside bisphosphate catabolic process (GO:0034031),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
tail-anchored membrane protein insertion into ER membrane (GO:0071816),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycolate transport (GO:1900866),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
RNA localization to chromatin (GO:1990280),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
acyl carnitine transport (GO:0006844),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
RNA fragment catabolic process (GO:0000292),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of trichoblast fate specification (GO:0010062),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to acetate (GO:0010034),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein ubiquitination (GO:0031397),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
"DNA replication, Okazaki fragment processing (GO:0033567)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
gamma-tubulin complex localization (GO:0033566),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
proanthocyanidin biosynthetic process (GO:0010023),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
far-red light signaling pathway (GO:0010018),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
"fatty acid beta-oxidation, unsaturated, even number (GO:0033542)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycine betaine biosynthetic process from choline (GO:0019285),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
L-methionine biosynthetic process from L-homoserine via cystathionine (GO:0019279),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to insecticide (GO:0017085),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
citrulline biosynthetic process (GO:0019240),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
lactate catabolic process (GO:1903457),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nitric oxide mediated signal transduction (GO:0007263),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
monoacylglycerol catabolic process (GO:0052651),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyruvate biosynthetic process (GO:0042866),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of TORC1 signaling (GO:1903432),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein-phytochromobilin linkage (GO:0017012),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein-phycocyanobilin linkage (GO:0017009),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
flavonoid transport from endoplasmic reticulum to plant-type vacuole (GO:1903415),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein-bilin linkage (GO:0017007),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,2,1.13,+,1.76,0.624,1,0,0.02,-, < 0.01,1,1
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
phenotypic switching (GO:0036166),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of actin filament depolymerization (GO:0030836),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone deubiquitination (GO:0016578),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
polyphosphate biosynthetic process (GO:0006799),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-K9 dimethylation (GO:0036123),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
polyphosphate metabolic process (GO:0006797),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic DNA replication preinitiation complex assembly (GO:1902977),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
heme A biosynthetic process (GO:0006784),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detoxification of arsenic-containing substance (GO:0071722),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
Kdo2-lipid A biosynthetic process (GO:0036104),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
Kdo2-lipid A metabolic process (GO:0036103),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
NADP biosynthetic process (GO:0006741),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
response to ether (GO:0045472),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of potassium ion transport (GO:0043268),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
steroid catabolic process (GO:0006706),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
replication fork processing (GO:0031297),7,0,4.19,-, < 0.01,0.0506,1,0,2.51,-, < 0.01,0.201,1,0,3.97,-, < 0.01,0.0539,1,0,0.07,-, < 0.01,1,1
CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process (GO:0033468),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
CMP-keto-3-deoxy-D-manno-octulosonic acid metabolic process (GO:0033467),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
trans-zeatin biosynthetic process (GO:0033466),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
callus formation (GO:1990110),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tRNA methylthiolation (GO:0035600),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sulfur amino acid transport (GO:0000101),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of antisense RNA transcription (GO:0060195),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of antisense RNA transcription (GO:0060194),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
trans-zeatin metabolic process (GO:0033400),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell cycle switching (GO:0060184),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
snRNA transcription by RNA polymerase III (GO:0042796),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
snRNA transcription by RNA polymerase II (GO:0042795),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
5S class rRNA transcription by RNA polymerase III (GO:0042791),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mRNA transcription by RNA polymerase II (GO:0042789),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
lycopene biosynthetic process (GO:1901177),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
lycopene metabolic process (GO:1901175),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
signal transduction in response to DNA damage (GO:0042770),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cell wall organization or biogenesis (GO:1903340),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
nucleosome mobilization (GO:0042766),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
male meiosis II (GO:0007142),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
male meiosis I (GO:0007141),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of iron-sulfur cluster assembly (GO:1903329),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
meiotic prophase II (GO:0007136),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
protein biotinylation (GO:0009305),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
meiotic prophase I (GO:0007128),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
snRNA transcription (GO:0009301),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
heme O biosynthetic process (GO:0048034),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
heme o metabolic process (GO:0048033),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
N-glycan fucosylation (GO:0036071),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
inositol phosphate-mediated signaling (GO:0048016),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of superoxide anion generation (GO:0032928),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of root hair elongation (GO:1902890),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of transcription by RNA polymerase III (GO:0016480),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
TORC1 signaling (GO:0038202),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ground tissue pattern formation (GO:1990064),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
vacuolar sequestering of sodium ion (GO:0043182),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cell cycle G1/S phase transition (GO:1902807),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
zeatin biosynthetic process (GO:0033398),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
zeatin metabolic process (GO:0033397),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to very low light intensity stimulus (GO:0055122),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
response to high fluence blue light stimulus by blue high-fluence system (GO:0055121),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pericentric heterochromatin organization (GO:0140462),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
argininosuccinate metabolic process (GO:0000053),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
citrulline metabolic process (GO:0000052),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of plant organ orientation (GO:0090707),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
specification of plant organ position (GO:0090706),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"DNA replication, removal of RNA primer (GO:0043137)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell wall mannoprotein biosynthetic process (GO:0000032),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
diadenosine tetraphosphate catabolic process (GO:0015967),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
diadenosine polyphosphate catabolic process (GO:0015961),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
replication fork arrest (GO:0043111),3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
oxidative DNA demethylation (GO:0035511),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ent-kaurene metabolic process (GO:0033331),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of mitotic recombination (GO:0000019),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protein localization to Golgi membrane (GO:1903292),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
coenzyme A catabolic process (GO:0015938),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of DNA duplex unwinding (GO:1905463),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA duplex unwinding (GO:1905462),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of potassium ion import across plasma membrane (GO:1903288),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of potassium ion import (GO:1903286),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
phytol metabolic process (GO:0033306),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitotic G2 DNA damage checkpoint (GO:0007095),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
regulation of autophagosome maturation (GO:1901096),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ribonucleotide catabolic process (GO:0009261),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mitotic metaphase plate congression (GO:0007080),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
fatty-acyl-CoA transport (GO:0015916),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
plasma membrane repair (GO:0001778),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
spindle assembly involved in male meiosis (GO:0007053),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"regulation of vacuole fusion, non-autophagic (GO:0032889)",4,0,2.39,-, < 0.01,0.304,1,1,1.43,-,0.7,1,1,3,2.27,+,1.32,0.709,1,1,0.04,+,24.89,0.0488,1
pyrimidine deoxyribonucleotide catabolic process (GO:0009223),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cell-cell junction assembly (GO:0007043),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of DNA endoreduplication (GO:0032877),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
endodermal cell fate specification (GO:0001714),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
endodermal cell fate commitment (GO:0001711),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of potassium ion transmembrane transporter activity (GO:1901016),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
telomere maintenance via telomerase (GO:0007004),8,0,4.78,-, < 0.01,0.029,1,1,2.87,-,0.35,0.461,1,0,4.53,-, < 0.01,0.0575,1,0,0.08,-, < 0.01,1,1
nucleolus organization (GO:0007000),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular chloride ion homeostasis (GO:0030644),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to bleomycin (GO:1904975),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cytochrome-c oxidase activity (GO:1904960),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ornithine biosynthetic process (GO:0006592),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cytochrome-c oxidase activity (GO:1904959),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial large ribosomal subunit assembly (GO:1902775),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of telomerase activity (GO:0051974),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of telomerase activity (GO:0051973),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of telomerase activity (GO:0051972),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
tRNA re-export from nucleus (GO:0071528),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
vesicle transport along microtubule (GO:0047496),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
amino-acid betaine biosynthetic process (GO:0006578),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
amino-acid betaine metabolic process (GO:0006577),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
meiotic chromosome movement towards spindle pole (GO:0016344),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
methotrexate transport (GO:0051958),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
miRNA export from nucleus (GO:0061716),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
reversible differentiation (GO:0090677),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
L-glutamate import (GO:0051938),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
anastral spindle assembly (GO:0055048),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
generative cell mitosis (GO:0055047),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
telomeric loop disassembly (GO:0090657),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
malonyl-CoA catabolic process (GO:2001294),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
plant epidermal cell fate specification (GO:0090628),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
mitochondrial mRNA 5'-end processing (GO:0090617),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dolichyl monophosphate biosynthetic process (GO:0043048),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial mRNA 3'-end processing (GO:0090616),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial mRNA processing (GO:0090615),5,0,2.99,-, < 0.01,0.165,1,1,1.79,-,0.56,1,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
bundle sheath cell fate specification (GO:0090610),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
borate transmembrane transport (GO:0035445),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),4,0,2.39,-, < 0.01,0.304,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",4,0,2.39,-, < 0.01,0.304,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
heme transport (GO:0015886),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
folic acid transport (GO:0015884),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
copper ion transmembrane transport (GO:0035434),3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of cation channel activity (GO:2001257),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of histone deacetylation (GO:0031063),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of histone methylation (GO:0031061),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of protein sumoylation (GO:0033234),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of protein sumoylation (GO:0033233),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
carbohydrate export (GO:0033231),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of apoptotic signaling pathway (GO:2001234),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
maintenance of rDNA (GO:0043007),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of apoptotic signaling pathway (GO:2001233),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-T11 phosphorylation (GO:0035407),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone-threonine phosphorylation (GO:0035405),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone-serine phosphorylation (GO:0035404),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
methylammonium transport (GO:0015843),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
amine transport (GO:0015837),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation by host of viral process (GO:0044794),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cytosol to endoplasmic reticulum transport (GO:0046967),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
proline transport (GO:0015824),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
modulation by host of viral process (GO:0044788),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fatty alcohol biosynthetic process (GO:1903175),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fatty alcohol metabolic process (GO:1903173),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
tRNA 3'-terminal CCA addition (GO:0001680),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic DNA integrity checkpoint (GO:0044778),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
L-cystine transport (GO:0015811),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
purine ribonucleotide catabolic process (GO:0009154),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
purine deoxyribonucleotide biosynthetic process (GO:0009153),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fatty-acyl-CoA biosynthetic process (GO:0046949),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyrimidine nucleoside triphosphate catabolic process (GO:0009149),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H3-R26 methylation (GO:0034972),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
histone H3-R17 methylation (GO:0034971),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
histone H3-R2 methylation (GO:0034970),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of double-strand break repair (GO:2000781),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of double-strand break repair (GO:2000780),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
symbiont intracellular protein transport in host (GO:0030581),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of peptidyl-lysine acetylation (GO:2000758),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
cellular response to acidic pH (GO:0071468),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to pH (GO:0071467),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ubiquitin recycling (GO:0010992),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mitochondrial ribosome assembly (GO:0061668),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transport along microtubule (GO:0010970),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of microtubule nucleation (GO:0010968),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
dolichyl diphosphate biosynthetic process (GO:0006489),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
N-terminal protein amino acid methylation (GO:0006480),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of glucose mediated signaling pathway (GO:1902661),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of glucose mediated signaling pathway (GO:1902659),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
negative regulation of macroautophagy (GO:0016242),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of macroautophagy (GO:0016241),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
modulation by host of symbiont process (GO:0051851),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of phosphatase activity (GO:0010922),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
pri-miRNA transcription by RNA polymerase II (GO:0061614),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
(R)-2-hydroxy-alpha-linolenic acid biosynthetic process (GO:1902609),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of oxidative stress (GO:0070994),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to carbon starvation (GO:0090549),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to low humidity (GO:0090547),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
snRNA export from nucleus (GO:0006408),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
RNA import into nucleus (GO:0006404),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
vesicle tethering involved in exocytosis (GO:0090522),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
NAD transmembrane transport (GO:0035352),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
azole transmembrane transport (GO:0045117),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
3'-UTR-mediated mRNA stabilization (GO:0070935),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3 deacetylation (GO:0070932),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
fructose transmembrane transport (GO:0015755),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of dephosphorylation (GO:0035306),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
UV-damage excision repair (GO:0070914),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of hormone biosynthetic process (GO:0046886),3,0,1.79,-, < 0.01,0.297,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
citrate transport (GO:0015746),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of CENP-A containing nucleosome assembly (GO:1903099),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of CENP-A containing nucleosome assembly (GO:1903097),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial double-strand break repair via homologous recombination (GO:0097552),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial double-strand break repair (GO:0097551),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycolipid transport (GO:0046836),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of RNA export from nucleus (GO:0046833),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cell growth by extracellular stimulus (GO:0001560),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of RNA export from nucleus (GO:0046831),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of protein export from nucleus (GO:0046827),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of nucleocytoplasmic transport (GO:0046824),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
histone H3-K4 dimethylation (GO:0044648),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"base-excision repair, AP site formation via deaminated base removal (GO:0097510)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of phragmoplast microtubule organization (GO:2000694),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cellular response to X-ray (GO:2000685),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cellular response to X-ray (GO:2000683),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
arginine biosynthetic process via ornithine (GO:0042450),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
positive regulation of protein deubiquitination (GO:1903003),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of genetic imprinting (GO:2000653),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of miRNA metabolic process (GO:2000630),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of triglyceride catabolic process (GO:0010896),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of miRNA metabolic process (GO:2000628),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of lipid storage (GO:0010888),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of lipid storage (GO:0010883),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of histone H3-K9 acetylation (GO:2000617),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of histone H3-K9 acetylation (GO:2000616),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of histone H3-K9 acetylation (GO:2000615),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of secondary growth (GO:2000604),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of secondary growth (GO:2000603),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of triglyceride biosynthetic process (GO:0010867),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nicotianamine biosynthetic process (GO:0030418),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
nicotianamine metabolic process (GO:0030417),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of flavonol biosynthetic process (GO:1900384),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of electron transfer activity (GO:1904734),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of electron transfer activity (GO:1904732),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to acetate (GO:0071311),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of catalase activity (GO:1902553),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of catalase activity (GO:1902551),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transcription elongation from RNA polymerase I promoter (GO:0006362),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transcription initiation from RNA polymerase I promoter (GO:0006361),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
positive regulation of DNA N-glycosylase activity (GO:1902546),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA N-glycosylase activity (GO:1902544),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of RNA interference (GO:1900369),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of transcription by RNA polymerase III (GO:0006359),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sterol catabolic process (GO:0016127),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of mitochondrion organization (GO:0010822),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
chromatin silencing at telomere (GO:0006348),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transcytosis (GO:0045056),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
homing of group II introns (GO:0006315),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
intron homing (GO:0006314),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
interaction with symbiont (GO:0051702),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein insertion into ER membrane (GO:0045048),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
protein import into peroxisome membrane (GO:0045046),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein O-linked mannosylation (GO:0035269),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein mannosylation (GO:0035268),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
perianth development (GO:0090428),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
early endosome to late endosome transport (GO:0045022),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
aluminum cation transport (GO:0015690),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
peptidyl-arginine omega-N-methylation (GO:0035247),3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
peptidyl-arginine N-methylation (GO:0035246),3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
protein maturation by copper ion transfer (GO:0015680),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),14,0,8.37,-, < 0.01,0.0017,0.81,1,5.02,-,0.2,0.138,1,1,7.94,-,0.13,0.0151,1,0,0.14,-, < 0.01,1,1
DNA replication proofreading (GO:0045004),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
double-strand break repair via single-strand annealing (GO:0045002),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of response to DNA damage stimulus (GO:2001021),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of double-strand break repair via homologous recombination (GO:1905168),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
acquisition of desiccation tolerance (GO:0097439),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"transport of virus in host, tissue to tissue (GO:0046741)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
fucose biosynthetic process (GO:0042353),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
GDP-L-fucose salvage (GO:0042352),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
membrane disassembly (GO:0030397),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of DNA biosynthetic process (GO:2000573),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to aluminum ion (GO:0071275),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
'de novo' L-methionine biosynthetic process (GO:0071266),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ubiquitin protein ligase activity (GO:1904667),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
cellular response to ammonium ion (GO:0071242),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic mismatch repair involved in reciprocal meiotic recombination (GO:0010777),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
ATP generation from poly-ADP-D-ribose (GO:1990966),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
"base-excision repair, gap-filling (GO:0006287)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
cellular response to lipopolysaccharide (GO:0071222),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
premeiotic DNA replication (GO:0006279),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
RNA-dependent DNA biosynthetic process (GO:0006278),8,0,4.78,-, < 0.01,0.029,1,1,2.87,-,0.35,0.461,1,0,4.53,-, < 0.01,0.0575,1,0,0.08,-, < 0.01,1,1
cholesterol transport (GO:0030301),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
leading strand elongation (GO:0006272),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
membrane raft localization (GO:0051665),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sepal giant cell differentiation (GO:0090392),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
tRNA import into mitochondrion (GO:0016031),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pyrimidine nucleotide catabolic process (GO:0006244),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of tryptophan metabolic process (GO:0090358),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of tryptophan metabolic process (GO:0090357),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of auxin metabolic process (GO:0090355),4,0,2.39,-, < 0.01,0.304,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
dUMP biosynthetic process (GO:0006226),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cytidine catabolic process (GO:0006216),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of protein deacetylation (GO:0090311),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
spindle assembly involved in meiosis (GO:0090306),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
positive regulation of protein acetylation (GO:1901985),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
negative regulation of gene silencing by RNA (GO:0060967),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
regulation of inward rectifier potassium channel activity (GO:1901979),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cell cycle checkpoint (GO:1901976),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of DNA-5-methylcytosine glycosylase activity (GO:1901972),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA-5-methylcytosine glycosylase activity (GO:1901971),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
positive regulation of polynucleotide 3'-phosphatase activity (GO:1901969),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of polynucleotide 3'-phosphatase activity (GO:1901968),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to DDT (GO:0046680),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of exoribonuclease activity (GO:1901918),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of exoribonuclease activity (GO:1901917),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycolate transmembrane transport (GO:0097339),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
detection of lipopolysaccharide (GO:0032497),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to lipopolysaccharide (GO:0032496),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of organ growth (GO:0046622),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
amino acid import across plasma membrane (GO:0089718),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of Rab protein signal transduction (GO:0032483),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
tissue regeneration (GO:0042246),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of peroxidase activity (GO:2000470),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cytokinesis (GO:0032467),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cytokinesis (GO:0032465),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of intracellular mRNA localization (GO:1904580),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of extent of cell growth (GO:0061387),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cell cycle arrest (GO:0071158),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of embryonic development (GO:0040019),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of cell cycle arrest (GO:0071156),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of multicellular organism growth (GO:0040014),3,0,1.79,-, < 0.01,0.297,1,1,1.08,-,0.93,1,1,2,1.7,+,1.18,1,1,1,0.03,+,33.18,0.0392,1
meiotic recombination checkpoint (GO:0051598),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3-S28 phosphorylation (GO:0043988),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3-S10 phosphorylation (GO:0043987),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H4-K16 acetylation (GO:0043984),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
histone H4-K12 acetylation (GO:0043983),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H4-K8 acetylation (GO:0043982),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
nucleic acid-protein covalent cross-linking (GO:0018143),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein-DNA covalent cross-linking (GO:0018142),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
generative cell differentiation (GO:0022619),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of histone H3-K9 methylation (GO:0051573),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of histone H3-K4 methylation (GO:0051572),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of clathrin-dependent endocytosis (GO:1900186),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
guanine salvage (GO:0006178),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dATP biosynthetic process from ADP (GO:0006176),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dATP biosynthetic process (GO:0006175),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
heparan sulfate proteoglycan metabolic process (GO:0030201),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of mitochondrial calcium ion concentration (GO:0051562),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sulfate transmembrane transport (GO:1902358),3,0,1.79,-, < 0.01,0.297,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to strigolactone (GO:1902348),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
fructose export from vacuole to cytoplasm (GO:1902334),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
circadian regulation of calcium ion oscillation (GO:0010617),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of 1-aminocyclopropane-1-carboxylate metabolic process (GO:0010602),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of auxin biosynthetic process (GO:0010601),3,0,1.79,-, < 0.01,0.297,1,2,1.08,+,1.86,0.613,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
negative regulation of histone H4 acetylation (GO:0090241),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of glycolytic process (GO:0006110),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of spindle checkpoint (GO:0090231),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of centromere complex assembly (GO:0090230),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of histone acetylation (GO:0035066),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
regulation of chromatin silencing at telomere (GO:0031938),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of chromatin silencing (GO:0031937),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nonfunctional rRNA decay (GO:0070651),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of triglyceride metabolic process (GO:0090208),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
self proteolysis (GO:0097264),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
piRNA metabolic process (GO:0034587),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial mRNA polyadenylation (GO:0097222),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
acquisition of desiccation tolerance in seed (GO:0048700),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of reactive oxygen species metabolic process (GO:2000378),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
strand invasion (GO:0042148),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
intracellular cholesterol transport (GO:0032367),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of clathrin-dependent endocytosis (GO:2000369),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
meiotic DNA double-strand break formation (GO:0042138),6,0,3.59,-, < 0.01,0.0903,1,0,2.15,-, < 0.01,0.351,1,0,3.4,-, < 0.01,0.0935,1,0,0.06,-, < 0.01,1,1
positive regulation of hormone metabolic process (GO:0032352),4,0,2.39,-, < 0.01,0.304,1,2,1.43,+,1.39,0.658,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
proteoglycan biosynthetic process (GO:0030166),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
molybdopterin cofactor biosynthetic process (GO:0032324),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell cycle DNA replication maintenance of fidelity (GO:1902298),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of ceramide biosynthetic process (GO:2000303),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of cytosolic calcium ion concentration (GO:0051480),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
regulation of double-strand break repair via homologous recombination (GO:0010569),6,0,3.59,-, < 0.01,0.0903,1,0,2.15,-, < 0.01,0.351,1,2,3.4,-,0.59,0.719,1,0,0.06,-, < 0.01,1,1
vesicle-mediated transport between endosomal compartments (GO:0098927),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
abscisic acid homeostasis (GO:1902265),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of t-circle formation (GO:1904430),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tRNA dihydrouridine synthesis (GO:0002943),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
maintenance of protein location in nucleus (GO:0051457),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of t-circle formation (GO:1904429),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to magnetism (GO:0071000),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of peroxisome organization (GO:1900064),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of peroxisome organization (GO:1900063),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
hexitol metabolic process (GO:0006059),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mannoprotein biosynthetic process (GO:0006057),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ceramide biosynthetic process (GO:1900060),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
mannoprotein metabolic process (GO:0006056),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of ubiquitin-protein transferase activity (GO:0051444),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of sulfate assimilation (GO:1900058),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of histone exchange (GO:1900051),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of histone exchange (GO:1900049),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
"DNA catabolic process, endonucleolytic (GO:0000737)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
removal of nonhomologous ends (GO:0000735),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cellular response to hypoxia (GO:1900038),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
RNA secondary structure unwinding (GO:0010501),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
cellular sphingolipid homeostasis (GO:0090156),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
DNA double-strand break processing (GO:0000729),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
negative regulation of sphingolipid biosynthetic process (GO:0090155),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of pectin biosynthetic process (GO:1900030),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of sphingolipid biosynthetic process (GO:0090153),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
microtubule nucleation by microtubule organizing center (GO:0051418),5,0,2.99,-, < 0.01,0.165,1,0,1.79,-, < 0.01,0.335,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
microtubule nucleation by interphase microtubule organizing center (GO:0051415),5,0,2.99,-, < 0.01,0.165,1,0,1.79,-, < 0.01,0.335,1,0,2.83,-, < 0.01,0.167,1,0,0.05,-, < 0.01,1,1
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
membrane fission (GO:0090148),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cell fate specification (GO:0009996),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
protection from non-homologous end joining at telomere (GO:0031848),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
glucose catabolic process (GO:0006007),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic DNA double-strand break processing (GO:0000706),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,0,1.7,-, < 0.01,0.558,1,0,0.03,-, < 0.01,1,1
cellular response to benomyl (GO:0072755),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell fate commitment involved in formation of primary germ layer (GO:0060795),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cytidine deamination (GO:0009972),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
anastral spindle assembly involved in male meiosis (GO:0009971),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
auxin mediated signaling pathway involved in phyllotactic patterning (GO:0060774),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to cisplatin (GO:0072718),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
histone H2A K63-linked deubiquitination (GO:0070537),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to hydroxyurea (GO:0072710),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of heterochromatin organization (GO:0120263),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
circadian regulation of translation (GO:0097167),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dynamin family protein polymerization involved in membrane fission (GO:0003373),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dolichyl diphosphate metabolic process (GO:0046465),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
monoacylglycerol metabolic process (GO:0046462),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
RNA polymerase I preinitiation complex assembly (GO:0001188),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of ribonuclease activity (GO:0060701),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of ribonuclease activity (GO:0060700),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
early endosome to Golgi transport (GO:0034498),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
D-cysteine metabolic process (GO:0046438),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
D-amino acid biosynthetic process (GO:0046437),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
U6 snRNA 3'-end processing (GO:0034477),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
wound healing (GO:0042060),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
urate metabolic process (GO:0046415),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of cellular amino acid biosynthetic process (GO:2000283),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
GMP salvage (GO:0032263),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein-DNA complex remodeling (GO:0001120),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sterol esterification (GO:0034434),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
steroid esterification (GO:0034433),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
transcription open complex formation at RNA polymerase II promoter (GO:0001113),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA-templated transcription open complex formation (GO:0001112),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of nucleobase-containing compound transport (GO:0032241),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of nucleobase-containing compound transport (GO:0032239),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of rRNA processing (GO:2000234),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of telomere maintenance via telomerase (GO:0032212),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of proline metabolic process (GO:2000215),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of sclerenchyma cell differentiation (GO:1904369),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of sclerenchyma cell differentiation (GO:1904368),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to sulfur dioxide (GO:0010477),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of telomere maintenance (GO:0032206),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
kinetochore organization (GO:0051383),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
kinetochore assembly (GO:0051382),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
positive regulation of mitotic recombination (GO:0045951),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of cell fate commitment (GO:0010454),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
inflorescence meristem growth (GO:0010450),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of ligase activity (GO:0051351),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
bract formation (GO:0010434),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
bract morphogenesis (GO:0010433),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
bract development (GO:0010432),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of protein deubiquitination (GO:0090085),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of ligase activity (GO:0051340),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3-K9 deacetylation (GO:1990619),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
meiotic G2 phase (GO:0051331),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitochondrial DNA inheritance (GO:0033955),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of microtubule nucleation (GO:0090063),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
meiotic interphase (GO:0051328),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of organelle assembly (GO:1902117),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
extensin metabolic process (GO:0010409),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
classical arabinogalactan protein metabolic process (GO:0010406),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pectic galactan metabolic process (GO:0010401),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
rhamnogalacturonan I side chain metabolic process (GO:0010400),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
root radial pattern formation (GO:0090057),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
metaphase plate congression (GO:0051310),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
chromosome movement towards spindle pole (GO:0051305),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)",2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of plant epidermal cell differentiation (GO:1903889),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
palisade mesophyll development (GO:1903866),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
auxin catabolic process (GO:0009852),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
urate catabolic process (GO:0019628),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
iron coordination entity transport (GO:1901678),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
D-galacturonate metabolic process (GO:0046396),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of anatomical structure orientation (GO:0048560),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cellular response to peptide (GO:1901653),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of floral organ orientation (GO:0048559),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of cellular protein localization (GO:1903828),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
L-arabinose metabolic process (GO:0046373),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of chromosome condensation (GO:0060623),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
galactose biosynthetic process (GO:0046369),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to copper ion starvation (GO:0120126),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
protein localization to cell surface (GO:0034394),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of viral process (GO:0048524),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
diacylglycerol catabolic process (GO:0046340),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of synapse structure or activity (GO:0050803),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"transposition, RNA-mediated (GO:0032197)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
transposition (GO:0032196),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
eukaryotic translation initiation factor 4F complex assembly (GO:0097010),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
protein-containing complex remodeling (GO:0034367),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
energy homeostasis (GO:0097009),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell junction assembly (GO:0034329),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiosis II cell cycle phase (GO:0098765),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiosis I cell cycle phase (GO:0098764),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic cell cycle phase (GO:0098762),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of transcription by RNA polymerase V (GO:1904281),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of histone H3-K27 methylation (GO:0061086),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of transcription by RNA polymerase V (GO:1904279),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of sister chromatid cohesion (GO:0045876),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
meiotic centromere clustering (GO:1990571),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell dedifferentiation (GO:0043697),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dedifferentiation (GO:0043696),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of TORC1 signaling (GO:1904263),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
guard cell fate commitment (GO:0010377),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
positive regulation of DNA-dependent DNA replication (GO:2000105),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,1,0.57,+,1.76,1,1,1,0.01,+,99.54,0.0198,1
L-glutamate import across plasma membrane (GO:0098712),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to non-ionic osmotic stress (GO:0010335),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nucleoside bisphosphate catabolic process (GO:0033869),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
snRNA import into nucleus (GO:0061015),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
mitotic DNA replication maintenance of fidelity (GO:1990505),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of endocytosis (GO:0045806),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3-K4 trimethylation (GO:0080182),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mannitol metabolic process (GO:0019594),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mannitol biosynthetic process (GO:0019593),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
lipopolysaccharide-mediated signaling pathway (GO:0031663),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of toxin transport (GO:1902009),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of toxin transport (GO:1902007),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of carbohydrate utilization (GO:0043610),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
negative regulation of proline biosynthetic process (GO:1902006),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of proline biosynthetic process (GO:1902005),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of nitric oxide metabolic process (GO:0080164),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sucrose induced translational repression (GO:0080149),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
receptor internalization (GO:0031623),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of lipid localization (GO:1905953),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
establishment of petal orientation (GO:0048498),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"negative regulation of DNA-templated transcription, termination (GO:0060567)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
seed growth (GO:0080112),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of cell fate determination (GO:1905933),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
trivalent inorganic cation transport (GO:0072512),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
replication fork protection (GO:0048478),5,0,2.99,-, < 0.01,0.165,1,0,1.79,-, < 0.01,0.335,1,1,2.83,-,0.35,0.428,1,0,0.05,-, < 0.01,1,1
response to benomyl (GO:1901561),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
flower calyx development (GO:0048464),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
flower structural organization (GO:0048461),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
floral whorl morphogenesis (GO:0048457),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sepal formation (GO:0048453),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sepal morphogenesis (GO:0048447),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
sepal development (GO:0048442),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
flower morphogenesis (GO:0048439),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,1,2.27,-,0.44,0.66,1,0,0.04,-, < 0.01,1,1
positive regulation of production of siRNA involved in RNA interference (GO:1903705),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
microtubule-based transport (GO:0099111),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to maltose (GO:0034286),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of nuclease activity (GO:0032074),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cyanide biosynthetic process (GO:0046202),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
snoRNA splicing (GO:0034247),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of nuclease activity (GO:0032069),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of translation in response to stress (GO:0032055),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cardiolipin biosynthetic process (GO:0032049),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
cardiolipin metabolic process (GO:0032048),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mitochondrial DNA metabolic process (GO:0032042),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of double-strand break repair via homologous recombination (GO:2000042),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of chromatin assembly or disassembly (GO:0045799),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of pyruvate dehydrogenase activity (GO:1904183),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of pyruvate dehydrogenase activity (GO:1904182),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
glycolipid translocation (GO:0034203),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of immune effector process (GO:0002698),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
negative regulation of protein localization to cell surface (GO:2000009),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
regulation of protein localization to cell surface (GO:2000008),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
megasporocyte differentiation (GO:1904159),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA damage checkpoint (GO:2000001),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular stress response to acidic pH (GO:1990451),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
nectary development (GO:0010254),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
ent-kaurene oxidation to kaurenoic acid (GO:0010241),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
negative regulation of DNA repair (GO:0045738),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
anther wall tapetum cell fate specification (GO:0010234),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
miRNA transport (GO:1990428),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
mitotic recombination-dependent replication fork processing (GO:1990426),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
snoRNA guided rRNA pseudouridine synthesis (GO:0000454),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to lithium ion (GO:0010226),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
non-photoreactive DNA repair (GO:0010213),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
G2 DNA damage checkpoint (GO:0031572),4,0,2.39,-, < 0.01,0.304,1,0,1.43,-, < 0.01,0.579,1,0,2.27,-, < 0.01,0.304,1,0,0.04,-, < 0.01,1,1
RNA import into mitochondrion (GO:0035927),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to very low fluence red light stimulus (GO:0010203),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to low fluence red light stimulus (GO:0010202),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"regulation of DNA-templated transcription, termination (GO:0031554)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of anthocyanin biosynthetic process (GO:0031542),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
sepal vascular tissue pattern formation (GO:0080057),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
petal vascular tissue pattern formation (GO:0080056),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
plus-end directed microtubule sliding (GO:0031535),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"9,9'-di-cis-zeta-carotene desaturation to 7,9,7',9'-tetra-cis-lycopene (GO:0052889)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"host response to induction by symbiont of tumor, nodule or growth in host (GO:0080034)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
D-cysteine catabolic process (GO:0019447),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
response to benzoic acid (GO:0080021),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
pericentric heterochromatin assembly (GO:0031508),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cell wall glycoprotein biosynthetic process (GO:0031506),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
DNA integration (GO:0015074),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
allantoin biosynthetic process (GO:0019428),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of defense response to virus (GO:0050687),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
internode patterning (GO:0080006),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
hexitol biosynthetic process (GO:0019406),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
heme a metabolic process (GO:0046160),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
NAD-cap decapping (GO:0110155),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
vesicle tethering (GO:0099022),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
heparan sulfate proteoglycan biosynthetic process (GO:0015012),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
triglyceride transport (GO:0034197),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
embryo sac morphogenesis (GO:0048314),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
inosine biosynthetic process (GO:0046103),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
hypoxanthine metabolic process (GO:0046100),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
replication fork reversal (GO:0071932),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
response to lipid hydroperoxide (GO:0006982),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
"2,4-dichlorophenoxyacetic acid metabolic process (GO:0018901)",1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of helicase activity (GO:0051097),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of cation transmembrane transport (GO:1904064),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
mRNA 3'-splice site recognition (GO:0000389),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of carbohydrate catabolic process (GO:0043470),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cellular response to copper ion starvation (GO:0035874),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
response to chlorate (GO:0010157),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
chloroplast elongation (GO:0010151),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
tRNA-type intron splice site recognition and cleavage (GO:0000379),1,0,0.6,-, < 0.01,1,1,1,0.36,+,2.79,0.458,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
Group III intron splicing (GO:0000374),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
cis assembly of pre-catalytic spliceosome (GO:0000354),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
generation of catalytic spliceosome for second transesterification step (GO:0000350),2,0,1.2,-, < 0.01,0.532,1,1,0.72,+,1.39,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
snRNA transport (GO:0051030),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
chiasma assembly (GO:0051026),12,0,7.18,-, < 0.01,0.00515,1,1,4.3,-,0.23,0.206,1,1,6.8,-,0.15,0.0403,1,0,0.12,-, < 0.01,1,1
organelle transport along microtubule (GO:0072384),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
urea catabolic process (GO:0043419),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
microtubule sliding (GO:0051012),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
glycine betaine biosynthetic process (GO:0031456),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
glycine betaine metabolic process (GO:0031455),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
positive regulation of heterochromatin assembly (GO:0031453),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of exonuclease activity (GO:1905778),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of exonuclease activity (GO:1905777),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of DNA helicase activity (GO:1905775),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
regulation of DNA helicase activity (GO:1905774),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
histone H3-T3 phosphorylation (GO:0072355),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
D-serine biosynthetic process (GO:0070179),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
tricarboxylic acid biosynthetic process (GO:0072351),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
D-serine metabolic process (GO:0070178),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
embryo sac egg cell differentiation (GO:0009560),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
antipodal cell differentiation (GO:0009557),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
positive regulation of potassium ion transmembrane transport (GO:1901381),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of potassium ion transmembrane transport (GO:1901379),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,1,1.13,-,0.88,1,1,0,0.02,-, < 0.01,1,1
guanine biosynthetic process (GO:0046099),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
guanine metabolic process (GO:0046098),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
biotin carboxyl carrier protein biosynthetic process (GO:0042966),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
nucleologenesis (GO:0017126),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of receptor-mediated endocytosis (GO:0048261),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
cytidine metabolic process (GO:0046087),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
plasma membrane phospholipid scrambling (GO:0017121),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
response to rapamycin (GO:1901355),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dUTP catabolic process (GO:0046081),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
dUTP metabolic process (GO:0046080),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
regulation of receptor-mediated endocytosis (GO:0048259),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
snoRNA localization (GO:0048254),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dUMP metabolic process (GO:0046078),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
positive regulation of secondary cell wall biogenesis (GO:1901348),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,2,1.7,+,1.18,1,1,0,0.03,-, < 0.01,1,1
DNA rewinding (GO:0036292),3,0,1.79,-, < 0.01,0.297,1,0,1.08,-, < 0.01,0.571,1,1,1.7,-,0.59,1,1,0,0.03,-, < 0.01,1,1
thioester transport (GO:1901337),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
negative regulation of lateral root development (GO:1901332),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
dATP metabolic process (GO:0046060),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
metabolite repair (GO:0110051),2,0,1.2,-, < 0.01,0.532,1,0,0.72,-, < 0.01,1,1,0,1.13,-, < 0.01,0.538,1,0,0.02,-, < 0.01,1,1
regulation of mitotic spindle checkpoint (GO:1903504),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,0.57,-, < 0.01,1,1,0,0.01,-, < 0.01,1,1
thiamine pyrophosphate transmembrane transport (GO:0030974),1,0,0.6,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,0.57,+,1.76,1,1,0,0.01,-, < 0.01,1,1
